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Molecular bacteriology for Helicobacter pylori
P724 cagA, vacA and babA2 genotypes of Helicobacter
pylori strains from patients with gastritis or peptic ulcer in Spain
J.A. Garcı´a-Campos, D. Domingo, T. Alarco´n, E. Aznar,
J. Dı´az-Regan˜o´n, M. Lo´pez-Brea
Madrid, E
Objectives: In this study we wanted to examine the prevalence of
cagA, vacA and babA2 status in Helicobacter pylori (Hp) isolates
from patients with gastritis or peptic ulcer; to compare them and
to know if there were any relationships between those virulence
factors in each group.
Methods: Gastric biopsy specimens from 44 Hp positive patients
with peptic ulcer (25 cases) and gastritis (19 cases) were studied.
DNA was extracted and PCR performed to detect cagA, vacA s1/
s2 alleles and babA2 gene.
Results: Gastritis: In 74% of strains, the expected cagA fragment
was ampliﬁed by PCR; 68% carried the s1-allele and 32% the s2-
allele; babA2 gene was detected in 37% of strains. Peptic ulcer:
84% of strains were cagA+; 72% were vacA s1-allele and 28%
were vacA s2-allele; babA2 gene was detected in 36% of strains.
No signiﬁcant differences in the prevalence of cagA, vacA or
babA2 were found in both groups. Neither of them showed rela-
tionship between the presence of babA2 gene and cagA gene or
vacA s1/s2-alleles.
Conclusions: Although the risk of developing more serious gastric
lesions increased as the number of virulence factor genes are
accumulated in a given Hp strain, we did not ﬁnd any signiﬁcant
differences or relationship in the cagA, vacA or babA2 status
between the Hp isolates from patients with gastritis or peptic
ulcer in this study. A low percentage of babA2 gene was found in
both groups.
P725 FISH detection of clarithromycin-resistant
Helicobacter pylori cells in clinical and wastewater samples
P. Piqueres, Y. Moreno, A. Jimenez, J. Herna´ndez, M. Ferru´s
Valencia, E
Introduction: The presence of viable but non-cultivable Helicobacter
pylori cells in environmental samples may underestimate the
importance of this way for its transmission. The determination of
resistance to antibiotics in these strains is important to a better
understanding of the epidemiology of the infection.
Objectives: We have evaluated the use of a ﬂuorescent in situ
hybridisation (FISH) assay directly from biopsies and wastewater
to detect H. pylori and simultaneously its macrolide resistance
genotype.
Methods: A total of 26 gastric biopsies samples from ulcer-
patients were homogenised in 2 mL of selective broth, and a
500 lL aliquot was used for FISH detection. Twenty-nine waste-
water samples collected from different treatment plants were cen-
trifuged and subsequently ﬁxed with 4% paraformaldehyde
solution for 4 h at 4C and then washed with 1% PBS buffer.
HPY probe, a 16S rRNA targeted FITC-labelled oligonucleotide
sequence was used for the detection of all H. pylori strains. In
addition to CLA1–3, a set of three CY3-labelled probes was used
for the detection of 23S rRNA mutations associated with resist-
ance to clarithromycin. Hybridisation was performed with 35%
formamide at 46C for 2 h.
Results: FISH allowed the detection of H. pylori in 20 out of 26
clinical samples and 12 samples were positive in wastewater. The
35% of the positive biopsies showed the presence of clarithromy-
cin resistant strains and 16.6% of the positive wastewater samples
yielded resistance genotype to this macrolide. By using a double
ﬁlter set we could observe directly the clarithromicyn resistant
H. pylori organisms in the samples and its morphology in the
different types of environments. The predominant cells’ morphol-
ogy in both clinical and wastewater samples was of helicoidal
form.
Conclusions: The FISH is a speciﬁc and rapid culture-independent
method to determine directly the presence of clarithromycin-
resistant H. pylori cells in clinical and environmental samples.
Results showed the presence of macrolide resistant cells in water
and, therefore, water must be considered a potential route of
H. pylori transmission.
Acknowledgement: This work was supported by Ministerio Espan˜ol
de Ciencia y Tecnologı´a, Project AGL2002-04480-C03-03.
P726 Effect of the therapy of patients with Helicobacter
pylori related gastritis is correlated with organisation of CAG
pathogenicity island
V. Simanenkov, D. Bovaeva, O. Solovjova, A. Suvorov
St Petersburg, RUS
Objectives: Helicobacter pylori is a leading cause of various gastro-
intestinal diseases such as atrophic gastritis and gastroduodenal
ulcer. The cagA gene product CagA is directly injected into the
bacteria-attached host cells and deregulates intracellular signalling
pathways and thereby initiates pathogenesis. cagA gene is located
on pathoginicty island but the function of other genes on the
island is unknown. The goal of the work was to evaluate the
impact of cag island genotype on the outcome of the therapy.
Materials and methods: Three groups of 25 patients each with total
number of 75 patients were investigated. First group was taking a
typical antibiotic therapy (amoxicillin, claritromycin, rabeprasol),
patients in the second group were treated with the same antibiot-
ics together with probiotic Laminolact (E. faecium strain L-3 in the
form of bon-bons together with pectin, soy bean amino acids and
sea weed), and the third group was taking only Laminolact with-
out any antibiotic. The genotype was determined by PCR with
DNA primers against three H. pylori genes ureB, cagA and cagH.
cagH was used as a marker cag island integrity and ureB was a
marker of H. pylori presence.
Results: Five different genotypes were determined:
ureB+,cagAcagH, ure+,cagAcagH+, ureB+,cagA+cagH+,
ureB+,cagAcagH+ and ureB+,cagA+cagH. Treatment with
antibiotics alone was leading to 68% of eradication. The best
eradication percentage (84%) took place in the second group
where classical antibiotic treatment was taken together with
probiotics. Interestingly, probiotic treatment alone was giving
48% of eradication. Results of the therapy were highly consis-
tent with cag genotype. Patients were found to be statistically
less susceptible (P < 0.05) to the therapy in case when the
entire cag regulon was present regardless of the therapy used.
This fact suggests immunosuppressant function of CagA or
other proteins encoded by the genes on cag pathogenicity
island.
Conclusion: The effect of H. pylori eradication depends on cag
pathogenicity island genotype. Probiotics including E. faecium L-3
might signiﬁcantly improve the anti-H. pylori treatment.
P727 AP-PCR genotyping of clinical isolates of
Pseudomonas aeruginosa
D.H. Binnet, G. Uraz, E. Senol, N. Akar
Ankara, TR
Objectives: Arbitrarily Primed Polymerase Chain Reaction (AP-
PCR) has been used for the epidemiological evolution clinical iso-
lates of P. aeruginosa. This method is recommended for ﬁrst-pass
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screening of P. aeruginosa isolates. This study was done to deter-
mine if the P. aeruginosa strains isolated from the cultures of
patients hospitalised in the Infectious Diseases Unit were from an
individual strain. This technique was preferred because it is cheap
and provides a rapid detection opportunity.
Methods: 45 samples obtained from the clinical specimens of the
patients and from the hands of the staff of the Infectious Dis-
eases Unit were cultured. Of the 45 samples, 15 were isolated
from blood, six from sputum, 10 from drainage and 14 from the
hands of the medical staff. P. aeruginosa identiﬁcation was made
by API 20NE system. DNA was extracted from the culture
material by phenol–chloroform extraction method. AP-PCR was
performed by using the primer 5¢-GTT GCG ATCC-3¢, and sub-
jected 8% PAGE. Band patterns were visualised by silver stain-
ing.
Results: In none of the isolates of the hospital staff P. aeruginosa
was cultured. Out of the 31 clinical samples of the patients, 15 dif-
ferent genotypes were determined.
Conclusions: The P. aeruginosa strains of the patients were individ-
ual strains, neither related to the staff of the department nor to a
speciﬁc patient.
P728 Pseudomonas aeruginosa – microarray for rapid
determination of antibiotic susceptibility and virulence factors
J. Weile, M. Susa, T. Bachmann, C. Knabbe
Stuttgart, D
Objectives: Pseudomonas aeruginosa is a leading cause of nosocomi-
al infections, particularly pneumonia or sepsis, on intensive care
units. Its high intrinsic antibiotic resistance and the ability to
develop multidrug resistance pose, especially for critically ill
patients, serious therapeutic problems. Since, culture based tech-
niques for pathogen identiﬁcation and resistance determination
requires at least 2 days, a calculated antibiotic therapy may har-
bour the risk of an increase in antibiotic resistance and therapy
failure. Therefore, the development of a fast and reliable identiﬁ-
cation and antimicrobial susceptibility test is essential for the
improvement of the therapy. The aim of the present study was to
develop an oligonucleotide-array for a quick, genotypic test of
antibiotic susceptibility combined with the determination of rele-
vant virulence factors.
Methods: DNA from different clinical specimen was isolated
with a modiﬁed QIAmp DNA Blood Mini Kit. Template DNA
was ampliﬁed and simultaneously labelled with Cy3 during
multiplex PCR. 146 oligonucleotide capture probes (17–24mer),
containing a poly-T(15)-spacer at the 5¢-end, were spotted on
epoxy-slides to build an array covering regulatory genes of
multidrug efﬂux pumps (mexR, mexT, nfxB), alginate synthesis
(mucA), metallo-beta-lactamases (bla-vim, bla-imp), aminoglyco-
side modifying enzymes (aac, aad, aph) and virulence factors
(exoU, exoS, exoT).
Results: 12 of 15 clinical P. aeruginosa isolates could be correctly
genotyped. Three isolates displayed a hybridisation pattern that
could be assigned neither to wild-type nor to known mutations.
A sequence analysis of these isolates revealed an unknown
mutation in mexR and nfxB. Hybridisation with DNA from
other non-fermenter or enterobacteriacea showed no cross-
reactivity. Genotypic resistance proﬁle of P. aeruginosa deduced
from the array data correlated fully with the susceptibility
pattern obtained by standard tests. The sensitivity of the array
was 100 genome equivalent even with an 10exp7-fold excess of
non-pseudomonas DNA. The whole analysis, including DNA
processing, array hybridisation and data evaluation could be
performed in less than 5 h.
Conclusions: Due to the good correlation with standard proce-
dures, the Pseudomonas-array may be used for a rapid susceptibil-
ity test even directly from clinical samples. Combined analysis of
antibiotic resistance and virulence factors may improve the out-
come of an antimicrobial therapy.
P729 Phenotypic and genotypic analysis of Pseudomonas
aeruginosa strains isolated from cystic ﬁbrosis patients
S. Scutera, T. Allice, S. Bianco, M.G. Chirillo, M. Zucca, D. Savoia
Orbassano, I
Objectives: Because of a high prevalence of Pseudomonas aeruginosa
infections in cystic ﬁbrosis (CF) patients, we conducted a study to
assess 60 P. aeruginosa isolates collected over 10 years from the
sputa of 38 CF adult patients attending an Italian CF centre. Some
phenotypic characters of bacteria (O-serotype, motility, production
of enzymes and resistance to antibiotics) and their PFGE geno-
typic patterns were evaluated to analyse for the presence of epi-
demic strains. Moreover some sequential isolates collected from
15 CF patients were investigated to look for the chronicisation of
the infection.
Methods: The strains were identiﬁed biochemically. The
O-serotype was determined by slide agglutination; the production
of enzymes (protease, elastase, gelatinase, haemolysin, beta-
lactamase) and motility were detected using speciﬁc techniques.
The antibiotic susceptibility was analysed by the Vitek AMS Sys-
tem and disc diffusion method. PFGE was used to discriminate
the genotypes of P. aeruginosa.
Results: In our hands, O serotyping failed to identify 26.3% of
isolates, considering the bacteria collected at the onset of colonisa-
tion; the most frequent serotypes were O: 10, O: 6 and O: 3. More-
over, the percentages of protease, haemolysin, gelatinase and
elastase production were respectively 78.9, 52.6, 55.3 and 39.5,
whereas 42.1% of the microorganisms were non-motile. PFGE
allowed the typing of all strains except one. The heterogeneity of
isolates indicated that cross-infection is unusual; we also observed
in several strains isolated in the last years a predominant pattern.
Some CF patients were harbouring the same P. aeruginosa geno-
type in sequential isolates and the susceptibility of bacteria to
antibiotics tested varies greatly, also in strains belonging to the
same PFGE proﬁle.
Conclusion: Our results indicate no relationship between genotype
and phenotype suggesting that the phenotypic variability is due
to an adaptation of the microorganism to the host. Moreover, the
presence of several strains with the same genotypic proﬁle sug-
gests a possible cross-colonisation in CF patients due to the circu-
lation of a transmissible strain.
P730 Construction of unmarked mutants in gene coding
for Ser/Thr protein kinases and phosphoprotein phosphatase of
Pseudomonas aeruginosa and analysis of their properties
J. Nedvedova, P. Lnenicka, K. Hercik, P. Branny
Prague, CZ
Objectives: Pseudomonas aeruginosa is an opportunistic pathogen
that causes infections in eye, urinary tract, burn, and immuno-
compromised patients. Three genetic loci of P. aeruginosa which
encodes Ser/Thr protein kinases were identiﬁed. Two of them,
ppkA and stk1, were also characterised but little is known about
their function in cell signalling. Gene stp1 localised upstream of
stk1 encodes Stk1 cognate phosphoprotein phosphatase. A poss-
ible relationship between quorum sensing and protein phosphory-
lation in Gram-negative bacteria has already been described. The
aim of this work was to prepare unmarked deletion mutants in
ppkA, stk1 and stp1 genes and to ﬁnd out if the linkage between
quorum sensing and protein phosphorylation in P. aeruginosa
exists.
Methods: To prepare the unmarked deletion mutants an
improved method for gene replacement in P. aeruginosa which
employs a broad-host-range Flp-FRT recombination system for
site-speciﬁc excision of chromosomally located DNA sequences
was used. The phosphorprotein pattern and biochemical proper-
ties of the mutants were examined. Double mutant in homoserine
lactone synthase genes (lasI and rhlI) was also subjected to
phosphoprotein pattern analysis.
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Results and conclusion: stk1, stp1 and a double mutant stk1/stp1
were prepared. No differences were found in either biochemical
properties or phosphoprotein pattern. Deletion of ppkA gene
failed due to the integration of vector into the unknown, but spe-
ciﬁc site of P. aeruginosa genome. The comparison of phosphopro-
tein patterns of lasI, rhlI double mutant and wild type strain
showed important differences. This result suggested that phos-
phorylation circuit operating in P. aeruginosa is related to quorum
sensing system(s).
P731 Application of real-time PCR assay to detect
fragments of the Clostridium botulinum types A, B and E
neurotoxin genes for public health microbiology
D. Akbulut, K. Grant, M.M. Brett, J. McLauchlin
London, UK
Objectives: Botulism is a rare but potentially fatal disease gener-
ally caused by the neurotoxin produced by Clostridium botulinum.
Symptoms of the disease include paralysis which is due to BoNT
inhibiting neuro-transmitter release. Laboratory diagnosis of botu-
lism relies on detecting BoNT in clinical or food specimens using
in vivo tests. Diagnosis also includes isolation and identiﬁcation of
the bacterium which again relies on in vivo tests for detection of
toxin production from the bacterium growing in vitro. We previ-
ously described the development of real-time PCR assays for
BoNTA, B and E gene fragments, and here presented further eval-
uation data.
Methods: DNA was extracted from faeces, enrichment cultures of
naturally contaminated food and clinical samples and from colon-
ies growing on agar plates. TaqMan-based assays for BoNTA, B
and E gene fragments were performed using a 7700 Sequence
Detector (Applied Biosystems). The assays were performed as a
duplex reaction for BoNTA and B using FAM and VIC labelled
probes, respectively, and as a monoplex for BoNTE using a single
FAM labelled probe. All samples were tested by using the con-
ventional bio-assay and results were compared with real-time
PCR assay results.
Results: PCR and bio-assay were found to be consistent in all
samples except those that contained ‘silent B’ neurotoxin genes in
addition to BoNTA genes. The samples tested comprised: direct
examination of six faecal samples, 18 enrichment cultures for six
clinical and 12 foods and 34 pure culture growing in vitro.
Conclusion: This study is the ﬁrst to report the successful identiﬁ-
cation of different C. botulinum toxin types for wild type BoNTA,
B and E by using Taq-Man real-time PCR assay. This assay has
already provided a useful adjunct to in vivo tests for the rapid
identiﬁcation of bacteria containing BoNT genes in wild type
C. botulinum.
P732 Evaluation of variable number tandem repeats
(VNTRs) polymorphisms for genotyping ‘Rickettsia conorii
complex’ strains
L. Vitorino, R. De Sousa, L. Ze´-Ze´, F. Bacellar, R. Tenreiro
Lisbon, P
Introduction: Mediterranean spotted fever (MSF) is an acute,
febrile tick transmitted rickettsiosis caused by strains of Rickettsia
conorii complex. MSF is endemic in Portugal and is an obligatory
notiﬁable disease. During 1989–2000 the annual incidence rate of
the disease was 9.8/105 inhabitants. In Portugal, MSF is caused
by two strains: R. conorii Malish and Israeli tick typhus (ITT). This
strain was isolated, for the ﬁrst time in 1997, from a patient.
Moreover, data from the National Institute of Health points out
that half of MSF cases occurring in Portugal are caused by ITT,
showing a similar prevalence of infection as R. conorii Malish.
Objective: In this work we present a PCR-based method to detect
VNTR sequences that enables amplicon size differentiation
between R. conorii Malish and ITT human isolate. VNTRs have a
high discriminatory capacity not only because they contain greater
diversity but also because they often vary in copy, therefore they
are being used for molecular typing of many bacteria species.
Methods: Human strains were isolated by Shell-vial technique
from patient’s total blood. DNA from tick isolates and reference
strains were also used for comparative purposes. VNTR loci were
identiﬁed by the Tandem Repeats Finder software within the R.
conorii genome. The VNTR65 locus was selected based on the fol-
lowing criteria: repeat units 50 nucleotides in length, 95% nucleo-
tide sequence identity between individual repeat units, and two
or more copies of the repeat unit. Primers ﬂanking this sequence
were designed to enable VNTR-PCR ampliﬁcation. The clinical
isolates’ identiﬁcation was also conﬁrmed by ompA gene sequen-
cing.
Results: The VNTR sequence chosen was highly informative since
it possesses different repeats of the consensus pattern among the
strains tested, namely R. conorii Malish and ITT. The former con-
tains ﬁve tandem repeats and the later only have three repeats of
the 65 bp motif unit, which can be easily detected by agarose gel
electrophoresis. Therefore, the polymorphism observed enabled
discrimination between these two strains. These results are in
agreement with ompA gene sequence.
Conclusion: This PCR-based method provides a useful and rapid
way for genotyping R. conorii Malish and ITT isolates (R. conorii
complex) which are responsible for MSF in Portugal. OmpA and
gltA gene ampliﬁcation are currently the most widely Rickettsiae
detection method used. However, strain identiﬁcation is only
accomplished by sequencing.
P733 Monitoring the ability of the human intestinal
microﬂora to become re-established after antibiotic treatment
using T-RFLP
C. Jernberg, A˚. Sullivan, C. Edlund, J. Jansson
Huddinge, Stockholm, S
Objectives: To study the composition of the human normal faecal
microﬂora during administration of clindamycin and a probiotic
or placebo product. Since only a small portion of the faecal ﬂora
is cultivable the samples were primarily analysed using a culture
independent molecular ﬁngerprinting technique, terminal-restric-
tion fragment length polymorphism (T-RFLP).
Methods: The study included eight healthy volunteers. All sub-
jects received clindamycin orally for 7 days. Four subjects
received a probiotic yoghurt concomitantly containing
10 exp 8 CFU/mL of the strains Lactobacillus F19, Lactobacillus
acidophilus NCFB 1748 and Biﬁdobacterium lactis Bb12. The placebo
group received ordinary yoghurt. Faecal samples were taken
before the administration (day 0), the last day of administration
(day 7) and 14 days after the administration (day 21). The samples
were analysed both by conventional cultivation and by T-RFLP.
Both universal bacterial primers and Lactobacillus speciﬁc primers
were used when analysing the samples using T-RFLP. The areas
of the different Terminal Restriction Fragments (TRFs), each of
which theoretically corresponds to one or a group of closely rela-
ted species, were used to calculate the relative abundance values
for the TRFs. These values were used for Principal Components
Analyses (PCA) and UPGMA analyses to compare the microbial
ﬂora at the three different time points.
Results and conclusions: In the group ingesting the probiotic, the
microﬂora in three out of four subjects became re-established close
to their original compositions 2 weeks after antibiotic treatment
ceased. By contrast, only one subject out of four in the placebo
group had an intestinal microﬂora that showed tendencies
towards normalisation during the same time period. These ﬁnd-
ings were in accordance with the results from the culture-based
analysis. T-RFLP was also used to monitor speciﬁc bacterial popu-
lations that were either positively or negatively impacted by clin-
damycin. For example, one of the dominating populations,
belonging to the Clostridium coccoides subgroup, was highly negat-
ively impacted by clindamycin administration in all subjects.
When using lactobacilli speciﬁc primers, L. acidophilus and Lactoba-
cillus F19 were the two dominating populations in the group
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receiving the probiotic. T-RFLP was shown to be a reproducible
technique for analyses of antibiotic and probiotic induced altera-
tions in the normal intestinal microﬂora.
P734 Exploring the potential for the rapid identiﬁcation of
Campylobacter species using MALDI-TOF mass spectrometry
D. Dare, H. Sutton, C. Keys, H. Shah, M. Lunt, G. Wells
Manchester, London, UK
Laser interrogation of bacteria by matrix assisted laser desorption/
ionisation time of ﬂight (MALDI-TOF) mass spectrometry (MS)
reveals unique ﬁngerprint patterns of biomarkers. These patterns
are reproducible for a given set of conditions and can be used as
the basis for bacterial identiﬁcation against a database of known
bacterial spectra. Manchester Metropolitan University in collabor-
ation with the Health Protection Agency (UK) and Waters Cor-
poration have created a MALDI-TOF mass spectral database of
clinical, environmental and food borne pathogens. These patho-
gens are all supplied from the UK National Collection of Type
Cultures (NCTC). The database spectra are therefore representa-
tive of organisms from a world-renowned collection. This database
has continued to grow over the last 3 years from the initial 300 to
currently over 3000 spectral entries covering 100 different genera.
Bacterial identiﬁcation using this database is often conclusive with
the top ﬁve matches suggesting the same genera/species. However
for identiﬁcation to be robust, the strains within the database must
be well characterised and their identity well established.
For Campylobacter the number of representative strains in the
database has increased signiﬁcantly from around 10 to 170 over
3 years. The species covered within this taxa are: C. coli, C. consi-
cus, C. curvus, C. fetus, C. gracilis, C. helveticus, C. hyolei, C. hyointes-
tinalis, C. jejuni, C. lari, C. rectus, C. sputorum and C. upsaliensis.
This study presents the results of analysing the same datasets for
21 Campylobacter strains against the expanding databases contain-
ing 300, 1099, 2159 and >3000 mass spectral entries respectively.
The results demonstrate a signiﬁcant improvement (i.e. 29–
100%) in the number of Campylobacter sp. correctly identiﬁed as
the number of representative strains increase. Therefore MALDI-
TOF MS provides a potential rapid identiﬁcation system for Cam-
pylobacter sp.
P735 Application of 23S-5S intergenic spacer sequencing
for the detection and molecular differentiation of Legionella
species
F. Grattard, C. Ginevra, S. Riffard, A. Ros, J. Etienne, B. Pozzetto
Saint-Etienne, F
Objectives: Among the more than 40 species of Legionella that have
been identiﬁed so far, 21 have been reported to be pathogenic for
humans. By now, the precise identiﬁcation of clinical isolates in
reference laboratories needs the use of monoclonal antibodies or of
molecular markers such as 16S rRNA-, mip-, rpoB- or dotA-gene
sequencing. We developed a rapid and convenient technique
based on the sequencing of the 23S-5S intergenic spacer using non-
degenerated primers speciﬁc for Legionella spp.
Methods: We tested 37 Legionella species (reference and clinical
isolates), including 15 serogroups of L. pneumophila subsp. pneumo-
phila. The ampliﬁcation step was performed by using a real-time
PCR (LightCycler, Roche Diagnostics) and sequencing was per-
formed on the Ceq8000 sequencer (Beckman). The comparative ana-
lysis of the sequences was done with the computer program MEGA
and the dendrograms obtained by the neighbour-joining method.
Results: The phylogenic tree of the 23S-5S intergenic spacer
sequences was found able to clearly differentiate all Legionella spe-
cies at the subspecies level. Actually three subspecies of L. pneu-
mophila (subsp. pneumophila, subsp. fraseri and subsp. pascullei)
were clearly distinguished. Species sharing the same autoﬂuores-
cence properties and ubiquinone and fatty acid composition were
shown to be phylogenetically related. In addition to rpoB sequen-
cing that was shown previously to exhibit similar results, our
technique was found able to detect and identify strains present in
clinical or environmental specimens that could not be cultured on
agar medium. Although this tool was not discriminatory enough
to differentiate all strains of L. pneumophila subsp. pneumophila at
the serogroup level, it was used in two different outbreaks to
demonstrate rapidly the identity of the sequences between strains
responsible for severe human infection and those isolated in the
hot water reservoir, suggesting a common origin.
Conclusion: The 23S-5S intergenic spacer sequencing was found to
be suitable for rapid detection and powerful identiﬁcation of
Legionella species in clinical settings.
P736 Cerebral Whipple’s disease diagnosed by PCR. The
ﬁrst case reported from Greece
M. Papdopoulou, M. Rentzos, V. Ioannidou, A. Ioannidis,
C. Nicolaou, S. Chatzipanagiotou
Athens, GR
Whipple’s disease (WD) is a rare multisystemic bacterial infection,
with variable clinical manifestations occasionally involving the cen-
tral nervous system. As the cultivation of the aetiologic agent,
Tropheryma whippelii, is difﬁcult, the laboratory diagnosis is usually
based on histological methods. In the last few years, molecular
detection of the bacterial 16SrRNS genes by the polymerase chain
reaction (PCR) with two primer sets, has greatly contributed to the
diagnosis. We present a cerebral case of WD in a 48-year-old male,
successfully diagnosed by PCR of T. whippelii in the blood and the
faeces. As far as we know this is the ﬁrst case reported from Greece.
For the diagnosis of WD histological examination of duodenum
biopsy for diastase resistant, non-acid fast, periodic acid Schiff
(PAS)-positive inclusions in macrophages, and molecular detection
of the 16SrRNA genes of by PCR in CSF, blood and faeces were per-
formed. The histological detection was negative. PCR was positive
in the blood and the faeces of the patient and negative in the CSF.
Seven months after the onset of antimicrobial therapy, PCR was
negative in all three clinical specimens. In conclusion, the applica-
tion of PCR proved to be an invaluable tool for the recognition, the
differential diagnosis and the early start of the antimicrobial ther-
apy of WD, a generally fatal disease, if it remains untreated.
P737 Corynebacterium amycolatum ATCC 49368 reference
strain is atypical for clinical Corynebacterium amycolatum
isolates with respect to biochemical properties, fatty acid
analysis and DNA analysis
K. Martienssen, A. Becker, D.H. Forster, K. Pelz, A. Sander,
E. Kniehl
Karlsruhe, Freiburg, D
Objective: C. amycolatum is an emerging pathogen selected by
antimicrobial chemotherapy. The aim of our study was to investi-
gate clinical C. amycolatum isolates, which were tested biochemi-
cally, by fatty acid analysis and by 16S rRNA gene sequencing.
Clinical isolates were thereby compared with the C. amycolatum
ATCC 49368 reference strain.
Methods: 182 clinical isolates of C. amycolatum, isolated from 158
in-patients of a tertiary hospital, were identiﬁed by API Coryne
(bioMe`rieux, Marcy L’Etoile, France) and additional tests. Fatty
acid analysis was performed from all isolates subcultured on
Columbia agar and from 33 isolates subcultured on TSB agar.
Specimens were prepared by standard methods and analysed by
gas chromatography (Hewlett Packard 5890A; Sherlock Microbial
Identiﬁcation system version 4.0). The ﬁrst 500 base pairs of the
16S rRNA gene of eight representative isolates were sequenced in
both directions using the Microseq 500 Kit (Applied Biosystems,
Foster City, CA, USA) on an ABI Prism 310 Genetic Analyser
(Applied Biosystems). Consensus sequences were compared with
those available in GenBank, EMBL, DDBJ and PDB.
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Results: Only one clinical isolate had the same API code proﬁle
as the reference strain. Fifteen per cent of clinical strains were tes-
ted urease positive, as was the reference strain. By fatty acid ana-
lysis, clinical isolates could be separated in four different groups
(I–IV), containing 77, 98, 5 and 1 isolates, respectively. ATCC
49368 was grouped to group II. Sequences were obtained from
three strains of groups I and II, respectively, and from one strain
of groups III and IV, respectively.
Comparison of the determined eight sequences with public dat-
abases showed the greatest similarity score with C. asperum
(X82050.1) with values between 98.7 and 100%. C. asperum and C.
amycolatum are considered as synonyms, because they exhibit a
level of DNA-DNA relatedness greater than 90% (Ruimy R et al.
Int J Syst Bacteriol 1995; 45: 740). Homology with C. amycolatum
ATCC 49368 (X82057.1) was only between 97.1 and 98.3%.
Sequencing of the C. amycolatum reference strain yielded 100%
homology with the published sequence (X82057.1).
Conclusions: Our data conﬁrm the hypothesis that ATCC 49368 is
atypical for clinical C. amycolatum strains. Furthermore, our data
are in concordance with the observation, that by pyrolysis-gas-
liquid chromatography C. amycolatum isolates can be separated in
two different groups (Voisin S et al. Res Microbiol 2002; 153: 307).
P738 Detection of mutations associated with resistance to
tetracycline and clarithromycin in Helicobacter pylori using the
Pyrosequencer
A. Lawson, C. Arnold, R. Owen
London, UK
Objectives: Clarithromycin and tetracycline are key components
of H. pylori eradication therapy. Resistance to clarithromycin
occurs due to single nucleotide mutations in 16S rDNA and an
assay to detect these was amongst the ﬁrst to be developed for
the Pyrosequencer. Recently it has been shown that resistance and
reduced susceptibility to tetracycline occur due to single, double
or triple mutations in 23S rDNA. The aim of this study was to
develop a single multiplex assay using the Pyrosequencer to
determine susceptibility to clarithromycin and tetracycline from
H. pylori isolates and direct from gastric biopsy samples.
Methods: Pyrosequencer assays to detect mutations conferring tet-
racycline and clarithromycin resistance were designed to work
singly and in multiplex. The assays were evaluated using 20 iso-
lates with fully characterised 16S and 23S rDNA sequences. Sub-
sequently, DNA extracts from 30 clinical isolates and 20 H. pylori-
positive human gastric biopsies – all of unknown antibiotic sus-
ceptibility – were examined and the results compared with those
achieved by conventional culture-based techniques, namely antibi-
otic disc diffusion and Etest.
Results: The Pyrosquencer multiplex assay correctly determined
the 16S and 23S rDNA sequences of the 20 characterised control
isolates. When applied to DNA extracted from clinical isolates
and gastric biopsy samples, the Pyrosequencer assay was in
agreement with the clarithromycin and tetracycline susceptibilities
determined by culture-based analysis.
Conclusion: The Pyrosequencer assay allowed rapid determination
of clarithromycin and tetracycline susceptibility from both H. py-
lori isolates and gastric biopsy samples. The sequence data
obtained for the mutations occurring in each strain may provide
useful epidemiological information and guide patient manage-
ment.
P739 Detection of Helicobacter pylori infection by ELISA
and Western blot techniques and evaluation of anti CagA
seropositivity in adult dyspeptic patients
N. Sen, O¨. Yilmaz, A.A. Ku¨pelioglu, I. Simsek
Izmir, TR
Objectives: Helicobacter pylori is a common human pathogen impli-
cated in certain gastrointestinal diseases and extra gastrointestinal
diseases. The aim of this prospective pilot study was to detect
IgA, IgG and anti-CagA antibody status and to evaluate the corre-
lation with anti- H. pylori IgA, IgG Western blot and ELISA tests
in adult dyspeptic patients.
Methods: Upper gastrointestinal endoscopy, two from gastric ant-
rum and two from corpus, was performed in 56 patients (mean
age 46.41) with dyspeptic symptoms. H. pylori was assessed by
rapid urease test and by histopathologic examination in these
biopsy specimens. Patients’ sera were tested by anti- H. pylori
IgA, IgG Western blot, IgA, IgG ELISA and anti-CagA-IgA, IgG
ELISA (EUROIMMUN Medizinische Labordiagnostika, Lu¨beck)
tests.
Results: A total of 56 patients were evaluated and H. pylori infec-
tion was diagnosed in 48 (85.71%) patients by rapid urease test
and/or histopathology. Serological anti- H. pylori test results were
shown as below (Table 1). Twenty-eight (50%) of 56 adult dys-
peptic patients sera were positive for anti-CagA-IgG ELISA and
17 (30.35%) were positive for anti-CagA-IgA ELISA.
Conclusion: Infection with H. pylori results in the production of
local and systemic antibodies. Cag A is the important pathologic
marker with high immunogenic power. A set of serological tests
may give more accurate determination of H. pylori infection than
one test detecting speciﬁc antibody or bacterial antigen. It seems
that there is a good correlation with Western blot and ELISA test
results and gold standards.
Acknowledgement: This work was supported by EUROIMMUN
Medizinische Labordiagnostika, Lu¨beck, Germany.
P740 Susceptibility of Helicobacter pylori isolates to the
anti-adhesion activity of a high-molecular-weight constituent of
cranberry
H. Shmuely, O. Burger, I. Neeman, J. Yahav, Z. Samra, Y. Niv,
N. Sharon, E. Weiss, M. Tabak, A. Athamna, I. Ofek
Petach Tiqva, Haifa, Rehovot, Jerusalem, Kfar Qaraa, Tel Aviv, IL
Background: Previous studies have shown that a high molecular
mass non-dialysable constituent derived from cranberry juice
inhibited the adhesion of Helicobacter pylori to human gastric
mucus and to human erythrocytes. The aim of the present study
was to determine the sensitivity of a large number of both antibi-
otic-resistant and susceptible clinical isolates of H. pylori to the
anti-adhesion effect of the cranberry constituent.
Material and methods: Conﬂuent monolayer of gastric cell line in
wells of a microtitre plate was exposed to bacterial suspensions
prepared from 83 H. pylori clinical isolates, including 17 from
patients after treatment failure. Adhesion was estimated by the
urease assay to calculate the percent inhibition of adhesion by the
non-dialysable material. Antibiotic susceptibility of H. pylori iso-
lates to metronidazole, tetracycline and amoxicillin were tested by
the Etest.
Results: In two-thirds of the isolates, adhesion to the gastric cells
was inhibited by 0.2 mg/mL of the non-dialysable material. All
isolates were susceptible to amoxicillin and tetracycline and 35
isolates (42%) were resistant to metronidazole. There was no rela-
tionship between the anti-adhesion effect of the cranberry material
and the resistance to metronidazole in isolates from either the
antibiotic-treated or untreated patients. Most important, only 13
isolates (16%) were resistant to both non-dialysable material and
metronidazole and 30 isolates (36%) were resistant to the
Table 1. Correlation of westernblot/ELISA test results of 56 adult dyspeptic patients sera
Westernblot IgG Westernblot IgA
Positive Borderline negative Positive Borderline Negative
Positive 40 4 2 Postive 15 4 8
Borderline 3 – – Borderline 1 1 5
ELISA
IgG
Negative 2 5 – ELISA
IgA
Negative 3 – 19
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non-dialysable material alone. No cross-resistance of the isolates
to cranberry constituent and metronidazole was found.
Conclusions: The data suggest that a combination of antibiotics
and a cranberry preparation may improve the eradication of
H. pylori.
P741 Helicobacter pylori infection in Venezuela. Public
health problem
M.E. Cavazza Porro, M. Correnti, M.I. Urrestarazu, J. Vivas,
M.E. Avila, D. Ortiz, V. Lecuna, R. Pin˜ero, M. Perrone
Caracas, San Cristo´bal, VE
Objectives: (1) Evaluation of the seroprevalence of Helicobacter
pylori infection in different counties of Venezuela and its associ-
ation with grastroduodenal diseases. (2) Analyse the presence
of the gene cagA and VacA in the H. pylori isolates from can-
cer endemic area (San Crsitobal) and Metropolitan area of
Caracas.
Methods: For the seroprevalence study a total of 1041 people of
different states from the country were evaluated: 370 sympto-
matic and 406 asymptomatic adults; 27 symptomatic and 238
asymptomatic children. The determination of speciﬁc IgG anti-
bodies was made by commercial ELISA. The presence of the
gene cagA was evaluated in 133 patients of the metropolitan
area and the Center of Gastric Cancer Control of San Cristo´bal
(endemic zone of gastric cancer). The detection of VacA was
determined in 29 biopsy from patients of San Cristo´bal and 36
biopsy from patients of the metropolitan area. The biopsies were
analysed by different methods for diagnosis of H. pylori: culture,
urease test, polymerase chain reaction and RAPDS for genoty-
ping the H. pylori isolates.
Results: The percentage of asymptomatic children with values of
speciﬁc IgG antibodies anti-H. pylori (over 300 U) varies from 30
to 60% (Metropolitan area vs. San Cristo´bal). In symptomatic
adults groups, the seroprevalence was between 68 and 93%
according to the studied geographic area. A decreased title of IgG
antibodies anti-H. pylori was observed in patients with diffuse
antral gastritis associated with metaplasia type II. In the group of
endemic cancer area the titles of IgG anti-Hp were elevated in
patients with antral diffuse gastritis. The cagA gene was detected
in 46% of patients of the Metropolitan Area unlike the group of
patients of San Cristo´bal a smaller frequency was observed
(26.41%) (P < 0.001). A high incidence of S1a and m2 genotype
was observed in the H. pylori isolated from the patients of ende-
mic gastric cancer area (40%), unlike what we observed in the
metropolitan H. pylori isolates where an elevated prevalence of
S1b and m1 genotypes was found.
Conclusions: In our country we observed a high prevalence of H.
pylori infection in adults and children. The determination of the
cagA and VacA genes of H. pylori demonstrates a high genetic
variability of this bacterium in our population.
Acknowledgement: Grant FONACIT Scientiﬁc Millenium 4572-B.
P742 Primary antibiotics susceptibility of Helicobacter
pylori in a general hospital
N. Montiel, J.M. Navarro, J.L. Prada, J. De La Torre, A. Del Arco,
C. De Sola, I. Lopez
Marbella, E
Objectives: To determine H. pylori primary resistance to different
antibiotics in our area.
Methods: From patients diagnosed of dyspepsia in the Gastro-
enterolgy Unit of Costa del Sol Hospital, we have studied 148
samples from gastric antro. No current resident in our area and
patients treated previously with eradicated therapy have been
excluded. Samples were homogenised and cultured in blood-agar,
chocolate-agar, pylori-agar and tioglicolate broth. It was incubated
to 37C in microaeroﬁle atmosphere during 5–7 days. We studied
the susceptibility to: amoxicillin (Am), claritromicin (Ch), metroni-
dazole (Mz), tetracycline (Te) and ciproﬂoxacin (Cp) by detection
of IMC by E-test (Biodisk). We have followed NCCLS criteria
for antibiogram lecture.
Results: From 148 samples, 60 were males and 88 females. We
found the follow primary resistance; Ch 16 (10.8%), Mz 52
(35.1%), Te 8 (5.4%), Am 2 (1.4%), Cp 23 (15.5%) and 10 samples
(6.8%) with a mix resistance to CH and Mz. Ch and Mz resistance
are more common in females, but the difference is only statisti-
cally signiﬁcant for Mz (P: 0.037).
Conclusions: There is a progressive increased antibiotic resistance
in H. Pylori in our area. This may be related with a raised used of
antibiotics for other indications. CH resistance data agree with
other Spanish and multicentre European studies, which show a
foremost rate in the Mediterranean area. The Mz resistance is
higher than other Spanish works. Our high prevalence of resist-
ance supports the idea of avoiding imidazol therapy as primary
choice treatment.
P743 The prevalence and consequences of antibiotic
resistance in Danish H. pylori strains isolated with an interval
of 10 years
S. Hartzen, H. Colding
Charlottenlund, Copenhagen, DK
Objectives and Background: The treatment of H. pylori (HP) infec-
tions is complex and the use of combination therapy is impera-
tive. The choice of the antibiotics is often made exclusively on
empirical basis although resistance to many therapeutically rele-
vant antibiotics has been described. The mainstay of HP treat-
ment in Denmark is various combinations of normally two of
the following antibiotics: metronidazole, amoxicillin, tetracycline
and clarithromycin. To clarify whether these compounds were
to remain the drugs of choice we decided to determine the sus-
ceptibilities of metronidazole, clarithromycin, tetracycline, and
amoxicillin against 180 HP strains recently isolated from
patients with duodenal ulcer. The results were compared with
results previously obtained by us in 1993 using a similar
methodology.
Materials and methods: Strains: 360 Danish HP strains, 180 from
about 1990–93, 180 from 2000–02. Susceptibility testing: E-test AB
Biodisk,Sweden. Antibiotics: Amoxicillin, metronidazole, clarith-
romycin, tetracycline. Medium: Isosensitest agar with 10% horse
blood. Inoculum: 106 CFU/mL. Microaerobic incubation for 72 h.
Results: Amoxicillin: 1993 MIC50 0.02 mg/L, MIC90 0.03 mg/L,
2002 MIC50 <0.02 mg/L, MIC90 0.03 mg/L. Metronidazole: 1993
MIC50 2 mg/L, MIC90 64 mg/L, 2002 MIC50 and MIC90 >256 mg/
L. Tetracycline: 1993 MIC50 0.25 mg/L, MIC90 0.5 mg/L, 2002
MIC50 0.125 mg/L, MIC90 0.5 mg/L. Clarithromycin: 1993 MIC50
0.03 mg/L, MIC90 0.06 mg/L, 2002 MIC50 0.02 mg/L, MIC90
0.06 mg/L.
Conclusions: Over a period of 10 years only the development of
resistance to metronidazole appears to constitute a problem. Oth-
erwise HP has remained remarkably susceptible to these thera-
peutically relevant antibiotics. On the basis of our results we
recommend that surveillance of especially metronidazole resist-
ance in Denmark is markedly intensiﬁed, e.g. by increasing the
use of diagnostic methods of HP infections that allow susceptibil-
ity testing. In cases where treatment with metronidazole is consid-
ered, susceptibility testing is of course of major importance, if not
downright necessary.
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P744 Prevalence of Helicobacter pylori resistance to
clarithromycin in Turkey
F. Can, M. Demirbilek, H. Selcuk, H. Arslan, S. Boyacioglu
Ankara, TR
Objectives: Helicobacter pylori is the main causative agent of peptic
ulcer disease. Clarithromycin resistance of H. pylori is the common
reason of failure of the eradication therapy, which includes amoxi-
cillin–clarithromycin and proton pomp inhibitor. The aim of this
study was to determine the prevalence of clarithromycin resist-
ance among H. pylori strains isolated from gastric biopsies
obtained during routine endoscopies at the Baskent University
Medical Faculty in Ankara, Turkey.
Methods: H. pylori strains were isolated from antral biopsy speci-
mens taken from dyspeptic patients. Antibiotic susceptibilities of
the isolates to clarithromycin were performed using the NCCLS
approved agar dilution and the E test methods.
Results: 78 H. pylori isolates were included in the study. Clarithro-
mycin resistance was found in 16 (20.5%) of the isolates. The resist-
ance rates were similar by the E test and agar dilution methods.
Conclusion: The percentage of the clarithromycin resistance
among H. pylori strains in our population is signiﬁcantly high.
This information is important to monitoring the eradication ther-
apy and deﬁnes regional treatment policies.
P745 Low seroprevalence of anti-Cag A in spite of high
seroprevalence of anti-Helicobacter pylori antibodies in a rural
Egyptian community
S. Zakaria, E. El Sherbini, M. El Raziki, S. Saad El Din,
M. Mubarak, R. Salama, S. Zakaria
Cairo, Giza, EGY
Introduction: Helicobacter pylori has been the subject of many stud-
ies that contributed to a better understanding of its epidemiology
and its clinical importance in the pathology of the upper gastroin-
testinal tract, being an important cause of duodenal, gastric ulcers
and a deﬁnite cause of gastric adenocarcinoma in human.
Objectives: to determine the seroprevalence of H. pylori among
population living in rural community, in relation to the epidemio-
logical aspect, and to study the seroprevalence of anti-CagA as a
virulence factor in a step that might be helpful in studying the
magnitude of H. pylori infection. Also, to determine a cut-off value
among the population in this community.
Subjects and methods: This is a community based, ﬁeld study
which was performed on 605 randomly chosen subjects represent-
ing villagers of eight villages in Giza governorate Egypt. Serologi-
cal testing for anti- H. pylori and anti-Cag A were performed by
ELISA.
Results: The overall seroprevalence of anti- H. pylori IgG was
91.7% with different degrees of positivity: 40.8% mild, 39.2%
moderate and 11.7% high. Anti-Cag A was present in 10.6%.
There was a signiﬁcant agreement between the presence of the
two antibodies; however, on studying the relation of anti-H. pylori
IgG level with anti-CagA no statistically signiﬁcant relation was
found denoting that the level of infection even if mild does not
rule out the possible association of virulent strain of H. pylori. No
age or sex difference was noted as regards anti-H. pylori
seropositivity but subjects seropositive for anti-Cag A had a statis-
tically signiﬁcant higher mean age. When relating the seropreva-
lence of anti-H. pylori to type of community, it was found to be
the same in semi-rural communities and rural ones and when
investigating the respective conditions in both communities it was
found that the prevalence is rather related to pattern of life, socio-
economic status and to other possible vehicle of transmission as
animals or ﬂies than faecaly contaminated water which is not con-
sidered the only vehicle for H. pylori transmission in our study.
Conclusion: H. pylori is holoendemic in Egypt; however, infection
by virulent strains is not common.
ESBL and metallo-beta-lactamases - I
P746 Extended-spectrum beta-lactamases detection in the
clinical microbiology laboratory
H. Moraitou, I. Galani, S. Kanavaki, S. Karabela, M. Makarona,
L. Choraiti, H. Giamarellou
Athens, GR
Objectives: Extended-spectrum beta lactamases (ESBLs) are an
increasing cause of resistance in Enterobacteriaceae. Unfortu-
nately, the laboratory detection of ESBLs can be complex and, at
times, misleading. The aim of this study was to determine whe-
ther routine methods performed in a clinical microbiology laborat-
ory of a tertiary care Hospital, are adequate for detecting
emerging ESBL producing clinical isolates.
Methods: To evaluate the ESBL conﬁrmation protocol, we collec-
ted 29 Enterobacteriacae strains, isolated in our Laboratory. Each
isolate met the NCCLS screening criteria for potential ESBL pro-
ducers (ceftazidime or cefotaxime MICs were 2 for all isolates).
We tested 13 Kl. pneumoniae, ﬁve Ent. cloacae, two Ent. aerogenes,
ﬁve E. coli and four Pr. mirabilis strains, by methods routinely
used in our laboratory. Initially, the isolates were tested for cla-
vulanic acid effect by disk diffusion method and all were ana-
lysed by the Vitek2 automated system (bioMerieux, France),
which performs a susceptibility testing, by determining the MIC
breakpoints. The Advanced Expert System (AES) of Vitek2 was
set on the phenotypic resistance knowledge-based system and the
panel GN020 was used. In parallel, the isolates were tested by the
ESBL E-test with ceftazidime and cefotaxime plus beta lactamase
inhibitor (AB, Biodisk, Sweden). In order to conﬁrm the ESBL pro-
duction, all strains were tested by isoelectric focusing (IEF)
followed by PCR for blaTEM, blaSHV, blaOXA, blaIBC and
blaCTX genes.
Results: Twenty-one out of 29 isolates proved to produce ESBLs
by molecular methods. All Enterobacter strains and one Proteus
mirabilis were not ESBL producers. No blaOXA or blaIBC genes
were detected. The PCR detection of ESBL genes results were
compared with the double disk diffusion, Vitek2 and ESBL E-test
to estimate the sensitivity, speciﬁcity and the predictive value of
the methods tested. The sensitivity of the methods was 84.6, 85.7
and 70.5%, respectively, the speciﬁcity 62.5, 87.5 and 66.6%,
respectively, and the predictive value 64.7, 93.3 and 75%, respect-
ively.
Discussion: Given the increasing incidence of ESBL producing
clinical isolates, it is important that ESBL screening is incorpor-
ated into routine diagnostic testing. The backup of the simple disk
diffusion method by the automated Vitek2 system increases the
possibility of identifying ESBL activity of clinical strains in the
Hospital Microbiology Laboratory setting.
P747 Rapid genotyping of the ESBL TEM beta-lactamases
using DNA-microarrays
V. Jung, S. Ezaki, M. Susa, C. Knabbe, R. Schmid, T. Bachmann
Stuttgart, D
Objectives: Extended-spectrum beta-lactamases (ESBL) are plas-
mid-mediated beta-lactamases and most of them are mutant of
TEM or SHV beta-lactamases. ESBLs have been associated with
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clinical failures due to serious interpretive problems of standard
laboratory tests. Detection of ESBLs remains a challenge for the
laboratory, since routine tests for monitoring a susceptibility to
oxyimino-cehalosporins and aztreonam have not been sensitive
enough to detect ESBL strains and require up to 2 days. We des-
cribe an oligonucleotide array for rapid identiﬁcation of single
nucleotide polymorphisms (SNPs) of the ESBL TEM beta-lacta-
mases.
Methods: Plasmid DNA was ampliﬁed and Cy5 labelled during
PCR with consensus primer pair ﬂanking the blaTEM gene. Oligo-
nucleotide arrays were constructed with 168 oligonucleotide cap-
ture probes. The probes were designed with the SNP at the
central base of the probe sequence for maximum perfect match/
mismatch discrimination.
Results: 40 of 41 SNP positions were correctly identiﬁed. The sig-
nal intensity values ranged up to 20 000 for the perfect match
probes. The discriminatory power of the array expressed as relat-
ive intensity of mismatches (RIMM) remained for 99% of the mis-
matches below 0.4. A perfect match was considered as correctly
identiﬁed, if RIMM did not exceed 0.7. Analysis of the array
reproducibility revealed that in analysed blaTEM-1 samples all 41
SNP positions could be identiﬁed. The mean RIMM values varied,
but 95% remained below 0.4. In DNA isolated from clinical sam-
ples all mismatches in blaTEM were identiﬁed without ambiguity,
and 91% of them remained below the RIMM limit. Since the
reduction of the array-hybridisation time to 30 min had no inﬂu-
ence on RIMM (RIMM limit less than 0.6 for 95% mismatch posi-
tions), the assay may be performed within 3.5 h while keeping its
discriminatory power.
Conclusion: The blaTEM gene variants could be ampliﬁed by the
use of a single consensus primer pair. Using DNA-array we were
able to discriminate SNPs in 102 of the 106 TEM variants. SNP
mismatches could be analysed by array within 3.5 h enabling the
identiﬁcation of the corresponding ESBLs or inhibitor resistant
TEMs.
P748 A simple, relevant and cost-effective ESBL testing
protocol for a routine clinical microbiology laboratory: a tertiary
care hospital study
A. Guleri, S.R. Alcock, G.D. Corcoran, S. Samavedam, J. Robinson,
J. Wilson
Glasgow, UK
Background: Routine, cost effective and clinically relevant testing
for ESBL/AmpC beta lactamases is of growing concern. A pilot
study was conducted to establish the prevalence of ESBL strains
in clinical isolates from high-risk units (ITU, HDU, nephrology,
oncology, haematology) and to develop an optimal protocol for
routine ESBL testing.
Methods: 72 clinical isolates of Gram-negative rods resistant
(NCCLS disc test) to cefotaxime and ceftazidime were tested for
ESBL/Amp-C beta lactamases. Three test panels were used:
(1) ESBL E-test (AB Biodisk) panel: cefepime, ceftazidime and
cefotaxime, each  clavulanate; (2) ESBL combination discs
(Oxoid) conventional panel: cefpodoxime, ceftazidime, and cefo-
taxime, each  clavulanate, and cefoxitin alone; (3) Combination
discs extended panel: Cefpirome (Oxoid) and cefepime (MAST),
each  clavulanate. Simultaneously MICs of meropenem, ertape-
nem, piptazobactam, ciproﬂoxacin, gentamicin and co-trimoxazole
were estimated by E-test.
Results: Of the 72 isolates, 20 produced ESBL only, 23 AmpC
b-lactamase only and 29 produced both. The isolates were Entero-
bacter cloacae (26), Escherichia coli (15), Klebsiella. pneumoniae (12),
Serratia marcescens and Cit. freundii (four each), Serratia liquefaciens
(three), Cit. koserii, Morganella morganii, Salmonella virchow (two
each), Cit. youngae and Enterobacter aerogenes (one each). Of the
overall 49 ESBLs, the E-test panel detected one additional isolate
compared with the extended combination disk panel but missed
three. The conventional combination disc panel missed detecting
ESBL in four isolates, which were detected by the extended disc
panel. MIC ranges (mg/L) were: meropenem 0.008–0.125, ertape-
nem 0.006–0.5, piptazobactam 0.5–256, ciproﬂoxacin 0.006–32, gen-
tamicin 0.125–256 and co-trimoxazole 0.064–256.
Conclusion: Use of more than one substrate for screening, and a
combination of ESBL combination discs including cefepime and
cefpirome (each  clavulanate) for conﬁrmation appears to make
ESBL testing more sensitive. ESBL E-test strips are simpler to use
and almost as sensitive as the combination of discs. All isolates
were sensitive to meropenem and ertapenem, but showed varying
degrees of resistance to piptazobactam, ciproﬂoxacin, gentamicin
and co-trimoxazole. Details with illustrations to be discussed.
P749 Characterisation of Enterobacteriaceae producing
extended-spectrum beta-lactamase enzymes in Scotland
F.M. MacKenzie, A. Leslie, I.M. Gould
Aberdeen, UK
Objectives: To characterise Scottish strains of Enterobacteriaceae
producing Extended Spectrum b-lactamase (ESBL) enzymes and
to characterise the ESBL enzymes produced by these strains.
Methods: Sixty-four isolates from six hospitals throughout Scot-
land were screened positive for ESBL production and sent to our
laboratory for conﬁrmation. All isolates were screened for ESBL
activity by disc diffusion, the Jarlier Double Disc test and the
NCCLS conﬁrmatory test. Thirty isolates were then selected com-
prising a representative of each species from each hospital. These
underwent MIC testing and isoelectric focusing (IEF) to presump-
tively identify the b-lactamases present.
Results: 53 of the 64 isolates conﬁrmed as ESBL producers by the
Jarlier Double Disc test and/or the NCCLS conﬁrmatory test. Of
these, one conﬁrmed by the Jarlier Double Disc test only and four
by the NCCLS conﬁrmatory test only. The 53 ESBL positive iso-
lates underwent disc diffusion testing; 100% appeared susceptible
to imipenem, 62% to piperacillin/tazobactam, 32% to cefotaxime,
31% to ceftazidime, 28% to co-amoxiclav, 9% to cefuroxime, 7%
to cefpodoxime and 0% to ampicillin. MICs were carried out on
25 ESBL positive isolates; 100% appeared susceptible to imipe-
nem, 40% to cefpirome, 32% to cefotaxime, 32% to ceftazidime
and 0% to cefpodoxime. By IEF 0–7 bands were detected (mean,
median and mode ¼ four bands). Eleven of 25 isolates produced
both TEM and SHV-like enzymes, 10/25 produced TEM-like
enzymes and 3/25 produced SHV-like enzymes. TEM-like
enzymes were most prevalent in E. coli and Klebsiella species,
whereas SHV-like enzymes were most prevalent in Enterobacter
species.
Conclusions: ESBL enzymes are produced by a wide variety of
species in Scotland. By disc diffusion and MIC testing, ESBL pos-
itive isolates appeared falsely susceptible to the third-generation
cephalosporins. The IEF results were diverse and complex and
showed that TEM- and SHV-like enzymes are both prevalent in
Scotland.
P750 Occurrence and transferability of beta-lactam and
aminoglycoside resistance in clinical isolates of the family
Enterobacteriaceae obtained from different wards of a hospital
in Nitra (Slovakia)
M. Vrabelova, P. Dianiskova, D. Michalkova-Papajova, A. Liskova,
M. Kettner
Bratislava, Nitra, SK
Objectives: The aim was to study the occurrence, mechanisms
and transferability of beta-lactam and aminoglycoside resistance
in the set of 34 clinical isolates (10 Serratia marcescens, six Citrobact-
er freundii, six Enterobacter cloacae, ﬁve Klebsiella pneumoniae, three
Morganella morganii, two Escherichia coli, one Proteus mirabilis, one
Providencia rettgeri) obtained from 13 different wards of the Hospi-
tal Nitra (Slovakia) in 2001.
Methods: The level of beta-lactam and aminoglycoside resistance
was determined by standard agar dilution method according to
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the NCCLS recommendations. The production of extended-spec-
trum beta-lactamases (ESBL) was detected by double diffusion
test. The presence of blaTEM gene was determined by PCR
method. Transferability of resistance determinants was studied by
bacterial conjugation.
Results: 70.5% of the clinical isolates were resistant to ampicillin
(AMPI); 76.5% to cefoxitine (CFOX); 55.8% to cefotaxime (CTAX);
55.8% to ceftazidime (CTAZ); 41.2% to ceftriaxone (CIAX); 14.7%
to cefepime (CEPI); 58.8% to azthreonam (AZTR); 5.8% to
meropenem (MERP); 53.0% to gentamicin (GEN); 41.0% to tobra-
mycin (TOB); 8.8% to netilmicin (NET); 5.8% to amikacin (AMI);
8.8% to isepamicin (ISE); 55.8% to ciproﬂoxacin (CIP). A total of
61.8% of clinical isolates were identiﬁed as ESBL producers. The
presence of blaTEM gene coding for TEM-type beta-lactamases
was detected in 82.4% of clinical isolates tested. Resistance deter-
minants to all antibiotics tested, with only one exception of MERP,
were transferable by bacterial conjugation to the recipient strain
Escherichia coli K-12 3110. Frequency of transfer ranged from
7.1  109 to 1.2  101.
Conclusions: The occurrence of resistance to beta-lactam antibiot-
ics was very high. The most efﬁcient beta-lactams were the
carbapenem meropenem and the fourth-generation cephalospo-
rin cefepime. Aminoglycoside antibiotics netilmicin, amikacin
and isepamicin had high efﬁciency, too. On the other hand,
more than one half of the clinical isolates tested were resistant
to the ﬂuoroquinolone ciproﬂoxacin. Beta-lactam resistance was
due to the production of ESBL and to the presence of the bla-
TEM gene in the majority of clinical isolates. Transferability of
beta-lactam and aminoglycoside resistance determinants by bac-
terial conjugation is important from the epidemiological point
of view.
P751 Clinical effectiveness of cefepime in case of third-
generation cephalosporins treatment failure in nosocomial
infections caused by Enterobacteriaceae producing extended-
spectrum beta-lactamases
O. Romashov, S. Yakovlev, S. Sidorenko, A. Berezin
Moscow, RUS
Objectives: Today there are very few signiﬁcant data on the effect-
iveness of cephalosporin antibiotics in nosocomial infections
caused by the microorganisms producing ESBL.
Methods: The cases of nosocomial infections caused by Enterobac-
teriaceae with a proved ESBL production were analysed. ESBL
producing Enterobacteriaceae strains were assayed for susceptibil-
ity to different antimicrobials and MICs were determined by a
broth microdilution method. To determine molecular typing of
ESBL genes polymerase chain reactions and sequencing reactions
were used. Patients received initial empiric intravenous antibacte-
rial therapy with third-generation cephalosporin (cefotaxime). In
case of failure cefepime 4 g a day was prescribed. Results of those
infections treatment with third- and fourth-generation cephalospo-
rins were assessed depending on MIC.
Results: ESBL production with speciﬁc SHV and CTX oligonucle-
otids was proved for six strains of Enterobacteriaceae in four
patients with nosocomial pneumonia (in two cases mixed infec-
tion took place), among them four strains were Klebsiella spp. and
two strains E. coli. The analysis of the dependence of MIC on
the results of the treatment gave the following results (Table
1). It may be stated that with the proved Enterobacteriaceae
ESBL production MIC values for third-generation cephalosporins
of the majority of strains were within the resistance range (more
than 32 lg/mL), and these antibiotics were not effective in all
cases. As for cefepime, MIC showed intermediate sensitivity
(32 lg/mL) to the drug only in 33.3% cases; the rest of the strains
(MIC ¼ 1–8 lg/mL) were sensitive. The therapy with cefepime
was effective in three of four patients.
Conclusion: Effectiveness of third-generation cephalosporins corre-
lates with existing NCCLS criteria: if MIC value is high the ther-
apy is not effective. MIC value for fourth-generation
cephalosporins does not have much effect on the drug clinical
effectiveness: cefepime preserves clinical effectiveness for ESBL
producers with MIC range from 1 to 32 lg/mL inclusively.
P752 High prevalence of CTX-M type extended-spectrum
beta-lactamases in members of Enterobacteriaceae in Turkey
Z. Gulay, G. Terek, B. Erac¸, C¸. Bal, D. Gur, I. Ko¨ksal, C. Ozakin,
M. Ozinel, B. Sumerkan
Izmir, Istanbul, Ankara, Trabzon, Bursa, Kayseri, TR
Objective: To ﬁnd the prevalance and predominant types of CTX-
M type beta-lactamases in Enterobacteriaceae isolated in different
regions of Turkey.
Methods: Seventy clinical isolates recovered between November
2002 and July 2003 at seven medical centres located in six cities,
were taken into the study. Isolates were chosen randomly on a 10
isolate per centre basis. The isolates consisted of 34 Escherichia coli,
23 Klebsiella pneumoniae, eight Enterobacter spp., two K. oxytoca,
two Proteus mirabilis and one Shigella sonnei. All isolates were
extended spectrum beta-lactamase (ESBL) producers according to
the NCCLS criteria and conﬁrmatory tests. B-lactamases were
characterised by PCR ampliﬁcation using speciﬁc primers. Conju-
gation experiments and isoelectric focusing was also performed.
PCR products of 20 isolates (two to three isolates per centre) were
sequenced in both strands.
Results: The prevalance of CTX-M type beta-lactamases was
50–100% at different centres. Enzyme production was detected in
76.5, 82.6 and 50% of E. coli, K. pneumoniae and Enterobacter iso-
lates, respectively. One K. oxytoca and the Shigella isolate also pro-
duced CTX-M type ESBL(s). None of the P. mirabilis isolates were
CTX-M producers. The beta-lactamases were transferred to the
recipient E. coli K-12 (SmR) from 66% of the donors. Sequencing
results revealed CTX-M-3 production in all isolates.
Conclusion: This study shows that CTX-M type enzymes and par-
ticularly CTX-M-3 is widely disseminated in microorganisms
belonging to the family of Enterobacteriaceae in Turkey.
P753 Prospective evaluation of carriage and colonisation
with extended-spectrum beta-lactamase (ESBL) producing
Enterobacteriaceae among newly admitted patients in medical
departments
B. Rudensky, D. Raveh, E. Zartzer, E. Broidie, A.M. Yinnon
Jerusalem, IL
Objectives: To determine the colonisation rate of ESBL producing
Enterobacteriaceae among patients newly admitted to depart-
ments of internal medicine, the rate of acquisition of these organ-
isms during hospitalisation, and risk factors for both.
Table 1.
Patient Pathogen ESBL
Initial therapy Effective theraphy
Antibiotic MIC Outcentre Antibiotic MIC Outcome
Z E. coli SHV Cefotaxime 16 Failure Cefepime 2 Cure
K. pneumoniae SHV 128 32
H E. coli CTX-UNI.A 128 32 Cure
K. pneumoniae SHV 16 1
T K. pneumoniae SHV 64 8 Cure
P K. pneumoniae SHV 128 2 Failure
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Methods: During a 5-month period, a representative sample of
167 newly admitted patients was enrolled. A nasal swab and a
rectal swab were obtained on admission and subsequently every
3–4 days until discharge or death. ESBL was tested by double disk
method for cefotaxime and ceftazidime with and without clavul-
anic acid. In addition, nasal swabs were tested for presence of
methicillin resistant Staphylococcus aureus (MRSA).
Results: On admission, 15 patients (9%) were nasal carriers of
MRSA; in addition, ﬁve (3%) and 13 (8%) patients were nasal
and rectal ESBL carriers, respectively. Bivariate risk factors for
rectal ESBL carriage included: male gender, functional depend-
ency, recent antibiotic treatment, and concomitant nasal carriage
of MRSA or ESBL (P < 0.05 to P < 0.005). Multivariate indicators
were male gender and recent antibiotic treatment. During hospita-
lisation, rectal carriage increased from 13 (8%) to 35 patients
(24% of the cohort, P for trend <0.001). Bivariate risk factors for
acquisition included: older age, functional dependency, impaired
cognition, recent antibiotic treatment, chemotherapy, being
mechanically ventilated, and nasal MRSA carriage (P < 0.05–
0.001). Multivariate indicators were older age and recent antibiotic
therapy (P < 0.05 to P < 0.01). Out of 35 rectal ESBL carriers, six
(21%) died, compared with 8/83 (9%), who were not ESBL car-
riers (P ¼ 0.1).
Conclusion: Nasal and particularly rectal ESBL colonisation occurs
in a signiﬁcant percentage of patients admitted to our medical
departments. Acquisition of rectal ESBL+ organisms increases to
25% of all patients within 2 weeks. Risk factors for both phenom-
ena were identiﬁed. Isolation and cohorting of colonised patients,
although in theory the way to prevent spread of ESBL organisms
among hospitalised patients, may be difﬁcult to implement
because of the large number of colonised patients. We fear an
imminent increase in infections due to ESBL+ strains with attend-
ant increased use of broad-spectrum antimicrobials.
P754 Extended-spectrum beta-lactamases in isolates of
Enterobacteriaceae from inpatients and outpatients in Northern
Italy
F. Luzzaro, M. Perilli, E. Dell’Amico, S. Stefani, G.M. Rossolini,
G. Amicosante, A. Toniolo
Varese, L’Aquila, Siena, Catania, I
Objectives: Extended-spectrum beta-lactamases (ESBL) are import-
ant resistance traits for nosocomial isolates of Enterobacteriaceae
and their spread in the community generates increasing concern.
This study was performed to investigate the prevalence of ESBL
producers in Enterobacteria isolated from both inpatients and out-
patients in three different geographic areas of Northern Italy.
Methods: 2600 consecutive nonreplicate isolates of Enterobacteria-
ceae were collected at three Clinical Microbiology Laboratories
(Novara, Varese, and Verona; 1850 isolates from inpatients and
750 from outpatients) from June to November 2003. ESBL produc-
tion was screened for by MIC analysis and conﬁrmed by the
double-disk synergy test. ESBL determinants of the TEM-, SHV-,
CTX-M-, and PER-type were investigated by molecular analysis
(colony-blot hybridisation, PCR and DNA sequencing).
Results: The average prevalence of ESBL producers was 7.5%
among isolates from inpatients (range 4.8–8.5% in different
hospitals) and 2.5% among outpatient isolates (range 0.8–5.6% in
different geographic areas). Approximately 70% of the ESBL-
producing strains belonged to just three species: Proteus mirabilis
(n ¼ 45), Escherichia coli (n ¼ 34), and Klebsiella pneumoniae
(n ¼ 31). Most ESBLs were of the TEM- or SHV-type, the TEM-52
and SHV-12 enzymes showing the highest prevalence. CTX-M
type enzymes appeared to emerge, with most of these resistance
traits detected in E. coli isolates. Enzymes of the PER-type were
not found.
Conclusions: ESBL producers are widespread in different hospitals
of Northern Italy and are also present in the community, though
at lower rates. A variety of ESBL has been detected in several dif-
ferent species of Enterobacteriaceae and their expression is usually
associated with multi-drug resistance. Thus, surveillance of ESBL
dissemination appears to be important also for community
acquired isolates.
Acknowledgement: Supported by an educational grant from
Wyeth-Lederle SpA, Italy.
P755 CTX-M is the dominating extended-spectrum beta-
lactamase type in Norwegian clinical ESBL-producing isolates
of Escherichia coli and Klebsiella pneumoniae
S. Tofteland, B. Haldorsen, K. Dahl, G. Simonsen, M. Steinbakk,
T. Walsh, A. Sundsfjord
Tromsø, Akerhus, N; Bristol, UK
Background: We have limited knowledge regarding the prevalence
and molecular epidemiology of extended spectrum betalactamase
(ESBL)-producing clinical isolates of Enterobacteriaceae in Norway.
Objectives: (i) Evaluate methods to detect ESBL-production in
Norwegian clinical isolates of Enterobacteriaceae. (ii) Perform
ESBL-genotyping.
Methods: Consecutive isolates of Enterobacteriaceae with reduced
susceptibility to third-generation cefalosporins and/or azetreonam
were collected during March to October 2003 from 18 Norwegian
laboratories. The routine antimicrobial susceptibility method was
used in each laboratory to screen isolates using MIC breakpoint
>1 mg/L for reduced susceptibility. Further analyses included:
(i) MIC determinations  Etest + Etest ESBL. (ii) Disc-approxima-
tion test with ﬁve substrates + amoxicillin–clavulanate. (iii) Com-
bined disc method. (iv) TEM-/SHV-/CTX-M PCRs and sequence-
typing.
Results: A total of 90 E. coli and 29 K. pneumoniae strains were
detected among 191 Enterobacteriaceae-isolates. ESBL-production
was conﬁrmed in 55 E. coli and 22 K. pneumoniae isolates. Several
strains had low ceftazidime and/or cefotaxime MIC-values
(0.5–2 mg/L). ESBL-positive E. coli and K. pneumoniae was detec-
ted by Etest ESBL (53/55 and 22/22), by disc-approximation (53/
55 and 22/20) and by combined discs (51/55 and 20/22). ESBL-
producing E. coli and K. pneumoniae expressed reduced suscepti-
bility towards cefpodoxime (54/55 and 19/22), cefotaxime (52/55
and 16/22), ceftazidime (37/55 and 19/22). ESBL-genotyping has
shown both TEM (type 42) and SHV (types 2a, 28 and 48) ESBLs,
but the CTX-M-types dominate. A total of 41/44 E. coli and 5/13
K. pneumoniae isolates examined were CTX-M PCR positive.
Sequence analyses of 35 different CTX-Ms have shown type-15/-
28 (n ¼ 25), 9/9a (n ¼ 4), 1 (n ¼ 3), 3/22 (n ¼ 2) and 2/
20 (n ¼ 1).
Conclusions: (i) Using MIC breakpoint >1 mg/L for reduced sus-
ceptibility to third-generation cephalosporins we detected ESBL-
producing E. coli and K. pneumoniae with low MIC-values (0.5–
2 mg/L). (ii) Cefotaxime-hydrolysis was the dominating proﬁle in
ESBL-positive E. coli strains whereas ceftazidime was the most
sensitive substrate for detection of ESBL-production in K. pneumo-
niae. (iii) The different methods showed almost the same sensitiv-
ity in detecting ESBL production assuming that more than one
substrate was used, i.e. both cefotaxime and ceftazidime. (iv)
CTX-M was the dominating ESBL-type.
P756 Simultaneous, bi-clonal outbreak of urinary tract
infection by E. coli O25 strains with CTX-M-15: community and
hospital effects in two English health districts
R. Warren, A. Doroshenko, R. Carr, D. Patel, P. O’Neill,
G. Harvey, A. Pearson, N. Woodford, J. Turton, E. Ward,
T. Cheastey, D. Livermore, C.J. Munday, V.M. Ensor, P. Hawkey
Shrewsbury, Colindale, Birmingham, UK
Objectives: English ESBL resistance, hitherto in Klebsiella, is now
emerging in E. coli.
Methods: Urine culture on chromogenic agar (not nationally
recommended CLED); susceptibility testing, serotyping, PFGE,
sequencing of beta-lactamase genes; policy review.
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Results: Two E. coli O25 strains with CTX-M-15 ESBL and resist-
ant to quinolones and trimethoprim caused simultaneous ‘com-
munity’ and hospital UTI outbreaks with >100 cases stabilising at
4% of UTI. Blood and surgical wounds also yielded strains.
Quinolone-resistant ESBL carriage was 4% in diarrhoeal samples.
The strains, one gentamicin-susceptible and with an insertion
sequence between promoter and bla ctx-m-15, the other resistant
and without the insertion sequence, were 78% related by PFGE
and were largely distinct from other UK CTX-M-15 producers.
They were susceptible to nitrofurantoin, carbapenems, and amika-
cin; the former two were used therapeutically. Most ‘community’
cases had associations with healthcare in the previous 3 years but
spread into community hospitals and nursing homes developed
during the outbreak. Cases exceeded hospital containment isola-
tion facilities, necessitating risk prioritisation scoring for single
rooms, but co-infection with MRSA and C. difﬁcile was noted.
Descriptive epidemiology identiﬁed no common source but a
wider region reported earlier and simultaneous Klebsiella and
E. coli with CTX-M-15. Hospital and community antibiotic policies
were changed: quinolone and cephalosporin reporting was
reduced; carbapenems (inc. ertapenem) were substituted in
empirical treatment.
Conclusion: ESBL-positive E. coli have epidemic potential, justify
urgent major change to chemotherapy, and can overwhelm lim-
ited containment facilities. Focussed national surveillance, changes
to low-cost national methods, early intervention and investment
in containment are needed to prevent establishment of this rap-
idly evolving resistance class.
P757 Increased incidence of ESBL in ICU isolates from
West Midlands region, UK
V.M. Ensor, C.J. Munday, W-E. Liu, P.M. Hawkey
Birmingham, UK
Objective: The incidence of Enterobacteriaceae producing exten-
ded spectrum beta-lactamase (ESBL) causing infections in ICU
patients in the UK is currently unknown. Surveillance was con-
ducted in the West Midlands to assess current rates of antibiotic
resistance and ESBL production on ICUs.
Methods: Consecutive, non-duplicate Enterobacteriaceae were col-
lected from 12 hospitals over a 6-month period in 2003. Isolates
were identiﬁed using MAST ID or API 20E. MICs were deter-
mined by BSAC agar dilution method. ESBL producing strains
were conﬁrmed by clavulanate synergy testing.
Results: A total of 343 (no. ESBL+) isolates consisting of 98 (26)
E. coli, 38 (10) K. pneumoniae, 18 (2) K. oxytoca, 83 (37) Enterobacter
spp., 34 (6) Serratia spp., and 72 (13) others. MICs were deter-
mined to 16 antibiotics. Ninety-ﬁve strains showed at least a four-
fold decrease in MIC with a third-generation cephalosporin in the
presence of clavulanate, giving an ESBL rate of 28%. The rates of
resistance were as follows: cefoxitin 58%; cefuroxime 56%;
co-amoxiclav 53%; cefotaxime 41%; aztreonam 36%; moxiﬂoxacin
28%; ceftazidime 27%; ciproﬂoxacin 24%; gatiﬂoxacin 22%; pip-
eracillin/tazobactam and cefpirome 19%; gentamicin 13%; me-
ropenem 0.3%.
Conclusion: In a UK survey in 1991 the ESBL rate was 1%. The
BSAC bacteraemia survey, 2001–2002 reported ESBL rates of 5
and 9% in E. coli and K. pneumoniae, respectively. The ESBL rate
in this study was 28% which is the highest to be reported from
the UK yet. ESBLs were present in all ICUs surveyed (range
12–39%). About 45% of Enterobacter spp. were ESBL producers
which was the highest proportion of all species. This emphasises
the need to carefully test species other than E. coli and K. pneumo-
niae for the presence of ESBLs. Enterobacter spp. are not currently
included in NCCLS guidelines for detection of this mechanism of
resistance.
P758 Molecular characterisation of Escherichia coli isolates
producing CTX-M-15 extended-spectrum beta-lactamase (ESBL)
in the United Kingdom
N. Woodford, E. Ward, M.E. Kaufmann, J. Turton, A. Pearson,
S. Harry, R.E. Warren, D.M. Livermore
London, Shrewsbury, UK
Objectives: During 2003, the SRMD received isolates of Escherichia
coli for conﬁrmation of ESBL production with a phenotype imply-
ing a CTX-M-type beta-lactamase, i.e. cefotaxime (CTX) MICs
fourfold greater than ceftazidime (CTZ) MICs. Isolates were from
hospital patients and, in some instances, from community patients
with little or no recent hospital contact. TEM- and SHV-type
ESBLs are largely conﬁned to nosocomial isolates, so the apparent
spread of CTX-M enzymes in the community is cause for concern.
We compared the isolates and investigated the genetic basis of
their CTX-M phenotype.
Methods: Isolates were compared by PFGE of XbaI-digested
genomic DNA and data were analysed using BioNumerics soft-
ware. MICs were determined by Etest or agar dilution, and inter-
preted using BSAC breakpoints. Isolates with a CTX-M phenotype
were tested for blaCTX-M alleles by PCR, initially with universal
primers, and then with primers speciﬁc for various blaCTX-M
groups. Selected amplicons were sequenced, either directly or
after cloning into pCR2.1. Transfer of CTX-M to E. coli J62 was
attempted in broth and on agar plates.
Results: Over 100 CTX-M-producing E. coli were obtained from
more than 20 UK centres. These isolates represented multiple
strains, although clusters of related isolates (>80% similarity)
were observed, some including isolates from more than one cen-
tre. Sequencing conﬁrmed that 12 E. coli from 11 different centres
all produced CTX-M-15. Most isolates had substantial resistance
to CTX (MICs >128 mg/L) and CTZ (MICs >16 mg/L), consistent
with CTX-M-15. Isolates (n ¼ 25) associated with a large commu-
nity cluster produced atypically large amplicons with group I
CTX-M primers, as did two related isolates from another centre.
These isolates were less resistant to CTX (MICs 16–64 mg/L) and
CTZ (MICs 1–4 mg/L), and susceptible to gentamicin; sequencing
of a representative isolate identiﬁed IS26 within the terminal
inverted repeat of the ISEcpI element upstream of blaCTX-M-15,
separating the allele from its usual promoter, and the spacer
between ISEcpI and blaCTX-M-15 had a T/C polymorphism not
seen in other sequenced isolates.
Conclusions: We have conﬁrmed the recent multifocal emergence
of CTX-M-15 in the community. The isolates represented many
different strains, but transfer of the enzyme in vitro was not dem-
onstrated. Because of the public health implications, this worrying
development merits close monitoring.
P759 The prevalence of ESBL producing E. coli and
Klebsiella strains in Copenhagen, Denmark
A. Kjerulf, D.S. Hansen, N. Frimodt-Møller
Herlev, Copenhagen, DK
Objectives: Four studies were conducted in order to elucidate the
frequency of ESBL producing E. coli and Klebsiella strains in iso-
lates from hospitalised patients.
Methods: Four collections of strains were investigated: (1) 380
consecutive E. coli and Klebsiella isolates mainly from the urine
(n ¼ 360) were collected during the period 27 February to 24
March 2003 at H:S Hvidovre Hospital. (2) 200 gentamicin resistant
E. coli and Klebsiella isolates collected from 1998 to 2003 at H:S
Hvidovre Hospital. (3) 210 consecutive E. coli isolates from blood
cultures collected during the period 1 July to 31 December 2001 at
Herlev University Hospital. (4) 68 cefuroxime resistant E. coli and
Klebsiella strains mainly from the urine (n ¼ 44) collected during
the period 1 January 2002 to 30 June 203 at Herlev University
Hospital. All strains were screened for susceptibility to cefpodoxi-
me, ceftazidime, ceftriaxone and cefotaxime by the disk diffusion
method. Strains with a zone diameter for cefpodoxime <22 mm
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were tested by a phenotypic conﬁrmatory test for ESBL produc-
tion by the Oxoid combination disk method, using the above men-
tioned cephalosporins  clavulanic acid; a zone difference of
>5 mm for any of these combinations was taken as conﬁrmation
of ESBL production.
Results: Number of screening-test positive strains in the four
studies – study 1: 11/380, study 2: 20/200, study 3: 3/210 and
study 4: 56/68. Number of conﬁrmatory-test positive – study 1:
2/11, study 2: 12/20, study 3: 0/3 and study 4: 41/56. This
gives an ESBL prevalence of 0.5% (2/380) in study 1, 6% (12/
200) in study 2, 0% (0/210) in study 3 and 60% (41/68) in
study 4.
Conclusion: The prevalence of ESBL producing E. coli and Klebsiella
isolates is low in the Copenhagen area of Denmark (0.5 and 0%).
These strains, however, deserve attention due to their epidemic
potential. Among gentamicin resistant strains the prevalence of
ESBL positive strains was 12 times higher so we suggest testing
these strains for ESBL production.
P760 Emergence of ESBL-producing E. coli and
antimicrobial use in a Spanish region
A. Yagu¨e, D. Sandvang, J.-C. Rodrı´guez, G. Royo, N. Gonzalo,
A. Garcı´a-Monsalve, P. Campillos, D. Monnet, J.-M. Lo´pez-Lozano
Orihuela, E; Copenhagen, DK; Elche, E
Objectives: To describe an important outbreak of Extended-Spec-
trum Beta-Lactamase (ESBL) producing strains of Escherichia coli
(EBSL-EC) in the Vega Baja sanitary district (250 000 inhabitants
region of the South of Spain including a 400-bed general hospital).
We studied also antimicrobial sensitivity of the strains, co-resist-
ance to non-beta-lactam antimicrobials and relationship with anti-
biotic use.
Methods: Data of monthly non-duplicate EBSL-EC and antibi-
otic use (hospital: DDD/1000 pat-day and community: DDD/
1000 inhabitants-day) were collected for January 1999 to Octo-
ber 2003. Time Series Dynamic Regression models were adjus-
ted to evaluate the relationship between the use of
antimicrobials and the emergence of the bacteria. Sensitivity
testing was determined by microdilution with Gram-negative
and Urine panels (MicroScan). ESBL producing strains were
initially selected by screening with MicroScanGram-negative
and Urine panels (MIC >1 lg/mL for cefotaxime, ceftazidime
or aztreonam, and/or a difference of three or more dilutions
between ceftazidime and ceftazidime with 2 lg/mL of clavul-
anic acid). Production of ESBL was conﬁrmed using the Double
Disk Screening Test.
Results: 231 of 7678 (3%) strains of non-duplicate E. coli isolated
from January 1999 to September 2003 were ESBL-EC (71 from
inpatients and 160 from outpatients). Monthly aggregation reveals
a clear increase of ESBL-EC isolates from January 2001 to the pre-
sent time, reaching a peak of 11.4% in August 2003. This evolu-
tion was clearly preceded by a similar increase, 2 months before,
in the hospital consumption of levoﬂoxacin (the rest of antibiotics
didn’t shown any relationship) (Figure), as well as in the levoﬂ-
oxacin community use (not shown). On the other hand, our ESBL-
EC strains have very high percentages of resistance to ciproﬂoxa-
cin (mean 65.3%), cotrimoxazole (62.3%) and gentamicin
(16.45%), in contrast with the non-ESBL-EC (28.2, 34.6 and 10.1%,
respectively).
Conclusion: we think we are in the presence of an important out-
break of ESBL-producing E. coli, that affects hospital and commu-
nity settings, and that could be causally related with the great
increase in the use of levoﬂoxacin. Fluoroquinolone-resistant
strains, selected by antibiotic pressure, could have acquired resist-
ance factors (ESBL production). Moreover, the presence of plas-
mids that code for resistance (ESBL) could favour the
development of resistance to ﬂuoroquinolones by chromosomal
mutation.
P761 Risk factors for community-acquired infections due to
Escherichia coli harbouring extended-spectrum-beta-lactamases
V. Romani, E. Calbo, C. Garcia-Vidal, L. Gomez, M. Xercavins,
C. Estrada, L. Lopez-Yeste, S. Quintana, J. Garau
Terrassa, E
Introduction: The prevalence of Extended-Spectrum-B-lactamase-
producing E. coli (ESBL Ec) is increasing. In Spain, current preval-
ence rates range from 0.06 to 2.4% of all E. coli isolates. ESBLs
have been found most often in the hospital setting. However,
ESBL Ec have been increasingly recognised in the community. We
have conducted a matched case–control study to identify risk fac-
tors for community acquired (CA) ESBL Ec non-epidemic infec-
tions.
Material and methods: Adult cases and matched controls were
identiﬁed through records of the clinical microbiology laboratory
in a 450 bed acute care teaching hospital with an area of inﬂuence
of circa 300 000 population. Patients with CA infection for whom
culture results were positive for ESBL Ec were eligible. Two dif-
ferent periods were studied: from January 2000 to January 2001,
and from August to November 2003. Controls were matched in a
3:1 ratio for age, gender, date of isolation, site of infection and
residence in long-term-care facility. Potential risk factors recorded
included: patient demographics, comorbidities, site of infection,
antimicrobial therapy, bacterial infections in the past year, immu-
nosupression, McCabe Jackson score, abnormalities and/or urin-
ary tract manipulation, recent hospitalisation and contact with the
Healthcare System.
Results: In our area, the prevalence of infection of ESBL produ-
cing Ec has increased from 0.47% in 2000 to 1.62% in 2003
(P < 0.001) with respect to all Ec isolates. CA infection shifted
from 47% in the ﬁrst period to 80% in 2003. Out of the 15 cases
of CA-ESBL Ec found were urinary tract infections, 87% were
women and the mean age was 65 (range 17–92). On univariate
analysis only connective tissue disease (P < 0.003), genitourinary
pathology (P < 0.008), infections in the past year (P < 0.007) and
previous exposure to second-generation cephalosporins
(P < 0.001) were factors associated with CA infection due to ESBL
Ec. In our regression model, only previous exposure to second-
generation cephalosporins was strongly associated (OR 18.25, CI
95% 1.92–175).
Conclusions: In the last 3 years there has been a marked increase
in infections due to ESBL Ec, especially from the community.
Only previous exposure to second-generation cephalosporins (not
to ciproﬂoxacin, third-generation cephalosporins or aminoglyco-
sides) was predictive of an ESBL Ec CA infection. Strikingly, nei-
ther comorbidity nor previous contact with the Healthcare System
was risk factors for ESBL Ec.
Figure 1. Emergence of Extended specturm Beta Lactamase E. coli
and use of ﬂuroquinolones. Vega Baja sanitary district (Spain)
(1999–2003).
190 Abstracts
P762 Emergence of CTX-M-type enzymes in hospital- and
community-acquired isolates of Escherichia coli from Northern
Italy
G. Brigante, F. Luzzaro, M. Perilli, G. Lombardi, G.M. Rossolini,
G. Amicosante, A. Toniolo
Varese, L’Aquila, Siena, I
Objectives: Enzymes of the CTX-M family are currently classiﬁed
as extended-spectrum beta-lactamases (ESBLs). Over the last dec-
ade, CTX-M-type enzymes have been increasingly reported from
several countries in Europe. The aim of this study was to search
for CTX-M-type enzymes in Escherichia coli isolates obtained at
our Institution (Varese, Northern Italy).
Methods: We studied consecutive E. coli isolates recovered over a
2-year period (2000–2002). Stains suspected of producing ESBLs
(according to NCCLS criteria) were further investigated. The dou-
ble-disk synergy test and Etest ESBL strips (AB Biodisk, Solna,
Sweden) were used to conﬁrm ESBL production. The Etest
method was also used to evaluate MICs of amikacin, gentamicin,
ciproﬂoxacin, and beta-lactams (including last-generation cephalo-
sporins, carbapenems, and aztreonam). ESBL-positive isolates
were evaluated for the presence of CTX-M-type genes using speci-
ﬁc DNA probes. Patient records were examined to assess risk fac-
tors for infections and underlying clinical conditions.
Results: A total of 12 386 consecutive E. coli isolates were studied.
Overall, 26 out of 124 ESBL-positive strains were found to carry a
CTX-M-type gene and to produce a CTX-M-type enzyme.
Most isolates (21/26) showed high MIC values for cefotaxime
(>32 mg/L) and borderline values for ceftazidime (1–2 mg/L).
The remaining ﬁve isolates had also high MICs for ceftazidime.
CTX-M-positive isolates were obtained both from inpatients
(n ¼ 17) and outpatients (n ¼ 9). Epidemiological analysis showed
that most strains were isolated from urinary tract infections, even
though some isolates were recovered from the lower respiratory
tract, wounds and blood. Most patients (20/26) were treated with
immunosuppressive therapy. Recurrent urinary infections
occurred in ﬁve outpatients.
Conclusions: CTX-M-type enzymes appear to be emerging among
E. coli isolates in both the hospital and community environments.
The analysis of clinical records demonstrated that these microor-
ganisms can cause severe and persistent infections. Therefore,
despite the currently low prevalence of CTX-M phenotype, we
suggest that a monitoring of this resistance phenotype should be
established to avoid the spreading of resistance traits.
P763 First detection of Escherichia coli and Klebsiella
pneumoniae clinical isolates producing acquired beta-lactamases
of the CMY-LAT lineage in Italy
L. Pagani, M.M. D’Andrea, R. Migliavacca, E. Dell’Amico,
M. Spalla, E. Nucleo, G.M. Rossolini
Pavia, Siena, I
Background and Objectives: Class C beta-lactamases (CBLs) are
enzymes that confer broad-spectrum beta-lactam resistance (inclu-
ding penicillin, expanded-spectrum cephalosporins, and cepha-
mycins) and are poorly or not susceptible to commercially
available beta-lactamase inhibitors. In strains with reduced outer
membrane permeability, they can also provide resistance to carb-
apenems. A number of these enzymes are chromosomally enco-
ded, but plasmid-mediated CBLs are also known as a cause of
acquired resistance to expanded-spectrum cephalosporins and
cephamycins in clinical isolates of Enterobacteriaceae. In Italy,
only the FOX-3 acquired CBL has previously been reported, in
Klebsiella spp. In this work we report the ﬁrst detection of
acquired CBLs of the CMY-LAT lineage in Escherichia coli and Kle-
bsiella pneumoniae clinical isolates from an Italian hospital.
Methods: Ten consecutive non-replicate clinical isolates of E. coli
(eight) and K. pneumoniae (two) resistant to expanded-spectrum
cephalosporins and cephamycins were collected, during 2002, at
the Laboratory of Microbiology of the S. Matteo Hospital of Pavia
(northern Italy). In vitro susceptibility testing was determined by a
microdilution method according to NCCLS. Beta-lactamase pro-
duction was investigated by analytical isoelectric focusing (IEF)
coupled with a bio-assay. Molecular characterisation of beta-lacta-
mase genes was carried out by a multiplex PCR approach
designed for detection of all major lineages of acquired CBLs
genes, and by sequencing. Transferability of resistance genes was
tested by mating assays in liquid medium.
Results: Two isolates, one of E. coli and one of K. pneumoniae, were
found to be resistant to expanded-spectrum cephalosporins, except
for cefepime, and cephamycins (cefoxitin MICs >128 mg/L). Both
isolates produced a beta-lactamase of pI >8.4 that showed hydro-
lytic activity against cefoxitin, cefotaxime and ceftazidime. Molecu-
lar characterisation revealed, in both cases, the presence of an
acquired CBL gene of the CMY-LAT lineage, which was compat-
ible with blaCMY-2/LAT-3 (the leader peptide-encoding region
was not sequenced). The CBL determinant was transferable by
conjugation from the E. coli isolate, while conjugal transfer was not
detected from the K. pneumoniae isolate.
Conclusions: These ﬁndings reveal that acquired CBLs of the
CMY-LAT lineage, which are the most common acquired CBLs,
can also be encountered in nosocomial settings from northern
Italy.
Enteropathogens
P764 Dissemination of sulphonamide resistance genes: ﬁrst
sul3 found in Salmonella from Portugal
P. Antunes, J. Machado, J.C. Sousa, L. Peixe
Porto, Lisbon, P
Objectives: The purpose of this study was to determine the distri-
bution of sulphonamide resistance genes sul1, sul2 and sul3 and
class 1 integrons in Portuguese Salmonella isolates collected during
2002–2003, from human and nonhuman sources.
Methods: Eight hundred and seventy-ﬁve isolates were tested for
resistance to 10 antimicrobial agents by the agar dilution method.
Sulphonamide resistant isolates were screened for resistance genes
sul1, sul2, and sul3 and class 1 integrons by PCR assays.
Results: Resistance was found in 54% and multiresistance in 21%
of the isolates. In 151 (17%) sulphonamide-resistant isolates (MICs
512 mg/L), 118 (78%) sul1 genes, 57 (38%) sul2 genes and nine
(6%) sul3 genes were detected. In 29 isolates, more than one gene
encoding sulphonamide resistance was present: sul1 and sul2 in
22, sul1 and sul3 in three and sul1, sul2 and sul3 in four. Class 1
integrons were found in 77% of those isolates. Among the 116 iso-
lates carrying class 1 integrons, 114 presented sul1 gene, found
alone (87 isolates) or simultaneously with sul2 (20) or sul3 (3) and
with sul2 and sul3 (4). The two strains with class 1 integrons,
which lacked the qacED1 and sul1 genes, carried a sul3 gene. Of
the 118 sul1-positive isolates, 114 harboured class 1 integrons.
Conclusion: Class 1 integrons and sulphonamide resistance genes
are widespread among Salmonella. The newly described sul3 gene
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has now been identiﬁed in nine Salmonella isolates collected from
human and nonhuman sources in Portugal.
P765 Characterisation of beta-lactamase production in
Salmonella from Portugal
P. Antunes, J. Machado, J.C. Sousa, L. Peixe
Porto, Lisbon, P
Objectives: The aim of this study was the characterisation of beta-
lactamase production in Portuguese Salmonella isolates collected
during 2002–2003, from human and non-human sources.
Methods: Eight hundred and seventy-ﬁve isolates were tested for
resistance to 10 antimicrobial agents by the agar dilution
method. A double-disk synergy test for the detection of exten-
ded-spectrum beta-lactamase production was performed by disk
diffusion method. The identiﬁcation of beta-lactamases was done
in ampicillin resistant isolates by IEF and PCR assays, with
primers, which detects genes encoding TEM, PSE-1 and OXA
group III enzymes. To evaluate the association of beta-lactamase
genes to class 1 integrons, 50CS–30CS primers were used in a
PCR assay. PCR products were puriﬁed and both strands
sequenced.
Results: In total, 17% of the isolates exhibited resistance to ampi-
cillin, with MICs 64 mg/L. Resistance to ampicillin was conferred
by a TEM-1 beta-lactamase in 99 (68%) of the isolates, PSE-1 in 37
(25%) and OXA-30 in nine isolates. It is to be noted that there is
the detection of the extended-spectrum beta-lactamase (ESBL)
TEM-52 in one isolate. The TEM-type beta-lactamases was not
associated with class 1 integrons. In contrast, all the blapse-1 and
blaoxa-30 genes were inserted in 1200 and 2000 bp class 1 integ-
rons, respectively.
Conclusion: A considerable percentage of Portuguese Salmonella
were resistant to beta-lactams, mostly due to the production of
TEM-1 like beta-lactamase and PSE-1 inserted in integrons. The
detection of an isolate that produce an ESBL, such as TEM-52,
and nine isolates carrying a class 1 integron with OXA-30, are
causes of concern due to the possible therapeutic failures with
broad-spectrum beta-lactams.
P766 Increasing incidence of Salmonella typhii with
reduced susceptibility to ciproﬂoxacin in Kuwait
A.A. Dashti, P.W.J. West, D. Panigrahi
Suleibikhat, KWT
Objectives: To determine the current incidence of reduced ciproﬂ-
oxacin susceptibility in Salmonella typhi, to compare with previous
data and to investigate the mechanism responsible.
Methods: 48 isolates of S. typhi collected in 2002–2003 were tested
for susceptibility to ciproﬂoxacin and other antibiotics using the
Vitek 2 and E-test. Isolates showing reduced ciproﬂoxacin suscep-
tibility were subjected to PCR to determine if a mutation of the
gyrA gene was responsible. PCR was carried out using two prim-
ers (ATGAGCGACCTTGCGAGAGAAATTACACCG) and (TTCC-
ATCAGCCCTTCAATGCTGATGTCTTC). Results were compared
with those for isolates collected from 1995–1997.
Results: 18 out of 48 (42%) of the isolates were resistant to mul-
tiple antibiotics, including ampicillin, chloramphenicol tetracycline
and trimethoprim. Of these 12 (67%) showed resistance to nali-
dixic acid and reduced susceptibility to ciproﬂoxacin (MIC 0.125–
0.38 mg/L). Of the 30 susceptible isolates, seven (23%) showed
reduced ciproﬂoxacin susceptibility. Isolates from 1995 to 1997
showed 11% of 53 multi-resistant strains, but none of 100 suscept-
ible isolates with reduced ciproﬂoxacin susceptibility. PCR results
showed mutations of the gyrA gene.
Conclusion: Reduced susceptibility to ciproﬂoxacin in multi-resist-
ant S. typhi has increased from 11% in 1995–1996 to 67% in 2002–
2003 and from 0 to 23% in susceptible strains. Mutation of gyrA
is the mechanism responsible.
P767 Comparison of antimicrobial resistance in
diarrhoeagenic Escherichia coli isolates causing traveller’s
diarrhoea between two periods, 1994–1997 and 2001–2003
E. Mendez Arancibia, J. Ruiz, R. Cabrera, J. Gascon, J. Vila
Barcelona, E
Objectives: To compare the antimicrobial resistance levels in
Escherichia coli clinical isolates causing traveller’s diarrhoea in two
periods, 1994–1997 and 2001–2003.
Material and methods: Presence of enteroaggregative (EAEC) and
enterotoxigenic E. coli (ETEC) was established by PCR among
those isolated from travellers with diarrhoea during the periods
1994–1997 and 2001–2003. Susceptibility to ampicillin (AMP),
amoxicillin plus clavulanic acid (AMC), tetracycline (TET), chlo-
ramphenicol (CHL), cotrimoxazole (SXT), nalidixic acid (NAL)
and ciproﬂoxacin (CIP) was determined by disk diffusion.
Results: One hundred thirty-two (50 EAEC, 82 ETEC) and 113
(49 EAEC, 64 ETEC) diarrhoeagenic E. coli were recovered dur-
ing two periods, 1994–1997 and 2001–2003, respectively. The
levels of resistance of EAEC to all tested antibacterial agents
increased in the second period: AMP from 52 to 73%, AMC
from 0 to 10%, TET from 64 to 86%, SXT from 48 to 69%,
NAL from 6 to 31% and CIP from 2 to 16% (P < 0.0001),
whereas the leaves of resistance to CHL showed a slight
decrease (28–22%) but not statistically signiﬁcant. In ETEC
strains resistance to AMP, NAL, CIP and AMC increased from
43 to 50%; 6 to 17%; 1 to 6%; 0 to 6%, respectively, while
resistance to CHL decreased from 20 to 14%. The levels of
resistance to TET and SXT did not present greater differences,
but suggested a slight increase in the resistance (57–61% and
50–53% respectively).
Conclusions: A trend to an increase in the resistance of EAEC and
ETEC to AMP, AMC, NAL, and CIP has been detected, and the
decrease of resistance to CIP is worthy of note due to the fact that
this antimocrobial agent is considered a ﬁrst choice treatment for
traveller’s diarrhoea.
P768 Increasing ﬂuoroquinolone resistance in Salmonella
isolates in Finland
A.J. Hakanen, S. Pitka¨nen, A. Siitonen, P. Kotilainen, J. Jalava,
P. Huovinen
Turku, Helsinki, FIN
Objectives: Quinolone-resistant Salmonella isolates emerged in Fin-
land in the mid-1990s. The main origin of these strains is travel-
lers returning from Southeast Asia. This study was performed to
evaluate the incidence and changes of ﬂuoroquinolone resistance
in Salmonella isolates between 2000 and 2003 in Finland.
Methods: We collected a total of 805 Salmonella enterica isolates
which were considered to be epidemiologically unrelated. The iso-
lates were divided into two groups (Finnish and foreign isolates)
on the basis of travel history. The collection was performed in
four phases: each year in 2000, 2001, 2002 and 2003 starting in
January, we consecutively collected 100 Finnish and 100 foreign
isolates. MICs for nalidixic acid, ciproﬂoxacin and 10 additional
ﬂuoroquinolones were determined by the standard agar dilution
method (NCCLS).
Results: During the study period, the number of isolates with
decreased ciproﬂoxacin susceptibility (MIC of ciproﬂoxacin
>0.125 lg/mL) increased from 16 to 34% of all isolates (P < 0.01).
A similar trend could be seen both among the isolates of foreign
and Finnish origin. In addition, within the non-susceptible popu-
lation the MIC values were increasing. MIC50 of ciproﬂoxacin
increased from 0.25 to 0.5 lg/mL among the isolates with
decreased ciproﬂoxacin susceptibility between 2000 and 2003. The
respective ﬁgures for MIC90 were 0.5 and 1 lg/mL. All isolates
with decreased ciproﬂoxacin susceptibility had also increased
MICs to additional ﬂuoroquinolones.
Conclusion: The number of Salmonella isolates with decreased
ciproﬂoxacin susceptibility continues to grow in Finland.
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Moreover, the MIC levels of these isolates have increased. This
phenomenon might have serious clinical implications.
P769 Bacteraemia caused by ESBL-producing Salmonella
enterica serovar. virchow 6.7:r:1,2 – a cause for concern
A. Guleri, G.D. Corcoran, S.R. Alcock, D.J. Brown
Glasgow, UK
Background: Antibiotic resistance in Salmonellae is now common.
In developed countries such strains are largely zoonotic and
acquire resistance in the animal host before transmission to
humans in food. We present our ﬁrst case of bacteraemic illness
with multi-resistant, extended spectrum beta lactamase (ESBL)
producing non-typhoidal Salmonella.
Case summary: A 34-year-old male, with a history of recent for-
eign travel was admitted to hospital with a 7–10 day history of
gastrointestinal symptoms/fever. On admission he was febrile
and splenomegaly was detected. Physical examination was other-
wise normal. Biochemistry revealed mildly deranged liver func-
tion. Salmonella enterica serovar. virchow 6.7:r:1,2 was isolated from
blood culture. It was sensitive in vitro (NCCLS disk test) to
ciproﬂoxacin and gentamicin but resistant to ampicillin, cefuroxi-
me, cefotaxime, ceftriaxone, ceftazidime, co-trimoxazole, nalidixic
acid and streptomycin. MIC of ciproﬂoxacin was 0.094 mg/L.
Antibiotic treatment was with ciproﬂoxacin, to which he respon-
ded well.
ESBL detection: The isolate was identiﬁed as Salmonella enterica
serovar. virchow 6.7:r:1,2 [API 20 identiﬁcation system (bio-
Me´rieux), serogrouping, serotyping and phagetyping]. The isolate,
resistant in vitro (NCCLS) to cefotaxime and ceftazidime, was tes-
ted for extended-spectrum beta lactamase/AmpC production by
phenotypic methods. AB Biodisk ESBL E–tests (cefepime, ceftazi-
dime and cefotaxime, each  clavulanic acid) and Oxoid ESBL
combination disks (cefpodoxime, ceftazidime, cefotaxime and
cefpirome, each  clavulanic acid) and cefoxitin alone were used
based on modiﬁed NCCLS/manufacturer’s guidelines. The isolate
tested positive for ESBL production by both ESBL E-tests and
combination disks. Molecular typing of the ESBL is awaited.
Conclusion: Invasive infection with Salmonella virchow is uncom-
mon. The source of infection in this case appears to have been un-
dercooked chicken. The emergence of resistance to antimicrobial
agents within the salmonellae is a worldwide problem that has
been associated with the use of antibiotics in livestock. Invasive
infection with S. virchow, resistant to broad-spectrum beta-lactams,
is a cause for concern. If antimicrobial therapy is indicated for
travellers with a history of recent foreign travel, physicians should
be aware of the possibility of treatment failures and in such cases
MICs of third-generation cephalosporins and ciproﬂoxacin should
be determined.
P770 The ﬁrst outbreak of Shiaga toxin producing
Escherichia coli (STEC) in Korea: molecular–epidemiological
approach
S. Kim, Y. Kim, M. Park, J. Kim, S. Jeon, H. Jang, S. Kim,
S.G. Chun, S. Kim, J.-H. Kim, J. Koo, Y. Kang, J. Lee, P. Park,
J. Hur, Y. Kim, B. Lee
Seoul, Suwon, KOR
Objectives: Since 1982, in many countries, epidemic or sporadic
cases caused by Shiga toxin producing E. coli (STEC) were repor-
ted. But in Korea, after active surveillance system to STEC was
initiated in 1996, only 21 STEC sporadic human infection cases
were reported until 2002. But in 2003, 39 strains of STEC were iso-
lated from epidemic or sporadic cases between June and July. We
try to elucidate the genetic relations between these 39 STEC iso-
lates in this study.
Methods: O Seorgroup of each STEC isolate was detected by
E. coli serotyping kit (Laboratorio de Reference de E. coli, Lugo,
Spain). Antimicrobial susceptibilities test was performed by the
disk diffusion method of National Committee of Clinical Laborat-
ory Standards. PFGE was conducted by PulseNet standardised
protocol and computer-assisted analysis of the PFGE banding pat-
terns was performed with Fingerprinting II Informatix software
(Bio-Rad).
Results: 39 STEC isolates were categorised to 11 O serogroups –
O21, O26, O55, O91, O103, O104, O111, O119, O121, O157 and
OUT. The most prevailed serogroup was O104 (nine strains) and
the next was O55 (eight strains). Antibiogram and PFGE type was
closely correlated with O serogroup. Eight of O104 isolates were
resistant to ampicillin and ticarcillin, and their PFGE type was
identical except one isolate, which showed 96.97% relatedness
with other O104 serpgroup isolates. All eight of O55 strains were
resistant to chloramphenicol, nalidixic acid, stereptomycin and tet-
racycline. Five of O55 strains showed identical PFGE type. From
the comparison with PFGE types of SETC strains isolated between
1998 and 2002, O104 and O55 serotype strains were not closely
related with isolates before 2002.
Conclusions: PFGE types of STEC strains isolated in 2003 were
closely correlated with O serogroup and their patterns of antibi-
otic susceptibility. Thirty-nine cases of STEC infection in 2003 can
be differentiated two remarkable outbreaks, caused from O104
and O55 serotype, and some sporadic cases.
P771 Epidemiology of antibiotic resistance of non-
typhoidal Salmonella isolates originating from non-human
sources during an 11-year period in Greece
A. Markogiannakis, E.N. Velonakis, L. Kondyli, M. Mouroutsou,
M. Katramadou, M. Lampiri, M. Passiotou, A. Bethimouti, A.C.
Vatopoulos
Athens, Halkis, GR
Objective: The aim of the present study was to assess the distribu-
tion and the antibiotic resistance rates (ARR) of the various non-
typhoidal Salmonella serotypes originated from non-human
sources in Greece, during a 11-year period (1990–2000).
Material and methods: A total of 753 isolates, belonging to 27 dif-
ferent serotypes, were selected from the collection of National Ref-
erence Center for Salmonella and Shigella (NRCSS), in order to
reﬂect the prevalence of these serotypes during the mentioned
period. The sample consisted of 382 isolates from animals, 295 iso-
lates from foods, and 76 environmental isolates. Susceptibilities to
10 antibiotics of various classes were determined using MICs
broth micro-dilution method.
Results and conclusions: The highest ARR and also the higher
incidence of multiresistance have been observed for S. virhow,
followed by S. hadar and S. typhimurium. The vast part of
Table 1. Distribution (%) of the main non-typhoidal salmonella antibiotic resist-
ance phenotypes originated from non-human sources during an 11-year period
(1999–2000)
Serotype Sens. A A/T A/T/* A/T/C/*
S. enteritidis (n ¼ 418)ðaÞ 62.4 18.2 3.3 0.9 0
S. eyphimurium (n ¼ 157) 42.7 0 1.9 10.2 32.5
S. virhow (n ¼ 38) 31.6 10.5 7.9 28.9 18.4
S. livingstone (n ¼ 33) 87.9 3 3 3 0
S. gallinarum (n ¼ 29) 93.1 0 3.5 0 0
S. hadar (n ¼ 27) 33.3 3.7 7.4 11.1 6
Other serotypes (n ¼ 51) 94.1 1.9 0 1.9 0
ðaÞNumber of tested isolates.
Sens.: Sensitive isolates, A: ampicillin, T:tetracycline, C: chloramphenicol, : any
other antibiotic.
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S. typhimurium isolates was resistant at least to ampicillin, tetra-
cycline and chloramphenicol, while the main resistance pheno-
type of S. enteritidis isolates was the monoresistance to ampicillin
(Table). The ARR and the phenotypes of resistance for the iso-
lates of the above four serotypes were similar with the corres-
ponding ones of human isolates as resulted from a recent Greek
study derived also from NRCSS (Eur J Epidemiol 2001; 17: 751–
755) a fact consistent with possible transfer of antibiotic resistant
strains from animals to humans through the food chain. The
incidence of resistance for the rest of serotypes was very low.
All the examined isolates were susceptible to ceftriaxone and ci-
proﬂoxacin. Interestingly, almost all the examined isolates
belonged to animals bred at a non-industrial scale (e.g. pigeons)
and the environmental isolates were sensitive to all tested anti-
microbials, possibly because of the reduced antibiotic pressure in
these isolates.
P772 Serotypes and antibiotic resistance patterns of
Salmonella species isolates in the province of South-Kivu,
Democratic Republic of Congo
N. Zozo, O. Vandenberg, B. Bisimwa, A. Dediste, P. Donnen,
G. Zissis, J. Butzler
Bukavu, CD; Brussels, B
Objective: Salmonella infections represent a major health problem
worldwide but particularly in developing countries. To ensure
appropriate treatment of salmonellosis in the province of South-
Kivu, Democratic Republic of Congo, we conducted a provincial
survey to determine the serotypes and antimicrobial resistance of
Salmonella isolates between September 1997 and November 2003.
Methods: All Salmonella isolates received at the Provincial Public
Health Reference laboratory during this period were studied for
serotyping and resistance to 11 antimicrobial agents, including
third-generation cephalosporins and ﬂuoroquinolones.
Results: Among the 182 Salmonella spp. studied, S. typhi (39.6%)
and S. typhimurium (30.9%) were the most common serogroups
found. Ninety-two per cent were multidrug resistant with the fol-
lowing proportion of resistant strains to: ampicillin (97.9%), chlo-
ramphenicol (92.9%), co-trimoxazole (95.7%) and tetracycline
(60.5%). The most common resistance pattern seen was ampicillin,
chloramphenicol, tetracyclin and co-trimoxazole. All but one
strain were sensitive to amikacin, ceftriaxone, ciproﬂoxacin and
nalidixic acid.
Conclusions: Due to the high prevalence of multidrug resistance,
third-generation cephalosporins or ﬂuoroquinolones are now the
drug of choice to treat severe Salmonella infection in the province
of South-Kivu. These ﬁndings indicate the need to use drugs
rationally in order to control the spread of multi-drug resistance
in province of South-Kivu.
P773 Antimicrobial resistance of human non-typhoidal
Salmonella in Ankara, Turkey
I. Mumcuoglu, N. Balaban, I. Baran, Z.C. Karahan, V. Yetener,
H. Bodur
Ankara, TR
Objectives: In this study we aimed to investigate the antimicrobial
resistance and the epidemiologic characteristics of 423 human
non-typhoidal Salmonella spp. isolates which were obtained from
stool specimens of 11 768 patients between 1996 and 2001.
Methods: Between 1996 and 2001, 423 Salmonella spp. isolates
were obtained from the community acquired infections in Ankara,
Turkey. Salmonella strains were identiﬁed by standard biochemical
reactions and using spesiﬁc O and H antisera. Antimicrobial sus-
ceptibility for Ampicillin (AMP), trimethoprim–sulfametoxazole
(TMP–SXT) and ciproﬂoxacin (CIP) was determined by the disk
diffusion method according to National Committee for Clinical
Laboratory Standards.
Results: Species which were identiﬁed in this study were 293
(69.2%) S. enteritidis, 86 (20.3%), S. typhimurium and 44 (10.3%)
others. In order to show the differences in epidemiology and anti-
microbial resistance, the study was divided into two periods:
1996–1998 and 1999–2001. The isolation rates of S. enteritidis, S. ty-
phimurium and the others were 74.2, 18.2 and 7.6%, respectively,
in the ﬁrst period. In the second period isolation rates were found
51.6, 29 and 18.4%, respectively. Antimicrobial resistance for
(AMP and TMP-SXT) in S. enteritidis, S. typhimurium and others
were found (33.0/11.6%), (31.6/16.6%) and (19.0/8.0%) in the
ﬁrst period and (41.0/17.0%), (42.3/19.2%) and (23.0/15.0%) in
the second period, respectively. All the isolates were susceptible
to ciproﬂoxacin except one in other non-typhoidal Salmonella
group.
Conclusions: The increasing number of ampicillin and trimetho-
prim–sulfametoxazole resistant Salmonella strains makes these
drugs unsuitable for empiric treatment.
P774 Epidemiology and antimicrobial resistance of Shigella
spp. in Ankara, Turkey, during a 9-year period (1992–2000)
N. Balaban, I. Mumcuoglu, A. Ulusoy, N. Hayirlioglu, V. Yetener,
H. Bodur
Ankara, TR
Objectives: The aim of this study was to investigate the epidemi-
ology and antimicrobial resistance of Shigella spp. in Ankara, Tur-
key.
Method: The laboratory data were analysed in 978 Shigella spp.
isolated from stool materials of adult patients over a 9-year period
(1992–2000) retrospectively. Shigella isolates were identiﬁed by
standard biochemical reactions and using speciﬁc antisera. Anti-
microbial susceptibility for ampicillin (AMP), trimethoprim–sulfa-
methoxazole (TMP–SXT) and ciproﬂoxacin (CIP) were determined
by the disk diffusion method according to National Committee
for Clinical Laboratory Standards.
Results: In order to show the differences in epidemiology and
antimicrobial resistance, the study was divided into two periods.
The ﬁrst period was from 1992 to1996, and the second period was
from 1997 to 2000. A total of 475 Shigella spp. isolates were
obtained in the ﬁrst period and 503 isolates in the second period.
Isolation rates of the strains in the ﬁrst and second periods were,
respectively, for Shigella ﬂexneri 55.7 and 21.5%; for Shigella sonnei
30.5 and 60.4%; for Shigella dysenteria 8.9 and 11.9%; and for Shig-
ella boydii 4.8 and 6.2%. The rates of resistance to (AMP) in the
ﬁrst and second periods were respectively in S. ﬂexneri 64.9 and
66.7%; S. sonnei 54.5 and 30.5%, S. dysenteria 32.4 and 62.0%;
S. boydii 46.0 and 65.0%. The rates of resistance to TMP–SXT in
S. ﬂexneri 22.6 and 40.8%; S. sonnei 38.0 and 41.3%; S. dysenteria
23.2 and 33.7%; S. boydii 40.0 and 56.5%. All strains were suscept-
ible to ciproﬂoksasin.
Conclusions: S. ﬂexneri was the most common species isolated in
the ﬁrst period and S. sonnei was the common species in the sec-
ond period. In Ankara, the data showed an increase in the resist-
ance to the commonly used antimicrobial agents are ampicillin
and trimethoprim–sulfamethoxazole. Ciproﬂoxacin seemed to be
the best choice for the treatment of Shigelliosis.
P775 Antimicrobial resistance in Salmonella and Shigella
strains isolated from stool cultures over a 2-year period in
Kocaeli, Turkey
S. Gu¨nde, H. U¨c¸karde, A. Willke
Kocaeli, TR
Objectives: To determine the antimicrobial resistance in Salmonella
and Shigella strains isolated from stool specimens during a 2-year
period, from patients admitted to our clinics with a diagnosis of
diarrhoea.
Methods: The identiﬁcation and susceptibility testing was done by
VITEC 2 (bioMerieux, Fr) automated system. The antibiotics
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tested for the study were ampicillin, ampicillin–sulbactam, cefo-
taxime, cefepim, ciproﬂoxacin, oﬂoxacin, and trimethoprim–sul-
fametaxazole.
Results: Nineteen Salmonella and seven Shigella isolates obtained
between 1 January 2002 and 30 November 2003 were tested for
their susceptibilities to seven antimicrobial agents. The total num-
bers of isolates during 1999–2001 (including the year of big Mar-
mara earthquake) were 39. Five of six Shigella isolates were
S. sonnei, one was S. ﬂexneri. Thirteen of 19 Salmonella isolates
were S. typhimurium, three were S. enteritidis, two were identiﬁed
as Salmonella spp., one was S. arizonae. Although all of the isolates
were found susceptible to the therapeutic agents, ampicillin sus-
ceptibility was decreased to 78% from 100% and trimethoprim–
sulfametaxazole susceptibility was decreased to 89% from 100%
in Salmonella strains during a 2-year period. Only one strain was
resistant to cefotaxime. No resistance was found against oﬂoxacin
and ciproﬂoxacin. All of the Shigella isolates were susceptible to
all tested antibiotics.
Conclusions: (1) The incidence of Salmonella and Shigella infections
seemed to decrease signiﬁcantly over a 5-year period.
(2) S. typhimurium and Shigella sonnei are the most commonly
identiﬁed serotypes. (3) There is no signiﬁcant change in resist-
ance to ‘old’ and ‘new’ antibiotics. (4) All of the isolates showed a
very good sensitivity all the antimicrobials tested. (5) A careful
rotational use of antibiotics might be the best policy to make old
drugs again active, and abuse of new agents.
P776 Transmission and antibiotic resistance of
Campylobacter sp. in a poultry slaughterhouse
J. Posch, W. Sixl, G. Wu¨st, S. Schmidt, F.F. Reinthaler, G. Feierl,
E. Marth
Graz, A
Objectives: Since 1996 the incidence of human Campylobacteriosis
has shown a signiﬁcant increase in Austria. Consumption of con-
taminated poultry products is a well known risk factor for human
infections. During the slaughter process meat products can
become contaminated with intestinal organisms. Furthermore anti-
biotic resistance is increasing in humans and animals. The aim of
the study was to determine the resistance patterns and the trans-
mission routes of Campylobacter sp. on the chicken-carcasses along
the slaughter line.
Methods: From June 2002 until October 2003, a total of 88 slaugh-
terhouse-equipment swab samples were collected and tested for
the presence of Campylobacter organisms. Further ﬁve measure-
ments of air were conducted during slaughtering, by using the
SKC Bio Sampler (two sampling sites). The strains were cultured
on mCCDA-agar (microaerophilic, 48 h, 42C). A total of 130
strains were tested by disc diffusion method for susceptibility to
nalidixic acid (NA), ciproﬂoxacin (CIP), tetracycline (TE) and
erythromycin (E).
Results: Among the 88 equipment swabs 65% were positive for
Campylobacter sp. Species distribution was: 75% C. jejuni and 25%
C. coli. Eight samples contained both, C. jej and C. coli; 49% of
strains were resistant to NA, 48% to CIP and 32% to TE. Further
a total of 65 airborne Campylobacter sp. were analysed; 52% were
C. jej and 48% C. coli and 68% of them showed resistance against
NA and CIP, and 31% to TE. All strains were susceptible to E.
The number of airborne Campylobacter sp. ranged from 0 to
4  104 CFU/m3.
Conclusion: The study shows signiﬁcant contamination of Campy-
lobacter sp. of both the equipment as well as the air of the slaugh-
terhouse. The slaughter of poultry is a largely mechanical
process, so it is evident that intestinal colonised ﬂocks lead to
cross-contamination of Campylobacter-free carcasses. The present
study shows importantly higher concentrations of airborne Cam-
pylobacter sp. in comparison to previous investigations. So we con-
sider these levels of airborne Campylobacter sp. as an
underestimated risk factor for transmission. Moreover resistant
strains in the food chain can compromise the antibiotic treatment
of human infections.
P777 Resistance of Shigella spp. in different regions of
Russia
O. Kretchikova, A. Ivanov, M. Sukhorukova, L. Stratchounski
Smolensk, RUS
Objectives: Incidence of shigellosis in Russia is high and greater
than in Western Europe and USA. In order to be efﬁcacious, to
decrease the risk of complications, and to restrict the spread of
multiresistant strains in population, antimicrobial therapy of shi-
gellosis should be based on local data on antimicrobial suscepti-
bilities of the causative pathogen.
Methods: The strains were isolated from faeces of in-patients with
clinically suspected shigellosis in 1998–2001 in Bryansk (B),
St-Petersburg (SP), Smolensk (S), Moscow and Ekaterinburg. The
tested antimicrobials were: ampicillin (AM), ampicillin/sulbactam
(AMS), cefotaxime (CTX), tetracycline (TE), chloramphenicol (CL),
ciproﬂoxacin (CIP), and co-thrimoxazole (SXT). An agar dilution
method was used in the study. All procedures were performed
and the results were interpreted according to the NCCLS recom-
mendations (January 2003).
Results: A total of 458 strains were tested. S. ﬂexneri (180 strains)
and S. sonnei (278 strains) were highly resistant to the following
drugs (respectively): SXT (92.2 and 91.4%), TE (98.3 and 83.5%),
CL (95.6 and 42.8%), AM (96.1 and 26.6%) and AMS (95.6 and
25.2%). No strains were resistant to CIP or CTX. Multiresistance
(to four or more drugs) was shown in 96.1% of S. ﬂexneri and
23.7% of S. sonnei strains. More strains of S. ﬂexneri (vs. S. sonnei)
were resistant in B (78 isolates), SP (50 isolates) and S (281 iso-
lates), respectively, to AM (100 vs. 10.9% in B, 96.6 vs. 38.1% in
SP, 95.5 vs. 30.7% in S), CL (100 vs. 26.6% in B, 100 vs. 66.7%
in SP, 93.3 vs. 45.8% in S), TE (92.9 vs. 62.5% in B, 100 vs. 66.7%
in SP, 97.8 vs. 92.2% in S), and SXT (92.9 vs. 75% in B, 65.5 vs.
95.2% in SP, 96.6 vs. 96.4% in S). As for S. sonnei, difference in
the resistance prevalence among the centres was statistically signi-
ﬁcant (P < 0.05) for all the antimicrobials; for S. ﬂexneri, it was sig-
niﬁcant for SXT.
Conclusions: In Russia, most strains of Shigella spp. are resistant
to AM, SXT, TE, and CL. All the strains are susceptible to ﬂuoro-
quinolones and the third-generation cefalosporins which should
be recommended as the drugs of choice.
P778 Campylobacter jejuni and C. coli resistance in
humans, poultry products and farm chickens: an
epidemiological and laboratory study
S. Uzunovic-Kamberovic, T. Zorman, L. Herman, I. Berce,
S. Smole-Mozina
Zenica, BIH; Ljubljana, SI; Melle, B; Nova Gorica, SI
Objectives: To compare the frequency of isolation and occurrence
of antimicrobial resistance among C. jejuni and C. coli isolated in
humans, retail poultry meat and farm broilers in 2002.
Methods: Fifty-three human, 51 retail poultry meat and 15 Campy-
lobacter spp. isolates from broiler cloacal swab were investigated
for antibiotic susceptibility to 12 antimicrobials by disk-diffusion
method. MICs were further determined for erythromycin- and
ciproﬂoxacin-resistant isolates by Etest. To conﬁrm ciproﬂoxacin-
resistance we used a mismatch ampliﬁcation mutation assay
(MAMA) PCR to detect the gyrA mutation. Species were deter-
mined by multiplex PCR and genetic diversity by PFGE typing.
Results: C. coli isolated in signiﬁcant proportion in all three
sources, 27.8, 56.9 and 53.3%, respectively. Resistance to one or
more antibiotic tested was 71.7, 89.5, and 53.8% and multiresis-
tance 30.2, 41.7 and 30.85% in human, retail poultry and farm iso-
lates, respectively. No signiﬁcant difference was found in the
overall resistance rates, and for each antibiotic tested between
C. jejuni and C. coli isolates from all three sources, which is unu-
sual ﬁnding. Moreover, they were higher in C. jejuni. Given that
after the war population in this region were mostly the Muslim,
C. coli in humans originated from other sources than pigs. Thus, it
may suggest that C. coli resistance is origin-related. Erythromycin-
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and ciproﬂoxacin-resistance was high and almost equal in all
three sources (30.2, 30.6, 38.5%, and 32.1, 26.5, 30.8%, respect-
ively).Imported retail poultry meat (from ﬁve countries) had
higher resistance rates for erythromycin than domestic one, 38.7
vs. 26.7%, but ciproﬂoxacin resistance was higher in domestic
one, 38.7 vs. 22.2%.
Conclusion: The distribution of C. jejuni and C. coli species and
drug resistance in isolates from chicken and farm animals were
similar to that seen in humans, even in the absence of antibiotic
pressure (57% of patients were under 6 years of age, and growth
promoters ban in Bosnia and Herzegovina), suggesting that
poultry may play a role in human infections. When PFGE patterns
were considered, they were remarkably diverse, suggesting con-
siderable genetic heterogeneity. It may support the hypothesis
that Campylobacter spp. from food animals and humans may not
be represented by discrete populations but rather, form part of a
common population shared by food animals and humans, sug-
gesting related sources of infection.
Linezolid and glycopeptides in Gram-positive bacterial infection
P779 Oral linezolid as alternative therapy in patients with
cellulitis referred to an infusion centre
G. Stein, S. Schooley, V. Kak
East Lansing, USA
Objectives: This investigation was designed to study the potential
usefulness and economic beneﬁts of oral linezolid as an alternat-
ive to outpatient parenteral antibiotic therapy (OPAT) in the treat-
ment of primary cellulitis.
Methods: Patients with moderately severe cellulitis referred to an
infusion centre for antibiotic treatment were enrolled into an
open, non-randomised, pilot study. After informed written con-
sent, patients were treated with oral linezolid, 600 mg q12 h, in
place of their prescribed parenteral antibiotic. Patients were fol-
lowed with clinic visits and lab monitoring.
Results: A total of 10 patients, ﬁve males and ﬁve females (mean
age, 49 years), were enrolled. Seven were obese (mean weight,
146 kg; range, 101–196 kg), six had lower extremity cellulitis, one
had lymphedema, and two were smokers. The average length of
linezolid therapy was 12 days (range, 5–27 days). All were com-
pliant with the treatment regimen and had a clinical cure of their
infection. Mild side-effects (nausea, loose stools, headache, metal-
lic taste) were reported by four patients. None developed
thrombocytopenia or prematurely discontinued therapy. A 12-day
course of linezolid therapy (drug costs, clinic visits, and lab mon-
itoring) was found to be less expensive than 4 days of vancomy-
cin treatment (1 g q12 h) in the infusion centre.
Conclusions: In this study, we found that oral linezolid was safe
and effective in the treatment of moderately severe cellulitis and
could be a suitable replacement for OPAT. Furthermore, oral
linezolid has the potential to improve patient satisfaction as well
as lower overall treatment costs when compared with OPAT.
P780 Gram-positive bacteria from diabetic foot ulcers and
resistance to second-line antibiotics (glycopeptides, linezolid,
quinopristin-dalfopristin) in a German university hospital
S. Monecke, S. Vogel, S. Weber
Dresden, Hoyerswerda, D
Objectives: Patients with diabetic foot ulcers are usually treated
with various antibiotics for a long time. In poorly circulated or
necrotic tissue, permanently low, i.e., sub-inhibitory concentra-
tions of antibiotics might prevail. This gives bacteria the oppor-
tunity to develop resistance by gene exchange or by accumulation
of mutations. In order to monitor this development, Gram-positive
isolates from diabetic foot ulcers were collected and tested. Special
emphasis was placed on second-line antibiotics such as glycopep-
tides, Linezolid and Quinopristin-Dalfopristin.
Methods: Diabetic patients included in the study were admitted
to a specialised outpatient department of a German university
hospital in November/December 2003. One hundred and seven
isolates were selected consecutively from swabs from diabetic foot
ulcers. They were identiﬁed and tested using MIC microdilution
and e-tests.
Results: Of the 107 isolated bacteria, 46 were Staphylococcus aureus,
34 coagulase-negative staphylococci (CNS), 18 Enterococcus faecalis,
one E. facium, one E. avium, four Streptococcus spp., two Corynebac-
terium spp., and one Micrococcus sp. Thirteen (28.2%) of the
S. aureus and 14 (41.2%) of the CNS isolates were methicillin/oxa-
cillin resistant. Neither vancomycin-resistant enterococci nor gly-
copeptide-intermediate staphylococci were found. Except for
E. faecalis isolates (naturally resistant), there was no strain resist-
ant to quinopristin-dalfopristin. No resistance to linezolid was
detected.
Conclusion: In a population of patients of a German university
hospital with diabetic foot ulcers the proportion of staphylococci
resistant to methicillin/oxacillin is high. No resistance to second
line antibiotics as glycopeptides, linezolid or quinopristin/dal-
fopristin was detected. Despite these favourable results, a close
monitoring of isolates from diabetic foot ulcers is necessary as
local conditions in these lesions might favour selection of multire-
sistant strains.
P781 Effects of oral linezolid treatment in methicillin-
resistant Staphylococcus aureus colonisation in cystic ﬁbrosis
patients
A. Molina, R. Del Campo, L. Ma´iz, H. Escobar, F. Baquero,
R. Canto´n
Madrid, E
Background: Methicillin-resistant Staphylococcus aureus (MRSA)
pulmonary colonisation is increasingly recognised in cystic ﬁbro-
sis (CF) patients. Linezolid (LNZ) has demonstrated relevant
in vitro activity against MRSA and its oral administration repre-
sents an excellent alternative to IV vancomycin, which is currently
recommended for CF patients colonised with MRSA.
Material and methods: Oral LNZ (600 mg/12 bid) was administra-
ted in two male CF patients (25 and 29 years) during 14 and
10 days, respectively. S. aureus isolates were cultured from differ-
ent sputum samples recovered before, during, and after LNZ
treatment. Antibiotic susceptibility was performed by NCCLS
microdilution method using the Wider system (Fco. Soria Melgui-
zo, S.A., Madrid, Spain). PFGE-Sma I was applied to analyse gen-
etic relatedness of S. aureus isolates.
Results: In the ﬁrst patient, a total of 10 isolates were analysed
during the studied period; six of them recovered in the previous
year to LNZ administration, two isolates during LNZ adminis-
tration period, and two isolates 4 and 6 months after the end of
treatment. With the exception of one isolate that was methicillin-
susceptible and recovered during LNZ treatment period, all
isolates were MRSA and presented homogeneous antibiotic sus-
ceptibility pattern. A single clone, with a subtype variant that
included two isolates, was identiﬁed in all isolates, except in the
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meticillin-susceptible one. In the second patient, two MRSA and
one meticillin-susceptible isolates were recovered during
5 months before LNZ therapy. No MRSA were identiﬁed in the
following CF controls during 8 months, but occasionally a methi-
cillin susceptible isolate was recovered. MRSA isolates shared
the same PFGE and antibiotic susceptibility pattern, whereas
meticillin-susceptible isolates corresponded to two different
clones unrelated with the MRSA clone. Independently of micro-
biology results, patients’ pulmonary function remains unchanged
after LNZ administration, although there was a mild improve-
ment of pulmonary symptoms.
Conclusion: Oral LNZ treatment in CF may affect population
dynamics of S. aureus colonisation, being effective in MRSA
eradication. Despite this fact and assuming the brief follow-up
period, maintenance or eradication of MRSA colonisation after
LNZ treatment seems not to affect pulmonary function, which
may be related to the uncertain role of this pathogen in CF
patients.
P782 Successful treatment of methicillin-resistant (MRSA),
teicoplanin-heteroresistant Staphylococcus aureus prosthetic
valve endocarditis (PVE) with linezolid
M. Souli, K. Pontikis, Z. Chryssouli, K. Orlandou, I. Galani,
D. Katsala, H. Giamarellou
Chaidari, GR
Objective: Vancomycin (V) in combination with rifampin (R) and
gentamicin (G) has been the recommended regimen for the treat-
ment of PVE caused by MRSA but intolerance to these agents
and emergence of MRSA strains with reduced susceptibility to
the glycopeptides create the need for alternative agents. We des-
cribe the case of a patient with MRSA tricuspid PVE who was
successfully treated with linezolid (L) after failure of glycopep-
tides.
Case: A 67-year-old man was admitted for persistent MRSA bac-
teraemia. He had been treated with V, G, R, and trimethoprim/
sulfamethoxazole (T/S) for MRSA PVE of the tricuspid valve
which had recurred after a 45-day course of V and a 60-day
course of T/S. Due to acute renal failure G was discontinued and
V was changed to teicoplanin (T). He was transferred to our
department because of persistent bacteraemia of 20 days duration
despite adequate blood levels of T. Blood cultures revealed a
MRSA strain with MICs of V, T, and L of 1, 2, and 0.75 mg/L,
respectively. He was started on L (600 mg bid) and R (300 mg
tid) and bacteraemia cleared the seventh day of treatment. He
completed a 6-week course of L and a 3-week course of R. During
his treatment he developed anaemia which was managed with
blood transfusions and erythropoetin, mild leucopenia and mild
thrombocytopenia. He was discharged afebrile with sterile blood
cultures and a TEE showing reduction in the size of the veget-
ation. The patient remained well and blood cultures were sterile
one month later while pancytopenia fully recovered. The MRSA
isolate was investigated for heteroresistance to glycopeptides with
(1) a simpliﬁed and (2) a detailed population analysis proﬁle
method. (1) 0.01 mL of a 108 CFU/mL bacterial suspension was
plated on BHI agar with V (4 mg/L). Subclones that grew after
48 h were submitted to MIC determination. (2) Tenfold serial
diluents of an inoculum of 108 CFU/mL were plated on BHI agar
plates with increasing concentrations of V or T alone or with 4%
NaCl. Viable colonies were counted at 48 h and plotted against
the antibiotic concentration. Subclones with V MIC 4–6 mg/L
were identiﬁed, suggesting that the isolate had heterogeneously
reduced susceptibility to V which probably explained the failure
of V treatment. The population curve showed that 50% of the ori-
ginal inoculum survived on T concentration 8 mg/L suggesting
heteroresistance to T.
Conclusions: L offers an alternative for the treatment of methicil-
lin-resistant–glycopeptide-heteroresistant S. aureus PVE.
P783 The possible role of linezolid in the control of
methicillin-resistant Staphylococcus aureus outbreaks
I. Pulay, D. Varga Szabo´, E. Ungva´ri, K. Kristo´f,
M. Konkoly-Thege
Budapest, HUN
Objectives: Patients treated on surgical and traumatological
wards, on burn and intensive care units are at highest risk of
nosocomial infections due to methicillin-resistant Staphylococcus
aureus (MRSA). The spread of MRSA results in many therapeu-
tic and economic difﬁculties for these departments. Epidemio-
logical measures and antibiotic treatment play the most
important role in the control of MRSA outbreaks. Vancomycin
and teicoplanin are widely used for treatment of patients, while
a new oxazolidinon – linezolid – has been introduced into the
clinical practice only recently. The aim of the study was to
determine the effectiveness of linezolid in the control of an
MRSA outbreak.
Patients and methods: An MRSA outbreak involving 10 patients
(nine men and one woman, mean age 62 years) was registered
at the 1st Department of Surgery, Semmelweis University, in a
4-month period in the middle of 2002. In the previous years
the incidence of MRSA infections was extremely rare in this ter-
tiary care centre: one to four sporadic cases per year. Seven
patients were infected, and three proved carriers. Extensive epi-
demiological and microbiological investigations were carried out
in order to ﬁnd the source of the outbreak, and characterise the
isolates by phage typing and pulsed-ﬁeld gel electrophoresis
(PFGE). All the 10 patients were treated with 2  600 mg
linezolid for a mean of 5.6 days intravenously, and 2.6 days per
os.
Results: Phage typing revealed that the outbreak was caused by
three different MRSA strains (phage type 623, 629, and non-typa-
ble). PFGE has conﬁrmed this result. In the seven infected cases
the complex treatment was effective: the patients cured. All the
three carriers died; however, the fatal outcome was independent
from the carrier state. The control nose and throat cultures per-
formed 3–6 weeks after the hospital emission of the patients were
MRSA negative in all seven cases. Any toxic or side effect of
linezolid has not been experienced.
Conclusions: The MRSA outbreak was stopped by the mandatory
epidemiological measures and by linezolid treatment. Linezolid
could be effective not only in curing the MRSA infections but in
eradication of the carrier state as well.
P784 Pharmacoeconomic advantages of linezolid for the
treatment of Gram-positive infections
D. Nathwani, S. Duttagupta
Dundee, UK; New York, USA
Objectives: Gram-positive bacterial infections, in particular methi-
cillin-resistant Staphylococcus aureus (MRSA), represent a major
economic burden worldwide. In cost-containment environments,
it is imperative to demonstrate the true value of innovative medi-
cations to physicians, patients, and payers. Clinical studies have
demonstrated the efﬁcacy and safety of linezolid (LNZ) for the
treatment of Gram-positive infections. Health-economic and out-
comes endpoints from three clinical trials were analysed to deter-
mine the value of LNZ to healthcare decision makers.
Methods: Out of three randomised, open-label, multinational
studies, two compared length of stay (LOS) between patients trea-
ted with either LNZ or vancomycin (VAN). The ﬁrst study com-
pared LOS in hospitalised patients with MRSA infections, while
the second study compared LOS in hospitalised patients with
complicated skin and soft-tissue infections (cSSTI) due to suspec-
ted/conﬁrmed MRSA. The third study compared hospital
resource use and cost of treatment between LNZ and teicoplanin
(TEI) in patients with severe Gram-positive infections from Eur-
ope, South America, and Mexico.
Results: In all three studies, patients treated with LNZ had
shorter intravenous antibiotic treatment (IVAT) duration than
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patients in comparator groups, which results in increased rates
of early patient discharges and reduced use of resources. In
two of the studies, patients had signiﬁcantly shorter mean LOS
and greater odds of early discharge from hospital. Indeed, com-
pared with TEI, treatment with LNZ had 66% greater odds of
early discharge (P ¼ 0.049); a similar early discharge potential
was also seen when LNZ was compared with VAN (P ¼ 0.005).
In select patient populations, such as those with cSSTI due to
suspected/conﬁrmed MRSA, reduction in LOS may be even
more pronounced in LNZ- vs. VAN-treated patients. For the
cost comparison in the third study, total mean adjusted cost
was also reduced by US $335 (P > 0.05) in the LNZ group com-
pared with the TEI group in patients from South America and
Mexico.
Conclusions: Across multiple studies, there is consistent evi-
dence of signiﬁcant reductions in LOS and IVAT associated
with LNZ treatment, with signiﬁcant differences in the rate of
early patient discharge. Therapy with LNZ shows pharmacoeco-
nomic advantages that have the potential to reduce total costs
of treatment.
P785 Linezolid vs. glycopeptides for the treatment of
suspected or known Gram-positive infections in critical patients
F. Alvarez-Lerma, M. Palomar, F. Bobillo, V. Gonza´lez, J. Sole´,
A. Blanco, C. Leo´n - Study Group for Gram-positive Infections
Introduction: Linezolid is the ﬁrst of a new antimicrobial class,
the oxazolidinones, which has been shown to be active against
most isolates of Gram-positive (GP) microorganisms, including
those resistant to methicillin and vancomycin. Its main indica-
tion is the treatment of GP infections due to multiresistant
bacteria.
Objective: To evaluate the efﬁcacy and tolerability of linezolid
(LNZ) vs. glycopeptides, either vancomycin (VAN) or teicoplanin
(TPN), in critically ill patients who have known or suspected
infections due to GP multiresistant bacteria.
Methods: Multicentre, controlled, open and randomised Phase
III Clinical Trial. Inclusion criteria: known or suspected multire-
sistant GP infection of inpatients in Intensive Care Units
with an APACHE II between 8 and 24. Study drugs: LNZ
600 mg b.i.d. or VAN, 1 g b.i.d or TPN 400 mg o.d. (the ﬁrst
three doses were administered b.i.d.). Each patient was random-
ised as follows: 2 LNZ : 1 VAN : 1 TPN. Study populations
selected for analysis: Intention to treat population (ITT), clinic-
ally and microbiologically evaluable population (CME). Data
selected for analysis: End of treatment (EOT). Statistical analy-
sis: chi-square for qualitative variables and Student’s t-test for
quantitative variables. We also included a logistical regression
analysis for identiﬁcation of factors that may have inﬂuence in
satisfactory response.
Results: 300 patients were recruited (155 LZD, 75 VCN, 70 TPN).
We excluded 91 patients from efﬁcacy analysis due to absence of
microorganisms or GP isolates. No signiﬁcant differences were
identiﬁed within the following variables, both in ITT and CME
populations: demographic data, infection severity, infection site,
type of infection and type of microorganism isolated. Main ﬁnd-
ings: Patients discontinuing therapy due to failure of treatment:
LZD, 3.7%; VCN, 9.3%; TPN, 12.5% (P ¼ NS). Average days of
treatment: LZD, 11.9; VCN, 13.7; TPN, 12.5 (P ¼ 0.08). Satisfactory
clinical response: LZD, 86.9%; VCN, 74.1%; TPN, 77.1%
(P ¼ NS). Individual factors associated with favourable response:
absence of abdominal infection (OR 0.11, IC95% 0.020–0.558), days
of treatment (OR 1.19, IC95% 1.066–1.324), treatment with LNZ
(OR 2.70, IC95% 1.157–6.310).
Conclusions: LNZ was an independent variable for favourable
response compared with glycopeptides (vancomycin and teicopla-
nin) for the treatment of GP infections in critically ill patients.
P786 Linezolid vs.vancomycin for culture-proven
complicated skin and soft tissue infections – trends of subjects
enrolled in Europe and globally in a global study
M. Dryden, N. Chaudry, A. Reisman, J. Weigelt
Winchester, UK; New York, Milwaukee, USA
Objective: This study examined the clinical efﬁcacy and safety in
subjects with culture-proven cSSTIs treated with either LZD or
VAN. The aim was to detect trends in efﬁcacy rates between sub-
jects enrolled in the European Union (EU) and overall (globally).
Methods: This was a controlled, multicentre, global study with
subjects randomised in a 1:1 ratio to receive open-label LZD
600 mg IV or PO q12 h or VAN 1 g IV q12 h for 7–21 days. Clin-
ical efﬁcacy was determined by investigator’s assessment of reso-
lution of signs and symptoms compared with baseline (Day 1) at
the test-of-cure (TOC) visit (7 days post-therapy). Primary popula-
tion was intent-to-treat (ITT), deﬁned as all treated subjects. Clin-
ically evaluable (CE) population included ITT subjects who
received >4 days of therapy and completed the TOC visit. Micro-
biologically evaluable (ME) population included all CE subjects
with 1 Gram-positive pathogen isolated at baseline. EU coun-
tries included Portugal, Spain, and United Kingdom. Global
regions included EU, North and South America, and Asia.
Results: 1200 subjects were enrolled globally, 92 in the EU. Glo-
bally, the clinical efﬁcacy rates of LZD were higher than VAN in
all populations at TOC (see table). Clinical efﬁcacy rates in EU
subjects appeared to be similar for LZD and lower for VAN to
global subjects for each treatment group in each population.
Methicillin-resistant S. aureus (MRSA) was the most isolated base-
line pathogen globally (LZD 140; VAN 145). Among global ME
subjects with MRSA, LZD demonstrated superior clinical efﬁcacy:
LZD, 94.0% (126/134); VAN, 83.6% (112/134) (95% CI, –3.00,
17.89; P ¼ 0.0108). Overall incidence of 1 treatment-related
adverse event was 22.1% for LZD and 20.8% for VAN.
Conclusions: LZD demonstrated higher clinical efﬁcacy than VAN
among all global subjects with culture-proven cSSTIs, including
MRSA. Clinical efﬁcacy rates of EU subjects appeared to exhibit
similar trends to rates of global subjects.
P787 Effects of oral linezolid treatment in methicillin-
resistant Staphylococcus aureus colonisation in cystic ﬁbrosis
patients
A. Molina, R. Del Campo, L. Ma´iz, H. Escobar, F. Baquero,
R. Canto´n
Madrid, E
Background: Methicillin-resistant Staphylococcus aureus (MRSA)
pulmonary colonisation is increasingly recognised in cystic ﬁbro-
sis (CF) patients. Linezolid (LNZ) has demonstrated relevant
Table. Clinical efﬁcacy, ITT, CE and ME population [N (%)]
LZD VAN 95% CI** P-value**
ITT
Global 439/476 (92.2) 402/454 (88.5) 0:11, 7.47 0.0565
EU* 37/40 (92.5) 34/42 (80.9)
CE
Global 436/462 (94.4) 394/436 (90.4) 0.53, 7.48 0.0234
EU* 37/39 (94.9) 33/39 (84.6)
ME
Global 312/330 (94.5) 278/310 (89.7) 0.69, 9.05 0.0218
EU* 26/28 (92.8) 28/33 (84.8)
*Included Portugal, Spain, and United Kingdom.
**CI for global is for difference LZD  VAN, EU not sufﬁciently
powered for analysis.
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in vitro activity against MRSA and its oral administration repre-
sents an excellent alternative to IV vancomycin, which is currently
recommended for CF patients colonised with MRSA.
Material and methods: Oral LNZ (600 mg/12 bid) was administra-
ted in two male CF patients (25 and 29 years) during 14 and
10 days, respectively. S. aureus isolates were cultured from different
sputum samples recovered before, during, and after LNZ treat-
ment. Antibiotic susceptibility was performed by NCCLS microdi-
lution method using the Wider system (Fco. Soria Melguizo, S.A.,
Madrid, Spain). PFGE-SmaI was applied to analyse genetic related-
ness of S. aureus isolates.
Results: In the ﬁrst patient, a total of 10 isolates were analysed
during the studied period; six of them recovered in the previous
year to LNZ administration, two isolates during LNZ administra-
tion period, and two isolates 4 and 6 months after the end of
treatment. With the exception of one isolate that was methicillin-
susceptible recovered during LNZ treatment period, all isolates
were MRSA and presented homogeneous antibiotic susceptibility
pattern. A single clone, with a subtype variant that included two
isolates, was identiﬁed in all isolates, except in the meticillin-sus-
ceptible one. In the second patient, two MRSA and one meticillin-
susceptible isolates were recovered during 5 months before LNZ
therapy. Another methicillin-susceptible isolate was recovered
after the LNZ therapy and no S. aureus were identiﬁed in the fol-
lowing CF controls during 8 months. MRSA isolates shared the
same PFGE and antibiotic susceptibility pattern, whereas meticil-
lin-susceptible isolates corresponded to two different clones unre-
lated with the MRSA clone. Independently of microbiology
results, patients’ pulmonary function remains unchanged after
LNZ administration.
Conclusion: Oral LNZ treatment in CF may affect population
dynamics of S. aureus colonisation, being effective in MRSA
eradication. Despite this fact and assuming the brief follow-up
period, maintenance or eradication of MRSA colonisation after
LNZ treatment seems not to affect pulmonary function, which
may be related to the uncertain role of this pathogen in CF
patients.
P788 In vitro spectrum of linezolid and other agents
against clinical isolates of anaerobes
K. Aldridge, C. Manders, S. Broyles
New Orleans, USA
Objectives: Linezolid is an oxazolidinone antimicrobial with estab-
lished in vitro and in vivo activity against aerobic Gram-positive
cocci. In infections such as wounds these Gram-positive pathogens
may be mixed with other pathogens including anaerobes. The role
of linezolid as an anti-anaerobe agent has yet to be determined.
This study was performed to establish the in vitro activity of linezo-
lid and comparative agents against recently isolated anaerobes.
Methods: Approximately 700 anaerobes were tested for suscepti-
bility to linezolid (LZD), ceftriaxone (AXO), cefoxitin (FOX), clin-
damycin (CL), and metronidazole (MRD) using twofold dilutions
(0.06–256 mg/L) of each agent using the NCCLS-recommended
broth microdilution method. The sources of test isolates included
wounds, abscesses, body ﬂuids, and tissues.
Results: Against all test isolates LZD had an MIC range of 0.06–
128 mg/L, a mode MIC of 4 mg/L, and MIC50 and MIC90 values
of 2 and 4 mg/L, respectively. LZD activity was judged by per-
centage of isolates inhibited at 2 and 4 mg/L. Overall LZD inhib-
ited 51 and 96% of isolates at 2 and 4 mg/L, respectively; at 2
and 4 mg/L, respectively, LZD inhibited 35 and 95% of Bactero-
ides fragilis group; 63 and 92% of Clostridium isolates; 71 and 97%
of Prevotella isolates; 100% of Fusobacterium isolates; and 100% of
Peptostreptococcus isolates. By comparison of MIC90 values LZD
was 2- to 64-fold more active than AXO, 0- to 16-fold more active
than FOX, and 2- to 32-fold more active than CL against these
same groups of isolates. LZD and MRD had virtually equal
in vitro activity. Interestingly, all isolates with MICs of 8 mg/L or
higher to LZD had MICs of 2 mg/L or less to MRD, while isolates
with MICs of 8 mg/L or higher to MRD had MICs of 4 mg/L or
less to LZD.
Conclusions: Based on these results and arbitrary use of NCCLS
breakpoints for Gram-positive isolates, we conclude that LZD is
highly active against anaerobe pathogens, but this needs to be
veriﬁed by pharmacokinetic and clinical studies.
Epidemiology of antibiotic susceptibility
P789 Decline in antimicrobial susceptibilities of anaerobic
bacteria from the academic hospitals in Bloemfontein, South
Africa, 1996–2003
P.O. Smith, M.N. Janse van Rensburg, M. Theron
Bloemfontein, ZA
Objectives: Susceptibility testing of anaerobic infections is not rou-
tinely done in all microbiology laboratories and concerns about
resistance development are on the increase. The study was con-
ducted to investigate the rate of resistance development in anaer-
obic bacteria over a period of 7 years.
Methods: The antimicrobial susceptibilities of 130 anaerobic bac-
teria collected from the Pelonomi and Universitas Hospitals in
Bloemfontein, South Africa, from March 2002 to April 2003 were
determined. The isolates included 13 Clostridium perfringens, 17
Clostridium spp., 11 Peptostreptococcus anaerobius, 20 Peptostreptococ-
cus spp., 41 Bacteroides fragilis, 17 Prevotella spp. and 11 Fusobacteri-
um spp. strains. MICs were determined for 12 antimicrobial
agents using the NCCLS agar-dilution method. Susceptibility data
were compared with the MICs obtained in a study done on iso-
lates from 1996/1997.
Results: On comparing the MICs from the current study with the
results from 7 years ago, an unmistakable and very alarming
decline in susceptibility was noted for all the antimicrobial agents
tested. The greatest difference in susceptibility was noted for
cefoxitin (from 91 to 62%), metronidazole (from 98 to 78%), pip-
eracillin (from 84 to 68%) and amoxicillin (from 74 to 60%). The
antimicrobial agents for which <5% decrease in susceptibility was
found, included meropenem (from 96 to 93%), clindamycin (85 to
81%) and ciproﬂoxacin (from 74 to 69%). A great concern, how-
ever, was an 8% decrease found in the susceptibility for imipe-
nem (from 96 to 88%).
Conclusions: A decade ago, most anaerobic bacteria were suscept-
ible to antimicrobial agents usually used for infections caused by
these bacteria. The results from this study, however, indicate a
situation that has undergone some dramatic changes in a relat-
ively short period. It is of concern that the agents most frequently
used in the empirical treatment of anaerobic infections, such as
metronidazole and the b-lactams such as cefoxitin and piperacillin
have shown the most alarming decrease in susceptibility. There is
now, more than ever before, a deﬁnite need for continuous sus-
ceptibility testing of anaerobes and a serious restructuring of the
treatment regimes for anaerobic infections.
199Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
P790 Antimicrobial resistance of enteropathogenic
Escherichia coli isolated from rabbits in South Italy
A. Camarda, D. Pennelli, P. Battista, M. Corrente, I. Alloggio
Valenzano, I
Objectives: Escherichia coli isolated from fattening-rabbits dead for
enteritis were biotypised, tested with PCR for the presence of
virulence genes eae and afr2 coding for intimin and the ﬁmbrial
adhesin AF/R2 and investigated for antimicrobial resistance.
Methods: Fifty-six strains of E. coli isolated in 28 farms were bio-
typised using the fermentation of sorbose, dulcitol, rafﬁnose,
sucrose and L-rhamnose. Detection of drug resistance was deter-
mined using the method of Kirby-Bauer on Mueller-Hinton agar
with antibiotic disks containing gentamicin (GM10), amikacin
(AN30), tetracycline (TE30), erythromicin (E15), spiramicin
(SP100), enroﬂoxacin (ENR5), ﬂumequine (AR30), trimethoprim/
sulphametoxazole (SXT), amoxicilline (AMX 25), apramycin
(APR30), diﬂoxacine (DFX10), marboﬂoxacine (MAR5), nalidixic
acid (NA30), neomycin (N30), colistin (CL50), streptomycin (S10).
Results: 10 biotypes (B0, B1, B8, B9, B12, B16, B17, B24, B25, B28)
were detected: biotypes 8 and 24 were predominant in rabbitries.
Eae and afr2 genes were almost observed in E. coli strains belong-
ing to them. Results of antibiograms have shown that all the iso-
lates (100%) were E15 resistant. High rate of resistance were also
found towards SP100 (98.2%), SXT (92.8%), TE30 (87.5%), S10
(73.2%), GM10 (71.4%), N30 (69.3%). About 91% of E. coli tested
showed the same susceptibility rate (91.5%) to MAR5 and CL50.
Susceptibility to DFX10, ENR5, AR30, NA30, was exhibited by the
80.3, 78.5, 75, 71.4%, of the strains, respectively. Sensitivity against
AMX25 was quite high (76.7%). Multiple antibiotic resistance was
expressed by all E. coli tested. The most prevalent resistotypes
were resistant to TE30-E15 SP100-SXT, detected in 47 strains
(83.9%), TE30-E15-SP100-SXT-S10, which accounted for over 60%
and TE30-E15-SP100-SXT-GM10 detected in 67.8% of isolates.
Conclusions: No signiﬁcant correlation was observed between
enteropathogenic E. coli (eae+ and AF/R2+) and pattern of antibi-
otic resistance. Quinolones have shown very good activity; in par-
ticular MAR5, which has been recently adopted in veterinary
medicine seems to possess high efﬁcacy. On the other hand, E. coli
strains exhibited high-level of resistance to antimicrobials. Like
human E. coli, rabbit strains revealed different patterns of multi-
resistance, which could make disease control difﬁcult in rabbits
and also promote dissemination and increasing of antimicrobial
resistance in human strains.
P791 Frequency and antimicrobial susceptibility of
bacterial pathogens isolated from bloodstream infections in
haematology–oncology patients: results from the Latin America
SENTRY Antimicrobial Surveillance Program (1997–2002)
S.S. Andrade, A.C. Gales, H.S. Sader, R.N. Jones, J.B. Silva,
A.C.C. Pignatari and The Sentry Participants Group – Latin
America
Objective: To determine the frequency and susceptibility patterns
of bacterial pathogens isolated from bloodstream (BSI) of haema-
tology–oncology patients hospitalised at Latin American medical
centres.
Material and methods: As part of the SENTRY Antimicrobial Sur-
veillance Program, a total of 1587 BSI isolates were recovered
from haematology–oncology patients from 1997 to 2002. The iso-
lates were susceptibility tested to >20 antimicrobial agents in a
central laboratory using NCCLS broth microdilution method.
Results: The most frequent isolated pathogen was coagulase-neg-
ative staphylococci (CoNS; 17.7%), followed by Escherichia coli
(17.5%), Staphylococcus aureus (15.8%), Klebsiella pneumoniae
(10.3%), Pseudomonas aeruginosa (8.9%), Enterobacter spp. (6.7%),
Acinetobacter spp. (4.5%), and Enterococcus spp. (3.1%). Oxacillin-
resistance rates were 33.9 and 74.4% among S. aureus and CoNS,
respectively, isolates. The prevalence of ESBL-producing strains
ranged from 9.4% for E. coli to 41.1% for K. pneumoniae. For Ente-
robacter spp., susceptibility rates were 54.7 and 86.9% to ceftazi-
dime and cefepime, respectively. All Enterobacteriaceae isolates
tested were susceptible to carbapenems. The susceptibility of
P. aeruginosa to imipenem and meropenem was 83.7 and 86.5%,
respectively; 82.2 and 92.8% of the Gram-negative bacilli were
susceptible to cefepime and meropenem, respectively. Only 4.1%
of the Enterococcus spp. isolates were resistant to vancomycin.
Conclusions: In contrast to American and European reports,
Gram-negative bacilli represented the major cause of BSI among
haematology–oncology patients in the Latin American hospitals
evaluated. The antimicrobial agents with the best covered against
such pathogens were the carbapenems and cefepime. However,
none of the evaluated antimicrobial agents inhibited the growth of
100.0% of the Gram-negative bacilli. Thus, continued monitoring
by surveillance programs is necessary to determine if the
observed trends would continue to be recorded.
P792 Frequency of occurrence and antimicrobial
susceptibility proﬁle of pathogens causing bloodstream
infections in paediatric patients from Latin America: report of
SENTRY Antimicrobial Surveillance Program (1997–2002)
A.C. Gales, S.S. Andrade, H.S. Sader, R.N. Jones, S. Silbert,
A.C.C. Pignatari and The Sentry Participants Group – Latin America
Objective: We attempted to verify if the frequency of occurrence
(FO) and antimicrobial susceptibility proﬁle (ASP) of bacterial iso-
lates responsible for causing bloodstream Infections (BSI) in pae-
diatric patients varied along the years and age categories.
Methods: A total of 2450 bloodstream isolates were collected from
paediatric patients hospitalised in Latin American hospitals
through the SENTRY Program between 1997 and 2002. The ASP
to various antimicrobials was determined by the NCCLS broth
microdilution method. The FO and ASP were studied according
to age categories (AC): 	1 year, 2–5 years, and 6–12 years.
Results: Overall, S. aureus (SA) was the most frequently isolated
pathogen among children 	1 year (18.3%) and 6–12 years (26.8%)
followed by coagulase negative staphylococci (CoNS). Among chil-
dren 	1 year and 2–5 years, S. pneumoniae (SPN) ranked among
the top ﬁve pathogens. In contrast, it has caused less than 5.0% of
BSI among children 6–12 years. Curiously, in this age group, Aci-
netobacter spp. and P. aeruginosa (5.8%) assumed the ﬁfth position
in the rank order of frequency. In general, among SA, the oxacillin
resistance (OR) rates were lower in the 6–12-year-old AC (17.2%;
P 	 0.05) than in children 	1 year (27.3%) and 2–5 years (25.0%).
In contrast, among the CoNS, elevated rates of OR were noticed in
all ACs (	1 year, 82.1%; 2–5 years, 81.2%; 6–12 years, 78.3%;
P > 0.05). ESBL-producing K. pneumoniae were more frequently
detected in the AC 	1 year (66.8% of the K. pneumoniae isolates)
and 2–5 years (64.1%) than 6–12 years (52.0%). On the contrary,
ESBL-producing E. coli isolates were less frequently encountered
among children 	1 year (12.1%) than children 6 years (21.9%).
However, these differences did not reach statistical signiﬁcance
(P > 0.05). SPN isolates showing reduced susceptibility to penicil-
lin were detected more frequently in the AC of 	1 year (39.2%)
and 2–5 years (32.7%) than in 6–12 years (15.0%; P 	 0.05).
Conclusions: Although only slight differences in the FO of BSI
pathogens was noticed along the years and AC, important differ-
ences were observed on the ASP of the BSI pathogens according
to the age categories, especially for SPN and SA isolates.
P793 Frequency of Gram-positive bacterial pathogens in
bloodstream infections and their resistance to antibiotics in the
Czech Republic
M. Kolar, T. Latal, B. Heinigeova, N. Bartonikova, P. Cerma´k
Olomouc, Prague, Jindrichuv Hradec, Zlin, Hradec Kralove, CZ
Objectives: The aim of this prospective, multicentric study was to
assess incidence of Gram-positive bacteria in bloodstream infec-
tions (BSI) and characteristics of their resistance to antibiotics in
the Czech Republic.
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Methods: The study was done in 15 sites in the Czech Republic
from January to April 2003. Consecutive Gram-positive strains iso-
lated from blood were assessed and their clinical signiﬁcance was
evaluated.
Results: The strains of Staphylococcus aureus (39%), coagulase-neg-
ative staphylococci (34%), Streptococcus pneumoniae (11%) and
Enterococcus spp. (9%) were identiﬁed as the etiologic agent of
Gram-positive BSI. The frequency of oxacillin-resistant strains was
in Staphylococcus aureus and in coagulase-negative staphylococci
10 and 41%, respectively. All Streptococcus pneumoniae strains were
susceptible to penicillin and chloramphenicol. No strains resistant
to glycopeptides were found in enterococci. Clinical signiﬁcance
of isolated Gram-positive bacteria was signiﬁcantly conditioned
by bacterial species (P ¼ 0.001) and reached 100% in Streptococcus
pneumoniae, 87% in Staphylococcus aureus, 82% in Enterococcus spp.
strains and 10% in coagulase-negative staphylococci. Production
of bacterial bioﬁlm was shown in 56% Staphylococcus aureus
strains and in 42% coagulase-negative staphylococci. BSI was the
immediate cause of death of the patient in 5%.
Conclusion: We could conﬁrm that presence of artiﬁcial material
means signiﬁcant risk factor for BSI. Catheter-related infections
were present in 32% of cases. Forty-six per cent of BSI can be char-
acterised as secondary and pneumonias, GIT infections and urin-
ary tract infections were the most common sources. The frequency
of Staphylococcus spp. with positive ﬁnding of bioﬁlm was 49% in
this study; this ﬁnding supports its clinical signiﬁcance.
Acknowledgements: The study was supported by a grant; Inde-
pendent Medical Grant – Gram-positive pathogens in bloodstream
infections; Pﬁzer, New York. Part of the results was obtained
under the support of IGA grant of the Ministry of Health, Czech
Republic, No. NI/7305-3.
P794 Trends of Staphylococcus aureus susceptibility to
antibiotics isolates in a university hospital in France, 1997–2002
L. Gambotti, P. Girardo, C.M. Couris, M.E. Reverdy, J. Etienne,
P. Vanhems
Lyon, F
Objectives: To describe the trends of methicillin-resistant Staphylo-
coccus aureus (MRSA) strains proportions during 6 years among
all Staphylococcus aureus (SA) positives isolates diagnosed in a
1100 bed university hospital.
Methods: A total of 6670 S. aureus positive sample isolates
between 1 January 1997 and 31 December 2002 from the laborat-
ory were analysed. The susceptibility to antibiotics was assessed
by antibiogram based on the API system (bioMe´rieux) according
to the French guidelines (CA-SFM). The SA strains were classiﬁed
as methicillin susceptible and gentamicin susceptible (gentaS-
MSSA), methicillin resistant and gentamicin susceptible (gentaS-
MRSA), methicillin susceptible and gentamicin resistant (gentaR-
MSSA) or methicillin resistant and gentamicin resistant (gentaR-
MRSA). The number of isolates was calculated for 1000 admis-
sions. Means per year were compared using Kruskal Wallis test.
The Spearman coefﬁcient (R) was used to calculate the correlation
between the proportion of isolates (for each antibiotic resistance
proﬁle) and months.
Results: The overall proportion of SA positive samples for 1000
admissions during the study period was: 11.2, 12.0, 12.7, 11.9, 11.4
and 11.8 for 1997, 1998, 1999, 2000, 2001 and 2002, respectively
(R ¼ 0.2; P ¼ 0.9). The percentage of MSSA was 76.2 (75.7 for
gentaS, 0.5 for gentaR) and the percentage of MSSA was 23.8 (20.1
for gentaS, 3.7 for gentaR) for the total period. Patients with
MRSA were older (57.3 years) compared with patients with MSSA
(mean age 41.5, P < 0.0001) but patients with gentaR-MRSA were
younger (53.2 years) compared with patients with gentaS-MRSA
(mean age 58.1, P ¼ 0.006). The proportion of gentaS-MSSA for
1000 admissions was similar by time (9.4, 9.0, 9.9, 8.8, 8.2, 9.0,
P ¼ 0.5) (R ¼ 0.1; P ¼ 0.5). However, the proportion of gentaS-
MRSA strains increased signiﬁcantly (1.7, 2.4, 2.4, 2.5, 2.9, 2.5,
P ¼ 0.001) (R ¼ 0.4; P < 0.0001) while the proportion of gentaR-
MRSA strains decreased signiﬁcantly during the period (0.6, 0.6,
0.3, 0.6, 0.3, 0.3, P ¼ 0.001) (R ¼ 0.4; P < 0.0001).
Conclusion: Although the proportion of SA positive samples for
1000 admissions remains constant during the last 6 years, there is
a continuous increasing trend of isolates with gentaS-MRSA and a
decreasing trend of isolates with gentaR-MRSA. The age differ-
ence between these two sub-groups should be explored.
P795 A map of bacterial frequency and resistance in a
Greek Region – Corfu Island
E. Gatsouli, M. Ovrenovits, A. Pasxali, A. Tzanavari
Corfu, GR
Background: In order to assess the regional trends of microbiologi-
cal resistance pattern, all cultured bacteria isolated in 2003 in our
Laboratory were reviewed as to specimen source and susceptibil-
ity proﬁle.
Materials and methods: In 2003, 7220 samples were cultured, 75%
(5415) of hospitalised patients and 25% (1805) from ambulatory
patients. The samples were: 3760 urine, 1276 blood cultures, 580
lesions and 1604 samples of other secretions. Classic culture meth-
ods, Vitek system and NCCLS breakpoints were used.
Results: Cultivations were positive in 23% (1661, 1381 adults and
280 children samples). The distribution of bacteria differed accord-
ing to the types of specimens. The distribution of 1147 Gram()
was 1003 Enterobacteriaceae and 145 Nonfermentative bacilli.
There were 460 Gram(+) cocci and 54 yeasts, too. E. Coli predom-
inated in enterobacteriaceae (65%), followed by Klebsiella sp.,
P. aeruginosa in non-fermentative bacilli (70%) and A. baumanii
(29%). Among the Gram(+) S. aureus was the most frequent
(42.5%), followed by CNS. Ampicillin inhibited growth of 35%
for E. Coli. Ttime/Sulfa combination could inhibit less than 16%
and the second-generation cephalosporins less than 25%, while
ﬂuoroquinolons were very effective against enterobacteriaceae
strains (more than 95%). Piperacillin inhibited growth of 8% of
P. aeruginosa and quinolons less than 17%. Enterococcus strains
were highly sensitive to teicoplanin (100%) and nitrofurantoin
(97.9%). MRSA were 31% but GISA were 1%. A. baumanii and
GISA were in ICU.
Conclusion: A permanent surveillance of frequency and sensitivity
levels of the most common pathogens responsible for infectious
enables to identify local antimicrobial activity and plays a key role
in starting empiric therapy pending bacterial identiﬁcation and
in vitro assay.
P796 The epidemiology of antibiotic resistance
M. Heginbothom
Cardiff, UK
Objectives: The biochemistry and genetics of antibiotic resistance
are well documented; however, information regarding the medical
and social factors that inﬂuence its occurrence remains lacking.
The aim of this study was to elucidate these latter relationships
and to examine the dynamics of their effects.
Methods: Antibiotic resistance data for bacterial isolates obtained
from the community was collected from all microbiology laborat-
ories in Wales from 1996 to 2003. Antibiotic prescribing data,
practice demographics, deprivation indices, general practitioner
demographics, and details of sampling behaviour was also
obtained for the same period for all general practices in Wales.
Initial analyses exploring the nature of these data and the relation-
ships of the various components were undertaken using Excel
and SPSS.
Results: Preliminary analyses indicate that both antibiotic resist-
ance and prescribing varied between practices. For coliform UTIs,
there was a clear association between high prescribing and higher
levels of resistance, with prescribing accounting for 10–20% of
variation in resistance. The correlation between prescribing and
resistance was not conﬁned to the urinary coliforms but seen
throughout a range of pathogens including those responsible for
respiratory and skin infections. There was an association between
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resistance and social deprivation exceeding that expected from
high prescribing in deprived areas and an apparent association
between resistance and the number of practitioners in a practice
and the practice list size. Resistance was more common in infec-
tions in the young (<10 years), the aged (>60 years) and for some
pathogens resistance was signiﬁcantly greater in males. Multi-
level modelling, regression analysis and time series analysis of
this complex data set is in progress.
Conclusions: Antibiotic usage appears to affect resistance at prac-
tice level and the dynamics of this selection process are currently
being investigated. It is hoped that these studies will assist in the
design of interventions to limit the future impact of resistance and
contribute to our ability to predict their outcomes.
P797 Antimicrobial resistance among Staphylococcus
aureus and Escherichia coli isolates in the Indonesian
population inside and outside hospitals
E.S. Lestari, K. Kuntaman, H.A. Verbrugh on behalf of the study
group Antimicrobial Resistance in Indonesia: Prevalence and
Prevention (AMRIN)
Objectives: Data about the prevalence of antimicrobial resistance
in Indonesia are limited. The AMRIN study measured the preval-
ence of antimicrobial resistance in the Indonesian population
inside and outside hospitals.
Methods: 4000 individuals were targeted to be screened constitu-
ting four different populations in each of two cities: patients
admitted to hospital, patients discharged from hospital, patients
visiting primary health centres, and relatives of patients admitted
to hospital. Nasal swabs and rectal swabs were taken and cul-
tured using phenol red mannitol agar for the isolation of Staphylo-
coccus aureus, and CHROM agar orientation medium for
Escherichia coli. Susceptibility testing was performed by disk diffu-
sion method recommended by NCCLS.
Results: 3996 individuals were included in the study between July
and October 2001 in Surabaya and between January and May
2002 in Semarang equally distributed over the four groups and
two cities. S. aureus isolates (n ¼ 298) were frequently resistant to
tetracycline (23%) and oxacillin (7%) without obvious differences
between the four populations. None of the oxacillin resistant
strains of S. aureus harboured mec A gene. E. coli isolates
(n ¼ 3284) showed considerable levels of resistance against a
number of commonly used antibiotics. The highest levels of resist-
ance to ampicillin (72.5%), chloramphenicol (42.5%), gentamicin
(17.5%), cefotaxim (12.5%), ciproﬂoxacin (22.5%), and cotrimoxaz-
ole (55.5%) were among E. coli isolated from patients on the day
of discharge from hospitals. Resistance rates were consistently
lowest among E. coli from relatives of patients on admission to
hospital and among patients visiting primary health care centres.
Conclusions: The results show that antimicrobial resistance among
common bacterial pathogens has emerged in Indonesia. Among
E. coli the prevalence of resistance to ciproﬂoxacin and other anti-
biotics is remarkable high, especially in individuals after hospitali-
sation. Although the prevalence of MRSA is low, tetracycline
resistance is common among S. aureus and not associated with
hospital stay.
P798 Surveillance of invasive bacterial diseases in
Greenland, Northern Canada, and the US Arctic: 2000–2003
T. Cottle, M. Bruce, J. Butler, D. Parks, T. Tam, S. Deeks,
K. Jenson, A. Parkinson
Anchorage, USA; Ottawa, CAN; Nuuk, GL
Objectives: The International Circumpolar Surveillance system
conducts population-based surveillance of invasive bacterial dis-
eases in Greenland (GN), Northern Canada (N Can), and in the
US Arctic (AK).
Methods: Isolates from patients with invasive diseases caused by
Haemophilus inﬂuenzae (Hi), Neisseria meningitidis (Nm), Group A
Streptococcus (GAS), and Group B Streptococcus (GBS) were forwar-
ded to reference laboratories in Alaska (2000–2003), Canada
(2000–2003), and Greenland (2001–2003) for conﬁrmation and sero-
typing. Chart reviews were conducted on conﬁrmed cases to ver-
ify illness episode information. Data reported for 2003 are
preliminary.
Results: The total numbers of reported cases were 86 Hi, 34 Nm,
126 GAS, and 92 GBS. Crude annual rates of invasive disease per
100 000 population varied by country and organism [Hi
(AK ¼ 1.96, N Can ¼ 6.68, GN ¼ 0), Nm (AK ¼ 1.02, N
Can ¼ 0.56, GN ¼ 2.95), GAS (AK ¼ 4.15, N Can ¼ 3.53,
GN ¼ 0.59), GBS (AK ¼ 2.94, N Can ¼ 2.60, GN ¼ 1.77)]. AK
Native and N Can aboriginal people had consistently higher rates
of disease (all organisms) than non-aboriginals. Of the 78 Hi cases
that were serotyped, 15 (19%) were Hib [AK 11 cases (rate 0.43),
N Can 4 cases (rate 0.74)] and age ranged from <1 to 69 years;
most Hib disease occurred in persons <2 years of age (AK ¼ 55%,
N Can ¼ 100%). Twenty-four (31%) Hi cases were serotype A
(Hia) [AK 7 cases (rate 0.36), N Can 17 cases (rate 4.38)]. No Hia
cases were reported in AK during 2000 and 2001; in 2002 and
2003, rates in AK were 0.62 and 0.46, respectively. In N Can, Hia
cases were reported during each year from 2000 to 2002; rates
were 2.99, 7.03, and 3.13, respectively. No Hia cases have been
reported in N Can in 2003. Case fatality ratios (CFRs) were higher
in AK than N Can and GN for invasive disease caused by both
Hi (AK ¼ 22.5%, N Can ¼ 4.2%) and Nm (AK ¼ 13.6%, N
Can ¼ 0%, GN ¼ 0%).
Conclusion: Native peoples of AK and N Can have high rates of
invasive bacterial disease caused by Hi, Nm, GAS and GBS. Over-
all rates of Nm disease are higher in GN than AK and N Can.
Cases of invasive Hib disease continue to occur in children
<2 years of age. Rates of Hia appear to be elevated in N Can and
increasing in AK, however, caution needs to be used when inter-
preting rates due to the small number of cases. This trend merits
further surveillance. Elevated case fatality rates in AK for Hi and
Nm also warrant further investigation.
P799 Region speciﬁcity, frequency of occurrence and
pattern of antimicrobial susceptibility of common bacterial
infections in Central Illinois
N. Khardori, M. El-Azizi, A. Mushtaq, C. Ball, C. Drake,
J. Lawhorn
Springﬁeld, USA
Objectives: For tertiary care hospitals, knowing the local patterns
of spectrum and susceptibility at the referring institutes can add
signiﬁcantly to the selection of appropriate antimicrobial therapy.
Our objective was to get information regarding the region speciﬁc-
ity, frequency of occurrence and pattern of antimicrobial suscepti-
bility of common bacterial infections in Central Illinois.
Methods: We used hospital antibiogram data to assess predomin-
ant pathogens and pattern of in vitro antimicrobial susceptibility
of bacterial infections in the four regions (west, southwest, central
and south) of central Illinois from January 2001 to June 2002.
Results: Gram-negative bacteria were predominant in four regions
(57, 48, 63 and 52% respectively). In all regions, E. coli was the
most common organism (20, 22, 32, and 25%) followed by S. aureus
(17, 21, 14, and 24%). E. faecalis, P. aeruginosa, and K. pneumoniae
were also among the ﬁve most frequently reported species. On the
other hand, the frequency of occurrence of S. pneumoniae was
1–3% in the four regions. The pattern of methicillin-resistant
S. aureus was different in the four regions (27, 53, 34, and 42%)
with only 0.1% of the total number of S. aureus showing intermedi-
ate resistance to vancomycin. E. faecalis, 99, 91, 96 and 96%,
respectively, were susceptible to vancomycin. Susceptibility of
S. pneumoniae to penicillin was almost the same in the four regions
(67, 74, 64, and 75%). It was not surprising that P. aeruginosa was
the least susceptible species among Gram-negative bacteria, and
this species showed decreased susceptibility to gentamicin (78, 80,
77, and 55%) and to ciproﬂoxacin (73, 81, 67, and 67%).
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Conclusions: Our data show that different communities in central
Illinois have variable occurrence and pattern of antimicrobial sus-
ceptibility of common bacterial infections. We plan to formulate a
regional antibiogram, distribute it to all hospitals in the area, and
follow the patterns prospectively with renewal of the antibiogram
once a year.
P800 Antimicrobial resistance surveillance of Gram-
negative anaerobic bacteria isolated in six Greek hospitals
J. Papaparaskevas, N.J. Legakis, A. Katsandri, A. Avlamis - The
Hellenic Study Group for Gram-Negative Anaerobic Bacteria
Objectives: The antimicrobial resistance surveillance of Gram-neg-
ative anaerobic bacteria isolated in six Greek hospitals.
Methods: A total of 122 Gram-negative anaerobic clinical strains
(72 Bacteroides fragilis group, 17 other Bacteroides spp. non-fragilis,
25 Prevotella spp., 4 Fusobacterium spp. and 4 miscellaneous) isola-
ted during the period November 2002 to November 2003 were tes-
ted using the Etest method on brucella blood agar plates.
Incubation in a ChelLab 1.5 Anaerobic Chamber was performed
for 48 h and interpretation was according to NCCLS guidelines.
Results: Overall Gram-negative non-susceptible (intermediate and
fully resistant) rates to penicillin, ticarcillin + clavulanic acid,
cefoxitin, tetracycline, clindamycin, metronidazole, imipenem and
ertapenem were 83, 2, 31, 55, 32, 6, 1 and 5%, respectively. Bacter-
oides fragilis group rates were 93, 4, 38, 65, 31, 1, 1 and 7%,
respectively. Prevotella spp. rates were 68, 0, 8, 32, 36, 16, 0 and
0%, respectively. Overall Gram-negative MIC90s were 256, 2, 64,
128, 256, 2, 0.5 and 1 mg/L, respectively. Bacteroides fragilis group
MIC90s were 256, 4, 128, 128, 256, 1, 1 and 4, respectively. Prevo-
tella spp. MIC90s were 256, 1, 16, 64, 256, 256, 0.125 and 0.5,
respectively. Metronidazole resistance was detected among four
Prevotella spp., one Bacteroides spp., one Porphyromonas spp. and
one Fusobacterium spp. isolates. Additionally, a B. fragilis strain
was found highly resistant (MIC > 32 mg/L) both to imipenem
and ertapenem and resistant to all other antimicrobials tested
except metronidazole.
Conclusions: Carbapenems, beta-lactam + inhibitor combinations
and metronidazole remain the antimicrobial agents of choice
against most Gram-negative anaerobes. However, metronidazole
resistance seems to be an emerging problem in Greece, especially
among Prevotella spp. isolates. In that respect species identiﬁcation
and periodic susceptibility surveillance is mandatory. Imipenem
and ertapenem activity was comparable, though ertapenem MICs
were slightly higher.
Acknowledgements: Members of the Hellenic Study Group for
Gram Negative Anaerobic Bacteria are Drs A. Avlamis, C. Kout-
sia-Karouzou, C. Kontou-Kastelanou, A. Pangalis, E. Papafrangas
and E. Trika-Grafakos.
P801 The value of quality control strains in susceptibility
tests
K. Huppertz, I. Noll, B. Wiedemann and the GENARS group
Objectives: The goals of a quality control programme are to assist
in monitoring the precision and accuracy of the susceptibility test
procedure, the performance of reagents used in the test and the
performance of persons who carry out the tests and read the
results. They are best accomplished by the testing of quality con-
trol (QC) strains with known susceptibility to the antimicrobial
agents to be tested (NCCLS). Therefore, QC strain measurements
done by laboratories taking part in the GENARS-project (German
Network for Antimicrobial Resistance Surveillance) were used for
a comparison of the performance of three different methods for
MIC determination.
Methods: In the GENARS-project two commercial MIC test sys-
tems and one manual microdilution system according to NCCLS
are used for the determination of antimicrobial susceptibility. The
commercial systems are the Vitek 2 (bioMe´rieux) and the Micro-
naut system (Merlin Diagnostics) with 384-well microtitre-plates.
QC strains measured by all test systems were evaluated for those
antibiotics where a range of 1 dilution step of the modal value
of the respective QC strain is included in the range of concentra-
tions tested. For reliable assessment of the test quality the distance
of the modal value from the lowest and highest concentration tes-
ted has to be two or more dilution steps.
Results: From a multitude of antibiotics tested only few drugs are
tested with a range of concentrations which meets the above men-
tioned requirements. Table 1 indicates the number of test combi-
nations available for evaluation. The Vitek 2 system offers the
shortest ranges of concentrations. However, from the range of
concentrations only few are tested, while the others are calculated,
e.g. for Gentamicin the range includes six concentrations while
only three are measured (AST-P526).
Conclusions: An evaluation of QC strain measurements should be
possible for all antibiotics tested. However, due to the concentra-
tions chosen and the short ranges of concentrations available in
the different test-systems only few antimicrobial agents can be
used for a comparison of the performance of the test methods.
Therefore, either the range of concentrations has to be extended,
or more suitable QC strains have to be implemented in a way that
their MICs fall into the range of concentrations which are sufﬁ-
cient in clinical terms.
P802 Lack of evidence for DNA in antibiotic preparations
as a source of antibiotic resistance genes
S.K.P. Lau, P.C.Y. Woo, A.P.C. To, A.T.K. Lau, K.Y. Yuen
Hong Kong, HK
Objective: To investigate the signiﬁcance of DNA encoding antibi-
otic resistance genes present in antibiotic preparations in the rapid
development of antibiotic-induced antimicrobial resistance.
Methods: A comprehensive study using sequence alignments and
phylogenetic analysis of genes encoding antibiotic resistance in
antibiotic-producing bacteria and the corresponding ones in non-
antibiotic-producing human or animal bacterial isolates [erythro-
mycin resistant methylase (erm), aminoglycoside 30-phosphotransf-
erase (aph3), aminoglycoside 60-phosphotransferase (aph6),
aminoglycoside acetyltransferase (aac), class A beta-lactamase, tet-
racycline resistance efﬂux protein, tetracycline resistance ribosom-
al protection protein and vancomycin resistance proteins (vanA,
vanH, vanX) and bacitracin transport proteins (bcrA, bcrB, bcrC)]
was carried out. If DNA encoding antibiotic resistance genes pre-
sent in antibiotic preparations has been important in the develop-
ment of antibiotic resistance, genes of almost identical amino acid
sequences would be expected to be present in antibiotic-produ-
cing organisms and other human or animal bacteria, inferring that
horizontal transfer of antibiotic-resistance genes had occurred
from the former to the latter.
Results: The maximum amino acid identities of genes among dif-
ferent non-antibiotic-producing bacterial isolates were close to
100% for most genes, but those between antibiotic-producing and
human or animal bacteria ranged from <28 to <77%. Therefore,
recent horizontal transfer of antibiotic resistance genes has not
occurred from antibiotic-producing organisms to human or animal
Table 1 Number of antibiotics (bold) which are tested in the
respective test system with at least one concentartion above and
under the MIC at the respective QC strain in relation to the total
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bacteria. On the other hand, frequent horizontal transfer of anti-
biotic resistance genes was observed among the human or animal
bacteria, even if they were phylogenetically distantly related.
Moreover, such transfer was particularly common among gastro-
intestinal tract ﬂora or pathogens.
Conclusion: DNA encoding antibiotic resistance genes in antibiotic
preparations has not been an important source of antibiotic resist-
ance genes. DNA decontamination during the process of antibiotic
synthesis is probably not necessary. The human gastrointestinal
tract has been an important place for bacterial gene exchange. The
role of the human gut in the dissemination of antibiotic resistance
should be further investigated.
Enterococci and other Gram-positive bacteria
P803 Molecular-biology analysis of vancomycin-resistant
enterococci isolated from the community in the Czech Republic
M. Kolar, L. Cekanova, I. Vagnerova, M. Kesselova, P. Sauer,
D. Koukalova, P. Hejnar
Olomouc, CZ
Objectives: Enterococci have become a signiﬁcant problem due to
their aetiologic role in bacterial infections. An alarming problem
is the increasing rate of enterococci with resistance to vancomycin
(VRE) and therefore the source and spreading of these strains are
very important epidemiological questions. The aim of the study
was the monitoring of VRE in the community of the Czech
Republic and molecular-biology analysis of VRE isolated.
Methods: Enterococci were isolated from rectal swabs of healthy
people in Olomouc region (population 300 000), Czech Republic,
during period September 2002 to September 2003. Enterococci
were identiﬁed by the evaluation of their biochemical activities.
Susceptibility to vancomycin and teicoplanin was detected by the
microdilution method in accordance with the NCCLS guideline.
Molecular-biology analysis of VRE was performed by analysis of
isolated DNA, which was cleaved by restriction enzyme SmaI and
separated by pulse ﬁeld gel electrophoresis (PFGE). Restriction
proﬁle was analysed by Gel compare programme.
Results: A total number of 5283 swabs were evaluated and 558
Enterococcus sp. strains were isolated during the follow-up period.
Nine strains (1.6%) were identiﬁed as VRE. Two strains were
E. faecium phenotype VanA, one strain was E. faecalis phenotype
VanB and six strains were E. casseliﬂavus phenotype VanC. By
PFGE nine different restriction proﬁles of VRE strains were
obtained. The analysis showed closer similarity of Enterococcus
casseliﬂavus strains (80–95%) than similarity between Enterococcus
faecium strains (41%).
Conclusion: It is evident that it is necessary to take into account a
possibility of VRE spreading from community into health care
facilities. A further opportunity of their spreading occurs in hospi-
tal divisions via environmental vectors and due to wide-spectrum
antibiotic treatment.
Acknowledgement: The study was supported by the grant of IGA
of the Ministry of Health, Czech Republic, No. NI/7305-3.
P804 Prevalence and resistance genotypes of glycopeptide-
resistant enterococci from human and animal sources in Styria,
Austria
A. Eisner, W. Sixl, G. Feierl, J. Koefer, G. Gorkiewicz, A.J. Grisold,
E. Marth
Graz, A
Introduction: Glycopeptide-resistant enterococci (GRE) have
emerged as important pathogens since the late 1980s. An import-
ant factor associated with the appearance of GRE in the commu-
nity in Europe has been avoparcin, a glycopeptide antimicrobial
drug used for years in many European countries as a growth pro-
moter in food-producing animals. In Europe, evidence suggests
that food-borne GRE may cause human colonisation or infection.
Objectives: The objective of this study was to investigate the pre-
valence and to determine the genotypes of GRE from different
human and animal sources in Styria, Austria.
Methods: Stool specimens from each 100 patients with precedent
antibiotic therapy and 100 non-hospitalised humans without pre-
cedent antibiotic therapy, 166 faecal cattle specimens, 117 faecal
pig specimens and 40 faecal poultry specimens were collected in
2003. One millilitre of diluted faeces was added to 9 mL of Enter-
ococcosel Bouillon (BD) for enrichment. After incubation, 100 mL
was subcultured on VRE Screen Agar (BD). Species identiﬁcation
was performed with the API STREP systems and Vitek2 (bio-
Me´rieux). Resistance to vancomycin and teicoplanin was deter-
mined by the E-test method (AB Biodisk). Determination of
glycopeptide resistance genotypes (vanA, vanB, vanC1, vanC2/3)
was performed by PCR.
Results: 4% of the patients with precedent antibiotic therapy har-
boured VRE. Among these, two were identiﬁed as E. faecium
vanA, two as E. gallinarum vanC1 and E. casseliﬂavus vanC2,
respectively. Eight per cent of the non-hospitalised human speci-
mens contained VRE (six E. gallinarum, two E. casseliﬂavus). A total
of 90 VRE strains were isolated out of the animal samples, 25.6%
E. faecium, 35.6% E. gallinarum, and 38.8% E. casseliﬂavus strains.
No resistant E. faecalis strains were detected. PCRs conﬁrmed that
all E. gallinarum were of the vanC1, all the E. casseliﬂavus of the
vanC2 and all the E. faecium strains of the vanA genotype. About
95.6% of all E. faecium vanA strains were isolated out of the poul-
try samples. One strain was isolated from a cattle sample, no spe-
cimen from pigs yielded glycopeptide-resistant E. faecium.
Conclusion: The present study indicates that the prevalence of
GRE in humans and in pig and cattle husbandry appears to be
low, but it reveals a high prevalence of GRE (E. faecium) in Styrian
poultry 6 years after the use of avoparcin was banned.
P805 Species distribution and antibiotic resistance patterns
of glycopeptide-resistant enterococci from food-producing
animals in Styria, Austria
A. Eisner, W. Sixl, G. Feierl, J. Koefer, G. Gorkiewicz, A.J. Grisold,
E. Marth
Graz, A
Introduction: Glycopeptide resistant enterococci (GRE) have
become an increasing problem in the US and in Europe. Entero-
cocci are intrinsically resistant against cephalosporins, aminogly-
cosides (low-level), polymixins, lincomycin and clindamycin.
Furthermore, enterococci are able to acquire resistance to a wide
range of antibiotics. There remain concerns that antibiotic use for
growth promotion, prophylaxis and therapy in animal husbandry
may lead to increased resistance to antibiotics used in human
medicine.
Objectives: The aim of this study was to evaluate the species dis-
tribution and the antibiotic resistance of GRE isolated from Sty-
rian food-producing animals.
Methods: A total of 90 GRE strains isolated from cattle, pig and
poultry faecal specimens in 2003 were collected. The strains were
identiﬁed using the Vitek2 automated methods (GPC) and the
API STREP systems (bioMe´rieux). Antimicrobial susceptibilities
were determined by Vitek 2 P524 card and by disk diffusion
(linezolid). The strains were studied for susceptibility to 13 antibi-
otics: ampicillin (Am), amoxicillin/sulbactame (Amc), ciproﬂoxa-
cin (Cip), erythromycin (Ery), gentamicin high level (Ge),
linezolid (Li), norﬂoxacin (Nor), penicillin (P), quinupristin/
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dalfopristin (Syn), streptomycin high level (Str), teicoplanin (Tp),
tetracycline (Te) and vancomycin (Va).
Results: E. casseliﬂavus was the most common GRE species isola-
ted (38.8%), followed by E. gallinarum (35.6%) and E. faecium
(25.6%). All E. gallinarum and E. casseliﬂavus were of the vanC, all
E. faecium of the vanA phenotype. All investigated strains were
sensitive against linezolid and gentamicin high level. P and Am
resistance (82.6%) and reduced susceptibility to Cip (17.4%) was
seen in E. faecium only. Ery resistance for E. faecium revealed
17.4%, for E. casseliﬂavus 85.7% and for E. gallinarum 31.3%.
Resistance against Te for E. faecium was 91.3%, for E. casseliﬂavus
11.4% and for E. gallinarum 68.8%. About 17.4% of E. faecium
strains were not susceptible to quinupristin/dalfopristin.
Conclusions: Resistance phenotypes to P, Am, Cip, Ery and Te dif-
fered among Enterococcus species. Resistances found against tetra-
cyclines, quinupristin/dalfopristin and erythromycin are causes of
concern. High levels of antibiotic and multidrug resistance were
observed among the E. faecium strains.
P806 Incidence and in vitro antibiotic resistance of
streptococci in urinary tract infections
E. Ikonomopoulou, S. Andreatou, T. Podimatas, I. Katsarou,
K. Papadopoulos, A. Kolotouros, A. Regli
Patras, Zante, GR
Objectives: To estimate the incidence of streptococci in urinary
tract infections (UTI) and also to carry out the in vitro antibiotic
resistance of streptococci in urinary tract infections.
Methods: From October 2002 to September 2003, 298 (9.4%) strep-
tococci strains were isolated from 3157 positive urine cultures.
The identiﬁcation was carried out by the Vitek system (Bio-
merieux). The susceptibility test was performed either by the
breakpoint system:mini API or the Vitek system (Biomerieux).
Results: 146 (49%) and 152 (51%) streptococci strains were isola-
ted from outpatients’ and inpatients’ urine cultures, respectively.
The distribution by sex was 65% women/35% men in outpatients
and 58% women/42% men in inpatients. A total of 157 (53%) of
streptococci strains were Enterococcus faecalis, 54 (18%) were
Enterococcus faecium, 10 (3%) were Enterococcus gallinarum and 77
(26%) were streptococci group B. The in vitro antibiotic resistance
of Enterococci spp. was: penicillin 38.5% (85/221), ampicillin 23%
(51/221), gentamicin 39% (86/221), nitrofurantoin 9.5% (21/221),
ciproﬂoxacin 58% (128/221), tetracyclines 56% (123/221), vanco-
mycin 6% (13/221), linezolid 0%. Eight VRE strains were Entero-
coccus faecium, three were Enterococcus gallinarum and two were
Enterococcus faecalis. The in vitro antibiotic resistance of group B
streptococci was: vancomycin 0%, nitrofurantoin 5.2% (4/77),
ampicillin 6.5% (5/77), penicillin 7.8% (6/77), erythromycin
14.3% (11/77), tetracyclines 61% (47/77).
Conclusions: Streptococci are responsible only for the 9.4% of
urinary tract infections. Enterococcus faecalis was the most frequent
pathogen (53%). Enterococci spp. showed high resistance in
ciproﬂoxacin, tetracyclines, gentamicin, penicillin, and ampicillin.
P807 Emergence of Enterococcus faecium clinical isolates
resistant to quinupristin/dalfopristin
F. Kolonitsiou, E. Petinaki, M. Maniati, G. Dimitracopoulos,
I. Spiliopoulou
Patras, Larissa, GR
Objectives: Enterococcal infections are becoming an increasing
concern, particularly due to the emergence and spread of resist-
ance to animicrobial agents. We have investigated the phenotypic
and genotypic properties of 66 Enterococcus faecium clinical iso-
lates, expressing resistance to the combination of quinupristin/
dalfopristin, recovered during a 3-year period in the University
Hospital of Patras.
Methods: All isolates were characterised at species level by Gram
stain, catalase production and by the Crystal ID Gram Positive
System (BBL). Minimal inhibitory concentrations (MICs) to ampi-
cillin (Amp), erythromycin (Em), chloramphenicol (Chl), gentami-
cin (Gm), ciproﬂoxacin (Cip), vancomycin (Va), teicoplanin (Tp),
quinupristin/dalfopristin (Rp) and linezolid (Lin) were performed
by the E-test (AB Biodisk) according to NCCLS recommendations.
The presence of VanA and VanB genes was investigated by the
Evigene commercial kit (Statens Serum Institut), while the pres-
ence of vga, vgb and sat1 genes by PCR with speciﬁc primers.
Clonal types were characterised by PFGE of SmaI DNA digests.
Results: In a collection of 88 E. faecium, 66 (75%) expressed MIC
of Rp  1 mg/L, and among them 10 isolates (15%) showed
MIC > 4 mg/L. High-level resistance to Gm was detected in 27
(41%) isolates, 53 (80%) to Cip, 5 (7.6%) to Chl, 58 (88%) to Amp
and 62 (94%) to Em. Forty-three (65%) isolates were vancomycin-
resistant, carrying the vanA gene. No isolate was found to carry
vga, vgb and sat1 genes. PFGE classiﬁed 36 isolates to clonal type
A, 11 to type B, 6 to type C and the remaining 13 isolates
belonged to 10 more types.
Conclusions: High prevalence of low-level resistance to quinupris-
tin/dalfopristin (MIC: 1–4 mg/L) was detected in this collection
of E. faecium, with 10 strains expressing higher MIC levels. This
was mainly due to the dissemination of certain clones in the hos-
pital.
P808 Patterns of antimicrobial resistance in nosocomial
strains of Enterococcus spp. isolated from patients with UTI in
different parts of Russia
V. Kretchikov, L. Stratchounski, A. Dekhnich, G. Reshedko
Smolensk, RUS
Objectives: To determine current state of antimicrobial resistance
in nosocomial strains of Enterococcus spp. isolated from urine in
patients with UTI in different regions of Russia.
Methods: A total of 87 clinical strains of Enterococcus spp. isolated
in 2001 from urine in patients with UTI hospitalised in 10 medical
institutions in different parts of Russia – two in Central region
(Moscow, Smolensk), two in North-West region (St. Petersburg),
two in South region (Krasnodar), two in Ural region (Ekaterin-
burg), two in Siberian region (Krasnoyarsk, Tomsk) were studied.
Antimicrobials tested included ampicillin (AMP), gentamicin
(GEN), streptomycin (STR), vancomycin (VAN), teicoplanin (TEI),
linezolid (LIN), tetracycline (TET), chloramphenicol (CHL), qui-
nupristin/dalfopristin (QND), ciproﬂoxacin (CIP), levoﬂoxacin
(LEV) and moxiﬂoxacin (MOX). Antimicrobial susceptibility test-
ing was performed by agar dilution method. The susceptibility
testing and interpretation of the results were performed according
Antimicrobial

















AMP 7.7 2/2 1–64 41.2 2/64 1–128
GEN 50.8 256/4096 8–4096 52.9 32/4096 16–4096
STR 50.8 512/8192 128–8192 52.9 512/8192 32–8192
VAN 0 1/2 0.5–4 0 1/2 0.5–2
TEI 0 0.25/1 0.125–2 0 0.25/2 0.125–2
LIN 0 2/2 1–2 0 2/2 1–2
TET 86.2 64/128 0.5–128 35.3 1/128 0.5–128
CHL 61.5 32/64 4–64 41.2 8/64 2–64
QND 93.8 8/16 0.5–16 35.3 1/16 0.5–16
CIP 58.5 2/4 1–128 76.5 2/16 0.5–32
LEV 9.2 2/2 0.5–64 17.6 2/8 0.5–8
MOX NA 0.5/2 0.125–32 NA 0.5/2 0.125–8
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to the NCCLS recommendations. E. faecalis ATCC 29212 was used
as a control.
Results: The majority of isolates (78.2%) were collected from
patients hospitalised in surgical units. Among 87 strains tested 65
(74.7%) were E. faecalis, 17 (19.6%) E. faecium, 3 (3.4%) E. durans
and 2 (2.3%) Enterococcus spp. Results of susceptibility testing are
presented in the table.
Conclusions: (1) The most active antimicrobials were linezolid and
glycopeptides with no resistant strains found. (2) High levels of
resistance to ampicillin, quinupristin/dalfopristin and ciproﬂoxa-
cin in E. faecium and to aminoglycosides in both E. faecalis and
E. faecium are the most important problems.
P809 Dynamic population evolution of enterococcal
intestinal carriage during ICU admittance
P. Ruiz-Garbajosa, V. Pintado, F. Baquero, R. Canto´n,
R. Del Campo
Madrid, E
Background: In a previous work, we described the dissemination
of RENC1 and RENC4 E. faecalis multiresistant clones colonising
patients of four different ICUs. The RENC4 clone was frequently
found in bacteraemias, suggesting a blood invasion from an intes-
tinal origin. The aim of this study was to analyse the dynamic
population evolution of enterococcal intestinal isolates and if the
acquisition of epidemic hospital clones may occurs during ICU
admittance.
Material and methods: A close follow-up of four patients from the
Neurosurgery ICU who were admitted after acute traumatism
was performed. Rectal swabs were collected at the admittance
and daily until they were discharged from the ICU. Stool samples
were seeded in m-Enterococcus agar, eventually supplemented
with selective antibiotics, and multiple colonies were analysed in
each sample. PFGE-SmaI and the Phoretrix 5.0 software were
applied to analyse the genetic relatedness among these isolates
and the previously described hospital endemic clones.
Results: Patient 1 and 2 stayed in the ICU for 12 days, and patient
3 and 4 for 7 days. Patient 1 carried along the 12 days the original
E. faecalis and E. faecium clones. Moreover, ﬁve E. faecalis clones,
one identical to the epidemic clone RENC1, and one E. faecium
clone were acquired during the ICU stay, all of them persisting
over the rest of the studied period. Patient 2 presented at admis-
sion three E. faecalis and two E. faecium clones; two E. faecalis were
lost in 5 days, and E. faecium were lost at the second day. Four
new E. faecalis and one E. faecium clones were found during all
stays, whereas ﬁve more clones were occasionally isolated without
persistence. In patient 3 an E. faecium clone was identiﬁed along
all the studied period, and two new E. faecium clones were later
acquired. Patient 4 had two E. faecium clones at admission, one of
them being lost after the ﬁrst day; the second persisted during all
7 days; a new E. faecium clone was acquired during the ICU stay.
Conclusion: In general, enterococcal intestinal isolates recovered at
the ICU admittance persisted along the ICU stay. However, sev-
eral multirresistant endemic hospital clones were able to fre-
quently colonise the intestinal tract of ICU patients, coexisting in
most cases with the previous resident clones. These facts repre-
sent a challenge for the persistence of multiresistant clones within
the ICU environment.
P810 Community-acquired urinary tract infection caused
by vancomycin-resistant Enterococcus faecalis clinical isolate
E. Aznar, T. Alarco´n, B. Buendı´a, E. Garcı´a-Pen˜uela, E. Escudero,
M. Lo´pez-Brea
Madrid, E
Background: Vancomycin-resistant Enterococcus faecalis is a rare
cause of community acquired infections.
Objective: We present a case of urinary tract infection caused by
vancomycin-resistant Enterococcus faecalis.
Patient and methods: The patient was a 62-year-old woman hyster-
ectomised 15 years ago. She reported four surgical interventions
due to a cystocele. The last operation took place 11 years ago and
she reported no further admittances at any hospital. In the last
years the patient also suffered from repeated urinary tract infec-
tions. In the present episode she consulted because of typical UTI
symptoms (dysuria, bladder tenesmus) and a urine sample was
collected. After 24 h of incubation, a Gram positive coccus was
isolated (more than 100 000 ufc/mL). The identiﬁcation and sus-
ceptibility were preliminarily achieved by a commercially avail-
able method following manufacturer’s recommendations
(MicroScan, DADE). Identiﬁcation was conﬁrmed by API rapid
strep system (BioMerieux). To discard Enterococcus species intrin-
sically resistant to vancomycin the absence of motility was
observed with direct microscopic detection and the absence of
pigmentation was determined by culture on TSA agar. Suscepti-
bility to vancomycin, teicoplanin and ampicillin were assessed by
disk diffusion, E-test and broth mcrodilution.
Results: The isolated microorganism was identiﬁed as Enterococcus
faecalis and showed high MICs to vancomycin (>128 mg/L by
broth microdilution and 6 mm by disk diffusion) and teicoplanin
(8 mg/L by broth microdilution and 10 mm by disk diffusion) but
was susceptible to ampicillin (0.5 mg/L by broth microdilution).
Discussion: The transmission ways of vancomycin resistant entero-
cocci in the community and its clinical implications remain uncer-
tain. In USA there is little evidence that VRE transmission may
occur in the community. The opposite is true in Europe where
these microorganisms have been isolated from different animal
sources and healthy individuals. In our country, some studies
have demonstrated the presence of VRE in animals and food.
Conclusion: The identiﬁcation of a VRE strain as the cause of a
community-acquired urinary tract infection is an unusual ﬁnding
and it may lay to important epidemiological implications.
P811 Detection of vanB2-containing Enterococcus faecium
strains with the same PFGE clonal type in two Spanish
hospitals
A. Portillo, S. Escobar, L. Torres, A. Rezusta, M. Revillo,
C. Aspiroz, F. Ruiz-Larrea, C. Torres
Logrono, Zaragoza, E
Objective: To characterise the resistance mechanism involved in a
series of 11 vancomycin resistant Enterococcus faecium (VREF)
strains recovered in two Spanish hospitals of the same city, and to
determine their clonal relationship.
Methods: A surveillance programme was carried out during a
1-year period in MS-Hospital in order to detect VREF intestinal
colonisation. Seven VREF strains were recovered from seven fae-
cal samples which represents <1% of VREF intestinal colonisation.
In the same period, four clinical VREF strains, implicated in infec-
tious processes were recovered in MS-Hospital (n ¼ 3) and
RV-Hospital (n ¼ 1). All VREF strains (n ¼ 11) were recovered
from 11 unrelated patients, most of them previously treated with
glycopeptides or broad spectrum antibiotics and diagnosed with
severe diseases. Antibiotic susceptibility testing was performed by
agar dilution method and vancomycin resistance genes (vanA,
vanB, vanC1, vanC-2/3, and vanD) were studied by PCR. vanB
amplicons were sequenced to determine the subtype and the vanB
cluster of genes were also characterised. Other resistance genes
were studied by PCR: aph(3¢)-IIIa, ant(6¢)-Ia and erm(B). PFGE
assays were performed with SmaI digestion.
Results: Nine of the 11 VREF strains (eight of MS-Hospital and
one of RV-Hospital) showed a VanB phenotype [MIC (mg/L):
vancomycin (16–32) and teicoplanin (0.5)]. The vanB2 gene was
detected in these nine strains and in addition, the intergenic
vanSB-YB region showed the characteristic mutations of the vanB2
subtype. The vanB2 gene cluster was integrated into the Tn5382-
like element in all of them, as it was demonstrated by speciﬁc
PCRs and sequencing. These strains were resistant to streptomy-
cin, kanamycin and erythromycin and ant(6¢)-Ia, aph(3¢)-IIIa and
erm(B) genes were detected by PCR. All of them were included in
the same PFGE clonal type A and two closely related subtypes
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were distinguished: A1 (seven strains from both hospitals) and A2
(two strains from MS-Hospital). Both subtypes were found in clin-
ical strains as well as in strains recovered from faecal samples.
The remaining two VREF strains, with unrelated PFGE patterns,
showed high level glycopeptide resistance (MIC > 64 mg/L) and
harboured the vanA gene.
Conclusions: VanB2 E. faecium strains with the same PFGE clonal
type were recovered from unrelated patients in two Spanish hos-
pitals. To our knowledge, this is the ﬁrst ﬁnding of vanB2 entero-
coccal strains of human origin in Spain.
P812 Molecular epidemiology of haematology ward
related VRE in Poland 2002–2003: from epidemic to endemic
M. Kawalec, R. Ziolkowski, T. Ozorowski, J. Kedzierska,
M. Baran, W. Hryniewicz
Warsaw, Poznan, Cracow, PL
At the end of 1996, the ﬁrst VRE appeared in haematology centres
in Poland. To the end of 2000, sporadic outbreaks, E. faecium VanB
mostly, were noticed in three of them. The next VRE (VanA)
appeared in June 2002 in the centre in Poznan that was not the
stage for the former outbreaks. Next outbreak was registered in
January 2003 in the centre in Cracov, in which one of the previous
VanB outbreaks had happened. There was an epidemiological link
found between the centres. There was transmission conﬁrmed to
non-haematological hospitals.
Methods: MICs of antibiotics were evaluated according to NCCLS
guidelines. Molecular typing of the isolates was performed by
PFGE. The vanA/vanB genes were detected by speciﬁc PCR. For
the analysis of Tn1546-like transposons and vanRSHAX regions
polymorphism, the L-PCR/RFLP approach was used.
Results: Vast majority of the isolates were MDR E. faecium (VRE,
HLAR, PenR). Until now (December 2003) 49 isolates of E. faecium
from Poznan were analysed, 39 from Haematology and 10 from
Transplantology. Only three of them were from serious infections,
the rest was isolated from carriers. All but one present VanA phe-
notype and harbour vanA gene. The only vanB harbouring strain
was resistant to teicoplanin. The outbreak at Haematology was at
the beginning polyclonal (10 PFGE clones) but eventually three of
them became predominant in both wards. The outbreak in Cracov
centre was spread to two other wards of this hospital (Surgery
and Geriatry) with 53, 27 and 7 VREM isolated up to now,
respectively. Five were from serious infections, 15 were from
wounds in the Surgery, the rest represents for carriers detected
during infection-control measurements. All but two of them were
VanA phenotype/genotype (2 VanB phenotype/genotype iso-
lates). One predominant PFGE clone was observed, differentiated
into 14 PFGE sub-types (‘hospital clone’). Five other PFGE clones
detected seemed to be unique (one to ﬁve isolates). In both out-
breaks two basic mechanisms of VRE spread were detected, clonal
spread of VRE strains and the VanA-elements horizontal transfer.
Conclusion: After time of VREM presenting VanB phenotype
caused sporadic outbreaks two of haematology centres in Poland
become the stages of multi-drug-resistant VanA VREM outbreaks,
eventually turning into endemic. The colonisation rate was 10–15
times higher than infection in both cases. The danger of transmis-
sion to other centres and non-haematological hospitals in the
country appears very high in these circumstances.
P813 Local engineering and the evolution of an
Enterococcus faecalis clone in three Portuguese cities during
a 7-year period (1996–2002)
C. Novais, T.M. Coque, F. Baquero, J.C. Sousa, L. Peixe and The
Enterococci Study Group
Objectives: To analyse the clonal relationship and the presence of
speciﬁc virulence and antibiotic resistance elements in vancomy-
cin resistant E. faecalis (VREﬂs) clinical isolates from hospitals of
different Portuguese cities.
Material and methods: Thirty-three selected VREﬂs from different
patients at three hospitals (HUC, HSA and HST) in the North and
Centre of Portugal (1996–2002) were studied. Susceptibility to 12
antibiotics was performed by the agar dilution method (NCCLS).
Isolates were searched for genes coding for resistance to glycopep-
tides, macrolides, and aminoglycosides. Tn1546 characterisation
was done by an overlapping PCR strategy and sequencing when
necessary. Clonal relatedness was performed by SmaI-PFGE. Viru-
lence traits (Cyl, Agg, GelE, Esp) were investigated by a multiplex
PCR assay.
Results: All VREﬂs showed VanA phenotype and were mostly
resistant to Ery, Cipro, HLRGm, and HLRKm (91, 88, 82, and
82%, respectively). Resistance genes found were vanA, erm(B),
aac6-aph2, and aph30-IIIa. Nine PFGE types were isolated: eight
from eight patients and one (clone B) from 25 patients. Clone B
was disseminated among the three hospitals for 7 years giving
eight PFGE subtypes, each one characteristic of a speciﬁc hospital.
VSEﬂs showing PFGE patterns identical to two clone B subtypes
were found in HST. Six variants of Tn1546 were found, ﬁve of
them among isolates of clone B. Tn1546- PP4 was found in all
hospitals for 7 years and predominates in HUC and HST. It con-
tains an ISEf1 insertion in the intergenic vanX-vanY region.
Tn1546-PP15, only found in HSA, lacks genes involved in transpo-
sition. PP5 and PP2 were variants of PP4 and were recovered at
HUC. PP16 was a PP-15 variant found in HSA. All VRE but one
isolate of clone B were Agg+ and Gel+. Cyl and Esp were present
in 43% of the VRE.
Conclusion: Our ﬁndings indicate that the dissemination and
establishment of successful E. faecalis clones in the hospital setting
amplify particular genetic determinants in local metagenomes
resistant to vancomycin, and therefore inﬂuences future evolution-
ary events. We also report the ﬁrst Tn1546-variant containing an
ISEf1 insertion.
P814 High diversity of Tn1546 among vancomycin-resistant
enterococci from Portuguese human, animal and environmental
sources
C. Novais, T.M. Coque, J.C. Sousa, F. Baquero, L. Peixe
Porto, P; Madrid, E
Objectives: To characterise the diversity of the genetic element
Tn1546 in vancomycin resistant enterococcal (VRE) isolates recov-
ered from different sources in different Portuguese regions.
Methods: VRE were searched in different sources from the North
and Centre of Portugal (1996–2003): (i) 99 poultry samples (P) for
human consumption, (ii) 37 swine faeces (S), (iii) six river water
samples (R), (iv) 32 samples collected upstream and downstream
hospital sewage water (SW), (v) 99 faecal samples from healthy
volunteers (HV), (vi) clinical isolates from three hospitals in three
cities (H). Identiﬁcation and characterisation of vancomycin resist-
ant genes vanA, vanB, vanC1 and vanC2 were determined by a
multiplex PCR. Tn1546-typing was performed by scoring the pres-
ence of 10 overlapping fragments, using a PCR assay.
Results: One hundred and two isolates showing vanA were iden-
tiﬁed (63 E. faecium, 35 E. faecalis and four Enterococcus spp.). Six-
teen Tn1546 variants were detected. The most common ones were
variant A (indistinguishable to Tn1546), and variant PP4 (with an
ISEfm1 insertion in the intergenic region of vanY-vanZ) which
were found in 16 and 22% of the isolates, respectively. Variant A
was recovered from P, S and H samples while PP4 was only
found in human samples. Ten Tn1546 variants lack amplicons
with primers corresponding to regions associated with transposi-
tion functions and 12 variants had alterations in regions down-
stream vanA. These include insertions in the vanY-vanZ (n ¼ 3)
or vanX-vanY (n ¼ 3) regions. Four Tn1546 variants have been
already described [groups A, D (HV,P,S), E (P) and S (P)]. Nine of
16 Tn1546 types were detected in different enterococcal species.
Three Tn1546 types were only found in human, three in animals
and humans, one in animals, humans and rivers, two in humans
and river and two found in both humans and sewage.
Conclusions: High diversity of Tn1546 was observed among Portu-
guese VRE. Variable distribution of Tn1546 variants suggests both
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local availability of speciﬁc types in local metagenomes and dis-
semination of speciﬁc genetic elements among different reservoirs.
Reasons underlying Tn1546 diversity needs further research.
P815 Bactericidal activity of daptomycin against European
staphylococci and enterococci
A. Fluit, A. Florijn, S. de Vaal , J. Verhoef, D. Milatovic
Utrecht, NL
Objective: Daptomycin is a novel lipopeptide antibiotic with very
good in vitro activity against Gram-positive cocci. We compared
the bactericidal activity of daptomycin with that of other agents
against European staphylococci and enterococci including methi-
cillin-resistant Staphylococcus aureus (MRSA) and vancomycin-
resistant enterococci (VRE).
Methods: A total of 18 isolates including methicillin-susceptible
S. aureus (MSSA), MRSA, vancomycin-susceptible and -resistant
E. faecium and E. faecalis were selected. Killing studies were per-
formed using daptomycin and quinupristin/dalfopristin, vancomy-
cin, linezolid, and oxacillin as comparators. Each isolate was
incubated with one, two and four times the MIC of the antibiotic
used. Viable cells were determined after 0, 1, 3, 6 and 24 h. Bacteri-
cidal activity was deﬁned as a 3 log 10 reduction in viable
CFU/mL.
Results: Bactericidal activity of oxacillin against MSSA required at
least 2 MIC for 6 h. Vancomycin showed bactericidal activity
against both MSSA and some MRSA in 6–24 h for 2 and 4 MIC,
but some isolates showed regrowth after 24 h. No bactericidal activ-
ity against enterococci was observed. Linezolid was bactericidal
after 24 h for three of the four MSSA isolates tested at 4 MIC. A
comparable result was obtained for MRSA. No bactericidal activity
against enterococci was observed, except for one vancomycin-resist-
ant E. faecium. Quinupristin/dalfopristin showed very good bacteri-
cidal activity against MSSA within 1 h with 1 MIC, but required
longer times for MRSA (up to 24 h). A similar pattern was observed
for E. faecium where vancomycin-resistant isolates were killed more
slowly. Quinupristin/dalfopristin is ineffective against E. faecalis.
Daptomycin showed excellent bactericidal activity against entero-
cocci. This was slightly more efﬁcient for E. faecium than E. faecalis
isolates. Vancomycin resistance did not have any inﬂuence. Bacteri-
cidal activity against staphylococci including MRSA was generally
achieved within 3–6 h at 2 the MIC of daptomycin.
Conclusion: Daptomycin showed excellent bactericidal activity
against enterococci and S. aureus isolates including VRE and
MRSA. None of the comparators achieved similar results.
P816 Bioﬁlm production and antibiotic resistance of
human and veterinary Staphylococcus strains
V. Cuteri, L. Bastianini, F. Panzarella, M. Marenzoni, A. Attili,
C. Pieramati, C. Valente
Matelica, Perugia, I
Staphylococcus spp. is widely distributed in medical and veterinary
pathology and represents one of the most important causes of
infection. Many strains are antibiotic-resistant even for the pres-
ence of an eso-polysaccharide matrix. The aim of this work was to
individuate, among 396 different Staphylococci of human and ani-
mal origin, the slime producing strains and to correlate the pres-
ence of bioﬁlm to the resistance to eight antibiotics. A total of 185
coagulase negative staphylococci (CNS) and 211 S. aureus isolated
from different sources and identiﬁed with Sceptor System, were
tested for antibiotic susceptibility (Kirby Bauer method) and for
slime production (Polystyrene plates – stained with Alcian blue –
Spectrophotometric reading at 450 nm). The strains were classiﬁed
as weak, strong and no slime-producing on the basis of OD results.
The results were submitted to statistical analysis using Student’s
t-test and chi-square tests. Evaluating the differences of slime pro-
duction among medical and veterinary strains, we found different
statistical frequencies (P > 0.001). No statistical differences were
obtained between S. aureus and the other CNS. Instead, the statisti-
cal analysis on S. epidermidis vs. the other staphylococci has shown
no statistical differences among average values using Student’s t-
test (P < 0.052) and signiﬁcant frequency differences using chi
square tests (P < 0.02). Finally in the CNS, between S. epidermidis
and the other strains, no statistical differences were found. The
relation between slime production and the origin of strains was
evaluated and no correlation was found. About the correlation
between antibiotic-resistance and slime production a resistance
increment of about 30% was obtained in strongly slime producing
strains. Staphylococcus spp. is often involved in nosocomial infec-
tions as complication of post-surgery wounds, catheters and ortho-
paedic devices. The presence of antibiotic-resistant strains
interferes in the therapy successes and seems to be strictly related
to bioﬁlm production beyond that genetically acquired. Human
and veterinary strains have shown a similar behaviour towards
bioﬁlm production and antibiotic-resistance. The results conﬁrm
that S. epidermidis is one of the most slime-producer and introduce
S. aureus as a new high slime-producer.
P817 Phenotypic characterisation of macrolide resistance in
S. agalactiae
Sp. Fokas, St. Fokas, F. Markatou, M. Kalkani, M. Dionysopoulou
Sparta, GR
Objective: In this study, we aimed to record the current trend
regarding macrolide resistance in S. agalactiae (GBS) as well as to
determine the phenotypes of resistance.
Methods: We investigated a total of 86 non-duplicated S. agalactiae
strains collected over a period of 2 years (2001–2002). The bacteria
were obtained from clinical specimens as follows: 20 strains from
vaginal secretions of healthy asymptomatic pregnant women, 30
strains from vaginal secretions of women with the clinical suspi-
cion of vaginitis, 30 strains from urine and six strains from cases
of invasive GBS infection. The identiﬁcation to the species level
was achieved by Gram stain, catalase test, colony morphology on
blood agar and determination of the group B antigen by latex
agglutination technique. The pattern of susceptibility to erythro-
mycin, clindamycin, penicillin G and vancomycin was examined
for all the strains performing the disk diffusion method according
to the NCCLS (2000) recommendations. The macrolide resistance
phenotypes were determined using the erythromycin–clindamycin
double disk test.
Results: All the S. agalactiae isolates tested were found susceptible
to penicillin G and vancomycin while the resistance rate to eryth-
romycin was 8.1% (seven strains). The expression (%) of the
macrolide resistance phenotypes among the resistant strains as
they were evaluated by the double disk test were: constitutive
(cMLSB) phenotype 57% (four isolates) and inducible (iMLSB)
phenotype 43% (three isolates). No S. agalactiae strain was
assigned to the M resistance phenotype. The overall resistance
rate to clindamycin was 8.1%.
Conclusions: Our ﬁndings demonstrate that S. agalactiae remains
fully susceptible to penicillin and vancomycin while there are rel-
atively low resistance values to macrolides and lincosamides. The
MLSB phenotype predominated among the macrolide-resistant
strains, a ﬁnding that raises concern about the use of clindamycin
instead of erythromycin in prophylaxis or treatment of S. agalacti-
ae infection in patients allergic to beta lactams. However, continu-
ing surveillance is needed to detect any change in susceptibility
patterns.
P818 Survival of antibiotic-resistant Propionibacterium
acnes in the environment
A. Qureshi, J.I. Ross, A.M. Snelling, E.A. Eady, J.H. Cove
Leeds, Bradford, UK
Objectives: Antibiotic treatment for acne is aimed at reducing lev-
els of the anaerobe, Propionibacterium acnes, on skin. Treatment can
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involve long and multiple courses of antibiotics, and patients are
often colonised with resistant strains. It is not clear if such strains
develop de novo or are transferred directly or indirectly between
individuals. It has been assumed P. acnes do not survive well in
the environment. This study aimed to test if this is the case by
modelling their survival on surfaces.
Methods: The P. acnes type strain, NCTC737, was used to assess
survival under different environmental conditions. Approximately
10 exp 7 to 10 exp 8 washed cells were dried onto individual
glass coverslips and maintained under different conditions of tem-
perature, relative humidity (RH) with and without oxygen. Tripli-
cate samples were assayed for up to 77 days. Standard conditions
(20C, 31% RH) were used to assess the survival of 10 antibiotic
resistant (erythromycin or tetracycline resistant) isolates and one
fully suceptible clinical isolate.
Results: P. acnes NCTC737 survived in air for >77 days at 20C,
31% RH (3 log reduction). Survival was adversely affected at 15%
RH, 20C (3 log reduction over 1 day) and 37C, 31% RH (3 log
reduction over 1 day 22 h). Survival was poor at 6C, 31% RH
(3 log reduction over 12 days 15 h) and under anaerobic condi-
tions, 20C, 31% RH (3 log reduction over 7 days 7 h). Survival of
the 10 resistant P. acnes isolates at 20C, 31% RH was variable
and eight strains had reduced survival (3 log reduction between
just 2–14 days), compared with NCTC737 and the susceptible clin-
ical isolate (3 log reduction >28 days). Two strains, one tetracyc-
line and one erythromycin resistant, were more resilient with
3 log reductions taking >17 days. Viable cells could be recovered
after 17 days with all strains.
Conclusions: Although P. acnes is sensitive to oxygen, it can sur-
vive on surfaces for extended periods at room temperature in air.
Antibiotic resistant clinical isolates remained viable on surfaces
for at least 17 days. These results suggest strains can be transmit-
ted between acne patients via inanimate objects. Infection control
policies in dermatology clinics should take these ﬁndings into
account.
Molecular and clinical virology
P819 Real-time PCR quantiﬁcation of enterovirus and
adenovirus in longitudinal series of stool samples from babies
at the highest genetic risk of type 1 diabetes mellitus
O. Cinek, P. Drevinek, E. Witso, T. Wetlesen, P. Sedlakova,
S. Jeansson, K. Ronningen
Prague, CZ; Oslo, N
Background: Effect of enterovirus infection on the risk of type 1
diabetes mellitus has been studied mainly using indirect serologi-
cal evidence of past infections, or using RT-PCR detection of the
virus in plasma. With respect to enterovirus biology, we decided
to assess the exposure to enterovirus using real-time RT-PCR
detection and quantiﬁcation from stool samples. This exposure is
studied in relation to signs of autoimmune process ultimately
leading to type 1 diabetes.
Methods: The study population comes from the Norwegian
‘MIDIA’ study which screens newborns from the general popula-
tion for the highest HLA-encoded risk of type 1 diabetes mellitus.
The high-risk babies are followed-up by questionnaires, serum
samples for markers of beta-cell autoimmunity, and stool samples
collected in monthly intervals from month 3 to month 24. The
stool samples are collected by parents and mailed to the laborat-
ory where RNA and DNA is co-puriﬁed on Qiagen columns
together with a low quantity of exogenous control RNA. Enterovi-
rus is quantiﬁed by real-time RT-PCR using Armored RNA as a
standard. Control RNA is detected in late cycles in the same reac-
tion using a differently coloured probe reporter. Adenovirus
quantity is simultaneously investigated as a viral exposure which
has not been implicated in triggering type 1 diabetes. Here we
present the results of the pilot study.
Results: Parents of 72 high-risk children collected and mailed
791 (93%) out of 850 scheduled monthly samples. Enterovirus
RNA was present in 10.4% samples. Longitudinal analysis was
performed in 592 samples from 44 subjects who had completed
12 months of age. Out of these children, 36% had enterovirus
in two to seven samples, 32% had one enterovirus-positive
sample, and 32% remained permanently negative. In children
with multiple positive samples there were both prolonged infec-
tions, and several isolated infections. Adenovirus was present
in 5.2% samples. Both viruses showed marked seasonality, and
adenovirus frequency was also dependent on the age of the
child.
Conclusions: The testing of viruses from stool samples using
real-time PCR is rapid and reliable. Since enteroviruses persist
in the gut for up to several months, stool tests provide good
information on enterovirus infection, its extent, duration and on
type of the virus. The good cooperation of the parents shows
that collecting stool samples is perceived as non-invasive and
easy.
Acknowledgement: Supported by grant GACR 301/02/d80.
P820 Genotypic distribution of Cytomegalovirus (CMV)
envelope glycoprotein in different population groups in
Honduras
A. Ferrera Boza, M. Arias, N. Ta´bora, M. Brytting
Tegucigalpa, HD; Stockholm, S
Objectives: Past studies indicate that genetically distinct strains
of CMV, identiﬁed by variations in the gene encoding envelope
glycoprotein B (gB) occur at variable frequencies and can be
associated with different clinical outcomes. The purpose of the
study was to determine if there is a distinct distribution fre-
quency of circulating CMV gB genotypes in plasma samples in
ﬁve different patient population groups in Tegucigalpa, Hon-
duras.
Methods: An analysis of CMV genotypes was conducted in
plasma samples of 276 patients belonging to ﬁve categories: vol-
untary blood donors, chronic alcoholics, pregnant women, HIV
infected patients and oncology children. The genotyping was
based on sequence variations in the gene encoding gB as detected
by restriction and sequencing analysis of a semi-nested polym-
erase chain reaction (PCR)-ampliﬁed gB DNA.
Results: The distribution of gB genotypes in patients of all studied
groups were similar. Among all samples studied, the distribution
of gB types 1–4 was 24, 66, 13 and 3%, respectively, with 5.6% of
all samples containing more than one gB type. However, there
was a unique distribution of gB genotypes in the HIV infected
people, which was distinct from those of all other categories. They
were the only group infected by the four CMV genotypes and
15% of them presented mixed infections.
Conclusions: Undoubtedly, there is a high prevalence of this virus
in Honduran population suggested by detection of the virus circu-
lating in plasma samples. The predominance of gB2, as described
by others, was conﬁrmed. We speculate that the mixed infections
encountered indicated that reinfection and reactivation are com-
mon traits in HIV infected people.
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P821 Prevalence of transfusion transmitted virus DNA in
serum samples in Austria
C. Koidl, M. Bozic, R.B. Raggam, J. Berg, E. Marth, H.H. Kessler
Graz, A
Objective: To investigate the endemic situation of transfusion
transmitted virus (TTV) infection in the Austrian population.
Methods: A molecular assay for detection of TTV based on auto-
mated nucleic acid extraction and real time PCR was developed
and used for screening of 103 clinical serum samples. The new
assay included a homologous internal control. All sera had been
tested for anti HCV and anti HIV-1 antibodies earlier.
Results: The new molecular assay showed an excellent ampliﬁca-
tion efﬁciency. The internal control was detected in all negative
and weak positive samples. When clinical specimens of four dif-
ferent groups of patients were tested, 84% of patients with both
anti-HCV and anti-HIV-1 antibodies, 89% of haemodialysis
patients without both anti-HCV and anti-HIV-1 antibodies, 74%
of patients aged below 18 years without both anti-HCV and anti-
HIV-1 antibodies, and 54% of bone marrow transplant donors
without both anti-HCV and anti-HIV-1 antibodies were found to
be positive for TTV DNA.
Conclusion: TTV is a common endemic virus in the Austrian pop-
ulation. With the employed assay, 76% of the clinical samples
were found to be positive for TTV. There was no signiﬁcant dif-
ference in TTV prevalence between the four groups of patients in
this study. The new molecular assay proved to be suitable for
routine detection of TTV in clinical samples.
P822 PID-ARI.net and year-round surveillance of 19
respiratory pathogens in children
J.A.I. Weigl, W. Puppe, C.U. Meyer, R. Berner, J. Forster, F. Zepp,
H.J. Schmitt on behalf of the PID-ARI.net
Background: No surveillance system, which delivers data for sev-
eral airway pathogens simultaneously and year round, exists in
Germany so far.
Objectives: To establish pathogen-speciﬁc surveillance in airway
infections in children as comprehensive as possible and to make
the data accessible to the medical community as quick as possible.
Method: Nasopharyngeal samples provided by hospitals and
ofﬁces in Freiburg, Mainz and Schleswig-Holstein including Kiel
are tested in the molecular–biological laboratory of our network
in Kiel by a 19-valent multiplex-RT-PCR: RSV, hMPV, parainﬂu-
enza types 1, 2, 3, 4, inﬂuenza A and B, entro- and rhinoviruses,
coronaviruses OC43, 229E, reoviruses, adenoviruses, Bordetella per-
tussis and parapertussis, Mycoplasma and Chlamydia pneumoniae,
Legionella pneumophila. This guarantees a centralised and uniform
detection of pathogens, which do not colonise the upper airways
in general. Children under 16 years of age with lower airway
infections treated in hospitals or as outpatients are enrolled. The
recruitment sites are located from the south to the north of Ger-
many. Children of a total population of roughly 1.5 million (2%)
of German citizens are under surveillance. Since October 2002 the
surveillance data are published online weekly via www.pid-ari.-
net including a web-based early warning system. In an overview
section seasonal data since 1999 are presented. In the commentar-
ies epidemiological predictions are made and the ﬁndings are
explained.
Conclusions: The surveillance system of PID-ARI.net is the ﬁrst,
pathogen-speciﬁc, relatively comprehensive and fast surveillance-
system for airway pathogens in Germany. Targeting health care
interventions in an epidemic-synchronous fashion is facilitated.
Acknowledgements: PID-ARI.net is sponsored by the German Min-
istry of Research; for collaboration to validate the PCR we thank
the Institute of Virology, Erasmus University Rotterdam,
Prof. A. Osterhaus.
P823 Genotypes of measles virus in Spain during 2001–
2003
M.M. Mosquera, F. de Ory, J.E. Echevarria
Majadahonda. Madrid, E
Objective: According to WHO recommendations for the Plan of
Elimination of Measles positive cases found between January 2001
and October 2003 by multiple RT-PCR (measles, rubella and par-
vovirus B19) were genotyped directly on the specimens to estab-
lish the surveillance of this virus in Spain.
Methods: Ampliﬁcation fragments of a different measles speciﬁc
nested PCR designed in the variable C terminus of the nucleopro-
tein gene were sequenced for this purpose. All positive sporadic
cases were genotyped and at least one case in outbreak situations.
Results: Eighty-ﬁve positive cases were sequenced in this period.
Fifty-ﬁve of them were from an outbreak in Almeria province (SE
Spain) in 2003, ﬁve from an outbreak in Benidorm (Alicante, E
Spain) in 2003, six from another outbreak occurred in Ibiza Island
(Mediterranean sea) in 2001, two from Valencia in 2003 and the
remaining 17 were sporadic cases throughout Spain. Genotype D7
was detected in 13 cases from Valencia, Canary Islands, Cordoba
and Ibiza outbreak. B3 was detected in 58 cases from the Almeria
outbreak, Murcia, Granada and one sporadic case coming from
Equatorial Guinea. Genotype C2 was seen in Madrid and Gra-
nada. Genotype D8 was detected in the Benidorm outbreak. Geno-
type D4 was seen in a sporadic case from Valencia and H1 in an
imported one originally from China coexistent with the Ibiza out-
break. Vaccine genotype A was demonstrated in one sporadic
case from Badajoz (W Spain), three previously included in the
Almeria outbreak and one initially assigned to the Ibiza outbreak.
Three cases were conﬁrmed by sequencing the strain obtained by
culture in B95a cells in a different gene.
Conclusion: Most cases showed imported genotypes as H1, des-
cribed in China; B3, found in different West and Central Africa
countries; D4, detected in East and Southern Africa, Russia, Iran,
India and Pakistan; and D8 circulating in India, Nepal and Ethi-
opia. Only genotype D7 is known to circulate nowadays in Eur-
ope, however its presence seems to be caused by importation
from other countries in Europe more than local circulation,
according to the high vaccine coverage and the broad variety of
genotypes detected. Post-vaccine cases can be detected in the con-
text of outbreaks of wild type strains. In summary, this technique
is useful not only to classify cases as imported or native but also
to trace virus circulation during outbreaks.
P824 Molecular epidemiology of rotavirus in Korea, July
2002 through June 2003: emergence of G4P6 and G9P8 strains in
two surveillance systems
J.O. Kang, P. Kilgore, J.S. Kim, B. Nyambat, J. Kim, H.S. Suh,
Y. Yoon, S. Jang, C. Chang, S. Choi, M. Kim, J. Gentsch, J. Bresee,
R. Glass
Guri, Seoul, Jeonju, Gangnung, Daegu, Cheju, Gwangju, Busan,
Daejun, KOR; Atlanta, USA
Objectives: This study was conducted to characterise the G (VP7)
and P (VP4) genotypes of group A human rotavirus strains collec-
ted from eight nationally representative hospitals (Korean Rotavi-
rus Strain Surveillance Network; KRSSN) and a community-based
rotavirus surveillance site in Jeongeub, Korea.
Methods: From July 2002 through June 2003, rotavirus antigen-
positive faecal specimens were collected from the eight KRSSN
hospitals. Each hospital laboratory stored the ﬁrst 10 rotavirus-
positive faecal specimens each month from hospitalised children.
Other rotavirus antigen-positive faecal specimens were obtained
from a community-based disease burden study region. G and P
genotypes were characterised by reverse transcription-polymerase
chain reaction. A total of 488 strains were obtained from the
KRSSN and 196 strains from Jeongeub.
Results: A total of 5612 faecal specimens were tested for rotavirus
antigen at the eight hospitals of the KRSSN and, of these, 1105
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(19.7%) were rotavirus-antigen positive. For community-based
rotavirus surveillance in Jeongeub, a total of 1081 specimens were
tested of which 199 (18.4%) were rotavirus-antigen positive. In
the KRSSN, the most common strain detected was G4P6 (26.7%),
of which 88.8% (111/125) were detected in specimens from neo-
nates, but this strain was not detected at all in Jeongeub, commu-
nity-based surveillance site. For the ﬁrst time in Korea, we report
G9P8 strains; these accounted for 41.4% of rotavirus strains in
Jeongeub and 10.5% of strains in the KRSSN. Globally important
strains (G1P8, G2P4, G3P8, and G4P8) accounted for 54.5% in
KRSSN and 52.0% in Jeongeub.
Conclusion: Globally unusual strain, G4P6, can be an important
cause of rotavirus diarrhoea in some countries, and emergent
strains (e.g. G9P8) can be detected in nationwide laboratory-based
surveillance. Given variations observed in circulating rotavirus
strains, continued monitoring of genotypes is essential to identify
emerging strains, track common strains, anticipate impact of rota-
virus vaccines, and detect nosocomial outbreaks among vulner-
able groups including neonates.
P825 CMV DNA in plasma and peripheral blood
leukocytes of healthy CMV-seropositive individuals
K. Midilli, S. Ergin, M. Ozdamar, M. Kuskucu, K. Altas
Istanbul, TR
Objective: There are conﬂicting reports regarding CMV-DNA
positivity among healthy CMV-seropositive individuals. We
aimed to determine the frequency of CMV-DNA positivity among
healthy subjects and to evaluate its association with physical and
mental stress in a longitudinal study. Subjects and methods:
Weekly peripheral blood samples were drawn into from 17
healthy CMV seropositive subjects aged between 24 and 53 years
during a 8-week study period. Each subject rated their physical
and mental stress and they also recorded their alcohol consump-
tion and any change in their health status. CMV DNA was
screened in plasma and peripheral blood leukocyte samples with
a nested PCR using primers targeting MIE gene of CMV.
Results: In total, 272 samples (136 plasma and peripheral blood
leukocytes, each) were screened and only one peripheral blood
sample obtained during the second week of the study gave posit-
ive result. This sample belonged to the oldest subject of the study.
According to our results, CMV-DNA positivity among healthy
CMV seropositive individuals seems to be a rare event.
P826 Acute cytomegalovirus meningoencephalitis in
immunocompetent patient
R. Mauri, A. Tocchetti, E. Rinaldi, E. Sala, E. Longoni, D. Santoro
Como, I
Objectives: Cytomegalovirus infection in immunocompetent sub-
jects is generally mild and self-limiting. We describe a case of
severe CMV meningoencephalitis in which the CNS is the only
one apparent site of disease, referred to a 61-year-old man with
hypertension history treated with amlodipine, admitted after
2 days of intermittent fever (39–40C) to our unit.
Methods: The patient showed headache and confusional state;
objective neurological signs were represented by nuchal rigidity
and Kernig signs positivity. We performed: CT brain scan, routine
haematological and chemical tests, lumbar puncture, CSF culture
and Gram stain, bacterial antigen latex test and PCR investigation
for neurotrophic viruses. HIV antibody test was also performed
with immunoelectrophoresis and limphocytes immunophenotyp-
ing and antibody research for CMV. Empirical therapy with ceftri-
axone, ampicilline and acyclovir started.
Results: CT brain scan gave negative results. Routine haematolog-
ical and chemical tests were normal. Lumbar puncture revealed
clear cerebrospinal ﬂuid with 250 WBC/mm3 (lymphocites), slight
increase in protein level (102 mg/dL) and normal glucose level.
Gram stain, culture and CSF latex bacterial antigen were negative.
HIV test, serum immunoelectrophoresis, lymphocytes immuno-
phenotyping gave negative results. PCR for EBV, HSV1 and HSV2
on CSF were negative, while PCR for CMV resulted positive on
CSF and negative on peripheral blood cells. CMV antibodies were
positive for IgG and negative for IgM. Empirical therapy was
interrupted and lumbar puncture performed 10 days after
revealed 32 WBC/mm3 and normal protein level. The patient was
discharged after 12 days in good clinical condition.
Conclusions: Our case shows that CMV’s replication in CNS is
able to cause a meningoencephalitis in the absence of systemic
infection’s clinical signs.
P827 Epstein–Barr virus and gastric carcinoma: the
frequency of EBV association and quantiﬁcation of viral DNA
C. Nogueira, M. Correia Leita˜o, P. Figueiredo, J. Ganho,
F. Martinho, C. Grego`rio, M. Martins, T. Lindo, P. Santos,
F. Regateiro, A. Magalha˜es-Sant’Ana
Coimbra, P
Objectives: Determination of the Epstein–Barr virus (EBV) associ-
ation with gastric carcinomas and quantiﬁcation of the viral DNA
in the biological samples.
Methods: In this work, 39 individuals with gastric carcinoma have
been studied. The detection and quantiﬁcation of EBV DNA was
carried out by real-time polymerase chain reaction (PCR) in
serum, in saliva, in gastric tumour and in normal gastric mucous
samples. The PCR reaction was performed using the Taqman PCR
kit as previously described in Kimura et al. (1999). The primers
were selected for the BALF5 gene that encodes the viral DNA
polymerase. The immunological status was established by the
detection of EBV-speciﬁc antibodies – VCA IgM, EBNA IgM, VCA
IgG, EBNA IgG and EA-D IgG using Enzyme-Linked Immuno-
sorbent Assay (ELISA).
Results: The DNA of the EBV was detected in 2.56% of serums,
in 33.3% of the saliva, in 25.6% of the gastric carcinomas and in
23.1% of the normal gastric mucous. In 41% of the patients the
search of the viral genoma was negative. The mean EBV-DNA
copy number in the serums was 24 copies/lg of DNA, in the sal-
iva 6089 copies/lg of DNA, in the gastric tumour 1728 copies/lg
of DNA and in normal gastric mucous 20 copies/lg of DNA. Ser-
ologic results indicated that 93.1% of the CG (gastric carcinoma)
EBV negative, 90% of positive GC EBV and 100% of the control
group show a past infection. A reactivation of the infection was
conﬁrmed in 10% of CG EBV positive; and 6.9% of CG EBV neg-
ative were seronegatives.
Conclusion: Gastric carcinoma is strongly associated with EBV
infection (25.6%). The survival was signiﬁcantly better in the
EBV-negative carcinomas than EBV-positive carcinomas; indeed
66.7% of the deaths were veriﬁed in EBV-positive gastric carcino-
mas (P ¼ 0.012). These ﬁndings suggest an association of the gas-
tric tumours with EBV and this variable emerges as a poorer
prognostic factor.
P828 External quality assessment for molecular detection
and quantiﬁcation of human cytomegalovirus (HCMV) DNA in
the Belgian centres for molecular diagnosis
F. Brancart, B. Vincart, C. Liesnard and the Belgian Centres for
Molecular Diagnosis
Brussels, B
Objective: A national external quality assessment was conducted
to evaluate CMDs’ performances in molecular detection and quan-
tiﬁcation of HCMV DNA.
Methods: The panel consisted of amniotic ﬂuid or Hank’s bal-
anced salt solution (HBSS) spiked with dilutions of AD169 virus
stock. Three different concentrations of human lymphocytes were
added to the samples. A questionnaire allowed gathering informa-
tion on laboratory methodology and use of sample internal con-
trol to detect PCR inhibition.
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Results: All 16 centres reported qualitative results; four centres
also reported quantitative results. All samples were correctly iden-
tiﬁed by all centres. Various extraction and ampliﬁcation methods
were used. Fourteen centres reported results of internal controls.
Most of the centres controlled only the ampliﬁcation step and did
not adjust the detection sensitivity of the internal control to the
detection limit of the target. Three centres failed to detect one
internal control in two positive samples and one negative sample.
For quantiﬁcation of HCMV DNA all centres used real-time quan-
titative PCR. CV of HCMV DNA load between centres were low
(3.6–7%) except for one sample (13%), but this could be attributed
to a heterogeneous preparation of this sample by the organisers.
Using Student’s t-test, no statistically signiﬁcant difference was
observed between HCMV load whatever the medium or the num-
ber of added cells.
Conclusion: Results of this external quality assessment for molecu-
lar detection and quantiﬁcation of HCMV DNA were excellent.
Almost all centres used internal control of PCR inhibition; how-
ever, control of the whole PCR process, including extraction and
better adjustment of the detection sensitivity of the internal con-
trol to the sensitivity limit of the PCR target is desirable.
P829 A simple technique for internal control of real-time
ampliﬁcation assays
S. Burggraf, K. Appel, N. Malik, J. Neumann, E. Schuhmacher,
B. Olgemo¨ller
Munich, D
Objectives: The most accurate way to identify false negative
results, e.g. those caused by PCR inhibitors, in real-time PCR
assays is to spike samples with an internal control that will be
co-ampliﬁed with the target (pathogen) DNA. However, current
internal control procedures, which usually involve the introduct-
ion of a DNA fragment, are complex, time consuming and expen-
sive. We present a novel technique for simple internal control of
real-time ampliﬁcation assays.
Methods: Single-stranded oligonucleotides, which contain little
more than primer and probe binding sites, were used as internal
controls in real-time PCR assays. Mismatches were included in
the probe-binding region of the internal control oligonucleotide
(ICO) to prevent probe-control hybridisation during the ﬂuores-
cence acquisition step of the PCR. ICOs could be added directly
to the sample material prior to DNA extraction.
Results: To demonstrate the feasibility of the new approach, we
designed ICOs for the following LightCycler hybridisation probe
assays: Mycobacterium tuberculosis complex, hepatitis B virus,
herpes simplex virus and varicella zoster virus. In each case, the
controls did not interfere with detection of the pathogen, but were
clearly detectable during a subsequent melting point analysis of
the PCR products.
Conclusion: A single-stranded oligonucleotide, which mimics the
target region of the pathogen yet is clearly distinguishable from
the target during analysis, can serve as a simple, cost-effective
internal control for real-time ampliﬁcation assays. Such control
oligonucleotides are easy to design and cheap. A costly second
probe system is not necessary. Moreover, the internally controlled
assay uses only one ﬂuorescence detection channel of the instru-
ment, leaving the second channel free for multiplex applications.
P830 External quality assessment for the molecular
detection of viruses in simulated cerebral spinal ﬂuid
V.J. Chalker, Z. Mee, V. James
London, UK
Background: Viral infections of the central nervous system (CNS)
can result in severe clinical signs including meningitis or enceph-
alitis and may have lasting side affects or be fatal. Several viruses
are known to infect the CNS including herpes and enteroviruses.
Molecular based technologies are being used in clinical diagnos-
tics to detect several viruses in cerebral spinal ﬂuid (CSF). Exter-
nal quality assessment (EQA) provides valuable information
regarding methods, standardisation and the success in detecting
and reporting infections in clinical diagnostic laboratories.
Objective: To provide an up to date summary of performance for
the molecular detection of HSV-1, HSV-2, VZV and enteroviruses
in a simulated CSF.
Method: UK NEQAS for Microbiology provides a scheme for
molecular detection of viruses in CSF in which participants are
asked to determine the presence and genotype (if relevant) in
freeze-dried simulated CSF spiked with live viruses. Some partici-
pants also provide quantitative data. This scheme was introduced
in 2001 and currently there are 71 registered participants in 15
countries. Reported results were analysed to determine the per-
centage of participants correctly detecting the virus type and spe-
cies in specimens and when provided, viral load. Performance
was analysed over time and by viral load for each virus.
Results: Standards of detection varied depending upon the type of
virus and quantity. For HSV DNA detection 46.5–100.0% of partic-
ipants detected HSV DNA depending upon viral load, whereas
100% of those participants typing the virus correctly identiﬁed
type HSV-1 or HSV-2. Although standards for VZV DNA detection
were of a similar level, with 56.0–95.9% of participants detecting
VZV DNA depending upon viral load, considerable improvement
has occurred with time. Enterovirus RNA was detected by
48.0–97.4% of participants depending upon viral load and for the
two negative specimens distributed false positives were reported
by 2.4 and 5.4% of participants, respectively. Quantitative results
were variable with differences in the log 10 copies/mL as high as
4.4 and improvements were seen with time and increasing viral
load.
Conclusions: This data provides an interesting insight into the
performance for the molecular detection of viruses in simulated
CSF. Variation in performance for the detection of HSV1/2, VZV
and enteroviruses is dependant upon viral load.
P831 EQA programmes in clinical virology and
microbiology
C. Forde, C. Scott, C. Steel, P. Wallace, A.M. van Loon
Glasgow, UK
Objectives: Quality Control for Molecular Diagnostics (QCMD) is
an independent ‘not for proﬁt’ organisation whose primary aim is
to establish and develop external quality assessment (EQA) pro-
grammes for the evaluation of nucleic acid ampliﬁcation tech-
niques (NATs) in the diagnostic laboratory. Since its
establishment in 2001, QCMD has evolved into the leading EQA
provider in the area of molecular diagnostics in infectious
diseases.
Methods: Proﬁciency programme panels were distributed to over
1000 participants in more than 40 countries worldwide in 2003.
Twelve different programmes were distributed covering a range
of infectious diseases and including molecular diagnosis of respir-
atory, blood-borne, STD and CNS pathogens as well as molecular
genotyping. In addition, a Human Immunodeﬁciency Virus (HIV)
DNA pilot programme was carried out by participants in South
Africa.
Results: In 2003, 1041 laboratories participated in QCMD proﬁ-
ciency programmes. This represented an overall increase of 24.2%
in the total number of laboratories participating in comparison to
the total number participating in programmes in 2002. Of these,
220 laboratories participated in proﬁciency programmes for Neisse-
ria gonorrhoae, Varicella-Zoster virus and Hepatitis C Virus (HCV)
genotyping which were offered for the ﬁrst time in 2003.
Conclusion: At present, over 1600 individuals from around 70
countries worldwide have registered an interest in QCMD pro-
grammes. The programme portfolio continues to grow and, in
2004, three new pilot programmes will be launched for Respirat-
ory Viruses, Toxoplasma gondii and Legionella pneumophila. In addi-
tion to expanding its portfolio of EQA programmes, in 2004
QCMD will launch an on-line information management and
knowledge retrieval system which will allow information
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exchange and act as a valuable QC information resource for par-
ticipants.
P832 Nucleic acid isolation using the NucliSens mini
MAG instrument
P. van Deursen, A. Verhoeven, P. de Bie, A. van Grinsven,
M. Jacobs, P. van de Wiel
Boxtel, NL
Objectives: BioMe´rieux has developed a new nucleic acid isolation
method (NucliSens Magnetic Extraction Reagents) that uses Boom
chemistry in combination with magnetic silica particles. The
NucliSens mini MAG instrument is facilitating the washing and
collection of the silica particles in a user friendly and efﬁcient
way. In principle the extraction method is generic and can be
applied to a broad range of different sample types. The objective
of this study was to measure the performance of this new extrac-
tion platform in terms of RNA and DNA recovery, purity and
integrity. In addition, user aspects were also addressed in the
study.
Methods: RNA recovery was measured by spiking E. coli RNA to
human normal EDTA plasma, extracted RNA was quantiﬁed by
using a ﬂuorescence dye for RNA detection (SYBR Green II).
DNA recovery was measured by spiking plasmid DNA (pBR322);
extracted DNA was determined by A260 measurement. An indica-
tion of RNA and DNA purity was obtained by measuring A260/
A280 ratios. The integrity/intactness of the extracted nucleic acid
was determined by gel analysis or by using the bioAnalyzer (Agi-
lent Technologies) for RNA and DNA, respectively. The extraction
method was tested on three external test sites in order to score
relevant user aspects.
Results: The average recovery rates were 83 and 85% for RNA
and DNA, respectively. For RNA extracts an average A260/A280
ratio of 2.13 was measured, whereas for DNA this value was 1.82.
These values indicate that the purity of both preparations is high
since for pure preparation the expected values are 2.0 and 1.8 for
RNA and DNA, respectively. In addition, it was found that both
RNA and DNA were intact recovered since no degradation prod-
ucts were detected. In addition, all users scored the method as
labour friendly. The total amount of time needed to process 12
samples was <60 min, the throughput time was improved further
by using two instruments in parallel, in this way 24 samples can
be completed within 90 min. In addition the method was also ver-
iﬁed for a broad range of different sample types including
plasma, serum, CSF, sputum and stool.
Conclusion: The NucliSens Magnetic Extraction Reagents in com-
bination with the NucliSens mini MAG instrument efﬁciently
extracted RNA and DNA, in terms of recovery, purity and integ-
rity. Moreover, the method is scored as labour-friendly, 24 sam-
ples can be processed within 90 min and was successfully used
for various sample types.
P833 Pyrosequencing technology: a novel DNA sequencing
technique for rapid and reliable typing of human
papillomaviruses
B. Gharizadeh, M. Oggionni, B. Zheng, N. Pourmand, E. Akom,
K. Wallin, P. Nyren
Stockholm, S; Milan, I; Palo Alto, USA; Quebec, CAN
DNA sequencing is the gold standard method for accurate geno-
typing of human papillomaviruses (HPV) and provides nucleic
acid sequence information, which is the core of every organism.
Pyrosequencing method has been successfully used for HPV gen-
otyping with sequencing of only 14–21 bases. Multiple HPV infec-
tions are a common phenomenon in clinical samples with a
varying rate depending on the group investigated. DNA sequen-
cing techniques cannot differentiate between different genotypes
as uninterruptible sequence results are obtained when multiples
infections and unspeciﬁc ampliﬁcation products are present in the
amplicon. To address these problems, a type-speciﬁc multiple-
sequencing primer DNA sequencing strategy, suitable for geno-
typing and detection of HPV-6, -11, -16, -18, -31, -33 and -45 has
been developed. In the new method seven type-speciﬁc sequen-
cing primers, combined in a pool, are added to the DNA sample.
The oligonucleotide hybridising to the DNA sample will function
as a primer during the subsequent DNA sequencing procedure.
The new method is especially suited for detection and typing of
samples harbouring different HPV genotypes (multiple infections)
and unspeciﬁc ampliﬁcations, which eliminates the need for nes-
ted PCR, stringent PCR conditions and cloning. Furthermore, the
method has proved to be useful for samples containing subdomi-
nant types/species, and samples with low PCR yield, which
avoids re-performing ‘failed’ PCRs. We also introduce the
sequence pattern recognition when there is a plurality of geno-
types in the sample, which facilitates typing of more than one tar-
get DNA in the sample. Moreover, target speciﬁc sequencing
primers could be easily tailored and adapted according to the
desired applications or clinical settings based on regional preval-
ence of HPV as well as other microorganisms and viruses. As the
cost for DNA sequencing is dropping, a sample could be
sequenced in parallel with two or three different target speciﬁc
primer pools covering a broader range of genotypes. The Pyro-
sequencing HPV detection assay is fully automated and could be
used for detection and identiﬁcation of different microorganisms
and viruses.
P834 Comparison of the NucliSens Magnetic Extraction
Reagents to reference extraction methods for the isolation of
RNA and DNA from various sample types
G. Onland, L. Bartels, P. van Deursen, M. Jacobs, C.H.E. Boel,
A.J.C. van den Brule
Veldhoven, Boxtel, NL
Objectives: A new nucleic acid extraction methodology that uses
Boom chemistry in combination with magnetic silica particles is
developed (NucliSens Magnetic Extraction Reagents, bioMe´rieux).
This method is generic and can be used for the simultaneous
nucleic acid extraction of 12 samples in combination with the
NucliSense miniMAG instrument to facilitate the extraction proce-
dure. The objective of this study was to investigate the suitability of
this method for the isolation of Enterovirus RNA and Mycobacteri-
um tuberculosis DNA from a broad spectrum of clinical specimens.
Methods: The NucliSens Magnetic Extraction procedure was com-
pared with reference extraction procedures, i.e. QIAamp (Qiagen)
and Boom, followed by Enterovirus RT-PCR and M. tuberculosis
PCR, respectively. Several clinical specimens (n ¼ 100) were used,
a.o. Cerebrospinal Fluid (CSF), faeces, throat swabs, etc.
Results: By performing several extractions (up to 12) of a dilu-
tion series of strain Coxacksie B5 in CSF, it was shown that the
analytical sensitivity of the Enterovirus RT-PCR was found to be
independent of the extraction method used, whereas in very low
frequency higher sensitivities were obtained in combination with
magnetic extraction. As expected the higher input samples gave
better reproducible results than lower input samples. After eval-
uation of the Enterovirus PCR using CSF and stool samples a
100% correlation between the two extraction methods was
found. In addition, using a broad panel of clinical specimens for
M. tuberculosis PCR, the same samples were identiﬁed as positive
using the Boom extraction method and magnetic extraction.
However, the latter method resulted in less samples having inhi-
bition in PCR, but this needs to be conﬁrmed in a larger study
group.
Conclusion: This new magnetic silica based nucleic acid extraction
method was successfully used to isolate Enterovirus RNA and
M. tuberculosis DNA from clinical samples. In comparison to the
reference methods (Qiagen and Boom), this procedure performed
at least equally well regarding the functional performance and the
throughput, but was considered to be more user convenient. For
high throughput sample processing this chemistry can be trans-
ferred to an automated magnetic extraction device.
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P835 Rapid detection of adenovirus DNA in conjunctival
scrapings by real-time PCR using SYBR Green I as the detection
dye
L. Folgueira, C. Prieto, S. Maldonado, M.J. Babiano, J.R. Otero
Madrid, E
Objectives: We have used a real-time PCR strategy, based on the
Light-Cycler technology, to detect Adenovirus DNA in conjuncti-
val scraping specimens collected from nursing home residents
that presented clinical signs of conjunctivitis, and the results were
compared with those obtained by conventional cell culture.
Methods: 23 conjunctival scrapings were sent to our laboratory in
2 mL of viral transport medium and were inoculated to monolay-
ers of A-549 and MRC-5 cells in tubes, incubated at 37C in sta-
tionary phase, and scored daily for cytophathic effect (CPE) for
7 days or until CPE developed. When a characteristic Adenovirus
CPE was observed (usually after 5 days of culture), a passage was
done to two homologous monolayers in shell vials that were incu-
bated 24 h at 37C and stained with speciﬁc ﬂuorescent reagents
to Adenovirus. DNA from 0.2 mL of the remaining transport med-
ium was puriﬁed by a commercial procedure and resuspended to
a ﬁnal volume of 50 lL. Five microlitres of this puriﬁed DNA was
used for real-time ampliﬁcation in a ﬁnal 20 lL reaction volume,
using 1 Fast Start SYBR Green I master mix (Roche), MgCl2
(3 mM), and 0.5 lM of each primer. The region ampliﬁed belongs
to the hexon gene. Total processing time was less than 3 h.
Results: Adenovirus was isolated in 10 of 23 samples processed
by conventional cell culture and all theses culture-positive sam-
ples were positive by real-time PCR; of 13 samples testing negat-
ive with conventional cell culture, real-time PCR detected eight as
negative and ﬁve as positive. Gel electrophoresis analysis showed
ampliﬁcation bands of the expected molecular weight in all these
real-time PCR positive, cell culture negative samples. A control
group of 20 samples from patients with bacterial conjunctivitis
was tested and all of them were negative by PCR.
Conclusions: Real-time PCR using the SYBR Green I ﬂuorescent
dye as the detection signal is simple, rapid and sensitive tool for
detection of Adenovirus DNA from conjunctival specimens.
P836 Enterovirus detection by real-time RT-PCR in the
study of aseptic meningitis
L. Santos, J. Simo˜es, S. Martins, A. Silvestre, R. Costa,
J. Freitas Da Fonseca, H. Lecour
Porto, P
Objectives: The aim of the study was the diagnosis of meningitis
by Enterovirus in an urban area using real time reverse transcrip-
tion polymerase chain reaction (RT-PCR) in cerebrospinal ﬂuid
(CSF) viral detection.
Methods: Aseptic meningitis was deﬁned when CSF cytosis excee-
ded 6 leukocytes/mL with negative culture or negative PCR for
usual bacterial aetiology. CSF samples were kept frozen at 70C
until used. Primers and probes were manufactured by Epoch Bio-
sciences (MGB Eclipse Probe system) and RT-PCR conditions
adapted to Rotor Gene real time cycler (Corbett Research).
Results: From 2001 to 2003, 185 patients were included. Ages ran-
ged from 11 days to 71 years with 116 (63%) less than 15 years
and eight newborns. On admission CSF cytosis vary from 10 to
1800 cells/mm3 (138  213), glucose from 15 to 143 mg/dL
(64  54), and proteins from 8 to 245 (52  72) mg/dL. Forty-six
per cent have blood leukocytosis and 35% high values of serum
protein C reactive. Antibiotics have been prescribed to 57 (31%)
of the patients on admission. Enterovirus RT-PCR assay was pos-
itive in 65 (35%) of the samples. Fifty-four (83%) of these were
from children younger than 15 years with four infants and two
newborns. No outbreak of acute meningitis was registered in that
2-year period. Enterovirus meningitis was observed all around the
year with a summer and fall peak incidence.
Conclusions: Although meningitis by Enterovirus is usually a
benign clinical condition, sometimes clinical and analytical data
overlap those of bacterial meningitis. Real time RT-PCR is then a
rapid and useful technique in clarifying the aetiology of acute
meningitis.
P837 Lack of detection of human retrovirus-5 (HRV-5)
proviral DNA in synovial tissue and blood specimens from
individuals with rheumatoid arthritis or osteoarthritis
K. Piper, A. Hanssen, D. Lewallen, E. Matteson, R. Hagan,
J. Steckelberg, R. Patel
Rochester, USA
Objectives: It had been suggested that there is an association
between HRV-5, a recently identiﬁed retrovirus, and rheumatoid
arthritis (RA). The purpose of this study was to determine if
HRV-5 proviral DNA is present in synovial tissue and blood spec-
imens from patients with RA or osteoarthritis (OA).
Methods: Synovial tissue and whole blood from 75 patients with
RA, 75 patients with OA, and 50 patients without joint disease
were collected in sterile containers. Whole blood was separated
into mononuclear cells and granulocytes using Histopaque 1119
and 1077 (Sigma, St Louis, MO, USA). DNA was extracted using
the QIAamp DNA mini kit (Qiagen, Valencia, CA, USA) and
assayed in duplicate by LightCycler (Roche Molecular Biochemi-
cal, Indianapolis, IN, USA) real-time quantitative PCR using
primers that amplify a 186-bp fragment of HRV-5 proviral DNA.
A plasmid containing the HRV-5 sequence spiked into a negat-
ive synovial tissue or blood specimen was used as a positive
control. Extracted DNA from a negative synovial tissue or blood
specimen was included between every two specimens as a neg-
ative control. Suitability of DNA for PCR was veriﬁed using a
PCR assay for beta-globin. Positive specimens were subjected to
bidirectional sequencing. Fisher exact test (two-tailed) was used
for statistical analysis.
Results: All 600 specimens were positive for beta-globin (extrac-
tion control). Cloned HRV-5 proviral DNA spiked into tissue,
mononuclear cells and granulocytes followed by extraction
yielded an ampliﬁed product in all cases. The limit of detection of
the assay was 166.6 copies/mL blood and 6.6 copies/mg tissue.
Two hundred tissue specimens, 200 mononuclear cells, and 196 of
200 granulocyte specimens tested negative for HRV-5 proviral
DNA. Two RA and two OA granulocyte specimens, however,
yielded a positive signal for HRV-5 proviral DNA. All were detec-
ted at a low copy number (quantitated by comparison to a known
quantity of cloned HRV-5 proviral DNA spiked into blood), range
83–1365 copies of HRV-5 proviral DNA/mL blood. All four
showed 95–98% identity to GenBank sequence AF480924 by NCBI
BLAST search.
Conclusion: We did not ﬁnd an association between HRV-5 and
RA or OA ( P ¼ 0.516) using a real time PCR assay. Recently it
has been shown that HRV-5 is actually rabbit endogenous retrovi-
rus H (J Virol 2002: 76; 7094–7102). We hypothesise that experi-
mental rabbit studies ongoing in our laboratory while the
granulocyte specimens were being prepared account for the low
level of ‘HRV-5’ proviral DNA detected in 0.7% of the specimens
tested.
P838 Diagnosis of viral infections of central nervous
system by polymerase chain reaction
A. Domingos, G. Marra˜o, C. Nogueira, A. Pinto de Oliveira,
G. Rocha, A. Magalha˜es-Sant’Ana
Coimbra, P
Objectives: Establish an aetiological diagnosis of viral infections of
the Central Nervous System (CNS) with the determination of the
most frequently virus implicated in those infections. It was also
our aim to improve the diagnosis efﬁciency through molecular
techniques.
Methods: We analysed a total of 31 cerebrospinal ﬂuid samples
(CSF) (12 paediatric and 19 non-paediatric) between September
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2002 and June 2003 from 30 patients with clinically suspicion of
viral encephalitis, meningitis or other CNS disease, from several
hospitals of Portugal’s Central region. The mean age of patients
was 26 years (range from 1 month to 65 years). We use the PCR
method in CSF samples to identify the following virus: HSV,
VZV, EBV, CMV, Parvovirus B19, Adenovirus and Enterovirus,
using speciﬁc primers for genome’s regions that are highly con-
served and that identify several serotypes of the same group,
such as the primers for the 50 non-coding region of Enterovirus
and the adenoviral hexon gene that allows the detection of 51
human adenovirus prototype strains and different genome vari-
ants, for the others virus we amplify the following gene frag-
ments, BamHIW, MCP, gene for DNA polymerase, gene 28 and
gene for VP1-VP2 of EBV, CMV, HSV, VZV and Parvovirus B19,
respectively. The viral nucleic acids were extracted from CSF spe-
cimen using the commercials kits, QIAampO`DNA Mini Kit and
QIAampO`Viral RNA Mini Kit, for DNA and RNA extractions,
respectively. The products of nucleic acid ampliﬁcation were
detected by visualisation of DNA bands of the expected size in
agarose gel electrophoresis after staining with ethidium-bromide.
Results: Of the 30 patients evaluated in this study, four (three
>19 years old) were enterovirus-positive (12.9%), four (one
>19 years old) were adenovirus-positive (12.9%), four (all with
age less than 19 years) were HSV-positive and eight (ﬁve
>19 years) were CMV-positive (25.8%), with three of them were
HIV seropositive.
Conclusion: CMV was the most frequent virus detected in our
study. Our study explains the growing interest of clinicians in
new technology, as offer a rapid, sensibility and speciﬁc response
to diagnosis.
P839 Infection of human cytomegalovirus (HCMV) DNA
in placenta using PCR
E. Paradowska, M. Przepiorkiewicz, D. Nowakowska,
M. Studzinska, J. Wilczynski, Z.J. Lesnikowski
Lodz, PL
Objectives: Placentas from pregnant women with suspected
human cytomegalovirus (HCMV) infection and diagnosed on the
basis of clinical symptoms, elevated HCMV IgM and IgA titres
were examined for the presence of HCMV DNA. Searching of
HCMV was focused on trophoblasts and Hofbauer cells from fetal
part of placenta as well as decidual macrophages. For the detec-
tion of viral genome three qualitative PCR assays, targeting the
US14, US13/US14 or UL55 gene, and a real-time quantitative PCR
were applied.
Methods: Twenty human placentas after delivery from pregnan-
cies complicated with HCMV infection were examined by PCR
method and indirect immunoﬂuorescent assay.
Results: HCMV DNA was found in 7/20 placentas (35%) either
in decidual and/or chorionic villi using different PCR tests. In
one placenta we observed inhibition of the virus transmission
from decidua to fetal tissues. Placental HCMV infection was also
characterised by immunoﬂuorescence staining with monoclonal
antibodies to HCMV antigens and speciﬁc cell markers.
Conclusions: Our results demonstrate that the detection of HCMV
DNA in placental tissues by ampliﬁcation methods provides a
rapid, speciﬁc and sensitive method for diagnostics of HCMV
infection. However, perinatal diagnosis should include PCR in
addition to viral culture and immunoﬂuoresence assay. Rapid
detection of HCMV in placenta may play an important role in
diagnostic process of congenital HCMV infection leading to iden-
tiﬁcation of newborns at risk of severe complications.
Acknowledgement: This work was supported by the State Commit-
tee for Scientiﬁc Research, grant no 3 P05E 001 25.
P840 Quantitative real-time PCR for diagnosis of VZV
infection in cerebrospinal ﬂuid
E. Zampachova, N. Piskunova
Ceske Budejovice, CZ
For the detection of Varicella zoster virus (VZV) in CSF, PCR is
the method of choice. Relation between the severity of illness and
quantity of virus in CSF is unknown.
Method: Quantitative real-time PCR was performed on Light
Cycler instrument (Roche, UK) using Real Art VZV LC kit (Artus,
Germany). Standards for quantitative curve assessment were a
part of the kit. DNA was isolated by High Pure Viral Nucleic
Acid Kit (Roche) according to the manufacturer protocol. In lim-
ited number of samples the interassay variability of the method
and variability in yield of isolation were tested. Interassay differ-
ence was maximum 163 copies per millilitre of sample. The differ-
ence in DNA isolation yield was higher, 188–881 copies per
millilitre of sample.
Patients: Samples for quantitative testing were selected by qualit-
ative PCR. VZV DNA was detected in 17 CSF samples from 16
patients with Herpes zoster (age 21–88 years) and in one sample
from a child with Varicella, complicated by meningitis. All
patients had clinical signs of meningeal irritation and biochemical
markers of neuroinfection in CSF. One additional sample of vesic-
ular ﬂuid and blood sample from an adult patient with acute
severe varicella without meningitis was tested.
Results: CSF virus load ranged from 102 to 5  104 copies per
millilitre. In comparison the virus load in vesicular ﬂuid was
3  106 copies per millilitre. The highest virus loads (5  104 and
2  104) were detected in a patient with paresis of facial nerve
and a young patient with relatively mild disease. The lowest virus
load (10  102 copies per millilitre) had a child with varicella
meningitis and an old patient with severe Herpes zoster of the
trunk. Quantitative PCR has good reproducibility and is useful
for assessment of viral load in CSF samples. However, the correla-
tion between virus load and severity of illness remains uncertain.
P841 Detection of herpes simplex virus and enteroviruses
in cerebrospinal ﬂuid by real-time PCR
J. Garcia-Martinez, L. Folgueira, C. Prieto, S. Maldonado,
M.J. Babiano, J. Otero
Madrid, E
Objectives: We evaluate real-time PCR as a laboratory tool for
Herpes simplex virus (HSV) DNA and Enterovirus (ETV) RNA
detection in cerebrospinal ﬂuid (CSF).
Methods: Over a 15-month period viral nucleic acids were extrac-
ted from 200 lL of CSF specimens from patients with clinical
signs of meningitis and/or encephalitis with the High Pure Viral
Nucleic Acid Kit (Roche Diagnostic GmbH). Glicoprotein D target
gene was ampliﬁed in a total volume of 20 lL in a LightCycler
Instrument (Roche Diagnostic GmbH) with the FastStart DNA
Polymerase ampliﬁcation kit (Roche Diagnostic GmbH). The tem-
perature of melting differentiated HSV-1 (89.9C) and HSV-2
(90.8C) viral types. ETV 50 non-translated region was reverse
transcribed and nested ampliﬁed in a LightCycler Instrument.
CSF specimens were also destined to viral culture on MRC-5 and
A-549 cellular lines.
Results: 325 CSF samples from 295 patients, mean age of
31.3 years (0–91) were investigated. HSV DNA was detected in
eight samples belonging to seven patients (2.37%) with a mean
age of 43.1 years (0–84). All but one were HSV-1; none of them
grew on cell culture. Fifty-ﬁve samples from unique patients were
tested for ETV RNA; six samples (10.9%) yielded a positive result
from patients with a mean age of 4 years (0–10); three of them
demonstrated a speciﬁc cytopathic effect on cell culture. Leuko-
cyte counts, glucose and protein levels in CSF ranged from
0–205 lL1, 40–100 mg/dL and 0.31–1.79 g/L, respectively, for
HSV DNA positive samples and 2–100 lL1, 40.9–60 mg/dL and
0.28–0.7 g/L, respectively, for ETV RNA positive samples. There
were no other microbiological data that accounted for the clinical
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signs. Although all seven patients with HSV DNA positive CSF
samples received different aciclovir iv doses based on their age,
three of them (42.8%) died.
Conclusion: Real-time PCR is an important tool in the diagnosis
of viral CNS infections because of its rapidity, sensitivity, speciﬁc-
ity and reliability compared with traditional viral diagnostic
methods. It is necessary to test systematically all CSF samples
from patients with clinical suspicions of meningitis and/or
encephalitis despite biochemical ﬁndings. A positive real-time
PCR result could anticipate antiviral treatment, diminish antibiotic
administration, avoid unnecessary procedures and allow earlier
discharges, which would improve patient outcome.
P842 Comparison of three commercial glycoprotein
G-based enzyme immunoassays for detection of HSV-1/HSV-2
IgG antibodies in pregnant women and sex workers
A. Akso¨zek, M. O¨zdamar, S. Ergin, K. Midilli, S. Serdaroglu,
S. Tu¨rkoglu, G. Yilmaz
Istanbul, TR
Objectives: Genital herpes is one of the most prevalent sexually
transmitted diseases, usually caused by herpes simplex virus type
2 (HSV-2). The high rate of undetected carriers is important in the
spread of HSV-2 as a sexually transmitted disease. Since direct
virus isolation methods are effective mostly in active phases of
infection, serological screening is necessary to able to detect past
HSV-2 infection which makes the choice of commercial assay dif-
ferentiating HSV-1/HSV-2 critical. In this study we aimed to com-
pare three commercial glycoprotein G-based ELISAs in screening
pregnant women and sex workers.
Materials and Methods: A total of 88 sera were tested (44 sex work-
ers, 44 pregnant women). The three HSV 1 and HSV 2 type speci-
ﬁc assays used were IgG-ELISA (Euroimmun, Lu¨beck, Germany),
HerpeSelect ELISA (Focus Technologies) and IBL (Hamburg, Ger-
many).
Results: Results are shown in Tables 1 and 2.
Conclusion: HSV-1 IgG results were concordant in all three assays
in both groups. In HSV-2 IgG detection, Euroimmun and HerpeS-
elect assays gave identical results but with IBL assay more posi-
tivity rates especially in pregnant women were obtained. Selection
of commercial ELISA kits may have a critical role in follow up of
pregnant women and screening of high risk groups of HSV infec-
tions.
P843 A novel enzyme immunoassay for the detection of
anti-herpesvirus-8 lytic IgG antibodies: evaluation of clinical
performance characteristics
F. Loftus, S. O’Keeffe, D. O’Leary, G. Elliott, S. Reid
Dublin, IRL
Objective: Human Herpesvirus-8 (HHV-8) is also known as
Kaposi’s Sarcoma-associated Herpesvirus (KSHV). The virus is
classiﬁed as a gamma herpesvirus and resembles EBV in its
tropism for B cells and ability to exist in a latent state. The Biotrin
HHV-8 IgG EIA was developed as a screening tool for HIV and
organ transplant associated populations.
Method: The EIA format incorporates synthetic peptides immobi-
lised on a solid phase. The peptides are derived from lytic anti-
gens K8.1 and KS65. A panel of 91 sera from HHV-8 seropositive
men with AIDS associated Kaposi’s sarcoma were analysed using
the Biotrin HHV-8 IgG EIA to determine the clinical sensitivity of
the assay kit. A HHV-8 negative panel consisting of 56 normal
human sera and 54 potential-cross-reactives (including HIV, EBV,
CMV and other Herpes sub-groups) were tested to evaluate the
speciﬁcity of the new assay.
Results: Of the 91 AIDS associated KS samples 82 were found to
be positive for anti-HHV-8 IgG antibodies, one specimen was neg-
ative, while eight specimens were within the equivocal zone
(greater than or equal to 0.8 and less than or equal to 1.2 index
value); these ﬁgures translate to a clinical sensitivity value of
90.1%. Speciﬁcity of the assay, including the cross-reactive speci-
mens, was measured at 94.65%.
Conclusion: These results demonstrate that rational selection of
peptide antigens and careful optimisation of assay conditions
have given high assay speciﬁcity while maintaining assay sensitiv-
ity.
P844 A new enzyme immunoassay for the detection herpes
simplex virus type 2 – speciﬁc antibodies
A. Obriadina, S. Klimashevskaya, M. Gladisheva, V. Puzyrev,
A. Burkov, T. Ulanova
Nizhniy Novgorod, RUS
Objectives: The purpose of this study was to develop enzyme
immunoassay (EIA) for the detection of IgG anti-HSV-2 activity
using two new recombinant proteins as antigenic targets, and to
evaluate these EIA with the aid of statistical methods.
Methods: Fragments of glycoprotein G (gG-2), comprising resi-
dues 525 to 578aa of herpes simplex virus type 2 (HSV-2) and gly-
coprotein D of HSV-2 (gD-2(266-394aa)), were expressed in the E.
coli as GST fusion proteins to develop an assay for the detection
and HSV-2 type-speciﬁc antibodies.
Results: A new enzyme immunoassay for the detection of IgG
anti-HSV-2 (IgG-EIA) in sera was developed using two new
recombinant proteins. The IgG-EIA was evaluated using serum
specimens obtained from patients with culture-proven HSV-2
infection (CP) (n ¼ 13) and from normal blood donors (BD)
(n ¼ 629). All specimens were additionally tested for IgG anti-
HSV-2 activity by two commercially available EIAs. This new
IgG-EIA detected anti-HSV2 activity in all specimens from HSV2
infected patients. When BD were tested the overall concordance
between these three assays varied between 39 and 63.6%, concor-
dance between positive samples ranged from 18.4 to 46.7%. In the
absence of a gold standard the accuracy of these EIAs was
assessed by the computer program based on a maximum likeli-
hood approach using a ‘latent class’ model. This analysis estima-
ted the IgG-EIA sensitivity and speciﬁcity to be within the range
98–100% and 95–100%, respectively.
Table 2




















Conclusion: The results show that the new two proteins-based
enzyme immunoassays may be useful tools for the detection of
type-speciﬁc HSV-2 antibodies. However, if only one assay is per-
formed, careful interpretation of the results is indicated and for
determination of the deﬁnitive HSV-2 serostatus, statistical models
may be necessary.
P845 Detection of the six commonest human herpesviruses
in clinical specimens by a single PCR (Herpes Consensus
methodology)
S. Levidiotou, G. Vrioni, C. Gartzonika, T. Priavali, C. Christaki
Ioannina, GR
Objectives: A wide spectrum of clinical disease is associated with
the human herpesviruses. The six most frequent aetiologic agents
of herpetic infections are herpes simplex virus 1 and 2 (HSV1,
HSV2), varicella-zoster virus (VZV), cytomegalovirus (CMV),
Epstein–Barr virus (EBV) and human herpesvirus 6 (HHV-6). The
aim of this study was the simultaneous detection and identiﬁca-
tion of the six major human herpesviruses in various clinical spec-
imens by a single PCR.
Methods: A total of 136 clinical samples obtained from 135
patients, including 78 specimens of cerebrospinal ﬂuid (CSF) from
patients with suspected encephalitis or meningitis, six swabs from
patients with vesicular skin lesions, 41 aqueous humor specimens
from patients with uveitis or iridocyclitis, nine conjunctival swabs
from patients with conjunctivitis, and one vesicle aspirate and one
bronchoalveolar lavage from the same patient with suspected var-
icella pneumonitis, were studied for the presence of herpesvirus
DNA. These specimens were collected from March 2001 to
November 2003. DNAs were ampliﬁed using a new type of pri-
mer system, ‘stair primer’, in a single tube, bringing simultaneous
ampliﬁcation of the six Herpesviruses (Herpes Consensus Hy-
bridowell, Argene Biosoft, France). The ampliﬁed product was
detected by hybridisation in a microtitre plate with six different
biotinylated probes, speciﬁc for the six viruses. The method was
successfully tested with positive and negative controls from the
European Union Concerted Action for Quality Control of Nucleic
Acid Ampliﬁcation in Diagnostic Virology (Herpes-2001 and
VZV-2003 Proﬁciency Panels). According to our results: (a) HSV1
DNA was detected in one CSF specimen from a patient with asep-
tic meningitis, in three aqueous humor specimens from patients
with uveitis, in one swab from a patient with herpetic vesicular
skin lesions and in three conjunctival swabs from patients with
conjunctivitis, and (b) VZV DNA was detected in two aqueous
humor specimens from patients with iridocyclitis, in two swabs
from patients with vesicular skin lesions, and in the vesicle aspir-
ate and bronchoalveolar lavage from the patient with varicella
pneumonitis. The precise diagnosis of herpetic infection was avail-
able within 24–48 h, which allowed for an early initiation of adap-
ted antiviral therapy.
Conclusion: The detection of the six commonest human herpesvi-
ruses in clinical specimens by the Herpesvirus Consensus PCR
methodology allowed rapid, sensitive and speciﬁc results.
P846 Questioning the programmed cell death in bovine
herpesvirus 1 infected MDBK cells and the possible role of
nitric oxide in this process
Z. Yazici, Y. Baskin, H. Baskin, O. Gecer, A. Ozkul, I.H. Bahar
Izmir, TR
Objectives: Bovine herpesvirus-1 (BHV-1) is the aetiological agent
of many infections and may predispose infected animals, possibly
through immunosupression, to secondary bacterial infections. Im-
munosupression may directly be associated with the induction of
programmed cell death (PCD) in some virus infected cells. Nitric
oxide (NO) has an important mediating role against fungal, bac-
terial, protozoal, viral pathogens and tumours. In this study, role
of NO was questioned in the PCD process.
Methods: This study was planned in two consecutive stages. In
the ﬁrst stage, the morphological (with and without staurosporin)
and biochemical changes caused by virus-induced PCD in MDBK
cells were investigated. Morphological assessment of PCD was
performed using Hoechst 33342 nuclear staining and ﬂuorescence
microscopy technique. In the second phase of the study, the
induction of PCD with staurosporin (SS) (alone or with BHV-1
addition) and apoptotic route of BHV-1 infections (with/without
staurosporin) were analysed by applying 1, 3, 8, 9 caspase inhibi-
tors (R&D, Germany).
Results: It was interesting to see that BHV-1 inhibited PCD fol-
lowing 1 h of poi instead of being induced by staurosporin and
induced apoptosis alone between 0.5 and 3 h of poi in MDBK
cells, however, between 3 and 6 h of poi, PCD response has found
to be decreased. These results showed similarities with those
obtained from herpes simplex type-1 infections in human epithe-
lial cells. Following caspase 1, 3, 8, and 9 inhibitors applications
PCD responses decreased after 1 h whereas NO responses
increased following 3 h of infections with caspase 1, 3, 8, and 9
inhibitory peptides.
Conclusion: In conclusion, BHV-1 inhibited the apoptotic response
in a caspase-independent way and BHV-1 may modulate the NO
response through the apoptotic pathways.
P847 Inversely proportional relation between programmed
cell death and nitric oxide responses: latency behaviour of
bovine herpesvirus-1 in an epithelial like microenvironment
Y. Baskin, Z. Yazici, H. Baskin, O. Gecer, N. Olgun, A. Ozkul,
I. Hakki Bahar
Izmir, TR
Objectives: The aim of this study is the questioning the pro-
grammed cell death (PCD) process in acute phase of BHV-1 infec-
tion in cultured epithelial like cells’ microenvironments and to
investigate its relation with possible nitric oxide responses in
HEp-2 cells infected with BHV-1 with and without staurosporin
induction.
Methods: This study was planned in two consecutive stages. In
the ﬁrst stage, the morphological (with and without staurosporin)
and biochemical changes caused by virus-induced PCD in HEp-2
cells were investigated. Morphological assessment of PCD was
performed using Hoechst 33342 nuclear staining and ﬂuorescence
microscopy technique. In the second phase of the study, the
induction of PCD with staurosporin (SS) (alone or with BHV-1
addition) and apoptotic route of BHV-1 infections (with/without
staurosporin) were analysed by applying 1, 3, 8, 9, and total ca-
spase inhibitors (R&D, Germany).
Results: It is known that following HSV-1 infection of 3–6 h of
poi anti-apoptotic activity is triggered in human cells. And this
activity is through caspase 3. It is interesting to see that in these
experiments following 1 h of BHV-1 infection the number of
apoptotic cells reduced whereas NO response continuously
increased following 1-h poi.
Conclusion: Anti-apoptotic activity of BHV-1 seems to be activa-
ted through caspase 3 like HSV-1, and this inversely proportional
relation between NO and PCD responses seem to be related with
the triggering effect of NO on PCD response.
P848 In vitro inhibition of herpes simplex virus type 1
replication caused by various probiotics
A. Voeikova, E. Ermolenko, V. Furaeva, A. Suvorov
Saint-Petersburg, RUS
Objectives: Anti-viral effect of various probiotics as alternative to
traditional anti-viral drug therapy was recently demonstrated.
This effect was explained as non-speciﬁc stimulation of the host
immune system. However, direct anti-viral effect cannot be exclu-
ded. The goal of present study was to evaluate the effect of probi-
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otics strains derivative metabolites on the reproduction of herpes
simplex virus type 1 (HSV-1).
Materials and methods: Probiotic strains used were: Lactobacillus
plantarum 8A-P3, Enterococcus faecium-L3, Escherichia coli M17. One
hundred and six Vero cells were infected with 103-104 ID of HSV-
1 and then incubated with supernatants from bacteria or bacterio-
cin preparations applied in serial dilutions. Acyclovir 20% (Lek,
Slovenia) was used as anti-viral drug control. Cytopathic effect of
the virus was determined by light or immunoﬂourescence micros-
copy after 72 h.
Results: HSV-1 alone or in the presence of the E. coli M17 extracts
caused the most profound cytopathic effect. Addition of acyclovir
completely inactivated the effect of the virus that was taken for
100%. Supernatants obtained from L. plantarum, and E. faecium
generated dose dependant effect from 90 to 35% of viral inhibi-
tion. E. faecium strain L-3 extract was 10–20% more active than L.
plantarum. Extract from the strain L-3 was analysed for the pres-
ence of bacteriocins. Two types of peptides were determined – en-
terocin A and enterocin B (5.5–5.6 kD). Bacteriocin preparation
demonstrated similar anti-viral effect (65–85% of inhibition)
which allows to consider enterococcal bacteriocins as major anti-
viral agents in present model.
Conclusions: Extracts of several probiotic bacterial strains express
a speciﬁc activity against reproduction of HSV-1 in vitro. Anti-
viral effect of E. faecium strain L-3 was the strongest due to the
presence of enterocins A and B in the supernatant.
Acknowledgement: Work was supported by Public Health Service
grants AI19304 and TW00188 from NIH, grant 03-04-49760 from
RFFI and regional foundation of support to new technologies in
medicine.
Clostridium difﬁcile
P849 Prevalence of Clostridium difﬁcile in hospitalised
patients
M. Lemeshevskay, I. Malov, S. Balakhonov, K. Aitov,
Y. Plotnikhova
Irkutsk, RUS
Objectives: Antimicrobial therapy renders the bowel susceptible to
colonisation and/or overgrowth of Clostridium difﬁcile. Cl. difﬁcile is
responsible for more than 90% cases of pseudomembranous colitis
and c. 25% cases of diarrhoea observed during or after antibiotic
therapy. The goal of this innovative study is to discover main epi-
demiological aspects and clinical examples of Cl. difﬁcile-associated
diseases (CDAD) on the basis of comprehensive use of the
most recent bacteriological, immunological, and molecular-genetic
methods.
Methods: Investigated population included 479 individuals ran-
ging in age from 13 to 79 years divided into four clinical and one
control sample. Stool specimens were examined using standard
bacteriological methods, PCR, and enzyme immunoassay. Identiﬁ-
cation of Cl. difﬁcile was done using the anaerobic technique on
cycloserine-cefoxitine-fructose agar. PCR with two speciﬁc primer
pairs of Cl. difﬁcile different genes was performed. The determined
genes (cytotoxins A and B) are localised on chromosome of
Cl. difﬁcile.
Results: The frequency of Cl. difﬁcile in hospitalised individuals
varied from 3.5 to 15.8% and depended on the hospital type
and the treatment administered. The Cl. difﬁcile infection was
most frequently detected in patients with HIV (15.8%) and
patients after surgical treatment (12.2%). A history of antibacte-
rial therapy and immunodeﬁciency conditions are risk factors
increasing the frequency of CDAD. To identify various microor-
ganisms in clinical material, we have developed a variant PCR-
based technique involving ampliﬁcation of the cytotoxine B
gene fragment. The method shows high degree of speciﬁcity
and sensitivity measuring not less than 103 xx/ml. Cl. difﬁcile-
associated diseases are characterised by a number of clinical
symptoms varying from asymptomatic carriage (60%) to various
forms of colitis (40%). The most frequent clinical symptoms
include the following: increased body temperature, continuous
stomach aches, most frequently localised in the mezogastric and
left abdominal area, and loose stool with variable blood con-
tent.
Conclusions: This research revealed wide prevalence of toxigenic
strains of Cl. difﬁcile among the sample population. This supports
the importance and necessity of implementing the most recent
methods to diagnose and treat CDAD.
P850 The ﬁrst report of the occurrence of Cardiff-PCR-
ribotypes among clinical Clostridium difﬁcile strains isolated
from patients with AAD in a university hospital, Warsaw
H. Pituch, J.S. Brazier, P. Obuch-Woszczatynski, D. Wultanska,
F. Meisel-Mikolajczyk, M. Luczak
Warsaw, PL; Cardiff, UK
Clostridium difﬁcile is the main aetiological agent of nosocomial
diarrhoea. The pathogenicity of this bacterium is determined by
the production of two major toxins: enterotoxin A (TcdA) and
cytotoxin B (TcdB). However, C. difﬁcile strains producing only
toxin B (TcdA–TcdB+) can be isolated from AAD. The applica-
tion of different typing methods has revealed that C. difﬁcile is a
heterogeneous species. O’Neill and colleagues developed a modi-
ﬁcation of PCR ribotyping method based on polymorphisms in
the 16S–23S rRNA intergenic region spacer for the routine typing
of C. difﬁcile. In this study we used PCR-ribotyping methods to
discriminate Polish C. difﬁcile strains. For this purpose 78 Polish
C. difﬁcile strains isolated between 2002 and 2003 including our
collection were studied. We have compared 49 Polish C. difﬁcile
strains randomly chosen with PCR-ribotypes of ARU Cardiff col-
lection. Among these strains 43 were toxigenic: 23 TcdA+TcdB+,
20 TcdATcdB+ but six strains were non-toxigenic
TcdATcdB. A total of 18 different ribotypes were detected
among 49 Polish isolates. Among toxigenic strains (TcdA+TcdB+)
we detected 13 ribotypes, among toxin B producing strains
(TcdATcdB+) only one ribotype was detected. Among non-toxi-
genic strains four ribotypes were detected. It seemed to be inter-
esting to observe the dominating ribotypes. Between toxigenic
(TcdA+TcdB+) ﬁve belonged to ribotype 014 and four to 046. All
strains (n ¼ 20) (TcdATcdB+) belonged to one ribotype - 017.
In summary, PCR-ribotyping is a good method to discriminate
C. difﬁcile strains. We decided to continue further epidemiologi-
cal study in Poland.
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P851 Risk factors of Clostridium difﬁcile-associated
diarrhoea due to actin-speciﬁc ADP-ribosyl transferase
producing strains
F. Barbut, D. Decre´, V. Lalande, L. Noussair, B. Burghoffer,
A. Gigandon, F. Espinasse, L. Raskine, J. Robert, A. Mangeol,
C. Branger, J. Petit
Paris, Clichy, Boulogne, Montfermeil, F
Clostridium difﬁcile (CD) is responsible for intestinal disorders
including post-antibiotic mild diarrhoea to fulminant pseudo-
membranous (PMC) colitis. The two large toxins A and B are
thought to be the primary virulence factors of C. difﬁcile. In 1988,
Popoff et al. (Infect Immun 1988; 56; 2299–2306) described a strain
which produces an actin-speciﬁc ADP-ribosyl transferase (CDT or
binary toxin) isolated from a patient with a severe PMC.
Objectives: The aim of the study was to identify risk factors of
C. difﬁcile-associated diarrhoea due to ADP-ribosyl transferase
producing strains.
Materials and Method: A retrospective case control study was per-
formed. Each case (patient with a diarrhoea due to an actin-speci-
ﬁc ADP-ribosyl transferase producing strain) was compared with
two controls (patient with diarrhoea due to a C. difﬁcile strain
which does not produce an actin-speciﬁc ADP-ribosyl transferase)
matched on ward and on date of hospitalisation. CdtA and cdtB
genes were screened by PCR (Stubbs et al., FEMS Microbiol Letters
2000; 186; 307–312). Production of CDT was studied by Western
blot using an antiserum anti Ia and Ib from C. perfringens and the
activity of the toxin was assessed using an ADP-ribosyl transf-
erase assay.
Results: Twenty-six cases (14 males and 12 females) were identi-
ﬁed in 1999 and 2000. They were hospitalised in six different hos-
pitals of Paris and its surrounding area. All the CDT positive
strains were also positive for toxins A and B. Cases were com-
pared with 42 controls. Cases and controls did not differ signiﬁ-
cantly for sex, age, previous administration of antibiotics, of
chemotherapy or immunosuppressive treatment. Endoscopic
examination was performed in 30.5% of cases and in 23.8% of
controls (P ¼ 0.52) and frequency of mucosal abnormalities was
similar. Diarrhoea was more often community-acquired in cases
than in controls (65.4 vs. 35.7%, P ¼ 0.017) and represented more
often the cause of hospitalisation (61.5 vs. 26.2%, P ¼ 0.003).
Moreover, diarrhoea from cases was more frequently associated
to abdominal pain (63.6 vs. 39.4%, P ¼ 0.007) and to liquid stools
(76.9 vs. 59.5%, P ¼ 0.14).
Conclusions: These results suggest that there could be a correlation
between the production of binary toxin and the severity of diar-
rhoea. The binary toxin could induce intestinal lesion independ-
ently of toxins A and B or it may act in synergy with these toxins.
P852 Control of an outbreak of Clostridium difﬁcile
infection among geriatric patients
S. Cheriﬁ, J. Robberecht, V. Ledeganck, B. Byl, M. Delmee,
G. Mascart
Brussels, B
Objectives: We investigated a nosocomial outbreak of Clostridium
difﬁcile-diarrhoea which occurred in March 2003 in the 127-bed
geriatrics department of the Brugmann University Hospital (21
March 2003 to 29 April 2003).
Methods: Outbreak was detected by the C. difﬁcile surveillance
programme survey of the Infection Control Unit. C. difﬁcile infec-
tion was diagnosed by stool culture and by detection of toxin A
with a qualitative rapid immunoassay. Isolates of C. difﬁcile were
genotyped using pulsed-ﬁeld gel electrophoresis.
Results: Incidence of C. difﬁcile-associated diarrhoea increased
from 16 cases per 100 000 patient-days before to 90 cases per
100 000 patient-days during the outbreak. This outbreak involved
21 patients of four geriatrics wards, located on two geographically
distinct sites (with the same medical team). Mean age was 83
(range 71–100) years; sex-ratio (F/M) ¼ 1.1; 90% (19/21) of cases
had received one or more antibiotics before onset of diarrhoea.
About 24% (5/21) of cases were long-term care facilities-acquired
diarrhoea, and secondary hospital transmission resulted in three
clusters involving 16 cases. Serotyping and genotyping were per-
formed on isolates from 19 different stools; 16 of these strains
belonged to the same type A1 whereas three displayed proﬁles
different from the outbreak strain. Management of this outbreak
consisted in reinforcement of contact isolation precautions for
patients with diarrhoea, cohortage of infected patients in the same
ward and in promotion of hand disinfection with an alcoholic
solution. Environmental disinfection with hypochlorite was intro-
duced during the outbreak. The ward where most transmission
occurred was closed during 10 days for a completed disinfection
after last patient discharge. After resolution of the outbreak, inci-
dence for acquisition was 12 cases per 100 000 patient-days.
Ninety per cent (19/21) of patients were treated by metronidazole
or vancomycin. Relapses occurred in 29% (6/21) of patients. Two
patients died with severe colitis. Mean hospital stay was 39 (range
11–97) days (annual mean of length of stay in the depart-
ment ¼ 21 days).
Conclusion: Rapid control of this nosocomial outbreak of C. difﬁ-
cile among geriatric patients was obtained with early implementa-
tion of cohortage and ward closure associated to reinforcement of
environmental disinfection, hand hygiene and enteric isolation.
P853 Toxigenic status of C. difﬁcile in a large hospital:
classical and molecular approaches
A. Martı´n, R. Alonso, T. Pela´ez, M. Marı´n, M. Rodrı´guez-Creix-
ems, E. Bouza
Madrid, E
Introduction: Toxigenic Clostridium difﬁcile is the main cause of no-
socomial diarrhoea and has recently been described as involved
in community acquired infections. Two main toxins have been
classically described as the main virulence factors although
strains that lack one of them are emerging with increasing fre-
quency.
Objective: We aimed to characterise toxigenic phenotypes in an
institution with high prevalence of C. difﬁcile-associated diarrhoea
(CDAD).
Materials and methods: C. difﬁcile isolates were obtained and collec-
ted over a 6-month period from diarrheic stools submitted to our
laboratory. Specimens were cultured in CCFA plates with blood
and presumptive colonies identiﬁed by standard procedures.
Toxin B was detected with a standard cytotoxicity assay on
human ﬁbroblast culture using both diluted samples and pure
broth cultures of the microorganism. Toxin A was detected by a
commercial enzyme-immunoassay (CdTOX A OIA, BioStar, Fin-
land) using colony suspensions in order to increase the sensitivity
of the test. All negative results for any of both toxins were
checked by PCR using previously published primers and condi-
tions.
Results: A total of 220 C. difﬁcile isolates were obtained during
the study period. One hundred and ninety-nine isolates (90.5%)
produced both toxins (A+B+); 10 isolates (4.5%) were classiﬁed
as non-toxigenic (AB) by phenotypic procedures; in 11 iso-
lates (5%) only toxin B was detected (AB+), while no isolates
were classiﬁed as producers of toxin A exclusively (A+B). All
non-toxigenic strains showed PCR positive results for gene B
and four of them also for gene A (six isolates were AB+ and
four were A+B+). From all AB+ isolates, only ﬁve were con-
ﬁrmed by PCR, while in six of them, toxin A gene was also
detected.
Conclusion: The vast majority of C. difﬁcile isolates obtained in
our laboratory were toxigenic (A+B+) by traditional approaches.
We have detected, using classical methods and conﬁrmation by
PCR, the presence of AB+ isolates in our collection. All isolates
considered as non-toxigenic by phenotypical methods were
PCR-positive for one or both toxins. Disagreements between
results of phenotypical and genetic methods can be justiﬁed as
the presence of incomplete or unexpressed genes or a lack of sen-
sitivity of the former methods.
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P854 An investigation into the carriage of Clostridium
difﬁcile on the hands of health care workers
S. Maxwell, F. Hudson
Stockport, UK
Background: It has been estimated that the extra cost to the NHS
for every patient that contracts C. difﬁcile in hospital is £4000. In
light of this it seemed imperative that the possible components
involved in the mode of transmission of this nosocomial infection
be investigated with a view to control the spread.
Objective: To look at the level of contamination of health care
workers’ hands with C. difﬁcile after dealing with a known posit-
ive patient.
Methods: Hands were sampled using the ﬁnger streak method on
a C. difﬁcile moxalactam norﬂoxacin (CDMN) agar plate. Plates
were incubated for 48 h under anaerobic conditions and then
examined for any possible colonies of C. difﬁcile. These were iden-
tiﬁed using the Gram stain and RapID ANA II system. Hands
were sampled directly after patient contact and the type of contact
was also noted. Hands were also sampled after the removal of
gloves and after hand washing. In all, 54 duplicate samples were
taken after various contacts with 14 colonised patients.
Results: 21% of samples taken immediately after patient contact
were positive. Nine per cent of samples taken after the removal of
gloves were positive. No samples taken after hand washing were
positive.
Conclusion: This study showed that hands do readily and regu-
larly become contaminated after contact with a known positive
patient and that this contamination can follow fairly minimal con-
tact with the patient.
P855 Tolemaver (GT160-246) binds Clostridium cytotoxins
A/B and is associated with restoration of components of the
anaerobic intestinal microﬂora during treatment of C. difﬁcile-
associated diarrhoea
T. Louie, B. Byrne, J. Emery, W. Krulicki, L. Ward,
D.R. MacCannell, M. Montgomery, D. Gregson, M. Mah
Calgary, CAN
Objectives: During the conduct of a Phase 2 clinical trial on the
efﬁcacy of tolevamer 1 or 2 g TID for 14 days compared with
vancomycin 125 mg QID for 10 days, we collected serial faecal
samples on study entry, days 4, 7, 10, 14, 21, 28 and 42 to deter-
mine if non-antibiotic therapy can neutralise C. difﬁcile toxin B in
faecal ﬁltrates, promote restoration of the normal microbiota and
achieve clinical response.
Methods: 33 patients were randomised into the study at Calgary
study sites (out of 289 patients/58 centres). Faecal ﬁltrate concen-
trations of C. difﬁcile cytotoxin B, quantitative counts of C. difﬁcile
vegetative organisms, C. difﬁcile spore counts were determined.
Quantitative aerobic/anaerobic cultures using serial dilutions of
faeces 10E-3,5,7,9,11 g1 wet weight were performed using criteria
as outlined in the Wadsworth Anaerobe Laboratory Manual.
Stools from healthy donors served as normal microﬂora controls.
Results: Thirty of 33 patients provided one or more samples, and
22/30 provided serial samples beyond 7 days and up to 42 days.
Normal ﬂora controls showed an average of four different Bacter-
oides species in counts of 101012 g1 faeces wet weight, plus
other anaerobic genera in a more inconsistent manner. Using Bac-
teroides species as a marker genus for the anaerobic microﬂora,
15, 8, and 7 patients had bacteroides counts below the limit of
detection, between 1038, or >108 CFU/g faeces, respectively, at
study entry. Vancomycin treatment eliminated vegetative C. difﬁ-
cile with variable spore persistence, and the Bacteroides genera
remained suppressed in the majority of patients during and after
the course of therapy. On the other hand, response to tolemaver
therapy appears to be accounted for by the inter-relationship
between toxin neutralisation, C. difﬁcile growth/persistence, and
the pattern of recovery of the microﬂora. In general, patients who
responded to toxin binding therapy exhibited non-emergence of
toxin combined with increase in the numbers of anaerobic organ-
isms. Recovery of the anaerobic microﬂora appeared not to be
complete at 14 days in the majority of patients.
Conclusion: Patients with C. difﬁcile diarrhoea have markedly
depleted components of the normal intestinal microbiota. Non-
antibiotic therapy of C. difﬁcile associated diarrhoea should be fur-
ther explored to optimise dosage and duration of toxin binding
therapy.
Nosocomial infections: nonfermentative Gram-negative bacilli - I
P856 Empirical antimicrobial treatment established
according to the temporal evolution of hospital outbreaks on
patients with bloodstream A. baumannii infections
J.J. Camarena, J.C. Navarro, R. Gonza´lez, R. Zaragoza, A. Artero,
A. Gea, J.M. Nogueira
Valencia, E
Objectives: The treatment of choice for A. baumannii bacteraemia
has not been established. There are few data to guide the selection
of agents for treating these infections. Carbapenems are generally
considered the drugs of choice, but an increasing of the resistant
strains has been described. Several alternatives guide lines have
been proposed: ampicillin–sulbactam (SAM) alone or associated
with an aminoglycoside, piperacillin–tazobactam (TZP) or tetracy-
clines. The aim of this study is to know the best alternative in the
empirical treatment of these infections according to the temporal
evolution of the nosocomial outbreaks or endemic infections in
our hospital.
Methods: From June 1995 to December 2001 we collected all A.
baumannii strains from bacteraemia infections and their related
focus. All the isolates were characterised by molecular methods in
order to obtain different clones using PFGE and REP-PCR. Sus-
ceptibility study was performed by disk diffusion to 23 antibiotics
and MIC-E-Test in the mainly treatment alternatives (imipenem,
meropenem, SAM, TZP, tobramicine (TM), amikacine (AN), and
ceftazidime) and interpreted according to NCCLS criteria.
Results: In 1995–1996 the empirical antimicrobial treatment (EAT)
of choice was imipenem because all 64 isolates were carbapenem
sensible (S), with two mainly molecular clones (34 isolates
C1-aminoglycosides resistant (R), and 30 C2-gentamicin-R, but
AN, netilmicin and TM-S). According to detection of an outbreak
carbapenem-R in 1997 (153 of the 163 isolates) clone C3 multire-
sistant (only some strains SAM or AN-TN-sensible) the EAT chan-
ged to SAM and AN or TM. This clone was persistent until 1999
and replaced with another multiresistant outbreak (C3B – 94%
SAM-R and 25–75% aminoglycosides-R). Then the EAT was cho-
sen as monotherapy with AN or TN (the only ones sensible of the
23 antimicrobial tested). In the last period (2000–2001) emerges a
new clone (C5-carbapenems, SAM, aminoglycosides and doxycy-
cline-S) and imipenem returns like the actual EAT in our hospital
to control bloodstream A. baumannii infections.
Conclusions: Empirical antimicrobial treatment on patients with
bloodstream A. baumannii infections in a hospital, with changes in
the temporal evolution of the clones associated to outbreaks or
endemic infections must be established according to the suscepti-
bility test and molecular characterisation of the strains in different
clones.
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P857 Outbreak of ampicillin-resistant and high-level
gentamicin-resistant enterococci in paediatric blood-stream
infections in a tertiary hospital in Tanzania
B. Blomberg, S.C. Mohn, K.P. Manji, N. Langeland on behalf of
the joint study group on antimicrobial resistance at Muhimbili
National Hospital, Dar es Salaam, Tanzania and the University of
Bergen, Norway
Objectives: Enterococci have emerged as major pathogens causing
urinary tract, wound and blood stream infections (BSI). Nosoco-
mial spread of enterococci resistant to multiple antimicrobials is a
great therapeutic challenge. Little is known about the role of these
pathogens in BSI in East Africa. The objective of the study was to
assess the prevalence and resistance patterns of enterococcal iso-
lates causing BSI in children at Muhimbili National Hospital, Dar
es Salaam, Tanzania.
Methods: Blood cultures were obtained from 1789 children (age
0–7 years) with fever or signs of serious infection admitted to the
hospital during the period August 2001 to August 2002. Isolates
were identiﬁed by standard methods. The identities of Enterococcus
fecalis and E. faecium isolates were conﬁrmed by polymerase chain
reaction (PCR), the isolates were susceptibility tested by E-test and
assessed for genetic relatedness by pulsed ﬁeld gel electrophoresis
(PFGE). Twelve E. faecium isolates were also investigated by MLST.
Results: Thirty-two of 1789 children (1.8%) had growth of entero-
coccal isolates in blood culture. Nine of 17 E. faecium isolates
showed combined resistance to ampicillin (ARE), ciproﬂoxacin
and high-level gentamicin resistance (HLGRE). Six of 15 E. fecalis
isolates were HLGRE, but none of these were resistant to ampicil-
lin or ciproﬂoxacin. All except one of the HLGRE were also resist-
ant to chloramphenicol. The resistant strains were recovered from
several geographically separated wards, including the neonatal
ward. The majority of the E. faecium and E. fecalis were closely
related when investigated by PFGE. MLST conducted on 12
E. faecium strains also conﬁrmed this result.
Conclusion: This is the ﬁrst study to identify outbreaks of blood-
stream infections caused by combined ARE/HLGRE E. faecium and
HLGRE E. fecalis in Tanzania. E. faecium was more frequent than
E. fecalis. The commonly used treatment regimens at the hospital
(ampicillin and gentamicin or penicillin and chloramphenicol) are
insufﬁcient for infections caused by ARE/HLGRE enterococci.
P858 Molecular characterisation of an outbreak caused by
cefoxitin-resistant Klebsiella pneumoniae
G. Kartali, E. Tzelepi, M. Tsivitanidou, D. Soﬁanou
Thessalonica, Athens, GR
Objectives: To describe the epidemiology, antimicrobial suscepti-
bility and genomic proﬁle of an outbreak due to cefoxitin (FOX) –
resistant Klebsiella pneumoniae.
Methods: During 7 months, from November 2000 to June 2001, 23
nonrepetitive (one per patient) resistant to FOX K. pneumoniae
strains were isolated from clinical specimens (10 from blood, two
from bronchial secretions, four from urine, two from wound and
ﬁve from catheter tips). Patients were cared in different wards
including intensive care unit (ICU) and neonatal intensive care unit
(NICU). Species identiﬁcation was done by using the Vitek system
(bioMerieux, France). MICs were determined with Vitek automa-
ted microdilution system and by disk diffusion method. The cri-
teria of the NCCLS were used to deﬁne susceptibility or resistance
to antimicrobial agents. Expanded spectrum a-lactamase (ESBL)
production was assessed by the double disk synergy test. The iso-
lates were typed by enterobacterial repetitive intergenic consensus
(ERIC) PCR with the ERIC-2 primer. Isoelectric focusing (IEF) of b-
lactamases was performed to representative group isolates.
Results: Antimicrobial proﬁles demonstrated that all isolates were
resistant to third-generation cephalosporins, to aztreonam, cefox-
itin, amoxicillin/clavulanate, ticarcillin/clavulanate and piperacil-
lin/tazobactam. Four isolates were also resistant to cefepime and
cefpirome. All isolates were susceptible to imipenem. IEF showed
that all isolates expressed two b-lactamases, one with pI of 8.2
which correlated with the SHV-5 and one with pI of 9.1 which
corresponded to LAT-2. ERIC-PCR analysis demonstrated three
strain types. Type I, consisting of two subtypes, was common to
15 strains, indicating that the clonal spread was mainly respon-
sible for the outbreak. Type II comprised two isolates and type III
was unique. Five isolates were not identiﬁed with ERIC-PCR.
Conclusions: K. pneumoniae strains, harbouring plasmid-coding for
AmpC-type b-lactamase, have been established in our hospital.
Nosocomial infection surveillance, such as restriction of particular
antibiotics and adjustment of the infection control measures, has
been recommended.
P859 Intensive care unit outbreak caused by a strain of




Objectives: Recently PER-1 extended-spectrum b-lactamase (ESBL)
was discovered in a Peudomonas aeruginosa strain in France and
was subsequently detected in Acinetobacter spp. and Pseudomonas
aeruginosa in other countries including Turkey. The purpose of
this study was to clarify the molecular epidemiology of infection
caused by a strain of cefepime-resistant A. baumannii and also to
determine the mechanism of drug resistance.
Methods: Cefepime-resistant A. baumannii strains were isolated
from clinical specimens of nine patients hospitalised in an inten-
sive care unit in Busan, Korea. Antimicrobial susceptibilities were
determined by the disk diffusion and agar dilution methods. The
double disk synergy (DDS) test was performed for screening of
ESBL production. Isoelectric focusing and conjugation experiments
were performed. blaPER-1 and blaPER-2 alleles were detected by
PCR, and sequences of ampliﬁed products were determined by
using the dideoxy-chain termination method. Pulsed-ﬁeld gel elec-
trophoresis (PFGE) was performed for molecular typing of isolates.
Results: The isolates showed same antimicrobial susceptibility
pattern, positive DDS results and PFGE patterns. The isolates con-
tained three b-lactamase bands: pI 5.3, 7.9, and 9.4. PCR-based
experiments detected blaPER-1 genes. MICs of ampicillin, pipera-
cillin, cephalothin, cefoxitin, cefoperazone, ceftazidime, cefotaxi-
me, cefepime, and aztreonam to these isolates were 256 mg/L,
respectively, and those of imipenem were 8–16 mg/L. Despite
repeated attempts, the resistance to cefepime of A. baumannii iso-
lates was not transferred to the recipient.
Conclusions: A. baumannii isolates from clinical specimens of nine
patients hospitalised in a same intensive care unit were shown to
be of the same clone. All these isolates contained blaPER-1 gene
which caused resistance to cefepime. To the best of our know-
ledge, outbreaks caused by PER-1 ESBL-producing A. baumannii
have not previously been described.
P860 Nosocomial outbreak of Salmonella enteritidis in a
neonatal unit
G. Gonzalez Mediero, H. Bello, M. Alvarez, I. Otero, I. Iglesias,
T. Del Blanco, M. Usera
Vigo, Madrid, E
Objectives: Hospital outbreaks of Salmonella spp. infections are
not uncommon not only in Europe but also in the United States,
but in neonatal Units it is rarer. The maternity unit has approxi-
mately 4000 deliveries each year. We described the results as well
as infection control that stopped the outbreak.
Methods: From October 2001 to January 2002 six neonates were
infected in the neonatal Unit of our Hospital. The index case cor-
responding to a newborn delivered in our Hospital, she was born
by normal vaginal delivery. The 15-day-old patient was admitted
again by neurological deﬁcits. Seven days at the Hospital she
developed diarrhoea. The group included ﬁve prematures, only
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case index was not premature. All stool specimens from family
case index were negative. Stool samples were request for culture
from asymtomatic staff and all babies from the neonatal Unit
(n ¼ 66). The isolates were identiﬁed by standard methods and
serotyped by agglutination with monospeciﬁc antisera. The antibi-
otics (AB) taken in the study were: ampicillin (A), ticarcillin (T),
amoxicillin/clavulanate (A/C), cefalothin (CE), ciproﬂoxacin (CP),
co-trimoxazole (CO), nalidixic acid (NA), gentamicin (G), third-
generation cephalosporins (3GC). Its was evaluated by a microdi-
lution method and conﬁrmation by E-test.
Results: Eight strains of Salmonella enteritidis serotype O 9,12:H
g,m were identiﬁed. The phage type (PT) involved was same in
all cases, PT 6a. Seven were isolated from faeces and one from
blood culture. All isolates demonstrated same antibiotic suscepti-
bility pattern with resistance to ampicillin and ticarcillin. Fortu-
nately no babies died. No salmonella from stools of nurses, staff
personnel and mothers was isolated.
Conclusions: A hand washing was not sufﬁciently frequent the
infection was probably transmitted by hand contact to prepared
milk, infusion and other equipment from the index case. This hypo-
thesis was subsequently conﬁrmed as the outbreak was terminated
after eradication of the presumed contamination sources by chan-
ging the mattresses, disinfecting the unit and ensuring strict obser-
vance of hand washing before and after every manipulation.
Salmonella enteritidis PT6 is third commonest phage type in Spain.
P861 Pseudo-outbreak of Pseudomonas aeruginosa
infections associated with bronchoscopic procedures
F.J. Vasallo, S. Pe´rez, M.A. Domı´nguez, A. Gonza´lez-Escalada,
V. del Campo, J.L. Guerra, J. Torres
Vigo, Barcelona, E
Objectives: To investigate the cause of an outbreak of Pseudomonas
aeruginosa isolations following bronchoscopic procedures.
Methods: From 16 to 31 January 2003, we detected a cluster of
P. aeruginosa isolates associated with bronchoscopy (nine samples
from eight patients). Laboratory culture, bronchoscope and med-
ical records of all cases were reviewed. All of them were related
with one bronchoscope and environmental samples were obtained
from it. Microbiological identiﬁcation and susceptibility testing
were performed with the MicroScan Walkaway 40 System (Dade
Behring). Random Ampliﬁed Polymorphic DNA analysis (RAPD)
and Pulsed Field Gel Electrophoresis (PFGE) were performed on
all available isolates of P. aeruginosa (eight clinical isolates from
seven patients and six bronchoscope related isolates).
Results: Two of the eight patients showed clinical evidence of
infection and required speciﬁc antimicrobial therapy (the index
case and other patient with two isolates separated by 8 days). All
isolates were ceftazidime, aminoglycosides and ciproﬂoxacin sus-
ceptible and imipenem resistant. RAPD and PFGE patterns
revealed that all the clinical and bronchoscope isolates (eight and
six, respectively) were indistinguishable. The bronchoscope was
replaced and no further cases appeared.
Conclusions: We documented contamination of a bronchoscope
with P. aeruginosa and possible secondary infection of at least one
patient. Microbiologists have an essential role in the detection of
medical devices contamination, especially by surveillance of the
emergence of infrequent bacterial recovery.
P862 Outbreak of Klebsiella pneumoniae causing fulminant
sepsis in a neonatal unit
R. Alonso, B. Padilla, C. Sa´nchez-Carrillo, E. Cercenado,
M. Sa´nchez-Luna, E. Bouza
Madrid, E
Introduction: Three cases of fulminant sepsis were detected in pre-
mature newborns, with no underlying diseases, admitted to the
neonatology unit of our hospital during a 14-day period. Blood
samples were taken and submitted to the microbiology laboratory.
In all three cases Klebsiella pneumoniae was isolated from the blood
cultures. The aim of this study was to investigate the epidemio-
logical relation among the isolates and to try to ﬁnd a common
source for the infection.
Methods: Environmental samples, including different i.v. ﬂuids
and drugs, and skin samples were obtained in order to detect the
source of the infection. Microbial identiﬁcation and in vitro sus-
ceptibility tests were carried out automatically with the MicroScan
System (DADE). Clinical isolates were molecular typed by Ran-
dom Ampliﬁcation of Polymorphic DNA (RAPD) using one 10-
mer oligonucleotide, PCR-Ribotyping with oligonucleotide of the
intergenic 16S/23S region and PFGE using XbaI as a restriction
enzyme. An unrelated strain was also included in all the experi-
ments, as a control, in order to check the discrimination power of
the techniques.
Results: All three clinical isolates of K. pneumoniae obtained from
blood cultures shared the same biotype and antibiotype, and were
all resistant to ampicillin, gentamycin and tobramycin. Molecular
typing methods proved clonal identities among the clinical
strains. Patterns generated were different from those of the control
strain. The source of the infection could not be demonstrated in
any of the environmental or newborn skin samples.
Conclusions: A single K. pneumoniae strain was the cause of the
fulminant sepsis in the three newborns. All three molecular typ-
ing methods, RAPD, PCR-Ribotyping and PFGE accurately dem-
onstrated clonal identities of the isolates. The common source of
the infection could not be detected due, probably, to the logical
delay in culture growth and identiﬁcation.
P863 Epidemic ceratoconjunctivitis outbreak at a university
eye clinic
A. Willke, L. Kocabas, A. Kubar, S. Erdogan, N. Yuksel,
S. Gu¨ndes, M. Celik, S. Ustacelebi, Y. Caglar
Kocaeli, Ankara, TR
Objectives: An outbreak of epidemic keratokonjunktivitis (EKC)
occurred at the eye clinic of Kocaeli University (KOU) Hospital
between early December 2001 and late January 2002. The objec-
tives of this presentation are to describe the outbreak and the
infection control measures implemented, and to constitute an
example for handling possible future outbreaks with limited
resources. This is the ﬁrst EKC outbreak reported from Turkey.
Methods: Eye clinic of KOU Hospital is equipped with modern
devices; however it has limited physical conditions (e.g. insufﬁ-
cient hand-washing facilities) because of temporary settlement of
the hospital after the earthquake of 1999.On 12 December 2001,
the Infection Control Team (ICT) was alerted to EKC cases. An
investigation began and infection control measures (ICM) were
implemented. Conjunctival swabs of patients with EKC and envi-
ronmental swabs were obtained and studied in GATA and Hacet-
tepe University microbiology laboratories. Infection control
protocol (ICP) was implemented as recommended by APIC guide-
lines with some modiﬁcations. In addition, terminal disinfection
(TD) was applied two times and after TDs clinic was closed for
ﬁrst 2 and than 4 days (Figure 1).
Results: A total of 116 EKC cases were diagnosed among the 1033
patients who visited the eye clinic during the outbreak (General
attack rate: 11.2%). Seventy-ﬁve of the EKC cases were male and
average age was 41.39  21.98 (range: 6 months to 85 years). Pri-
mary and secondary attack rates were found to be 26 and 119%,
respectively. Adenovirus type D was isolated from patient sam-
ples, biomicroscope and device solution. With the implementation
of ICP and TD, EKC cases decreased by time and outbreak disap-
peared about 14 days after the second TD and closing the clinic
for four days (Figure 1).
Conclusion: This is the ﬁrst outbreak reported from Turkey. Isola-
tion of virus from biomicroscope and device solutions which are
used for more than one patient is an evidence of transmission
from environment. Although several reports have described ICM
that terminated outbreaks of nosocomial EKC, this study demon-
strates that implementing TD and/or closing the clinic for four
days in addition to ICM, may control nosocomial EKC outbreaks.
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Catheter-related infections
P864 Health and economic outcomes of nosocomial
catheter-related candidaemia in critically ill patients
S. Blot, K. Vandewoude, J. De Waele, E. Hoste, J. Deschuijmer,
J.Decruyenaere, F. Colardyn
Ghent, B
Background: Because of severity of underlying disease, multiple
venous accesses, parenteral nutrition and often increased length
of stay, intensive care unit (ICU) patients are at increased risk for
catheter-related candidemia (CRC). We investigated health and
economic outcomes in ICU patients with CRC.
Methods: In a retrospective matched cohort study (1992–2002)
attributable mortality and excess length of stay for CRC was
investigated. Matching was (1:2 ratio) based on severity of under-
lying disease and acute illness (APACHE II score and admission
diagnosis) and length of ICU stay prior to the onset of the can-
didemia. As expected mortality can be derived from APACHE II;
this matching procedure results in an equal prognosis for cases
and control subjects. Attributable mortality is determined by sub-
tracting the hospital mortality rate of the controls from this of the
candidemic cases. Excesses in length of ICU stay and hospitalisa-
tion were determined by subtracting the median length of stay of
the controls from this of the cases.
Results: During the study period 21 ICU patients developed a
microbiologically documented CRC (out of a total of 83 candidem-
ic patients). Nineteen catheters were removed within 24 h. Cases
(n ¼ 21) and controls (n ¼ 42) had an equal age (resp. 49  20 vs.
53  19 year; P ¼ 0.470), APACHE II score (resp. 23  8
vs. 23  8; P ¼ 0.754) and incidence of respiratory failure (95 vs.
86%; P ¼ 0.479), acute renal failure (33 vs. 14%; P ¼ 0.153) and
haemodynamic instability (76 vs. 69%; P ¼ 0.767). The excess
length of ICU stay was 11 days (median 31 vs. 20 days;
P ¼ 0.002). Although patients with CRC had a longer length of
hospital stay this difference was not signiﬁcant (52 vs. 30 days;
P ¼ 0.508). The attributable mortality of CRC was 19.1% (95%
CI: 6 to 44%) as hospital mortality rates in cases and controls
were 42.9 and 23.8%, respectively (P ¼ 0.207).
Conclusion: Our data revealed that, after careful adjustment for
severity of underlying disease and acute illness, CRC is not asso-
ciated with a signiﬁcantly higher mortality in ICU patients. It is,
however, associated with a signiﬁcant excess in length of ICU
stay, thereby representing an important economic burden.
P865 Investigation of central intravenous catheter-related
bacteraemia
A. Tarpatzi, I. Stefanou, A. Katsandri, J. Papaparaskevas,
G. Petrikkos, G.L. Daikos, A. Avlamis
Athens, GR
Aim: To determine the cause of Central Catheter Bloodstream
Infection (CCBRI) with respect to the colonisation of the different
parts and connections of the intravenous catheter device.
Material and methods: A total of 187 central i.v. catheters from
patients of ‘Laikon’ General Hospital in Athens were studied.
Patients were hospitalised in two Internal Medicine departments,
two Surgical departments, the Nephrology department and the
Intensive Care Unit, during the period July 2001 to November
2003. The catheter tips were cultured using the following meth-
ods: (a) Semi-quantitative Maki’s and co. and (b) quantitative
Cleri’s and co. Samples for culture were taken also from the site
of catheter insertion into the skin and from the hub. Blood culture
samples were taken from a peripheral vein in cases of clinical sus-
picion of bacteraemia or sepsis and they were incubated using the
BactAlert (Organon Teknika) automated system for 6 days.
Results: 33 cases of CCBRI were recorded. The incidence of
CCBRI was 9.3 per 1000 catheter days. In 29 of the 33 cases of
CCBRI the origin of colonisation was determined. In 10 cases
which all had positive catheter tip and hub cultures with the same
strain, the Gram-negative bacteria prevailed (6/10, analytically
E. aerogenes three, K. pneumoniae two and P. aeruginosa one) while
in four cases Candida spp. (three cases) and coagulase negative
staphylococcus (CoNS) (one case) were isolated. In contrast, in 19
cases of CCBRI with positive catheter tip and skin point entry cul-
tures with the same strain, the Gram-positive bacteria prevailed
(15/19, analytically S. aureus eight, CoNS six and Corynobacterium
spp. one).
Conclusions: (1) The incidence of CCBRI was 9.3 per 1000 catheter
days. (2) CCBRI caused from Gram-positive bacteria was mainly
derived from the catheter site entry, whilst colonisation of hub
caused mainly Gram-negative CCBRI. (3) The preventive meas-
ures should be focused on better aseptic techniques and hand
hygiene, care of the catheter’s entry site and better training of the
medical staff.
P866 Differences in development of catheter-related
infections in critically ill adults
M. Sredkova, V. Edreva, V. Todorov
Pleven, BG
Objectives: To study and compare some characteristics of infec-
tions associated with central venous catheters in patients in units
with high risk – Intensive Care Unit (ICU) and Haemodialysis
unit (HDU).
Methods: Semiquantitative method of Maki et al. for study of
external surface of 5 cm catheter tip, quantitative method of
Linares et al. for study of catheter lumen, semiquantitative
analysis of the skin in insertion site and blood cultures
obtained from peripheral vein at the moment of removing of
the catheter.
Results: We studied 104 patients, suspect for catheter-related
infections (CRI) – 52 from ICU and 52 from HDU with central
venous catheters used for parenteral nutrition, drug administra-
tion or haemodialysis. The preferred vein in ICU was v.subclavia,
48, and in HDU, v. femoralis, 50 catheters. Mean duration of cath-
eterisation – 10 days in ICU and 22.8 days in HDU. Signs for colo-
nisation of the catheters were found in 57 cases – 32 in ICU and
25 in HDU. The most common microorganisms in ICU were
Gram-negative rods (KESgroup, B. cepacia, Pseudomonas spp.) – 21
(65.6%) followed by Coagulase-negative staphylococci (CNS) –10
(31.2%). In HDU in most of cases were isolated CNS – 19 (73.0%)
and S. aureus – 4 (15.3%) (P < 0.01). As catheter-related bacterae-
mias (CRB) were considered in 16 cases, 11 of them in ICU and 5
in HDU. Causative microorganisms of CRB in ICU were most
Gram-negative rods – 9(81.8%) and Syaphylococcus spp. 3 (60.0%)
in HDU (P < 0.01).
Conclusions: The frequency of CRB in ICU is signiﬁcantly higher,
21.1–9.6%, in HDU (P < 0.01).They developed earlier and were
caused by Gram-negative rods. More probable way to develop-
ment of CRB in ICU is the catheter hub and HDU is the skin of
the patients.
P867 Catheter-related sepsis in critically ill and associated
mortality
I. Leonard, A. Vandenberghe, P. Laterre
Brussels, B
Catheter-related infection (CRI) is considered as a cause of
increased Hospital morbidity but its inﬂuence on Hospital mortal-
ity remains a matter of debate. In critically ill patients, baseline
severity, underlying conditions and various confounding factors
may explain the observed increased mortality rather than CRI
itself. In order to determine the inﬂuence of CRI on Hospital
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mortality in ICU, all episodes of nosocomial septicaemia were
reviewed.
Material and methods: Retrospective analysis of all nosocomial sep-
ticaemia occurring over a 7-year period in a teaching Hospital.
Septicaemia episodes were separated in secondary, primary and
proven catheter-related bloodstream infections. Baseline severity
(SAPS score), delay between admission and infection, and Hospi-
tal mortality were determined.
Results: Over this 7-year period, 195 853 patients were admitted
to the Hospital and 2720 episodes of CRI were recorded (1.38%,
1.5/1000 Catheter-day (KTD)). Hospital mortality for all septicae-
mia was 21.7% while mortality related to secondary septicaemia
was 28.5% (P < 0.05). During the same period, 22 313 patients
were admitted to the ICU, corresponding to 81 740 KTD. Four
hundred twenty-four episodes of septicaemia occurred in these
patients (5/1000 KTD), of which 166 were primary septicaemia
and 87 were proven CRI (1.06/1000 KTD). Mean SAPS score for
all ICU patients was 30 and Hospital mortality 6.9%. ICU patients
developing infection had a mean baseline SAPS score >40. CRI
occurred more than 2 weeks after ICU admission (median :
14 days, mean 20.5 days). Pathogen-associated CRI were SCN
31%, S. Aureus 18%, E. faecalis 12%, Candida spp. 10%, Other
29%. Hospital mortality in patients developing CRI was 42/87
(48.2%).
Conclusions: In this study, Hospital mortality in Critically Ill
patients developing CRI was high but seemed to be primarily
determined by baseline severity and underlying conditions as
reﬂected by SAPS score and prolonged delay between ICU admis-
sion and septicaemia.
P868 Relationship of catheter-related infections in patients
with skin and nasal colonisation by endemic hospital-acquired
oxacillin-resistant Staphylococcus epidermidis strains
D. Blum-Menezes, O.J. Bratﬁch, M.C. Padoveze, M.L. Moretti
Sao Paulo, BR
Background: Central vascular catheters (CVC) represent an
important risk for nosocomial bloodstream infections and
Staphylococcus epidermidis is the most important pathogen of these
systemic infections.
Objectives: To study the genomic DNA proﬁles of S. epidermidis
isolated from catheter-related infections and bloodstream infec-
tions comparing with the strains isolated from skin and nasal
swab in patients hospitalised in a tertiary care university hospital.
Methods: Catheter-related infections were deﬁned according to
the CDC deﬁnitions. Patients with a culture for S. epidermidis from
blood and catheter tip (>15 CFU) were selected to have swabs
from skin and nasal for S. epidermidis. The S. epidermidis were
typed using PFGE, antibiotic susceptibility testing and bioﬁlm
detection, by Congo red method, were performed.
Results: Twelve patients with 17 episodes of catheter-related
infections were included in this study and 255 strains were ana-
lysed. In 10 episodes, the same DNA proﬁle was detected in
CVC/blood and in the skin/nasal and in seven episodes the clone
causing CVC/blood infections were not found in skin/nasal. The
mean time of isolation of S. epidermidis with clonal relation
between CVC/blood and skin/ nasal colonisation from the ﬁrst
day of hospitalisation until the detection in CVC/blood was
25.3 days. In episodes without S. epidermidis clonal relation, the
mean time was 13.7 days. PFGE identiﬁed three hospital endemic
proﬁles that were present in 46.6% (119/225) of all strains from
10 episodes, including the strains from CVC/blood infections and
in skin/nasal colonisation. In the strains from skin/nasal colonisa-
tion, the endemic proﬁles were present in 47.9% (93/194) of the
strains. The endemic DNA proﬁles were bioﬁlm producers and
were resistant to penicillin G, oxacillin and ciproﬂoxacin, variable
susceptibility to aminoglycosides and were susceptible to vanco-
mycin.
Conclusion: Patients with long term hospitalisation were previ-
ously colonised by hospital endemic S. epidermidis strains that
were responsible for catheter-related infections.
P869 Incidence and risk factors of central venous catheter-
related bacteraemia in gastrointestinal surgical units
J.-M. Januel, P. Vanhems, C. Chambrier, C. Chemorin, E. Tissot,
X. Barth, J. Fabry, P. Bouletreau, R. Ecochard
Lyon, F
Objectives: To calculate the incidence and the risk factors of Cen-
tral Venous Catheter-related infections (CVC-RI) in digestive sur-
gery units.
Methods: All patients admitted in two emergency gastrointesti-
nal surgery units (A and B) of Edouard Herriot University hos-
pital (Lyon, France) between 1 July 2002 and 31 December
2002, and requiring a CVC were included in this retrospective
cohort. The following data were analysed: patient and CVC
characteristics, risk factors and microbiological results. The diag-
nosis of CVC-RI was based on Brun-Buisson methodology
(1987). The comparisons were done using the Chi-square and
Student’s t-tests. A multiple logistic-regression model was used
to identify risk factors of CVC-RI according to their adjusted
odds ratio (aOR; 95% CI) and completed by a survival analysis
adjusted on duration of hospitalisation and CVC, the unit and
the timing of CVC implementation (before or after admission in
the unit).
Results: A total of 89 patients were included who required 102
CVC (60 CVC were implanted as per the hospitalisation in this
study units [Gr#1] and 42 before the patient admission in this
same units [Gr#2]). The total of catheter days was 1086 (respect-
ively 581 for Gr#1 and 505 for Gr#2). The number of CVC-RI was
21 that is 20.6% of CVC and the incidence rate per patient was
21%. The part number of CVC-RI were respectively 9 (15%) for
Gr#1and 12 (28.6%) for Gr#2. The incidence density of CVC-RI
was 1.93/100 catheter days for the totally cohort, 1.55/100 for
Gr#1 and 2.38/100 for Gr#2. In the totally cohort CVC-RI was
monomicrobial in 16 cases (76.2%). In that case the most preval-
ent bacteria were: Coagulase-negative Staphylococcus spp. (43.8%)
and Staphylococcus aureus (37.5%) and in case of plurimicrobial
infection the most prevalent agents were: Staphylococcus aureus
(60%), Coagulase-negative Staphylococcus spp. and Enterococcus
faecalis (40% for each). Intestinum somatoplasty was not was a
risk factor for CVC-RI in this study. The crude mortality rate was
5.3% (1/19) and 10% (7/70) for CVC-RI and non-CVC-RI,
respectively (P ¼ 0.5).
Conclusion: In these surgical units, the incidence of CVC-RI is
high and was related to the frequency of manipulations of the line
such as infusion, parenteral nutrition, injections and dressing even
after adjustment on the duration of CVC and timing of CVC
implantation. An intervention focused on these risk factors is
planned to reduced CVC-RI and improve the quality of care.
Table 1. Risk factors associated with CVC-RI in a multiple logis-
tic-regression (n ¼ 102 CVC)
Included data aOR* CI 95%** P***
Male gender 21.1 [3.6–123] 0.001
Unit B 13.1 [2.4–72.2] 0.003
Daily use of CVC for
intravenous antibiotic1
0.6 [0.3–0.9] 0.024
Nb. of daily access to CVC
for dressing removal
1.42 [1.0–1.9] 0.048
Nb. of daily use of CVC
for infusion1
2.0 [1–4.02] 0.053
Nb. of daily use of CVC
for parenteral nutrition1
4.0 [0.9–16.2] 0.06
*Adjusted odds ratios. ** 95% Conﬁdence interval. ***P-value for
stastic signiﬁcant.
1Daily mean of total number on the duration of CVC in the units.
2Per one dressing-removal increase.
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P870 Usefulness of a disinfectable needleless connector in
the prevention of arterial catheter colonisation
J.C. Ye´benes, G. Sauca, G. Miro´, J. Almirall, R. Martı´nez,
M. Serra-Prat, X. Buquet, X. Balanzo´
Mataro´, E
Objective: Novel technologies have been reported to aid in the
prevention of endovascular catheter colonisation in experimental
studies. The aim of this study is to evaluate the usefulness of a
disinfectable needleless connector in the prevention of radial
arterial catheter related infection in critically ill patients.
Methods: In a medical–surgical intensive care unit (ICU), radial
artery catheters (RAC) inserted in critically ill patients were pro-
spectively randomised and assigned to control group (catheter
covered with conventional cap) or study group (catheter covered
with a disinfectable needleless connector, Smartsite-plus).
Patients and RAC inserted during more than 48 h characteristics
were registered. At their removal, a hub brush culture, subcuta-
neous catheter segment culture and a catheter tip culture (Cleri’s
method) were performed. Two peripheral blood cultures were
also performed if bacteraemia was suspected.
Results: One hundred consecutive RACs were inserted in 77 crit-
ically ill patients (85% medical/15% surgical, mean age
69.1  15.9, SAPS II 44.2  18.7, length of ICU stay 7.8  14.5).
Ninety-nine were correctly randomised (53 in control and 46 in
study group). Twenty-four RACs were removed in less than 48 h
(10 in control and 14 in study group) and 11 were lost (six in con-
trol and ﬁve in study group) and not included in the analysis.
Mean length of insertion of studied catheters was 6.2  2.9. No
catheter related bacteraemia was observed. In the control group
hub colonisation was higher than in the study group, 22.2%
(8/36) vs. 3.5% (1/28) (Fisher exact test P value 0.034). No differ-
ences were observed in catheter, 0% (0/36) vs. 7% (2/28), or skin
colonisation, 2.8% (1/36) vs. 3.5% (1/28), in control or study
group respectively. Coagulase-negative staphylococci were the
predominant microorganisms involved. No differences were
observed in ICU stay or mortality.
Conclusion: Despite the needleless disinfectable connector is use-
ful to prevent hub colonisation, a higher number of catheters must
be analysed to evaluate its impact in the prevention of arterial
catheter related bacteraemia. Coagulase-negative staphylococci
were the predominant microorganisms involved.
P871 The ‘antibiotic-lock technique’ for eradication of
‘difﬁcult’ or multiple micro-organisms in infections of long-term
central venous catheters
A. Scalzini, G. Gattuso, D. Tomasoni, L. Palvarini
Mantua, I
Background: Catheter-related bacteraemia is a major complication
in patients with long-term surgically implanted central venous
catheters (CVC) and their removal for infection is difﬁcult and
expensive; now many catheter infections can be handled with
so-called ‘antibiotic lock-in technique’ combined or not with a sys-
temic antibiotic treatment. Results of several open studies indicate
that this method may be regarded as an alternative to the removal
of the device infected with coagulase-negative staphylococci; for
‘difﬁcult’ microorganism reports are rare. The Aa refer case-
reports of long-term CVC infections with multi-drug-R or mul-
tiple microogranisms treated combining a local antibiotic lock
with a systemic antibiotic treatment.
Case 1: a schizophrenic 41-year-old man was admitted to the hos-
pital because of fever of 2 weeks duration; he was affected by dia-
betes type II and NH lymphoma diagnosed 6 months earlier and
treated with chemotherapy through a Groshong CVC and, subse-
quently, with chronic steroid. Multiple blood cultures, performed
from CVC and peripheric veins, were positive for E. faecalis and
E. coli; the patient was treated with ceftriaxone 2 g ev qid
2w + lock-in therapy with teicoplanin 60 mg (in 3 mL) and ci-
proﬂoxacin 6 mg (in 3 mL) for 6 h a day for 10 days. It was
obtained a clinical and microbiological resolution without removal
of CVC.
Case 2: a 49-year-old man was admitted to the hospital for septic
fever; 3 months earlier a Groshong CVC had been placed to treat
with chemotherapy a rhinopharyngeal carcinoma. Multiple blood
cultures (from CVC and peripheric veins) were positive for a
multi-drug-resistant Stenotrophomonas maltophilia (S only to chlo-
ramphenicol, trimethoprim-sulfamethoxazole and levoﬂoxacin).
The patient was successfully treated, without removal CVC, with
systemic trimethoprim–sulfamethoxazole + levoﬂoxacin combined
to antibiotic lock (ciproﬂoxacin 8 mg in 4 mL for 12 h a day for
7 days).
Conclusion: The cases reported by the Aa conﬁrm that many
catheter infections can be maintained in place and sterilised with
lock-in therapy avoiding to replace expensive intravascular lines
with unnecessary and risky insertions. One of the questions to
resolve will be whether or not concomitant systemic antibiotic
therapy is necessary.
P872 Determination of disinfectants’ effectiveness and
their activity to adherent catheter bacterial strains isolated in
the hospital environment
K.W. Pancer, E. Mikulak, A.E. Laudy, B. Sawicka, D. Rabczenko,
T. Wernik, A. Gliniewicz, H. Stypulkowska-Misiurewicz
Warsaw, PL
Background: Nosocomial infections inﬂuence upon the mortality,
quality of patients’ life, costs and length of hospitalisation. The
source of those infections might be staff members, contaminated
water system, air-conditioning or pests. Disinfectants are helpful
in reducing or eradicating harmful pathogens existing in hospital
environment. Some bacteria are able to grow on a surface as a
bioﬁlm. This form is more resistant to external harmful condi-
tions such as antibiotics, disinfectants or host defence. Bacterial
adhesion was recognised as the important virulence factor for
colonisation of patient or bioﬁlm formation. In our study the
susceptibility of 65 bacterial strains isolated in hospital environ-
ment (colonising or infecting patients or carried by German
cockroaches) to antibiotics and chemical disinfectants was deter-
mined. Moreover the efﬁcacy of the disinfectant working
solution (active ingredients: sodium dichloroisocyanorate
1795.2 mg/L; glucoprotamine 5200 mg/L; potassium persulphate
4300 mg/L) on selected bacterial strains adherent to catheter
(after growing for 5 days on it) by treating then for 15 min was
determined.
Results: Susceptibility proﬁle to antibiotics varied; among Gram-
positive bacteria the MLSb, MRCNS strains were found; among
Gram-negative bacteria the ESBL, AmpC phenotype were des-
cribed. Determined MIC values or disinfectants were in range:
sodium dichloroisocyanorate 7.8125–2000 mg/L; glucoprotamine
1.453–500 mg/L; potassium persulphate 7.8125–1000 mg/L. The
results indicate that the working solution of the disinfectant might
be ineffective to some strains of well-known pathogens: Serratia
marcescens, Citrobacter freundii, Enterobacter cloacae and Staphylococ-
cus epidermidis. The examination of disinfectants efﬁcacy on selec-
ted strains showed that some bacterial strains were more resistant
when they were grown on catheter for 5 days. The MIC value
was lower than working solution of that chemical even more than
300 times. Moreover it was found that all tested disinfectants were
ineffective to some strains adherent to catheter ex. S. marcescens
and E. cloacae strains isolated from the body surface of German
cockroaches.
Conclusions: The possibility of bioﬁlm formation could explain
the increase of resistance to disinfectants of some strains. German
cockroaches carrying them in hospital should be considered not
only as nuisance insects, but also as a real source of resistant to
antibiotics and disinfectants bacteria.
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P873 Propionibacterium acnes is a common coloniser of
intravascular catheter tips
P. Martı´n-Rabada´n, L. Alcala´, M. Rodriguez, E. Bouza
Madrid, E
Background: Indwelling catheters are commonly colonised by skin
ﬂora. Propionibacterium spp. are among the commonest bacteria of
normal human skin but currently recommended catheter-culture
procedures would not detect its presence. Furthermore, Propioni-
bacterium is nearly always regarded as a blood culture contamin-
ant and automated blood culture methods may not detect a
proportion of them. Our objective was to determine the rate of
catheter colonisation by Propionibacterium spp. in unselected intra-
vascular catheters submitted for culture.
Methods: 368 intravascular catheters were processed by the roll-
plate technique and incubated in air at 37C for at least 2 days.
Organisms that were present in signiﬁcant counts were subcul-
tured for identiﬁcation and susceptibility testing. When the con-
ventional aerobic processing was ﬁnished, all primary culture
plates were reincubated in an anaerobic jar. After 7 days of
anaerobic incubation the plates were read looking for bacterial
colonies that were not initially present. Control plates were
inoculated with a suspension of P. acnes to assess the inﬂuence
of aerobic preincubation on the ﬁnal number of colony forming
units (CFU). Conventional processing detected signiﬁcant growth
of bacteria in 24.8% of all catheters and no signiﬁcant number
of colonies (<15) in an additional 17.6% samples. Anaerobic rein-
cubation yielded P. acnes in signiﬁcant counts in 3.5% of all
catheters (15% of all positive catheters) and no signiﬁcant num-
ber of colonies in an additional 14.1% of samples. Three samples
yielded signiﬁcant growth of both aerobic and anaerobic
bacteria. Of all the organisms recovered in signiﬁcant counts,
Coagulase-Negative staphylococci represented 55.5%, P. acnes
11.1%, S. aureus 7.7% and Corynebacterium spp. 6%, Enterococcus
spp. 5.1% and other bacteria and yeast 14.5%. Anaerobic bac-
teria other than P. acnes were rarely recovered in non-signiﬁcant
counts. Aerobic preincubation for 5 days did not substantially
affect the ﬁnal number of CFU.
Conclusion: P. acnes is the second most frequent coloniser of intra-
vascular catheters. Anaerobic reincubation of plates used in stand-
ard routine is a simple method that could be useful for catheter-
related research projects. The potential of P. acnes as a cause of
catheter-related bacteraemia merits further studies.
P874 Vascular access site infections in haemodialysis
patients in Italy: a surveillance study
L. Scudeller, G. Brunori, N. Petrosillo, G. Cancarini, G. Carosi,
P. Viale
Udine, Brescia, Rome, I
Objective: To estimate the incidence of vascular access-related
infections (VARI) in chronic haemodialysis patients in Italy, over-
all and by access type.
Methods: All vascular accesses (ﬁstula, graft, temporary or perma-
nent vascular access) in haemodialysis patients in 10 centres
(10–50 beds) in Italy were surveyed from June 2002 to July 2003.
Data were collected on a standardised form. VARI were detected
using two key events: antibiotics prescription or hospital admis-
sion. Rates were calculated per 1000 access-days (AD). Variables
associated to VARI were assessed by Cox regression.
Results: 810 patients were recruited, with mean age 64.8 years
(SD 15.2), median dialysis duration 31 months (IQR 8–76). Males
were 56%, the median Karnovsky index 80 (IQR 60–90). Preval-
ence of HCV infection was 16%, HBsAg carriage 5%, HIV infec-
tion 2%, diabetes 20%. Four per cent were taking steroid therapy,
3% were on immunosuppressants, 3% had autoimmune diseases,
4% a malignancy and 2% other causes of immunodepression.
Most patients (90%) had three dialysis sessions per week. Most
(89%) had only one access during the study, 7% two, the rest up
to 7. Data on 949 accesses were collected: 53 were grafts, 629 ﬁstu-
las, 140 permanent CVC, 127 temporary CVC. Of permanent
CVC, 74.4% were tunnelled. Eighty-four VARI were observed, for
an overall rate of 0.41/1000 AD (95% CI 0.33–0.51). Local infec-
tions were 41%, systemic 53%, both 6%. Isolates were 94; the
most common were S. aureus (n ¼ 40; 72% methicillin resistant),
Coagulase Negative staphylococci (n ¼ 32), E. coli (n ¼ 9). Rates
per access type were: ﬁstulas 0.07/1000 AD, grafts 0.63, perma-
nent CVC 2.39, temporary CVC 1.21, for a HR (vs. ﬁstulas) of 8.8,
30.2, 16.4, respectively. Rates were lower when the access was in
the subclavian site (1.45/1000 AD), than in the jugular (1.78) or in
the femoral site (2.8).
Conclusions: In Italy, rates of VARI appear comparable to those
reported in the medical literature. Rates were lowest for ﬁstulas,
and highest for permanent CVC. Surprisingly, rates for temporary
CVC were somewhat lower than for permanent CVC, possibly
indicating poor CVC management in the long-term. The femoral
site of insertion had the highest rate of infection. The most com-
mon isolate was, by far, S. aureus, conﬁrming the growing rele-
vance of this pathogen in all access site infections. Ongoing
surveillance of VARI in Italy appears feasible and reproducible.
Nosocomial infections: I
P875 Catheter-associated urinary tract infections in
hospitalised elderly women
M. Kompoti, A. Mousouli, K. Kontos, A. Georgopali, O. Zarkotou,
C. Nikolopoulou, S. Drimis
Athens, GR
Objectives: To detect the incidence of bacteriuria and/or funguria
following indwelling urethral catheterisation among hospitalised
elderly women.
Methods: We studied prospectively all elderly female patients
>70 years old who were admitted to our medical department dur-
ing a two-month period, provided that they were newly catheter-
ised upon admission and that the ﬁrst urine culture obtained
within the ﬁrst 24 h of hospitalisation was sterile. A urine speci-
men was obtained everyday for culture and microscopic examina-
tion.
Results: Thirty-four consecutive patients were enrolled in the
study. Mean age was 77.0  6.2 years. Main comorbidity included
arterial hypertension (54%), diabetes mellitus (37.5%), coronary
heart disease (20%), Parkinson’s disease (11.8%), chronic obstruct-
ive pulmonary disease (8.8%), cerebral vascular disease (26.4%).
Twenty-one patients (61.7%) had 22 episodes of bacteriuria. Med-
ian duration of hospitalisation before detection of catheter coloni-
sation was 4.0 days (range 3–22 days). Mean duration of
hospitalisation was 12.8  8.9 days in patients with bacteriuria
and 10.0  6.5 days in patients without bacteriuria (P ¼ NS). Iso-
lated microorganisms were Escherichia coli (15/22), Candida albicans
(3/22), Enterococcus faecalis (1/22), Citrobacter freundii (1/22), Provi-
dencia rettgeri (1/22) and Klebsiella sp. (1/22). Antimicrobial resist-
ance rates of the isolated strains were low. In 13 patients (61.9%),
the microorganism isolation accounted for cystitis, while in the
rest it accounted for asymptomatic bacteriuria. Cystitis was trea-
ted with the appropriate antimicrobials according to susceptibility
tests. In patients with candiduria, the urinary catheter was
removed or replaced.
Conclusions: Urinary bladder catheterisation in our series of hos-
pitalised elderly women was frequently followed by bacterial
and/or fungal catheter colonisation, while in most cases the latter
accounted for cystitis.
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P876 Antimicrobial resistance and causative agents of
nosocomial urinary tract infection in the medical wards in a
tertiary hospital
E. Vagiakou-Voudris, A. Kapogli, G. Zorbas, A. Strouza,
E. Malamou-Lada
Athens, GR
Objectives: To establish the frequency and antibiotic resistance of
uropathogens of nosocomial urinary tract infection in three medi-
cals wards in a tertiary hospital of Athens.
Methods: During a 1-year period (1/11/2002 to 1/11/2003) 2300
urine samples were obtained from inpatients, from three medical
wards 48 h after their admission. Urine cultures were performed
according to standard techniques. The identiﬁcation of urinary
isolates was performed using API and Crystal ID systems, while
the susceptibility of them was tested by Kirby-Bauer and M.I.C
methods.
Results: 803 out of 2300 urine samples (35%) fulﬁlled the criteria
for signiﬁcant bacteriuria (Pure growth of >100 000 CFU/mL
urine for bacteria and >1000 CFU/mL for Candida sp.). The no-
socomial isolated uropathogens were as following: E. coli 276
(34.37%), Candida sp. 116 (20.6%), Proteus sp. 87 (10.83%), Ps.
aeruginosa 86 (10.7%), Klebsiella sp. 75 (9.33%), Enterobacter sp. 18
(2.24%), A. baumannii 19 (2.36%), Serratia sp. 3 (0.37%), E. faecalis
36 (4.48%), E. faecium 10 (1.24%), S. aureus 6 (0.74%), CoNS 19
(2.36%). The resistance of isolated strains to antibiotics was as
following: E. coli and Klebsiella sp. were resistant to ampicillin
(41.3–100%), amoxicillin–clavulanic acid (2.53–2.66%), cephalothin
(8.69–33.3%), cefuroxime (3.6–30.6%), nitrofurantoin (1.44–
18.66%), cotrimoxazole (10.86–25.3%), quinolones (3.26–9.33%)
retrospectively. The resistance of P. aeruginosa and A. baumannii to
imipenem was (11.6–31.5%), ceftazidime (12.7–10.5%), quinolones
(31.3–15%) and aminoglycosides (36–26%) retrospectively. The
resistance of CoNS to oxacillin was 47.3%, gentamycin 31.5%,
cotrimoxazole 31.5%, quinolones 31.5% and nitrofurantoin 21%.
E. faecalis was resistant to gentamycin high level 5.55% and
E. faecium 30%. There was no resistance to glycopeptides for
Staphylococci as well as Enterococcus sp. About 5.2, 3.5 and 2.5%
of isolates E. coli, Proteus sp. and Klebsiella sp. expressed ESBL
production.
Conclusions: E. coli, Candida sp., Proteus sp., Klebsiella sp.,
Pseudomonas sp. and Enterococcus sp. were the most common uro-
pathogens isolated from inpatients in the three medical wards in
our hospital. About 41% of isolates of E. coli isolates were resist-
ant to ampicillin and 11.2% of Enterobacteriaceae were ESBL
producers. Additionally, 4% of P. aeruginosa and 12.5% of
A. baumannii produced carbapenemases.
P877 Epidemiology of ventriculostomy-related infections in
neurosurgical patients
B. Tiodorovic, M. Babic, M. Dinic
Nis, CS
Objective: To assess the epidemiology of meningitis related to
external ventricular CSF drainage in neurosurgical patients.
Methods: From 01/01/2001 to 01/01/2002, 121 patients undergo-
ing ventricular catheterisation (VC) were surveyed in the 12-bed
ICU of the neurosurgery ward. All patients were managed in a
standardised way for nursing, daily bacteriological and chemical
CSF examination with removal of VC in case of infection.
Results: Meningitis was diagnosis in 14 patients (12.31%). Five
cases were not documented (15.3%) and other cases were due
principally to Gram-positive cocci (76%).The median delay of
onset was 7 days. No signiﬁcant difference was found between
infected and non-infected patients in terms of age. SAPS II, pres-
ence of comorbity and mortality (duration of VC-19 vs. 10 days).
Conclusion: The proportion of VC-related meningitis without bac-
teriological documentation appears not negligible and these no-
socomial infections seem to have an impact on morbidity but not
on mortality rates.
P878 Cerebrospinal ﬂuid shunt infections in adults:
a 15-year experience
X. Santesmases, A. Pallare´s, N. Sopena, M. Gime´nez,
M.L. Pedro-Botet, J.M. Cladellas, S. Colet, C. Rey-Joly, M. Sabria`
Badalona, E
Background: Cerebrospinal ﬂuid (CSF) shunt infection is a com-
mon cause of shunt failure.
Objectives: To study CSF shunt infections occurring in Hospital
Germans Trias i Pujol.
Methods: Retrospective study of adult patients with CSF shunt
infections between April 1987 and December 2002 in a tertiary
600-bed hospital in Badalona (Barcelona). Epidemiological and
clinical characteristics and outcome of these patients were recor-
ded in a data base and analysed by SPSS.
Results: Eighteen patients with CSF shunt infections, eight
(44.4%) males, with a mean age of 56.22  20.4 years and seven
(38.9%) with comorbity, were included in the study. The most
common indication of shunt was normal-pressure communicating
hydrocephalus in six (33.3%), hydrocephalus due to intraventricu-
lar haemorrhage in six (33.3%) and secondary to tumour in four
(22.2%). The shunt was ventriculoperitoneal (VP) in 16 (88.9%)
cases and lumboperitoneal (LP) in 2 (11.1%). The clinical presen-
tation was fever in 16 (88.9%), symptoms related to shunt mal-
function in 12 (66.6%) (lethargy in 55.6%, nausea-vomiting in
22.2%, headache in 16.7%, convulsions in 5.6%), meningeal signs
in 5 (27.8%), symptoms related to distal end (abdominal pain) in
4 (22.2%) and wound infection in 2 (11.1%). Mean duration of
symptoms before diagnosis was 3.28  5.67 days. The mean per-
ipheral white blood count was 11 384  6716.4 mm3. The ﬁnd-
ings of CSF (mean, SD) were: leucocyte count 408.8  1034.6,
glucose 3.48  2.2 mmol/mm3, proteins 0.59  0.74 g/L. The CSF
Gram stain was positive in six (33.3%) of the cases. The aetiologic
agents of shunt infections were: coagulase-negative staphylococci
(nine cases, 56.2%), Sthaphycoccus aureus (one), Streptococcus
sanguis (one), Pseudomonas aeruginosa (two), Escherichia coli (one),
Citrobacter diversus (one), Propionibacterium acnes (one), Polimicro-
bial infection (two). Blood cultures were positive in only one case.
Antibiotic treatment was indicated in all the cases; moreover,
prosthetic shunt was removed in 14 (77.8%) with reshunt in six
(33.3%) cases. The outcome was known in 16 cases: resolution of
infection in 11 cases, relapse in one case and death in four cases
(related to shunt infection in two).
Conclusions: CSF shunt infections in adults occurred mainly in
patients with ventriculoperitoneal shunts, presenting with symp-
toms related to shunt malfunction. These infections were mainly
caused by coagulase-negative staphylococci and require removal
of the prosthetic shunt.
P879 Evaluation of postneurosurgical nosocomial
meningitis in adults
C. Bulut, A. Tekiner, M.A. Yetkin, C.A. Hatipoglu, Z. Buharali,
N. Tulek
Ankara, TR
Objectives: To assess the clinical and therapeutic outcomes of
nosocomial Gram-negative bacillary meningitis (GNBM) in adult
postneurosurgical patients.
Methods: Between 1 January 2000 and 31 December 2002, 19 adult
patient with GNBM were included in this study. Nosocomial
meningitis was deﬁned according to the CDC criteria. Their clin-
ical features, laboratory data, predisposing factors and therapeutic
outcome were analysed.
Results: Nineteen patients included 10 males and nine females,
whose ages ranged from 15 to 67 years (mean 41 years). All of the
patients were hospitalised in the neurosurgical department. The
most common underlying conditions were intracranial haemor-
rhage (8/19 cases), followed by hydrocephalus (4/19 cases) and
cranial injury secondary to trauma (3/19). All patients underwent
surgical procedures prior to infection, which included 15 cranioto-
mies and four ventriculostomies. All patients were receiving
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antibiotic therapy at the onset of infection. Mean time between
surgical procedure and diagnosis of meningitis was 15 days
(6–27 days). Fever and neck stiffness was found in eight and
seven patients, respectively. In 12 patients serum leukocyte count
was higher than 10  1000/cu mm. Mean leukocyte count in
serum and cerebrospinal ﬂuid was 16  1000/cu mm (min
10  1000/cu mm, max; 35  1000/cu mm) and 19  1000/
cu mm (min 10/cu mm, max; 5620/cu mm) respectively. Mean
CSF protein concentration was 210 mg/dL and mean CSF glucose
concentration was 44 mg/dL. Only in 14 of 19 cases the microor-
ganism was isolated from cerebrospinal ﬂuid. Acinetobacter spp.
(11 cases), K. pneumoniae (two cases) and E. cloacae were the isola-
ted microorganisms. Most of the Acinetobacter isolates were sus-
ceptible to carbapenems but all of them were resistant to third-
generation cephalosporins. A combination of carbapenem plus an
aminoglycoside and/or vancomycin therapy was applied most of
the patients. An additional intrathecal aminoglycoside dosage was
needed for seven patients who responded poorly. The overall
mortality rate in these patients was 43%.
Conclusion: There has been an increase of post neurosurgery men-
ingitis cases. In addition, the emergence of strains resistant to
third-generation cephalosporins in this group has also been noted
in recent years, and has become a great therapeutic challenge.
Early diagnosis and initiation of appropriate antibiotic therapy is
needed in this potentially fatal disease.
P880 The inﬂuence of antimicrobial prophylaxis on upper
respiratory tract microﬂora in hospitalised patients with
resectable lung cancer
U. Kosikowska, R. Los, A. Biernasiuk, M. Juda, A. Malm,
P. Rybojad, F. Furmanik
Lublin, PL
Objectives: Pulmonary resection is associated with considerable
risk of infection, so antimicrobial prophylaxis has become routine
practice in thoracic surgery. The aim of this study was to assess
changes in microﬂora of upper respiratory tract in hospitalised
patients with non-small cell lung cancer (NSCLC) before and after
preoperative antimicrobial prophylaxis.
Methods: 51 patients with NSCLC aged 37–73 years were subdi-
vided into two groups: (A) control group (21 patients without
antimicrobial prophylaxis and surgery), (B) ‘prophylaxis’ group
(30 patients undergoing pulmonary operation with preoperative
antimicrobial prophylaxis, including piperacillin, cefuroxime or
ceftriaxone alone or in combination with amikacin). Throat and
nasal specimens were taken up two times: examination I – on
the day of hospital admission and examination II – on the third
or fourth day of hospitalisation in group A and on the third or
fourth day after the surgery in group B. The routine microbiolo-
gical methods were used for isolation and identiﬁcation of bac-
teria and fungi. Statistical analyses were performed by
nonparametric tests.
Results: The colonisation of nasal mucous membranes by patho-
genic microﬂora did not differ signiﬁcantly during hospitalisation
between group A and B. Similar situation was observed in the
case of pathogenic microﬂora on throat mucous membranes in
group A. Different results were obtained in group B. The
increased prevalence of pathogenic microﬂora on throat mucous
membranes was observed – from 46.67% in examination I to 80%
in examination II. This difference was statistically signiﬁcant
(P ¼ 0.007). In group B colonisation of throat mucous membranes
by Enterobacteriaceae family and Candida spp. was increased sig-
niﬁcantly during hospitalisation (from 10 to 26.67% and from
36.67 to 70%, respectively).
Conclusion: Our results indicate that antimicrobial prophylaxis
can be regarded as an important predisposing factor for changes
of upper respiratory tract microﬂora and for colonisation of
mucous membrane of throat with enteric Gram-negative rods and
yeast-like fungi – Candida spp. These microorganisms are potential
causative agents of endogenous infections in immunocompro-
mised patients with lung cancer.
P881 Aerobic and anaerobic ﬂora isolated from pleural
drains in patients with lung cancer after thoracic surgery
R. Los, I. Korona-Glowniak, A. Malm, P. Rybojad, F. Furmanik
Lublin, PL
Objectives: The purpose of this study was to determine aerobic
and anaerobic bacteria colonising pleural drains in patients with
non-small cell lung cancer (NSCLC) undergoing thoracic surgery
and to deﬁne antimicrobial agents susceptibility of isolated
strains. Routine antimicrobial prophylaxis included piperacillin or
cefuroxime. In some cases beta-lactam was used in combination
with amikacin.
Methods: Material for research was ﬂuid from pleural drains col-
lected from 34 patients aged 38–72 years two times – on the day
of pulmonary resection and on the fourth day after operation.
Samples were routinely cultured under aerobic and anaerobic
conditions and determined using Api system (bioMerieux). Anti-
microbial resistance was estimated by the disc diffusion method
according NCCLS recommendations.
Results: Aerobic (49 strains) and anaerobic (23 strains) bacteria
were found in 30 (44%) and 15 (22%) samples, respectively.
Among aerobic bacteria, Gram-negative rods (22 strains;
18 – belonging to non-fermenting rods) and coagulase negative
staphylococci (CNS; 14 strains) were most often cultured. Fifteen
strains of non-fermenting rods and 11 isolates of CNS were clas-
siﬁed as multidrug resistant (MDR) organisms. Two isolates of
S. marcescens were producers of extended spectrum beta-lacta-
mases (ESBLs) and inducible beta-lactamases (IBLs). All staphy-
lococci were susceptible to vancomycin and teicoplanin. CNS
strains resistant to penicillin and oxacillin but sensitive to
amoxicillin/clavulanate were most frequently isolated. Only two
methicillin-resistant strains, belonging to S. haemolyticus were
found. The most common anaerobic bacteria were from the
genera Eubacterium (nine strains) and Actinomyces (six strains).
All of them were highly susceptible to antimicrobial agents
except metronidazol (69.6% resistant strains) and chlorampheni-
col (52.2% resistant isolates).
Conclusion: Colonisation of pleural drains does not mean infec-
tion, however knowledge about bacterial species found in drain
ﬂuid in a local population and antimicrobial resistance (especially
MDR strains) has a major impact on the success of prophylaxis
and therapy of potential postoperative infections.
P882 Severe bacteraemic infections in patients with
diabetes mellitus
A. Artero, J.J. Camarena, R. Zaragoza, S. Sancho, J. Tamarit,
R. Gonza´lez, J. Nogueira
Valencia, E
Objectives: To know the clinical and microbiological characteris-
tics of diabetic patients with severe bacteraemia. To identify the
differential features of severe bacteraemia between patients with
and without diabetes mellitus (DM).
Materials and methods: During a 7-year period (1996–2003) we
have evaluated all bacteraemias with severe sepsis or septic shock
in an intensive care unit of a teaching hospital. Clinical and
microbiological features were recorded from clinical charts. The
SPSS package (9.0) was used to identify signiﬁcant differences
between DM and no-DM cases, and to determine if the presence
of DM was associated with mortality by a multivariate analysis.
Results: The prevalence of DM in patients with severe bacteremic
infections was 23.8% (n ¼ 60). In the group of DM the mean
age of patients was 69.2  7.9 years, the relation between
men/women was 1.06, the origin of the bacteraemias was nosoco-
mial in 88.3%, severe sepsis was present in 61.6% and septic
shock in 31.6%. The focus of infection in diabetic patients was:
unknown (n ¼ 29), catheter (n ¼ 11), respiratory (n ¼ 9), urinary
(n ¼ 5), abdominal (n ¼ 3), vascular (n ¼ 2) and cutaneous
(n ¼ 1). The main microorganisms causing of bacteraemias in
patients with DM were: CNS (21.6%), Acinetobacter baumannii
(15%), Staphylococcus aureus (11.6%), Escherichia coli (8.3%) and
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Enterococcus spp. (8.3%). A higher proportion of nosocomial cases
in DM was the only differential feature between patients with and
without DM (P ¼ 0.041). The global mortality in patients with
and without DM were 43.3 and 56.7% (P ¼ 0.068), respectively,
and the related mortality were 21.6 and 27.6% (P ¼ 0.361),
respectively. DM was related neither to global (OR ¼ 0.523, 95%
IC 0.269–1.015) nor related mortality (OR ¼ 0.730, 95% IC 0.337–
1.583) by multivariate analysis.
Conclusion: DM is prevalent between critically ill patients with
severe bacteraemic sepsis and bacteraemic septic shock. Diabetic
patients had a higher proportion of nosocomial origin of bacterae-
mia. We did not ﬁnd that DM was related to mortality in severe
bacteraemic infections.
P883 A rare case of Brucella infection of an obstetrician
during the delivery of an infected infant
A. Poulou, F. Markou, X. Efthimiou, F. Mountaki
Serres, GR
Objectives: Brucellosis is a zoonotic disease whose prevalence in
Northern Greece is high and constitutes a signiﬁcant problem for
the local health authorities. The aim of this study is to report a
rare case of transmission of Brucella melitensis.
Patients: A female infant showed signs of respiratory distress dur-
ing delivery. The obstetrician in charge tried to clear the respirat-
ory tract of saliva and amniotic ﬂuid. In his attempt he swallowed
some secretions. A blood culture from the infant was incubated in
the Bactec 9120. After 3 days B. melitansis was isolated. The case
was proved to be a rare case of congenital brucellosis. The family
of the infant was checked and the mother was found to be posit-
ive at 1/80 titre by Brucella agglutination test though her blood
culture was negative. Neither her husband nor her other two chil-
dren were positive on the Wright agglutination test. Both parents
were involved in animal husbandry. Two months after the deliv-
ery of the infected infant the obstetrician reported pains in the
back of his neck and low fever. A blood test revealed leucopenia
and neutropenia (white cell count 2800/mm3). The Wright agglu-
tination test was positive at titre 1/80. A blood culture was taken
and B. melitensis was isolated. Transaminases were normal. The
obstetrician reported that he had not consumed unpasteurised
milk or dairy products. He was treated with vibramycin and rifa-
din for 40 days. Two months later the Wright agglutination test
was found negative and the white cell count was normal.
Conclusions: B. melitansis is usually transmitted through consump-
tion of unpasteurised diary products. In these cases we had trans-
placental transmission and transmission through infectious
secretions via the gastro-intestinal tract. Therefore it is essential
that detailed medical case histories should be taken from pregnant
women in order to avoid congenital infections and that medical
personnel should be aware of the possibility of such transmission.
P884 Characterisation and sensitivity of coryneforme
bacteria isolated in clinically signiﬁcant pictures: a 3-year study
J.L. Go´mez-Garce´s, A. Alhambra Mosquera, J.-I. Alo´s
Madrid, E
Objectives: Coryneforme bacteria have gradually acquired greater
importance in infectious pathologies, especially as opportunistic
nosocomial pathogens, some of them displaying resistance to var-
ious antibiotics. The aim of this report is to describe some of these
bacteria with signiﬁcant implication in different clinical pictures.
Methods: Over a 3-year period we characterised the coryneforme
isolates with presumable clinical signiﬁcance. Clinical signiﬁcance
of the isolates was evaluated according to clinical information
received (fever, intravascular devices, underlying disease, pro-
longed antibiotic therapy, etc.) as well as microbiological criteria
(more than one isolation from habitually sterile anatomical areas
and/or repeated isolations as predominant ﬂora in sites contamin-
ated with comensal ﬂora).
Results: In 35 patients the isolations were clinically signiﬁcant.
The most frequent isolations (18) were found in blood culture:
seven Corynebacterium amycolatum, ﬁve Corynebacterium jeikeium,
two Corynebacterium minutissimum, two Dermabacter hominis, one
Corynebacterium group G, one Brevibacterium sp. In another eight
cases bacteraemia was accompanied by isolation of the same
species in intravenous catheters (two C. amycolatum, one
C. striatum, one C. jeikeium, one C. group G), a pace-maker
cable (C. minutissimum) or soft tissue wound (one C. urealyticum,
one Brevibacterium sp.). In addition, four C. striatum were
isolated (three in respiratory secretions and one in a lower limb
abcess), two C. amycolatum in mammary abscesses, one
C. jeikeium in articular ﬂuid and two C. urealyticum in urine. All
the isolates were sensitive to vancomycin (MICs <0.5 mg/L),
while sensitivity to beta-lactamics, macrolides and ﬂuorquino-
lones was variable.
Conclusions: (1) C. amycolatum and C. jeikeium were the most fre-
quently found corynebacteria with presumable clinical signiﬁ-
cance. Dermabacter and Brevibacterium were the genera identiﬁed
among the non-corynebacterias. (2) In 26 of the 35 patients the iso-
lates were obtained from bacteraemias with or without identiﬁ-
able origin. (3) Vancomycin and linezolid were the only
antibiotics with efﬁcacy against all isolates. (4) More attention
should be paid to the isolation of coryneforme bacteria in clinical
samples from hospitalised patients since their role as opportunis-
tic infections agents has been clearly demonstrated.
P885 Enterotoxigenic Bacteroides fragilis (ETBF) strains
isolated from clinical specimens of human and animal origin
P. Obuch-Woszczatynski, A. Rokosz, A. Sawicka-Grzelak,
H. Pituch, M. Luczak
Warsaw, PL
Objectives: To detect the presence of B. fragilis enterotoxin
(fragilysin) gene in clinical B. fragilis strains by polymerase chain
reaction (PCR) and to deﬁne types of infections in which ETBF
strains are involved.
Methods: Clinical B. fragilis strains of human origin isolated in
different European countries and of animal origin cultured in the
United States of America were examined. PCR was performed
with primers 404/407 detecting B. fragilis enterotoxin (fragilysin)
gene. Susceptibility of strains to antimicrobial agents was deter-
mined with Etest. Two reference enterotoxigenic B. fragilis (ETBF)
strains: ATCC 43858, ATCC 43859 and two reference non-entero-
toxigenic (NTBF) strains ATCC 25285, IPL E 323 served as control
strains in all experiments.
Results: In 18 strains isolated from human clinical samples in
England, France, The Netherlands and Poland the presence of B.
fragilis enterotoxin-fragilysin gene was found by PCR. Also, four
strains cultured from animal clinical samples in the United States
were positive for fragilysin gene. All examined reference and clin-
ical strains were susceptible to amoxicillin/clavulanic acid, imipe-
nem and metronidazole.
Conclusions: Enterotoxigenic B. fragilis strains cause different
types of infections (intestinal and extra-intestinal) in hospitalised
patients. ETBF strains are also involved in intestinal and extra-
intestinal infections in animals. Susceptibility of ETBF strains to
antimicrobial agents is typical of B. fragilis rods. The most active
in vitro antimicrobials are beta-lactams combined with beta-lacta-
mase inhibitors, carbapenems and metronidazole.
P886 Impetigo bullosa at the neonatological and
obstetrician department – molecular analysis
J. Jursa, A. Kordek, S. Giedrys-Kalemba
Szczecin, PL
Introduction: Staphylococcal scalded syndrome (SSSS) and local-
ised SSSS such as impetigo bullosa are caused by an epidermolyt-
ic toxin od S. aureus (S.a.) that can be either chromosomally
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encoded as exfoliative toxin A (ETA) or plasmid-encoded as toxin
B. Outbreaks of nosocomial SSSS and impetigo bullosa in infants
have been well-described to be associated with the well baby nur-
sery. The source of infection has been traced to health care work-
ers in the delivery room or the newborn nursery. The initial site
of S.a. colonisation/infection may be the anterior nares, nasophar-
ynx, conjuctiva, umbilicus and/or the blood rather than the skin.
Often the personnel are asymptomatic carriers of the epidemic
strain of S.a.
Objectives: The aim was determine the genetic relatedness of S.a.
isolated from patients and staff and investigation of the potential
source of the infection.
Material and methods: In November 2001 27 strains of S.a. were
isolated from various materials from newborns hospitalised at ne-
onatological and obstetrician departments as well as from the
staff. Biochemical test Api Staph was used for the species identiﬁ-
cation. To molecular typing of isolates was used pulsed ﬁeld gel
electrophoresis (PFGE). Interpretation criteria for the gels followed
manufacturer’s guidelines: isolates with identical restriction pro-
ﬁles were assigned the same type, isolates that differed by one
genetic event (one to three bands) were considered closely related,
isolates with a four- to ﬁve-band difference were considered poss-
ibly related, and isolates that differed by more than six bands
were different strains.
Results: Comparative analysis of the banding pattern for the iso-
lates can be divided into several categories: Genetic: type A –
six strains from newborns with impetigo bullosa and one from
staff (baby nursery); type B – two strains from the staff; type C
– seven strains from the staff; type D – two strains from the
staff; nine other types – each one from one person from the
staff.
Conclusions: All the cases of impetigo bullosa were caused by one
genetic type of S. aureus which allows to characterise the infection
as a hospital infection. Strains isolated from the staff (except one
person) belonged to different genetic types (unrelated strains).
Isolation of the same genetic type from infected newborns and a
person from the stuff may suggest that this person was the source
of the infection, but we can not exclude that she was accidentally
colonised during the hospital outbreaks.
P887 The potential role of the German cockroach (Blatella
germanica) in carrying pathogens in two general hospitals,
Tehran
K. Holakouie Naieni, H. Ladoni, H. Soliemani, S. Afhami,
B. Haghighat
Tehran, IR
Background: Cockroaches are capable of carrying many human
pathogens and they may have a role in transmitting some serious
nosocomial infections.
Objectives: To determine the potential role of the German cock-
roach in carrying pathogens in general hospitals belonging to Teh-
ran University of Medical Sciences.
Methods: Using adhesive traps and manual methods to catch the
cockroaches. Hospitals were located in different areas. A total of
30 cockroaches were caught and subjected to microbial investiga-
tion at the Research and Diagnostic Laboratories, Institute of Pub-
lic Health.
Results: The rate of bacterial contamination was 100%. Isolated
organisms included Klebsiella, Pseudomonas, Proteus, Acinetobacter,
Entrobacter and Seratia. Single and multiple antibiotic resistances
were detected in the isolates. The most frequently recovered
fungal pathogens were Aspergillus ﬂavus and Aspergillus fumiga-
tus.
Conclusions: The German cockroach could play an important role
as a mechanical carrier of pathogens in the hospital setting. Hence
a thorough knowledge of the biological characteristics of this
insect would be essential in designing effective control pro-
grammes.
P888 Role of Coxiella burnetii in hospitalised patients with
atypical pneumonia
P. Douramani, S. Mavrea, E. Anastasakou
Athens, GR
Introduction: Coxiella burnetii is a small Gram-negative coccoba-
cillus that is an obligate intacellular parasite. The most com-
mon animal reservoirs are goats, cattle, sheep, cats, and
occasionally dogs. Aerosolisation occurs at the time of partur-
ition and infection follows inhalation of this aerosol. The pneu-
monic form of the illness can range from very mild to severe
pneumonia requiring assisted ventilation. The aim of this study
is to evaluate the proportion of cases of atypical pneumonia
caused by Coxiella burnetii in adults at a Chest Diseases Greek
hospital.
Materials and methods: The study population consisted of 280
patients (160 males and 120 females) with ages ranging from 20 to
65 years. The diagnosis of atypical pneumonia was based on the
clinical symptoms, the chest X-ray and the serological study. An
immunoﬂuorescene assay (IFA) was used to detect the presence
of antibodies of the IgG isotope against epitopes from phase II of
Coxiella burnetii, which are the ﬁrst antibodies to appear in infec-
ted people. The criteria for acute infection from C. burnetii were:
phase II IgG titres 1/5122, phase II IgM 1/20.
Results: Our serological study showed that the positive rate of
IgG antibodies (titre 1:512) against phase II of C. burnetii was
12.1% (34/280). IgM antibodies were detected in 23 out of the 34
patients with positive IgG antibodies (65%). Furthermore two of
the infected patients had fourfold increase in C. burnetii-speciﬁc
IgG antibody titre. There was no signiﬁcant difference in age and
gender in these patients.
Conclusion: C. burnetii seems to play signiﬁcant role in hospital-
ised patients with atypical pneumonia. C. burnetii pneumonia
should be considered when there is a suitable exposure history
and when outbreaks of a pneumonic illness are being investi-
gated. A wider use of the serology in cases of atypical pneumonia
should lead to an increase of diagnosed cases.
P889 Prediction of post-cardiosurgery infectious
complications by means of procalcitonin monitoring
N. Beloborodova, D. Popov
Moscow, RUS
Objectives: To study the predictive value of the procalcitonin
(PCT) as an early marker of postoperative infectious complications
in adult high-risk patients (pts) with acquired heart diseases after
cardiac surgery with cardiopulmonary bypass.
Methods: Consecutive immunoluminometric tests (LUMItest
PCT, B.R.A.H.M.S Aktiengesellschaft, Germany) taken in 60
patents before and at ﬁrst, second, third and sixth days after car-
diac valve(s) replacement. Following established correlations all
cases were retrospectively distributed into four groups (A–D)
according to the ﬁrst post-operative reading and consecutive
dynamic change of PCT serum concentration: Group A – no
increase of PCT concentration, Group B – 0.5–2 ng/mL, Group
C – >2 ng/mL with subsequent decrease and Group D – >2 ng/
mL, persisting. Also the post-op infection rates were analysed in
these groups.
Results: None of the pts had exhibited any signs of infection
before surgery. Initial PCT concentrations did not exceed the nor-
mal values (<0.5 ng/mL). Postoperatively 14 (23.3%) out of 60 pts
developed infectious complications: pneumonia – ten, surgical site
infection (SSI) – one, pneumonia and SSI – one, sepsis – one,
pneumonia and sepsis – one. Correlation between the incidence of
postoperative infectious complications and PCT levels after sur-
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*p[C,D vs. B] < 0.01.
Conclusions: PCT monitoring is useful to early diagnosis and pre-
diction of severe post-op infections in cardiac surgery patients.
PCT serum concentration more than 2 ng/mL on the ﬁrst day
after surgery, especially with a tendency to persist till third day
postoperatively is associated with high prevalence of infectious
complications.
Animal models
P890 Is multiple trauma accompanied by bacterial
translocation? An experimental model
E. Bathrelos, E.J. Giamarellos-Bourboulis, N. Efstathopoulos,
J. Lazarettos, V. Nikolaou, A. Papalois, P. Grecka
Athens, GR
Objectives: To deﬁne whether bacterial translocation is a process
involved in the series of events following multiple trauma.
Methods: Crushing fracture of the middle of the right femor was
performed in 12 New Zealand rabbits. Blood sampling was per-
formed before and 4 h after fracture for the determination of
tumour necrosis factor-alpha (TNF-alpha) and of nitric oxide
(NO). TNF-alpha was estimated by a bioassay on L929 ﬁbrosarco-
ma cell line and NO by a colorimetric assay. Survival was recor-
ded and after death segments of liver, spleen and lower lobe of
the right lung were cut for quantitative culture.
Results: Mean  SE survival was 0.80  0.15 days. Mean  SE of
serum TNF-alpha was 6.06  1.34 and 44.65  25.77 pg/mL (P:
0.05) before and after fracture, respectively. Mean  SE of serum
NO after fracture was 195.8  24.9 lM. In tissue segments
derived from all animals viable counts of Serratia marscecens and
of Pseudomonas aeruginosa were identiﬁed. Mean  SD of log 10
of viable cell counts of S. marscecens of liver, spleen, and lower
lobe of the right lung after death were 7.30  0.44, 7.16  0.32
and 6.14  2.56 CFU/g, respectively. Those of P. aeruginosa were
6.11  1.52, 4.41  2.31 and 5.69  1.84 CFU/g, respectively.
Conclusions: In an experimental model of multiple trauma with
an absolute mortality rate and elevated serum levels of TNF-alpha
and NO, bacterial translocation was found in deep organs. That
process might be correlated to the elevated serum levels of NO.
P891 Pharmacodynamic conditions of emergence and
extinction of mutant resistant Streptococcus pneumoniae in
experimental pneumonia treated with moxiﬂoxacin: interest of
the Mutant Selection Window Concept
M. Etienne, D. Croisier, P. Charles, L. Piroth, H. Portier, Chavanet
Dijon, F
Background: We showed that a MFX human-like treatment
(400 mg qd) was associated with the emergence of MRSp, when
PNP in immunocompetent rabbits was induced by parC mutated
strains (Abstract B-708, 42nd ICAAC). The MSW was delineated
by PKPD parameters using the Selection Index (SI: Mutant Pre-
vention Concentration-MPC-/MIC).
Objectives: To conﬁrm the MSW concept, we enforced to: (a)
make mutants emerge with PKPD parameters within the MSW
boundaries; (b) extinct resistant mutants with PKPD parameters
exceeding the upper MSW boundary.
Methods: To reach the target PKPD values corresponding to the
boundaries of the MSW, we simulated a 48-h-long MFX underex-
posure in PNP induced by WT (S1) and efﬂux (S2) strains, and
an overexposure for PNP induced by parC-79 mutated strain
(S3). Susceptibilities to MFX [MIC/MPC (mg/L)] were:
S1 ¼ 0.125/0.125; S2 ¼ 0.25/0.25; S3 ¼ 0.25/4.
Results: We could not open the window since no MRSp emerged
with PKPD parameters within the MSW, when PNP was due to
WT and efﬂux strains. When parC strains was used mutant
appeared for very low drug exposition (6–10% of the standard
400 mg regimen). We could close the window, extinction MRSp
with PKPD parameters exceeding the MSW upper boundary,
when PNP was due to parC mutated strains.
Conclusion: In our in vivo model of experimental PNP we could
not conﬁrm both parts of the MSW concept, but we validated a
PKPD threshold of mutant extinction. Par C mutation was strongly













AUCn24 (mg h/L)* 6.3  1.5 8.5  2 27.6  1.9 137  31




0.7  1.6 1.8  0.5 1  1.7 6.62  0.46y
Rabbits with
MRSp/Rabbits
0/4 0/6 11/11 0/17
*Protein-free fraction; **as compared to untreated rabbits;
yP < 0.001.
P892 Pharmacodynamic evaluation of the efﬁcacy of a
human-like treatment with gatiﬂoxacin on experimental
pneumococcal pneumonia: impact of low levels of resistance
D. Croisier, M. Etienne, P. Charles, L. Piroth, H. Portier,
P. Chavanet
Dijon, F
Background: The efﬁcacy of last generation ﬂuoroquinolones (FQ)
was recently questioned by the emergence of Streptococcus pneumo-
niae (Sp) strains having low levels of resistance. These strains
exhibit low MICs, thus remaining susceptible, but high Mutant
Prevention Concentrations (MPCs); the difference between MIC
and MPC was used to determine PKPD parameters delineating
the Mutant Selection Window (MSW).
Objectives: To investigate the in vivo efﬁcacy of GAT in a model
of PP due to Sp exhibiting various levels of susceptibility to FQ,
by determining both the pulmonary bacterial reduction and the
PKPD conditions associated with the emergence of resistant
mutants (RM).
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Methods: To induce PP in immunocompetent rabbits, ﬁve penicil-
lin-resistant strains were used, deﬁned for GAT as [MIC/MPC
(mg/L)/genotype]: A ¼ 0.25/0.25/Wild Type; B ¼ 0.5/1/efﬂux;
C ¼ 1/8/parC S79F; D ¼ 1/8/parC S79T; E ¼ 4/4/gyrA S81F. A
48-h standard GAT treatment was simulated. Pharmacokinetic
(PK) data (Cmax, AUC0-24 h) and residual pulmonary bacterial
concentration were obtained for each animal. *P < 0.05.
Results: 7–11 animals per group were tested. Mean unbound PK
parameters were AUC0-24 (mg h/L) ¼ 28.5  8.1 and Cmax (mg/
L) ¼ 2.6  0.5. Lung bacterial reductions (log 10 CFU/g) as
compared with controls (percentage % of animals exhibiting at
least one mutant) were: A ¼ 6.95  0.88* (0); B ¼ 5.67  1.65*
(27); C ¼ 0.49  0.45 (100); D ¼ 0.03  0.96 (100), E ¼ 0.54  0.96
(0), respectively. RM appeared for following PKPD parameters
(unbound fraction): 2.5 < Cmax/MIC < 3.4, 27.2 < AUC/
MIC < 40.6, 0.28 < Cmax/MPC < 0.96, 2.7 < AUC/MPC < 11.5.
Conclusion: In this in vivo model of PP (1) GAT was strongly
effective on the fully susceptible strain and its efﬂux derivative,
despite the emergence of RM for this later one. (2) GAT was inef-
fective, as expected on resistant gyrA strain, but more surprisingly
on parC mutated strains, mainly due to the presence of RM. (3)
these mutants were selected in vivo in a MSW more precisely
deﬁned by PKPD parameters using MPC. (4) Low levels of resist-
ance to FQ should be detected by simple tests to guide the thera-
peutic options.
P893 Hearing loss in experimental pneumococcal
meningitis increases after pretreatment with G-CSF
C. Brandt, S.P. Lund, C. stergaard, N. Frimodt-Møller,
F. Espersen, P. Caye-Thomassen, J.D. Lundgren
Copenhagen, DK
Background: Mechanisms leading to hearing loss in pneumococcal
meningitis is poorly understood.
Objective: Boost of systemic neutrophil count by G-CSF prior to
infection leads to diminished growth of pneumococci in experi-
mental meninigitis and improves survival. Whether this protective
effect also includes attenuation of hearing loss is reported here.
Materials and methods: Rats – infected intracisternally with
1  105 S. pneumoniae serotype 3 – were randomly allocated to
receive G-CSF (10 lg/kg s.c. TD) 48 h prior to infection (n ¼ 16),
late treatment (28 h postinfection, n ¼ 16) or no G-CSF (n ¼ 22).
All animals also received ceftriaxone started 28 h postinfection.
Infection was documented by blood and CSF tap 24 h post infec-
tion. Just before, 24 h and 7 days after infection, assessments of
hearing was made by measurements of distortion product oto-
acoustic emissions (DPOAE) at f2 ¼ 4–70 kHz and by assessment
of hearing thresholds by auditory brain stem responses (ABR) at
52 kHz in levels from 20 to 100 dB SPL.
Results: 24-h postinfection hearing loss was signiﬁcantly increased
in G-CSF treated animals compared with untreated (hearing loss
in 37.5 vs. 14.3% of animals from f2 ¼ 10–50 000 Hz and 75 vs.
42.9% f2 > 50 000 Hz, respectively, Mann–Whitney, P ¼ 0.026).
On day 8 postinfection among surviving animals, severity of hear-
ing loss in G-CSF pretreated animals was furthermore increased
compared with the control group (severe hearing loss in 92.3 vs.
50% from f2 ¼ 10–65 000 Hz, respectively, Mann–Whitney,
P ¼ 0.013). Late G-CSF treatment did not affect hearing loss signi-
ﬁcantly compared with the control group.
Conclusion: Increased systemic neutrophil level at time of infec-
tion increased risk of hearing loss and development of deafness in
a rat model of experimental meningitis despite better control of
bacterial growth and better survival. Neutrophils contribute to the
sensorineural hearing loss seen in experimental meningitis.
P894 In pneumococcal meningitis adjuvant doxycycline
improves survival, and reduces neuronal injury
D.N. Meli, D.G. Erhardt, J. Kummer, S.L. Leib
Berne, CH
Objective: Bacterial meningitis is characterised by an intense
inﬂammatory host response that contributes to the high mortality
and morbidity of the disease. Doxycycline is a clinically used anti-
biotic which has anti-inﬂammatory effects that are separate and
distinct from its antimicrobial action, including the reduction of
cytokine release and the inhibition of matrix metalloproteases.
The present study assessed the effect of doxycycline, when given
as adjuvant therapy in experimental pneumococcal meningitis.
Methods: Eleven-day-old rats were infected intracisternally with
10 lL of saline containing 2.5–1.5  106 CFU/mL Streptococcus
pneumoniae. At 18 h after infection all animals received ceftriaxone
(100 mg/kg i.p., q12 h) and were randomised for administration
of a single dose of doxycycline (30 mg/kg s.c.; n ¼ 67) or an equal
volume of saline (500 lL; n ¼ 65). At 40 h after infection, survi-
ving animals were sacriﬁced. Albumin concentration in the brain
was assessed as an index for blood–brain barrier (BBB) leakage.
Brain damage was quantiﬁed by histomorphometry.
Results: A single dose of doxycycline (30 mg/kg) vs. saline
improved survival (survival rate: 80 vs. 52%, P < 0.001), protected
the BBB (cortical albumin/total protein: 7.9 vs. 12.7 lg/mg,
P < 0.04) and reduced injury in the cerebral cortex (damage in
percent of cortex; median [range] 0 [0–2.8] vs. 0 [0–26.9], P < 0.05).
Conclusion: Adjuvant treatment with doxycycline may be a prom-
ising approach to prevent death or neuronal injury as a conse-
quence bacterial meningitis.
P895 In vivo synergism of amoxicillin sub-inhibitory
concentrations and speciﬁc antibodies against Streptococcus
pneumoniae in a mice sepsis model
J. Casal, M. Gime´nez, D. Tarrago´, A. Fenoll, L. Aguilar
Majadahonda Madrid, E
Objective: To explore if the in vivo combined effect of speciﬁc
antibodies and amoxicillin is a synergistic or additive effect by
Figure 1. DP-grams from control and G-CSF pretreatment groups
7 days after infection.
232 Abstracts
establishing conditions resulting in null survival by antibodies
protection or antibiotic treatment.
Methods: A fully amoxicillin-resistant (MIC of 8 mg/L) serotype
6B Streptococcus pneumoniae was used as infecting strain. Amoxicil-
lin was administered at a dose (3.12 mg/kg) producing serum
concentration lower than the MIC of the infecting strain all over
the treatment period (Cmax: 6.1 mg/L). Passive immunisation was
performed with hyperimmune serum (HS; obtained from mice
weekly inoculated with whole cell heat-inactivated inoculum for
5 weeks) diluted in PBS up to dilution 1/6 that had shown null
protection (0% survival) in preliminary experiments. Groups of 10
BALB/c mice weighing 19–22 g were passively immunised with
one-single intraperitoneal (ip) injection of the 1/6 dilution of HS,
1 h prior to infection with the 6B pneumococcus. Amoxicillin
treatment was started 1 h after inoculation and continued t.i.d for
48 h. Groups of animals receiving placebo (PBS), non-immune
serum, non-diluted HS, 1/6 dilution of HS or amoxicillin
3.12 mg/kg alone were included as control groups. Mortality was
recorded over the 7-day follow-up period.
Results: Survival rates in all control groups were lower than 10%
except in the non-diluted HS that was 100%. Antibiotic treatment in
passively immunised animals produced survival rates of 100%,
with signiﬁcant differences vs. controls (except the non-diluted HS).
Conclusion: Since amoxicillin concentrations were below the MIC
(8 mg/L) of the infecting organisms all over the treatment period
(Cmax of 6.1 mg/L), the presence of speciﬁc antibodies produced
in vivo efﬁcacy of sub-inhibitory concentrations. The in vivo com-
bined effect antibodies/amoxicillin is synergistic and not only
additive considering the survival rates obtained by the antibodies
(0% survival) and amoxicillin sub-inhibitory concentrations (10%
survival) alone and those obtained when acting together (100%
survival).
P896 Daptomycin is highly efﬁcacious against penicillin-
resistant and penicillin- and quinolone-resistant pneumococci in
experimental meningitis by sterilising the CSF within 4 h
P. Cottagnoud, M. Pﬁster, M. Cottagnoud, F. Acosta, L. Flatz,
F. Ku¨hn, A. Stucki
Berne, CH; San Francisco, USA
Objective: Daptomycin (D) was tested against a penicillin-resistant
(PenR) and against a penicillin- and quinolone-resistant (PenR + -
QuR) pneumococcal strain in the rabbit meningitis model.
Methods: Standard regimen was ceftriaxone(CRO) combined with
vancomycin (V). MICs of the PenR strain in mg/L: PenG: 4, D:
0.06, CRO: 0.5, V: 0.12–0.25. MICs of the PenR + QuR strain:
PenG: 4, D: 0.06, CRO: 0.5, V: 0.12–0.25, trovaﬂoxacin: 4, ciproﬂ-
oxacin: 32. Meningitis was induced by intracisternal inoculation of
10 000 CFU. Ten hours later treatment was started for 8 h. D
(15 mg/kg) and CRO (100 mg/kg) were injected at hour 0 and V
(20 mg/kg) were injected at hours 0 and 4. CRO and V were
standard doses. D corresponded to high doses in humans. CSF
samples were repeatedly collected during therapy in order to
determine antibiotic levels and killing rates. D serum levels
peaked at 200 mg/L decreasing slowly to 36 mg/L 8 h later. D
CSF levels ranges between 5 and 3 mg/L. D penetration into
inﬂamed meninges was 5%. Results of bactericidal activity of the
different regimens are expressed in Delta log 10 CFU/mL h and
Delta log 10 CFU/mL over 8 h. Results are presented in Table 1.
Conclusions: (1) D is highly efﬁcacious against PenR and PenR+
QurR pneumococci in experimental meningitis, sterilising the CSF
of rabbits within 4 h (9 out of 10 in both D treatment groups). (2) D
as monotherapy is signiﬁcantly superior to the standard regimen
based on a combination of CRO with V against both strains. (3) The
efﬁcacy of D was also conﬁrmed in time-killing assays over 8 h.
P897 Moxiﬂoxacin and levoﬂoxacin treatment outcomes
against pneumococcal pneumonia in a novel skin-temperature
murine model
D. Bast, D. Bell, X. Chen, L. Dresser, L. Mandell, D. Low,
J. Azavedo de
Toronto, Hamilton, CAN
Objectives: Skin-temperature is an effective measure of the sever-
ity of pneumococcal pneumonia in mice and can be used to pre-
dict lung bacterial counts and imminent death. Skin-temperatures
vary considerably in groups of infected mice and thus, drug inter-
vention at a particular skin-temperature more closely resembles
that which is used in humans. In this study, we compared the
efﬁcacy of moxiﬂoxacin (MFX) with levoﬂoxacin (LVX) in the
treatment of pneumococcal pneumonia using our novel skin-tem-
perature model.
Methods: Swiss Webster mice were inoculated endotracheally
with 5-log 10 CFU of the Streptococcus pneumoniae A66 strain
(MICs: MFX, 0.12 lg/mL; LVX, 0.5 lg/mL). Skin temperature at
35 h was used to assess disease severity prior to drug treatment.
A skin temperature of 32C is indicative of a moderate infection
with a pulmonary bacterial count of 6-log 10 CFU whereas tem-
peratures <32C but >30C are suggestive of a severe infection
with a count of 7-log 10 CFU. All mice with a temperature of
	30C were excluded from the study, as death is imminent within
24 h. A 50 mg/kg subcutaneous dose of MFX or LVX was given
twice daily for 5 days. Skin temperature was measured daily to
monitor clinical improvement or failure (	30C for at least 48 h).
All mice deemed to have failed therapy were euthanised immedi-
ately. Viable counts in the lungs were determined for all mice.
Results: Of the mice classed as moderate, 24/29 (83%) mice trea-
ted with MFX and 10/20 (50%) mice treated with LVX survived.
Complete eradication was obtained in 93 and 20% of mice treated
with MFX and LVX, respectively, in this group. Of the mice classed
as severe, 24/31 (77%) and 5/20 (20%) mice treated with MFX and
LVX, respectively, survived. Complete eradication was obtained in
84 and 15% of mice treated with MFX and LVX in this group.
Conclusions: MFX showed signiﬁcantly enhanced activity over
LVX at both an early and late stage pneumococcal lung infection.
P898 Evaluation of fosfomycin in the treatment of
experimental meningitis caused by a high-level cephalosporin-
resistant Streptococcus pneumoniae
S. Ribes, A. Domenech, F. Taberner, C. Cabellos, F. Tubau, J. Lin˜-
ares, P. Ferna´ndez Viladrich, F. Gudiol
Hospitalet de Llobregat, Barcelona, E
Objective: Fosfomycin, a broad-spectrum antibiotic with good
penetration into the cerebrospinal ﬂuid (CSF), could be useful in
















6.75 ± 0.30 +0.04 ± 0.06 +0.04 ± 0.421
D (10) [PenR] 6.95 ± 0.85 )1.20 ± 0.321 )6.95 ± 0.391
CRO + V (10)
[PenR]
6.25 ± 0.45 )0.57 ± 0.241 )4.50 ± 0.471
Controls (10)
[PenR + QuR]
5.39 ± 1.0 +0.20 ± 0.19 +1.31 ± 0.87
D (10) [PenR
+ QuR]
6.22 ± 0.23 )0.91 ± 0.082 )6.22 ± 0.233
CRO+V (10)
[PenR + QuR]
5.79 ± 0.64 )0.63 ± 0.132 )5.02 ± 1.113
1: P < 0.001 D vs. CRO + D; 2: P < 0.001 D vs. CRO + D; 3: P < 0.03
D vs. CRO + V.
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Methods: We tested the efﬁcacy of fosfomycin (FOS) 300 mg/kg/
6 h compared with those of ceftriaxone (CRO) 100 mg/kg/day,
rifampicin (RIF) 15 mg/kg/day and teicoplanin (TEI) 15 mg/kg/
day. These dosage regimens were selected after pharmacokinetic
studies in order to achieve serum concentrations comparable to
those observed in humans. Meningitis was induced by intracister-
nal inoculation of 10  106 CFU/mL of a high CR pneumococcus
strain (ATCC 51916). MICs (mg/L) were: PEN 0.12, CRO 32, FOS
2, RIF 0.06, TEI 0.03. After 40 h inoculation a baseline CSF sample
was taken (hour 0) and therapy was started. Antibiotics were
given intravenously for 26 h. Control animals received saline solu-
tion. CSF samples were collected during therapy to determine
bacterial killing rates, antibiotic concentrations and inﬂammatory
parameters.
Results: FOS serum levels ranged between 324.5 and 1.02 mg/L
and CSF levels between 35.06 and 1.09 mg/L. CSF penetration of
FOS was 49% based on comparison of areas under the curve
(serum AUC/CSF AUC). FOS was as effective as RIF and TEI.
Bacterial counts at 0 h expressed as mean log 10 CFU/mL (SD),
and killing rates (KR) in CSF calculated as mean delta -
log 10 CFU/mL (SD), are shown in the table.
Conclusion: FOS penetrated to a high extent into the CSF and
showed good bactericidal activity against this particular pneumo-
coccal strain.
P899 Combination of linezolid and rifampin is highly
synergistic in experimental Staphylococcus aureus joint
prosthesis infection
A. Saleh-Mghir, C. Muller-Serieys, L. Massias, A.C. Cre´mieux
Paris, F
Background: Prosthesis infections are difﬁcult to cure. Methicillin-
resistant Staphylococcus aureus (MRSA) are becoming more com-
mon and optimal therapy (Rx) remains to be deﬁned. Linezolid
(LZD), the ﬁrst oxazolidinone antibiotic, is active on Gram-posit-
ive pathogens as MRSA strains.
Methods: In a MRSA knee prosthesis infection in rabbits, we com-
pared the efﬁcacies of LZD (70 mg/kg t.i.d.) or vancomycin (VAN)
(60 mg/kg b.i.d.) alone or combined with rifampin (RIF) (10 mg/
kg b.i.d.). A partial knee replacement was performed with a sili-
cone implant ﬁtting into the intramedullary canal of the tibia, and
107 CFU of MRSA, were injected into the knees. Rx was started
7 days after inoculation and continued for 7 days intramuscularly.
Results: MICs (mg/L) of LZD, Van and RIF were 1.5, 1.5 and
0.008, respectively. In vivo, LZD reduced signiﬁcantly the mean
log 10 CFU/g of bone (2.58  0.85, n ¼ 9) vs. controls and VAN
(6.22  0.43, n ¼ 7; 4.87  0.61, n ¼ 8), respectively (P < 0.01).
Both Rx were not sufﬁcient to sterilise animals (1/9 and 0/6
respectively). The combination of RIF with LZD (1.6  0.01, CFU/
g of bone, 6/6 sterile animals) or with VAN (1.6  0.08 CFU/g of
bone, 6/6 sterile animals), was signiﬁcantly more effective than
monotherapy (P < 0.01). Emergence of resistance to Rif was not
detected in vivo.
Conclusion: In this MRSA joint prosthesis infection, LZD com-
bined with Rif was highly effective in vivo and prevented the
selection of mutant resistant of rifampin. LZD should be of inter-
est for treating MRSA joint prothesis infection.
P900 Evaluation of lauric acid monoester compounds in a
Staphylococcus aureus nasal decolonisation model
M. Rouse, M. Scholz, J. Steckelberg, R. Patel
Rochester, St. Paul, USA
Objectives: Topical mupirocin is used to eradicate S. aureus from
the nares of S. aureus colonised patients. Mupirocin resistance in
S. aureus has been reported and associated with failure of nasal
eradication of S. aureus. Lauric acid monoester compounds are
active in vitro against methicillin-resistant S. aureus (MRSA) and
may be effective MRSA nasal decontaminants. We used a murine
model of MRSA nasopharangeal colonisation to compare in vivo
activity of mupirocin with 3 lauric acid monoester formulations
for nasal S. aureus decolonisation.
Methods: 239 Hsd:ICR mice were challenged intranasally with 108
colony forming units of MRSA. Five days later, S. aureus colonisa-
tion was documented by culture in 189 mice. Colonised mice were
treated intranasally with bland ointment, mupirocin or one of
three lauric acid monoester ointments (49D, 49E or 53A), three
times daily for 2 days. Three days after treatment was complete,
both anterior nares were cultured for S. aureus.
Results: Results of treatment are listed as number (percent) suc-
cess (MRSA negative nasopharynx cultures). Twelve of 38 (32%)
mice were successfully treated with bland ointment. Nineteen of
38 (50%) mice were successfully treated with mupirocin. Eigh-
teen of 39 (46%) mice were successfully treated with 49-D.
Twenty-four of 34 (71%) mice were successfully treated with
49E. Thirty-three of 40 (83%) mice were successfully treated with
53A. Treatment with 49E or 53A was more effective than bland
ointment (P < 0.05) and 53A was more active than mupirocin
(P < 0.002) in this model. MRSA recovered from mice after treat-
ment were tested for susceptibility to the antimicrobial used for
treatment to detect emergence of resistance. We recovered mupir-
ocin resistant (MIC <4 lg/mL) MRSA in four of 19 mice that
failed mupirocin treatment. MRSA recovered from mice failing
lauric acid monoester treatment had MIC values within three
dilutions of pre-treatment MRSA.
Conclusions: In a murine model of MRSA nasal decolonisation,
53A was signiﬁcantly more active than mupirocin and 49D or 49E
was as active as mupirocin as measured by eradication of MRSA
from the nasopharynx and emergence of resistance to mupirocin
after treatment was observed.
P901 TolC but not AcrB plays an essential role in
colonisation of chicks with multi-resistant Salmonella
typhimurium DT104
S. Baucheron, C. Mouline, K. Praud, E. Chaslus-Dancla,
A. Cloeckaert
Nouzilly, F
Objectives: To study the role of the multidrug efﬂux system
AcrAB–TolC in resistance of Salmonella typhimurium DT104 to
detergents and bile salts. To evaluate the importance of the com-
ponents AcrB and TolC of this efﬂux system in the colonisation of
a multidrug-resistant S. typhimurium DT104 strain in chicks.
Methods: acrB and tolC mutants of a multidrug-resistant S. ty-
phimurium DT104 strain were constructed by deletion or insertion-
al inactivation of the genes. MICs of detergents and bile salts
were determined for the acrB and the tolC mutants, comparatively
to the wild type mutidrug-resistant strain. The effect of sodium
choleate on the in vitro growth of these three strains was evalu-
ated. The LD50s of the strains were measured in a one day old
chicken model, inoculated with several doses (3–9 log CFU) by
the oral route, during 7 days post-inoculation. The colonisation
levels were assessed at the subletal dose 7 days post-inoculation
by determining the number of CFU of Salmonella in the faeces,





0 h KR 6 h KR 24 h KR 26 h
FOS (9) 5.16 (±0.89) )2.95(±1.31)a )4.38(±0.86)a )5.15(±0.96)a
CRO (9) 5.23 (±0.88) )0.76(±1.7) )0.75(±1.7) )1.01(±1.8)
RIF (8) 5.45 (±0.76) )2.42(±0.48) )4.33(±0.93)a )5.14(±1.09)a
TEI (8) 5.21 (±0.83) )3.21(±0.80)a )4.39(±0.86)a )5.19(±0.89)a
Control (11) 4.91 (±0.73) +1.1(±0.91) +1.41(±1.18) +0.65(±2.45)
aP < 0.01 vs. CRO (ANOVA).
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Results: The decrease of resistance to detergents and bile salts
was much more important for the tolC mutant than for the acrB
mutant. For example, MICs of SDS decreased of 1024 and 128
times, MICs of sodium deoxycholate decreased of 64 and 8 times,
for the tolC and acrB mutants, respectively. Addition of choleate
in culture medium had no effect on the growth of the wild type
strains and of the acrB mutant but inhibited the growth of the
tolC mutant. The LD50s in the 1-day old chicken model, were
6 log CFU and 7 log CFU for the wild type strain and the acrB
mutant, respectively, and not calculable for the tolC mutant
because of a too small number of dead chicks. Furthermore,
in contrast to the acrB mutant, the tolC mutant was unable to
colonise the caeca, spleen, and liver after 1 week of infection.
Moreover, in most chicks no intestinal excretion was detected for
the tolC mutant. The colonisation levels of the acrB mutant were
the same as those of the parental strain.
Conclusion: TolC but not AcrB appears to be essential in multi-
drug-resistant S. typhimurium DT104 colonisation of chicks, which
is in accordance with their respective roles in resistance to deter-
gents and bile salts. Therefore, TolC could be a better target than
AcrB for the development of efﬂux system inhibitors.
P902 Efﬁcacy of cefepime and imipenem in experimental
pneumonia caused by porin-deﬁcient Klebsiella pneumoniae
producing CMY-2 -lactamase
C. Pichardo, J.M. Rodriguez-Martinez, M. Herrero, M.-C. Conejo,
M. Aguilar, L. Martinez-Martinez, J. Pacho´n, A. Pascual
Seville, E
Objectives: To compare the activity of CFP and IMP in the experi-
mental pneumonia caused by Kp.
Methods: Strains: Porin deﬁcient Kp (Kp17) and its derivative pro-
ducing the plasmid-mediated AmpC-type b-lactamase CMY-2
(Kp27). In vitro studies: MIC/MBC: microdilution method
(NCCLS), inoculum: 105, 106 and 107 CFU/mL. The in vitro post-
antibiotic effect (PAE) was investigated by exposing the bacteria
to IMP and CEP at concentration equal to two and six times the
MICs for 1.5 h. The PAE was quantitated calculating the differ-
ence between the times required for the numbers of drug-exposed
and untreated organism to increase 10-fold above the numbers
present immediately after removal of the antibiotic. PK/PD
parameters (Cmax and time above the MIC) were determined after
a single dose of antimicrobials. In vivo studies: Experimental
pneumonia in C57BL/6 mice, with intratracheal inoculum of
108 CFU/mL. The animals were grouped in: CON (no treatment),
CFP (360 mg/kg/day) and IMP (240 mg/kg/day), during 72 h.
Variables: mortality rates and bacterial clearance from lungs. Sta-
tistical analysis: Chi-squared and Fisher tests, ANOVA, and post-
hoc tests.
Results: In vitro: MIC/MBC (105, 106, and 107): CFP (0.125/
0.125, 0.125/0.125, 4/8) for Kp17 and (8/16, 16/16, 32/32) for
Kp27; IMP (0.25/0.25, 0.5/0.5, 1/1) for Kp17 and (16/16, 32/32,
32/32) for Kp27. PAE: The study demonstrate a signiﬁcant PAE
of IMP (2 h at least) on Kp27 at 2  MIC and 6  MIC. No in vi-
tro PAE of IMP was observed on Kp17, and no in vitro PAE of
CEP was observed on Kp17 or Kp27. PK/PD parameters: Cmax
(mg/L), time above the MIC (h) for Kp17 and for Kp27, respect-
ively: CFP (124.06, 1.88, 1.79), IMP (16.9, 1.32, 0.23). In vivo: For
Kp17, CFP and IMP decreased the mortality respect to CON (0
vs. 73%, P < 0.003) and (33.3 vs. 60%, P < 0.05); for Kp27, IMP
was the only therapy that decreased the mortality compared with
CON and CFP (13 vs. 60% and 60%, P < 0.01). Bacterial clear-
ance from lungs: For Kp17, CFP and IMP cleared the lungs
respect to CON (1.74 and 3.38 vs. 9.16 log CFU/mL, P < 0.01),
CFP being better than IMP (P < 0.001); for Kp27, CFP and IMP
cleared the lung respect to CON (4.33 and 4.06 vs. 9.07 log CFU/
mL, P < 0.000).
Conclusions: The presence of plasmid-mediated AmpC-type b-lac-
tamase CMY-2 in K. pneumoniae diminished the in vivo efﬁcacy of
cefepime and not that of imipenem. The inoculum effect for cefep-
ime and the PAE of imipenem partially explain these results.
P903 Mycobacterium abscessus causes a granulomatous
infection controlled by IFNc in C57BL/6 mice
P. Hochedez, M. Rottman, C. Soudais, F. Ripoll, J.-F. Emile,
J.-L. Gaillard
Garches, Paris, Boulogne Billancourt, F
M. abscessus is a rapidly growing mycobacterium (RGM) that is
emerging as a signiﬁcant pathogen in humans, both as a respirat-
ory pathogen in patients with or without recognised comorbidi-
ties, and as the agent of inoculation infections. The
histopathologic features of the human infection suggest that
M. abscessus causes a tuberculosis-like infection. We investigated
the systemic challenge of C57BL/6 mice with the type strain of
M. abscessus through intravenous and intraperitoneal routes. With
both high (107 CFU) and low (105 CFU) doses, the initial bacterial
load remained stable for 5 days in liver and spleen until the estab-
lishment of a granulomatous response. The differentiation of the
granuloma (central F4/80+ epithelioid cells with a peripheral
CD4+ and CD8+ lymphocytic crown) was contemporary to a dras-
tic decrease of the bacterial load in the organs studied. However,
90 days following the challenge some mice still harboured bac-
teria capable of in vitro growth in their livers and spleens despite
an overall effective control of the infection, and all mice infected
presented granulomas of various differentiation stages in their liv-
ers. This response is highly reminiscent of the IFNc dependent
response to M. tuberculosis. Mice deleted for the gene encoding
IFNc were challenged intraperitoneally with M. abscessus and sig-
niﬁcantly failed to reduce the bacterial load by day 14. We show
for the ﬁrst time that the rapidly growing M. abscessus can cause a
long lasting, tuberculosis-like, IFNc dependent infection in
C57BL/6 mice. These results show promise for the elucidation of
M. abscessus disease since data from M. tuberculosis might be rele-
vant. Reciprocally, M. abscessus faithfully models key features of
mycobacterial infection.
P904 Animal model of Guillain–Barre´ syndrome by
sensitisation with a Campylobacter jejuni lipopolysaccharide
P. Gandolﬁ, M. Luciani, C.M. Caporale, G. Armillotta, A. Uncini
Teramo, Chieti, I
Objectives: Campylobacter jejuni infection is the most common
antecedent in the axonal variant of Guillain–Barre´ syndrome
(GBS). Antibodies against nerve gangliosides found in GBS
patients recognise cross reactive epitopes in the lipopolysaccha-
ride (LPS) of C. jejuni. This led to the molecular mimicry hypothe-
sis of GBS. To investigate the connection among C. jejuni,
antibodies anti gangliosides and GBS we designed an animal
model employing a LPS isolated from a GBS patient.
Methods: We immunised eleven rabbits with a LPS extracted from
Penner serotype 0:19 C. jejuni strain isolated from patient with
GBS and Freund’s adjuvant (CFA) (group I). In a second experi-
ment we immunised seven rabbits with LPS, CFA and keyhole
limpet hemocyanin (KLH) (group II).
Results: All rabbits of groups I and II developed a strong humoral
response to LPS. Elevated IgM and IgG antibodies to LPS could
be detected as early as 2 weeks after the ﬁrst immunisation. IgG
raised during the immunisation period up to 25 600 in group I
and 6400 in group II. Anti-GM1 IgM antibodies were detectable at
low titres 2 weeks after the ﬁrst immunisation in both groups and
raised up to 3200 in group I and to 6400 in group II. IgG anti-
GM1 could already be detected at low titres in both groups
2 weeks after the ﬁrst immunisation and increased up to 51 200 in
group I and up to 25 600 in group II. Titre of anti-GM1 IgG
showed a steep rise during the 6 weeks following the ﬁrst immu-
nisation. In Western immunoblotting of C. jejuni LPS, the serum
of immunised rabbits reacted strongly with a band that co-migra-
ted at 10 kD at the same level of CT, PNA and serum of the
patient with anti-GM1 antibodies. The kinetics of IgM and IgG
anti-GD1b was similar to that of antibody anti-GM1 but the max-
imal titres were lower as IgG raised up to 3200 in group I and
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12 800 in group II. IgM anti-GD1a were at low titre in both
groups throughout the experiment whereas IgG anti-GD1a raised
up to 3200 in group I and to 800 in group II. IgM and IgG anti-
GQ1b were not detectable in group I and II sera.
Conclusion: C. jejuni LPS is a potent B-cell stimulator capable to
induce a strong antiganglioside response in rabbits. However to
induce the neuropathy is crucial to employ KLH a glycoprotein
known to stimulate both humoral and cellular responses. This is
the ﬁrst animal model reproducing the pathogenetic process
hypothesised in axonal GBS with antiganglioside antibodies
post-C. jejuni infection.
P905 Campylobacter concisus infection in mice
R. Aabenhus, A˚. Ljungh, U. Stenram, H. Permin, L. Andersen
Copenhagen, DK; Lund, S
Objective: To establish a model of Campylobacter concisus infection
in mice.
Methods: Three separate experiments were conducted in order to
screen the ability of ﬁve clinical C. concisus isolates and the ATCC
33237 type strain of oral origin to infect BALB/cA mice. All mice
were pre-treated with vancomycin, and half of the animals received
cyclophosphamide to disturb immune functions, prior to C. conci-
sus challenge by direct intragastrical inoculation with 0.3 mL
109 CFU, controls received 0.3 mL of PBS. Measured parameters
were bacterial isolation from stool and internal organs, loss of body
weight and histological examinations of tissue samples. Mice were
sacriﬁced on days 7, 21 and 56 of the studies. Isolation of C. concisus
was performed by the selective ﬁlter method and PCR.
Results: Isolation and identiﬁcation: C. concisus was isolated on
day 7 from the cyclophosphamide treated group infected with the
clinical isolate 10776 (study 1). Liver (3/3), ileum (3/3) and jeju-
num (1/3) were culture positive. PCR results from tissue samples
were only positive in one mouse from the same group (liver,
ileum and jejunum). Faecal pellets were consistently negative.
During the two following studies, no isolation of C. concisus was
possible. Histological examination: Microabscesses (1/3) were
found in the liver in two untreated groups. Oedema of villi in the
ileum was occasionally noted in infected groups, but not in con-
trols (study 2). Two mice in the untreated group infected with the
ATCC 33237 type strain, presented leukocyte inﬁltration of colon.
Loss of body weight: Compared with controls, the C. concisus
infected mice had a signiﬁcant weight loss (P < 0.05) (study 3).
Loose stools: On days 2 and 3, C. concisus inoculated groups had
loose and slimy stools compared with control groups (study 3).
One mouse inoculated with the clinical isolate 10776 died on day
5 (study 3).
Discussion: The present model mimics a relevant intragastrical
exposure to C. concisus infection of imunocompetent BALB/cA
mice upon cyclophosphamide treatment and results indicate a
possible transient colonisation of liver and ileum, with clinical signs
of illness as loss of bodyweight and loose stools. Histological exam-
ination was inconclusive. Isolation of C. concisus was not reprodu-
cible in two subsequent studies, which severely hampers the
present model. Future studies should concentrate on the ﬁrst days
of infection, as the organism is rapidly cleared from the GI tract.
P906 n–6 Polyunsaturated fatty acids enhance the activity
of antimicrobials in experimental sepsis by multiresistant
Pseudomonas aeruginosa
M. Mouktaroudi, P. Koutoukas, T. Adamis, I. Alexandrou,
H. Giamarellou, E.J. Giamarellos-Bourboulis
Athens, GR
Objectives: n  6 polyunsaturated fatty acids (PUFAs) like
gamma-linolenate (GLA) and arachidonate (AA) have been shown
to enhance the activity of ceftazidime and amikacin both in vitro
and ex vivo on multidrug-resistant (MDR) P. aeruginosa (Giamarel-
los-Bourboulis et al. AAC 2000; JAC 2003). They were co-adminis-
tered with antimicrobials in an experimental model of sepsis by
an MDR isolate.
Methods: Sepsis was induced in 30 rabbits after the iv infusion of
an 8 log 10 inoculum of a P. aeruginosa isolate resistant to ceftazi-
dime (CZ), imipenem, ciproﬂoxacin and amikacin (AM) by a cath-
eter inserted into the right jugular vein. Animals were assigned
into ﬁve groups of treatment of six animals each: A controls; B iv
CZ and AM; C iv CZ, AM and alcohol 99%; D iv CZ, AM and an
alcoholic solution of GLA; and E iv CZ, AM and an alcoholic
solution of AA. Therapy was administered 30 min after bacterial
challenge. CZ was given at a 50 mg/kg dose, AM at 15 mg/kg
and both n  6 PUFAs at 25 mg/kg. n  6 PUFAs were infused
within 10 min. All agents were administered by a catheter inser-
ted into the left jugular vein. Survival was recorded; after death
segments of various organs were cut for quantitative cultures.
Results: Mean (SE) survival of groups A, B, C, D and E were
2.58  0.74, 9.52  2.59 (pNS compared with A), 9.67  2.50 (pNS
compared with A), 9.53  2.58 (pNS compared with A)
and12.25  1.60 days (P: 0.017 compared with A) respectively.
Mean log 10 of viable cell counts of P. aeruginosa form liver of
groups A, B, C, D and E were 3.27, 1.82, 2.78, 2.34 and 1.26 CFU/
g, respectively. Respective values of spleen counts were 4.63, 1.74,
3.00, 2.30 and 1.32 CFU/g. Respective values of the counts from
the lower lobe of the right lung were 2.85, 3.17, 5.95, 1.36 and
1.20 CFU/g. Respective values of counts of mesenterial lymph
nodes were 2.87, 1.25, 2.23, 1.35 and 1.20 CFU/g.
Conclusions: Co-administration of n  6 PUFAs with antimicrobi-
als in an experimental model of sepsis by MDR P. aeruginosa
enhances their effect by prolonging survival and decreasing the
number of viable cell counts in organs.
P907 Successful management of experimental sepsis by
Acinetobacter baumannii with the co-administration of colistin
and rifampin
A. Pantopoulou, M. Raftogiannis, M. Mouktaroudi, I. Dontas,
D. Perrea, E. J. Giamarellos-Bourboulis
Athens, GR
Objectives: In vitro synergy between colistin (CL) and rifampin
(RF) has been reported on multidrug-resistant (MDR) isolates of
A. baumannii (Giamarellos-Bourboulis et al. DMID 2001). This syn-
ergy is tested in an experimental model.
Methods: Thirty-ﬁve Wistar rats became neutropenic by the in-
traperitoneal injection of 100 mg/kg of cyclophosphamide on
day 1 and 150 mg/kg on day 3. On day 5 an 8 log 10 inocu-
lum of one MDR isolate was intramuscularly injected into the
right femor of animals. Rats were assigned into four groups of
treatment: A (n ¼ 6) controls; B (n ¼ 8) RF treated; C (n ¼ 11)
CL treated; and D (n ¼ 10) treated with both agents. Therapy
was given four hours after bacterial challenge. CL was adminis-
tered im 3 mg/kg into the left femor and RF iv from a catheter
inserted into the right jugular vein at 5 mg/kg. Survival was
recorded.
Results: Mean  SE survival of animals of groups A, B, C and D
were 1.75  0.17 days, 3.13  0.52 days (P: 0.031 compared with
A), 3.86  0.50 (P: 0.004 compared with A) and 5.50  0.11 (P:
0.011 compared with A) respectively.
Conclusions: Co-administration of CL and RF is beneﬁciary
accompanied by prolonged survival in an experimental model of
sepsis by MDR A. baumannii.
P908 Beta-lactams and aminoglycosides in combination for
pneumonia by carbapenem-resistant Acinetobacter baumannii in
a mice model
A. Montero, J. Ariza, X. Corbella, A. Domenech, S. Ribes, J. Ayats,
F. Tubau, F. Gudiol
L’Hospitalet, Barcelona, E
Infections by Acinetobacter baumannii (Ab) with high-degree resist-
ance (HDR) to carbapenems have recently increased. Only colistin
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seems to keep its in vitro efﬁcacy, but clinical practice is scarce. To
our knowledge, no clinical data are currently available to evaluate
the systematic use of the beta-lactam (BL)–aminoglycoside (AG)
combination to treat serious Ab infections in a way similar to that
in other infections by Gram-negative bacteria.
Objective: To analyse the efﬁcacy of the combination of two BL
(imipenem [I] or sulbactam [S]) and one AG (tobramycin [T]) in
an experimental model of pneumonia by Ab in mice.
Methods: We used immunocompetent C57BL/6 mice and three
strains of Ab with susceptibility, moderate-degree resistance and
HDR to carbapenems (A, D and E respectively). MICs (mg/L)
were (strains A, D, E): I: 1, 8, 512; S: 2, 4, 128; and T: 128, 8, 8. The
in vivo activity was examined by quantitative evaluation of the
lung homogenate cultures after 48 h of induction of pneumonia.
Results: In control (CON) animals (n ¼ 45), the bacterial counts in
lungs at 48 h were (mean  SD): 10.66  0.37, 10.83  0.32 and
10.77  0.35 log 10 CFU/g of tissue for strains A, D and E,
respectively (P ¼ NS between strains). Results of antibiotic activ-
ity were expressed as differences between treated (n ¼ 4 in each
therapy) and CON groups (delta log 10 CFU/g) (see Table).
Conclusions: In this mice pneumonia model, I or S kept his efﬁc-
acy for Ab with moderate resistance to carbapenems. In infections
caused by this strain D, T in combination conferred a possible
greater efﬁcacy on these BLs. In infections by Ab with HDR to
carbapenems, T alone was also effective. Interestingly the combi-
nation BL + AG also showed a higher effect on the infection by
this HDR strain E, against which monotherapy with I or S were
totally ineffective. Although the pharmacodynamics of T in this
model may have been overestimated, because of the peak levels
achieved are not usually found in humans at the recommended
doses (Cmax 32.87  5.45 mg/L), these results are promising to
treat multiresistant Ab infections.
P909 Cranberry juice and its organic acids inhibits
Escherichia coli colonisation of the bladder in a mice model of
urinary tract infection
H.D. Jensen, S.B. Christensen, K.A. Krogfelt
Copenhagen, DK
Objectives: To investigate the effect of orally administered cran-
berry juice and its organic acids on Escherichia coli in an experi-
mental mouse model of ascending urinary tract infection.
Methods: E. coli C175-94, a clinical isolate from a patient with UTI
was used. It expresses type 1 ﬁmbriae but not P or S ﬁmbriae. The
transurethrally infected mice were at all times were allowed free
access to chow and water (control group) or treatments. The con-
trol group and the treated groups all consisted of six mice in every
trial; after 1 week, the mice were sacriﬁced and urine, bladders
and kidneys collected for determination of bacterial counts. Most
of the treatments were repeated two or more times in independent
trials and these data were pooled. Treatments were commercially
available cranberry juice cocktail, freshly prepared cranberry juice,
the hydrophilic fraction of cranberry juice (contains sugars and
organic acids) and organic acids (quinic, malic, shikimic and citric
acid in concentrations corresponding to cranberry juice).
Results: A reduced number of organisms could be recovered from
the bladder (P < 0.01) and urine (P < 0.05) of mice orally treated
with unsweetened cranberry juice. Commercially available cran-
berry juice cocktail also reduced the CFU in the bladder (P < 0.01),
as did the hydrophilic fraction of cranberry juice (P < 0.05). Qui-
nic, malic, shikimic and citric acid were administered in combina-
tion and one by one. The four organic acids decreased the CFU in
the bladder when administered together (P < 0.001), and so did
the combination of malic plus citric acid (P < 0.01) and malic plus
quinic acid (P < 0.05). These data indicate that the beneﬁcial effect
of the organic acids from cranberry juice during urinary tract
infection is obtained when the acids are administered together.
Conclusion: For the ﬁst time the effect of cranberry juice and its
dominating organic acids has been tested in an experimental
mouse model of long-term ascending urinary tract infection under
controlled conditions. Cranberry juice inhibited E. coli colonisation
of the bladder, and the organic acids were the active component
involved. The active treatments reduced the bacterial load in the
bladder to sub therapeutic concentrations, which indicates that
cranberry juice is no ﬁnal treatment but a remedy that could help
the patient to clear the infection, before it eventually becomes a
ﬁnal cystitis.
P910 Correlation between growth rates and murine LD90
for a variety of Aspergillus fumigatus isolates
D. Paisley, G. Robson, D. Denning
Manchester, UK
Objectives: Determinants of pathogenicity have been elusive in
Aspergillus fumigatus, despite the overwhelmingly high frequency
of this species of Aspergillus compared with others. Growth arrest
in vivo (as in PABA synthase mutants) abolished infection (Brown
et al., Mol Microbiol 2000; 36: 1371–1380) and deletions of differ-
ent chitin synthase genes had an effect on virulence only if radial
growth rate was reduced (Mellado et al., Mol Microbiol 1996; 20:
667–679). We describe a kinetic microbroth method of measuring
the growth rates of Aspergillus fumigatus spectrophotometrically.
Using this method, growth rates (as deﬁned by Vmax values) were
determined for nine Aspergillus fumigatus isolates for which an
LD90 value in temporarily neutropenic CD-1 mice, infected intra-
venously, had previously been obtained.
Methods: An inoculum of 104 spores in 50 lL Sab medium gave
us uniformly shaped growth curves and allowed the measurement
of Vmax values with greater sensitivity. Soft max pro software was
used to determine the Vmax value for each growth curve by per-
forming linear regression on as many ﬁve data point line segments
as possible, calculating the slope for each line segment and report-
ing the steepest slope as the Vmax (mOD/min). Growth rate was
determined in quadruplicate in three separate experiments and the
average Vmax measurement across these experiments calculated.
Results: Mean growth rate varied from 1.558 (AF10) to 2.411
(AF71). LD90 varied from 3  105 to 5  106. Comparison of the
growth rates and LD90 values of these isolates suggests a correla-
tion exists between the two parameters, omitting the one signiﬁ-
cant outlier (AF65, which is amphotericin B resistant), r2 ¼ 0.6687.
Conclusion: These data are important in describing a simple
method for measuring the growth rate of the common ﬁlamentous
fungus A. fumigatus, and proving a direct link between pathogen-
icity in vivo and growth rate in vitro.
P911 Histopathological follow-up of the pancreas and
small intestines of mice, experimentally infected by the oral and
intraperitoneal routes
J. Kovacova, S. Bopegamage, A. Vargova, J. Motusova,
M. Borsanyiova, A. Petrovicova, M. Benkovicova, P. Gomolcak,
J. Galama
Bratislava, SK; Nijmegen, NL
Background: Coxsackieviruses belong to genus Human Enterovi-
rus of the family Picornaviridae. The natural infection is acquired
by the faecal–oral route, whereas in mouse studies the intraperito-
neal route is used. We have established a new mouse model with
infection by the oral route.
Table.
Therapy (dose) Strain A Strain D Strain E
I (200 mg/kg/day) )5.38a )4.48a 0.24a
S (120 mg/kg/day) )4.64a )3.67a )0.04a
T (60mg/kg/day) 0.02 )3.45a )4.16a
I+T )4.54a )5.37a,b )5.59a,b
S+T )3.83a )4.62a,b )4.95a,b
aP < 0.05 vs. CON (t-student).
bP < 0.05 vs. monotherapies (ANOVA).
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Objective: To compare the histological changes, viral persistence
and localisation of the virus in the pancreas and the small intestines
of mice, experimentally infected by oral or intraperitoneal route.
Method: Mice were infected with CVB 3 (Nancy) by the oral or
intraperitoneal route. Doses ranged from 5  103 to 5  109
TCID50. Selected organs from each mouse were embedded into
parafﬁn and sections were attached on silanised slides. For histo-
logical observation the sections were stained by Mayer’s haema-
toxylin eosin method. For localisation of the antigen by
immunohistochemical staining, the VP1 protein served as an indi-
cator for the presence of the virus. The method was standardised.
The tissue sections were processed and stained by the avidin–
biotin method, using the monoclonal mouse anti-enterovirus anti-
body against VP1 protein.
Results: The histological observations reveal that the tissue of exo-
crine pancreas showed inﬂammatory changes on the 3rd, 7th, 10th,
14th and 21st day post-infection in exocrine pancreas of the intra-
peritoneally infected mice. After oral infection no destruction of
the exocrine pancreas was observed, but on day 35th post-peroral
infection liposis was seen. VP1 was detected mainly on the third
and seventh days after infection in the small intestine. We found
differences in VP1 localisation between oral and intraperitoneal
infection. In small intestine of orally infected mice positive staining
was localised in smooth intestinal muscles whereas after intraperi-
toneal infection. VP1 was detected within the villi. There was no
correlation between the virus concentration and tissue damage.
Conclusions: The pathogenesis of CVB3 infection is inﬂuenced by
the route of virus administration, which has direct implications
for the use of mouse models to study the pathogenesis of Cox-
sackieviruses.
P912 Mouse models of Coxsackie B virus infection:
comparison of oral and intraperitoneal route of infection with
follow-up of virus shedding in stool and virus replication in the
small intestine
A. Vargova, M. Borsanyiova, A. Petrovicova, S. Bopegamage
Bratislava, SK
Objectives: The portal of entry of coxsackieviruses may inﬂuence
the pathogenesis of infections caused by these viruses. In this
study an outbred murine model (Swiss albino mice) was used for
experimental infection with coxsackie B3 virus (CVB3), strain
Nancy to follow-up the virus shedding in the stool and the pres-
ence of replicating virus in the small intestine of mice after oral
and intraperitoneal route of infection.
Methods: For infection of mice different concentrations of the
virus (104, 106, 108 and 1010) were used. The stool and small intes-
tine specimens of dissected mice were collected on days 3, 7, 10
post-infection (p.i.) and from day 14 in weekly intervals up to a
day 147 p.i. The suspensions made from the collected specimens
were studied for presence of replicating virus in Hep-2 cell cul-
tures. The virus titre was determined in Hep-2 monolayers on
microtitre plates and calculated by Reed and Muench method.
Results: The replicating virus in the stool pellets was detectable
from day 3 p.i. to day 14 p.i. in both orally and intraperitoneally
infected mice with a virus titre reaching the level 101:5 TCID50/
mL. In the small intestine of orally infected mice the presence of
replicating virus was detected up to day 35 p.i. In the small intes-
tine of intraperitoneally infected mice the replicating virus was
present for a shorter time, up to day 21 p.i., irrespective of the
dose of infection.
Conclusion: There was no difference in the length of virus shed-
ding in stool specimens of mice infected by oral or intraperitoneal
route. However a longer presence of replicating virus in the small
intestine of orally infected mice in contrast to intraperitoneally
infected mice was observed. This was conﬁrmed by the immuno-
histopathological studies, these observations support the sugges-
tion that the pathogenesis of coxsackieviral infections is
inﬂuenced by the route of virus administration.
P913 Identiﬁcation of porcine endogenous retroviruses in
severe combined immunodeﬁcient mice and Lewis rats
xenotransplanted with porcine neonatal pancreatic cell clusters
S. Kim, Y. Kim, J. Sohn, K. Yoon, W. Shin, M. Kang
Seoul, KOR
Object: In xenotransplantation with porcine neonatal pancreatic
cell clusters (NPCCs), the risk of cross-species porcine endog-
enous retrovirus (PERV) infection remained as problem. We used
the severe combined immunodeﬁcient (SCID) mouse and the
Lewis rat model to identify the PERV transmission with the time
course and the differences between the models.
Methods: NPCCs were transplanted to SCID mice and Lewis rats
and left for 1–70 days before being sacriﬁced. DNA and RNA
were extracted from the liver, spleen, pancreas, lung, kidney and
testis. To examine the PERV transmission, nested-PCR and
RT-PCR were used upon pol/env/gag regions of PERV. The pig
mitochondrial cytochrome oxidase II subunit gene (COII) was
ampliﬁed simultaneously to monitor the microchimerism.
Results: Total 264 samples from seven mice and ﬁve rats were tes-
ted. Ten weeks after xenotransplantation, two mice and four rats
were identiﬁed to have permissive PERV infection. In the SCID
mice, 92.9% of tested organs were positive for PERV-pol gene
and 85.7% were positive for COII gene with DNA examination.
In the Lewis rats, 86.7% of organs were positive for PERV-pol
gene and 14.1% for COII gene with DNA examination. Examina-
tions of organs of mice showed that 35 (83.3%) organs were posit-
ive for the PERV-pol gene and COII gene simultaneously that
presumed as microchimerism, but 15 (50%) organs of rats were
presumed as microchimerism. Results of PERV-pol positive and
COII negative that presumed as permissive PERV infection were
observed in 9.5% of organs in the SCID mice and 36.7% in the
Lewis rats. Organs presumed as permissive PERV infection were
the spleen (day 3), liver (day 70), lung (day 70), and testis (day
70) in the SCID mice by DNA examinations. In the Lewis rats, the
spleen and testis of day 1; the liver, spleen, and kidney of day 5;
the testis and kidney of day 7; the liver, spleen, lung, and testis of
day 14 were identiﬁed to have permissive PERV infection.
Conclusion: The cross-species PERV infection was identiﬁed from
these animal models. Expression of PERV depends on the immu-
nity of the recipients, because the xenotransplanted SCID mice
had more PERV microchimerism but less permissive infection
than that of the Lewis rats. Detection rate was increased with the
time course, accordingly in the early period after transplantation,
PERV considered to exist as an inactive form.
New drugs
P914 Antimicrobial spectrum and activity of NVP PDF-713
(PDF7), a novel peptide deformylase inhibitor, tested against
1837 recent Gram-positive clinical isolates
R. Jones, T. Fritsche, H. Sader
North Liberty, USA
Background: The continued development and expansion of resi-
stance (R) among Gram-positive pathogens (GPP) has threatened
the therapy of numerous antimicrobial classes including the
recently introduced quinupristin/dalfopristin, telithromycin and
the oxazolidinones. Clearly the need for antimicrobial
discovery persists, and this should be a continued priority for
the pharmaceutical industry. This report addresses the
spectrum of activity for PDF7 tested against a collection of
recent (2002) clinical isolates cultured from patients infected
with pathogens within the spectrum for peptide deformylase
inhibitors.
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Methods: PDF7 was acquired from Novartis. The compound was
dispensed into reference broth microdilution trays in appropriate
media over the range of 0.06–8 mg/L. Mueller–Hinton broth was
supplemented with 2–5% lysed horse blood when testing fastidi-
ous streptococci, and the Corynebacteria. NCCLS QC strains were
used concurrently and all PDF7 MIC results were within pro-
posed ranges.
Results: 1837 Gram-positive strains were tested with a species
rank order of S. aureus (875 strains) > CoNS (381) > streptococci
(285) > enterococci (273) > Listeria spp. (11). The PDF7 MIC results
against S. aureus and the CoNS strains ranged from 
0.06 to
4 mg/L, but the vast majority of staphylococci (87.0%) had MICs
of 0.25–2 mg/L. Staphylococcal MIC90 results for PDF7 were 1 or
2 mg/L, regardless of oxacillin R pattern. Also tested were Co-
rynebacterium spp. (eight strains; PDF7 MIC50, 0.25 mg/L), Bacillus
spp. (three; MIC50, 0.12 mg/L) and one Micrococcus spp. (MIC,
0.25 mg/L). PDF7 MICs for enterococci ranged to >8 mg/L, but
99.3% of strains were inhibited at 
8 mg/L, the proposed sus-
ceptible breakpoint. R to other classes of agents did not inﬂuence
the PDF7 MIC values among enterococci. All streptococci were
inhibited at 
4 mg/L, and the fO`-haemolytic and S. bovis strains
were susceptible to PDF7 at 
1 mg/L. Previous reports have
shown that >90% of H. inﬂuenzae (MIC90, 8 mg/L) and all M. ca-
tarrhalis (MIC90, 0.5 mg/L) are inhibited by PDF7.
Conclusions: To address the established decline in potency or cov-
erage of GPP by existing antimicrobials, PDF7 appears to be a
promising new agent applicable by oral and parenteral routes. The
combined spectrum of activity against MRSA, VRE, DRSP and key
Gram-negative community-acquired respiratory tract pathogens
warrants further investigations of PDF7 in human trials.
P915 Antistaphylococcal activity of NVP-PDF713, a new
peptide deformylase inhibitor compared with other agents
P. Appelbaum, L. Ednie, M. Jacobs
Hershey, Cleveland, USA
Background: Resistance of staphylococci to b-lactams, quinolones
and other agents is increasing and recently VISA as well as VRSA
strains have been reported.
Objective: NVP-PDF713 is a new peptide deformylase inhibitor
active against a wide variety of Gram-positive and -negative bac-
teria. The current study examines the activity of NVP-PDF713
compared with those of ciproﬂoxacin, levoﬂoxacin, gatiﬂoxacin,
moxiﬂoxacin, vancomycin, teicoplanin, linezolid, ranbezolid, dap-
tomycin, oritavancin and quinupristin/dalfopristin against 131
S. aureus (62 methicillin resistant) and 127 coagulase-negative sta-
phylococci (60 methicillin resistant).
Methods: Microdilution using frozen trays containing cat-
ion-adjusted Mueller–Hinton broth and inocula of 1  105 CFU/
mL with trays incubated in air.
Results: MIC50 and MIC90 values (lg/mL) were as seen in the fol-
lowing table. NVP-PDF713 was equally active against all sta-
phylococcal strains (MICs <0.06–4 lg/mL), irrespective of
susceptibility to other agents. Quinolone resistance was mainly
seen in methicillin R strains. Vancomycin, linezolid, ranbezolid,
daptomycin, oritavancin and quinupristin/dalfopristin were all
active at MICs <4.0 lg/mL and teicoplanin was less active against
coagulase-negative strains.
Conclusions: NVP-PDF713, a new peptide deformylase inhibitor,
was active in vitro against staphylococci.
P916 Antipneumococcal activity of NVP-PDF713 compared
with 18 other agents
P. Appelbaum, L. Ednie, M. Jacobs
Hershey, Cleveland, USA
Background: Drug resistance in pneumococci is found worldwide.
Objective: NVP-PDF713 is a new peptide deformylase inhibitor
active against Gram-positive and -negative bacteria. This study
tests activities of NVP-PDF713, amoxicillin  clavulanate, imipe-
nem, meropenem, ceftriaxone, cefuroxime, cefpodoxime, cefdinir,
ciproﬂoxacin, levoﬂoxacin, gatiﬂoxacin, moxiﬂoxacin, azithromy-
cin, clarithromycin, linezolid, quinupristin/dalfopristin, vancomy-
cin and teicoplanin against 80 pen S, 88 pen I, 132 pen R
pneumococci (154 macrolide R and 30 quinolone R strains with
deﬁned R genotypes).
Methods: Agar dilution using cation-adjusted Mueller–Hinton
agar + 5% sheep blood and inocula of 1  104 CFU/spot; plates
incubated in air.
Results: MIC50 and MIC90 values (lg/mL) are shown in Table 1.
NVP-PDF713 was equally active against all pneumococci, irres-
pective of activity of other drugs. Beta-Lactam MICs rose with
those of pen G. Moxi was the most potent quinolone followed by
gati, levo cipro. Vanco, teico, linez, quin/dalf were all active at
MICs <4.0 lg/mL.
Conclusions: NVP-PDF713 was active in vitro against Beta-lactam,













MIC30 MIC90 MIC30 MIC90 MIC30 MIC90 MIC30 MIC90
NVP PDF-713 2 4 1 2 1 2 1 2
Ciproﬂoxacin >16 >16 0.25 >16 8 >16 0.125 4
Levoﬂoxacin 8 >16 0.125 8 4 8 0.125 4
Gatiﬂoxacin 4 8 0.06 4 1 2 0.06 1
Moxiﬂoxacin 2 4 0.03 2 1 2 0.03 0.5
Vanomycin 1 1 0.5 1 2 2 1 2
Teicoplanin 0.5 1 0.5 1 4 8 1 8
Linezolid 2 4 2 4 1 2 1 2
Ranbezolid 2 4 1 2 0.25 1 0.125 0.5
Deptomycin 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Oritavancin 2 2 2 2 2 2 2 2
Quin/delfo 0.5 0.5 0.25 0.5 0.125 0.5 0.125 0.5
Drug Pen S Pen I Pen R Macrolide R Quin R
NVP 1.0/2.0 0.5/1.0 0.5/1.0 0.5/2.0 0.5/2.0
Amox 0.03/0.03 0.25/1.0 2.0/8.0 0.25/8.0 0.06/4.0
Amox/clav 0.03 0.25/1.0 2.0/4.0 0.25/4.0 0.06/2.0
Imip 0.008/0.008 0.03/0.12 0.25/0.25 0.06/0.25 0.016/0.25
Merop 0.016/0.016 0.06/0.25 0.5/0.5 0.12/0.5 0.03/0.5
Ceftriax 0.03/0.06 0.12/1.0 1.0/2.0 0.25/2.0 0.12/2.0
Cefurox 0.03/0.12 0.25/4.0 4.0/16.0 0.5/8.0 0.25/8.0
Cefpodox 0.03/0.06 0.25/2.0 4.0/8.0 0.5/4.0 0.25/8.0
Cefdinir 0.06/0.12 0.5/4.0 8.0/8.0 0.5/8.0 0.25/8.0
Cipro 2.0/32.0 1.0/2.0 2.0/4.0 1.0/2.0 32.0/>32.0
Levo 1.0/6.0 1.0/2.0 1.0/2.0 1.0/2.0 16.0/32.0
Gati 0.5/4.0 0.25/0.5 0.5/1.0 0.5/0.5 4.0/8.0
Moxi 0.25/4.0 0.12/0.25 0.25/0.5 0.12/0.25 2.0/4.0
Azithro 2.0/>64.0 2.0/>64.0 0.12/>64.0 >64.0/ >64.0 0.12/>64.0
Clarithro 0.5/>64.0 1.0/>64.0 0.06/>64.0 64.0/ >64.0 0.03/32.0
Linez 1.0/2.0 1.0/2.0 1.0/2.0 1.0/2.0 1.0/2.0
Quin/Dalf 0.5/0.5 0.25/0.5 0.5/1.0 0.5/1.0 0.5/0.5
Vanco 0.25/0.5 0.25/0.5 0.25/0.5 0.25/0.5 0.25/0.5
Teico 0.06/0.06 0.06/0.06 0.06/0.06 0.06/0.06 0.06/0.12
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P917 Evaluation of the in vitro activity of NVP PDF-713
against clinical anaerobic isolates with emphasis on the
Bacteroides fragilis group
D.R. Snydman, N.V. Jacobus, L.A. McDermott
Boston, USA
Objective: NVP PDF-713 is a novel peptide deformylase (PDF)
that targets bacterial metalloproteases. Recent reports have dem-
onstrated its potent in vitro activity against respiratory and skin
pathogens such as MRSA, S. pneumoniae, S. pyogenes, S. agalactiae
and enterococci. We undertook this study to compare the in vitro
activity NVP PDF-713 to that of agents with antianaerobic activity
against clinical anaerobic isolates emphasising on the B. fragilis
group.
Method: The MICs of 400 B. fragilis group and 90 Gram-positive
anaerobic isolates were determined using NCCLS recommended
procedures. The activity of NVP PDF-713 was compared with that
of cefoxitin, clindamycin, imipenem, garenoxacin, linezolid, mox-
iﬂoxacin and tigecycline. Vancomycin was included in the evalua-
tion of the Gram-positive organisms. All B. fragilis group isolates
were referred during 2002–2003 by various medical centres
throughout the USA and represented the various species within
the group.
Results: Against the B. fragilis group isolates, NVP PDF-713
showed excellent in vitro activity against all the species. The
new agent showed the lowest MICs among all comparators
(MIC range of 0.03–0.5 mg/L and an MIC90 of 0.5 mg/L. Of
the comparators, only imipenem showed such low MICs. NVP
PDF-713 was active against strains resistant to beta-lactams,
quinolones or clindamycin and the MICs were much lower than
those of newer agents such as linezolid, tigecycline or garenoxa-
cin. Next to imipenem, NVP PDF-713 was the most active agent
against anaerobic positive cocci, MIC range of 0.03–1 mg/L.
The activity of NVP PDF-713 was somewhat decreased against
Clostridium species and MICs greater than 4 mg/L were
observed.
Conclusion: Given the frequency of isolation of anaerobic bacteria
and their increasing resistance, a novel agent effective against a
new bacterial target such as NVP PDF-713 (with activity against
a broad range of bacteria) is an ideal agent for potential use
against mixed infections. PK and PD parameters, safety and
usage in clinical trials will determine the clinical efﬁcacy of the
new agent.
P918 Potential utility of a peptide deformylase inhibitor,
NVP PDF-713 (PDF7) against oxazolidinone-resistant or
streptogramin-resistant Gram-positive isolates
R. Jones, G. Moet, H. Sader, T. Fritsche
North Liberty, USA
Background: New and novel antimicrobials have been introduced
into infectious disease practice in the last decade to address emer-
ging resistances (R) among Gram-positive cocci. R to oxazolidi-
nones, streptogramin combinations and various glycopeptides
require expanded development of agents with alternative modes
of action. In this investigation, PDF7, a new peptide deformylase
inhibitor, was tested against clinical isolates having documented
R to linezolid (LZD) or quinupristin/dalfopristin (Q/D) using ref-
erence susceptibility test methods.
Methods: A total of 45 organisms were collected from our
recent (2001–2002) stock culture collection that were originally
isolated at R surveillance sites in the United States, Canada,
Brazil and Europe. These organisms included E. faecalis (LZD-R,
three strains; Q/D-R was intrinsic), E. faecium (LZD-R, 10
strains; Q/D-R, six strains), S. aureus (LZD-R, ﬁve strains;
Q/D-R, 10 strains), CoNS (LZD-R, one strain; Q/D-R, nine
strains) and S. oralis (LZD-R, one strain). The mechanisms of R
for all LZD-R strains (MIC 	8 mg/L) were conﬁrmed by gene
sequencing with the detection of a G2576U mutation. PCR tests
for vatD and vatE were negative. QC of the reference PDF7
MIC results was performed using acceptable MIC ranges repor-
ted by Anderegg et al. The proposed or tentative susceptible
breakpoint for PDF7 was 
8 mg/mL based on pharmacokinet-
ic/pharmacodynamic characteristics.
Results: Among the 13 LZD-R strains, three were E. faecalis and
10 were E. faecium. Also 10 enterococci were R to vancomycin
(VANCO) and all E. faecalis strains had the intrinsic Q/D R (MIC,
8 mg/L). These enterococci had PDF7 MIC results between 0.5
and 4 mg/L (MIC90, 4 mg/L). The six Q/D-R E. faecium were
susceptible to VANCO and were inhibited by 1 or 2 mg/L of
PDF7. PDF7 was highly active against LZD-R S. aureus (MICs,
0.25–0.5 mg/L), S. epidermidis (MIC, 2 mg/L) and the viridans
group streptococcus (MIC, 0.5 mg/L). Q/D and vancomycin were
active against these LZD-R organisms. The Q/D-R staphylococci
(19) were inhibited by PDF7 (MIC range, 0.12–2 mg/L), LZD (1 or
2 mg/L) and VANCO (1 or 2 mg/L).
Conclusions: These results indicate that PDF7 among the candi-
date peptide deformylase inhibitors, demonstrated excellent activ-
ity (all MICs at 	4 mg/L) against emerging Gram-positive clinical
isolates that have become R to oxazolidinones or streptogramin
combinations.
P919 Time-kill study of antistaphylococcal activity of NVP
PDF-713 compared with other agents
P. Appelbaum, K. Credito, G. Lin, M. Jacobs
Hershey, Cleveland, USA
Background: Methicillin resistance is increasingly seen in S. aureus
and coagulase-negative staph (CONS).
Objective: NVP PDF-713 is a new peptide deformylase inhibitor
active against Gram-positive and Gram-negative strains. This
study tested activity of NVP PDF-713, ciproﬂoxacin, levoﬂoxacin,
gatiﬂoxacin, moxiﬂoxacin, vancomycin, teicoplanin, linezolid, ran-
bezolid, daptomycin, tigecycline, oritavancin and quinupristin/
dalfopristin against six S. aureus (3 methi R) and six CONS (3
methi R).
Methods: NCCLS macrodilution MIC was used. For time-kills,
5  105–5  106 CFU/mL inocula in cation-adjusted Mueller–Hin-
ton broth were incubated aerobically in a shaking water bath at
1, 2, 4 MIC. Viabilities were done after 3, 6, 12, 24 h. Ca2þ
was added for dapto.
Results: MIC ranges (lg/mL) were: NVP PDF-713, 0.25–2; cipro,
0.25 to >32; levo, 0.25–32; gati, 0.125–16; moxi, 0.03–8; vanco, 1–4;
teico, 0.5–16; linez, 1–4; ranbez, 0.125–4; dapto, 0.125–2; tige,
Table.
Drug
3 h 6 h 12 h 24 h
)1 )2 )3 )1 )2 )3 )1 )2 )3 )1 )2 )3
NVP 0/0 0/0 0/0 1/1 1/1 0/0 1/2 1/1 0/0 0/0 0/0 0/0
Cipro 3/5 1/2 0/0 6/7 2/3 2/2 6/7 2/5 2/3 6/7 2/7 2/4
Levo 4/5 1/2 0/0 8/8 3/5 1/1 9/9 4/8 1/5 9/9 7/8 3/7
Gati 6/10 2/2 0/0 10/12 5/9 3/4 11/12 9/12 2/7 10/12 7/12 3/8
Moxi 8/10 2/5 0/0 9/11 4/9 1/3 10/12 7/9 2/7 8/12 3/9 2/7
Vanco 33 0/0 0/0 9/10 1/2 0/0 11/12 4/9 3/3 8/12 5/10 3/9
Teico 02 0/0 0/0 4/8 0/0 0/0 10/10 4/6 0/0 9/12 6/11 3/6
Linezolid 00 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/1 0/0 0/0
Ranbez 00 0/0 0/0 1/1 0/0 0/0 1/3 0/0 0/0 2/10 0/1 0/0
Depto 911 6/9 0/5 12/12 9/11 6/9 12/12 11/12 5/10 11/12 10/12 8/11
Tigecyt 00 0/0 0/0 0/0 0/0 0/0 0/2 0/1 0/0 0/6 0/0 0/0
Oritavan 1212 10/12 2/7 12/12 12/12 8/12 11/12 9/11 9/10 8/12 6/12 6/12
Quin/Dalf 00 0/0 0/0 4/5 0/0 0/0 5/7 1/2 0/0 5/8 1/3 0/1
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0.25–1; orita, 0.25–1; quinu/dalfo, 0.125–1. No. of strains at MIC/
2  MIC with delta-1 log 10 CFU/mL (90%), delta-2 log 10 CFU/
mL (99%) and delta-3 log 10 CFU/mL (99.9%) Killing at the var-
ious time periods are shown in Table 1. NVP PDF-713 was not
cidal at 1  MIC and 2  MIC, but was static against all 12
strains at MIC after 24 h. Cipro and moxi were cidal against four
to seven strains at 2  MIC after 24 h. Vanco was cidal at
2  MIC for nine strains after 24 h. Oxazolidinones, tigec and qui-
nu/dalfo were mainly bacteriostatic and dapto and orita rapidly
cidal.
Conclusions: NVP PDF-713 gave low MICs and static activity
against all strains, irrespective of methicillin susceptibility sta-
tus.
P920 Time-kill study of the antipneumococcal activity of
NVP PDF-713, a new peptide deformylase inhibitor, compared
with 13 other agents
P. Appelbaum, G. Pankuch, M. Jacobs
Hershey, Cleveland, USA
Background: Drug-resistant pneumococci are an increasing world-
wide problem.
Objective: NVP PDF-713 is a new peptide deformylase inhibitor.
This study used time-kill analysis to examine the antipneumococ-
cal activity of NVP PDF-713 compared with imipenem, merope-
nem, ceftriaxone, moxiﬂoxacin, levoﬂoxacin, gatiﬂoxacin,
azithromycin, clarithromycin, vancomycin, teicoplanin, linezolid,
daptomycin, and quinupristin/dalfopristin. Twelve strains were
tested: Three penicillin sensitive, two intermediate, and seven
resistant pneumococci. Of the 12 strains tested; 10 were macrolide
resistant [4 erm (B), 4 mef, 2 L4], and two quinolone resistant.
Methodology: NCCLS macrodilution MIC methodology was used.
Time-kill analyses were in cation-adjusted Mueller–Hinton broth
with 5% lysed horse blood, and ﬁnal inocula of 5  105–
5  106 CFU/mL. Mueller–Hinton broth was supplemented to a
ﬁnal concentration of 50 mg Ca2þ/L for testing daptomycin. Viab-
ility counts were done after 0, 3, 6, 12, and 24 h.
Results: MICs (lg/mL) were as follows: NVP PDF-713, 0.125–2.0;
imipen, 0.004–0.25; meropen, 0.008–1.0; ceftriax, 0.016–4.0; moxi,
0.125–4.0; levo, 1.0–16; gati, 0.25–8.0; azithro, 0.06 to >64; clarithro,
0.016 to >64; vanco 0.25–0.5; teico, 0.06–0.125; linez, 0.5–2.0; dapto,
0.125–0.5; quin/dal, 0.25–1.0. The number of strains at MIC/
2  MIC with log 10 CFU/mL values of 1 (90% killing), 2
(99% killing) and 3 (99.9% killing) at the various time periods
are shown in Table 1.
Conclusions: NVP PDF-713 had kill kinetics similar to those of li-
nezolid. NVP PDF-713 at 2  MIC was bactericidal (99.9% killing)
against six strains after 24 h. Linezolid at 2  MIC was bacteri-
cidal against seven strains at the same period. Daptomycin and
quinupristin/dalfopristin showed rapid killing. Imipenem, me-
ropenem, vancomycin, and quinupristin/dalfopristin were bacteri-
cidal against all 12 strains at 2  MIC after 24 h.
P921 In vivo pharmacodynamics of NVP-PDF-713, a new
peptide deformylase inhibitor
W. Craig, D. Andes
Madison, USA
Objectives: NVP-PDF-713 is a new peptide deformylase inhibitor
antimicrobial with excellent activity against Gram-positive cocci,
including methicillin-resistant Staphylococcus aureus (MRSA) and
penicillin-resistant Streptococcus pneumoniae (PRSP). We used the
neutropenic murine thigh-infection model to measure in vivo post-
antibiotic effects (PAEs) and determine which PK/PD parameter
best correlated with in vivo efﬁcacy.
Methods: Mice had 106.6–7.4 CFU/thigh of Staphylococcus aureus
ATCC 29213 and Streptococcus pneumoniae ATCC 10813 when
treated for 24 h with 40–1280 mg/kg/day of NVP-PDF-713
fractionated for 3-, 6-, 12-, and 24-h dosing. Mice were sacri-
ﬁced at the end of therapy. Ten per cent thigh homogenates
were prepared, and serial dilutions were plated for CFU deter-
minations. Serum levels after both oral and subcutaneous injec-
tion of doses of 20, 80 and 320 mg/kg were measured by
microbiologic assay. Non-linear regression analysis was used to
determine which PK/PD parameter (24-h AUC/MIC, peak/MIC
or time above MIC) best correlated with CFU/thigh at 24 h. In
vivo PAEs were measured from serial 2–6 h CFU/thigh values
after doses of 80 and 320 mg/kg.
Results: Pharmacokinetic studies exhibited linear kinetics with
doses from 20 to 320 mg/kg, with peak/dose values of 0.10–
0.12, AUC/dose values of 0.09–0.11 and half-lives of 26–30 min.
Oral bioavailability was 67–88%. Protein binding in mouse
serum was low at 25%. NAV-PDF-713 produced in vivo PAEs
of 3–5 h with S. aureus and 10–13.5 h with S. pneumoniae. The
24-h AUC/MIC was highly correlated with efﬁcacy (R2 ¼ 84–
87% for 24-h AUC/MIC compared with 34–76% for peak/MIC
and 40–60% for time above MIC for S. pneumoniae and S. aure-
us, respectively). Because of the rapid half-life in mice, once-
daily dosing was slightly less effective than the more frequent
dosing regimens.
Conclusions: The 24-h AUC/MIC is the parameter that best corre-
lates with in vivo activity of NVP-PDF-713. The prolonged in vivo
PAEs would support at least twice daily dosing.
P922 In vivo pharmacodynamic activity of NVP-PDF-713
against multiple bacterial pathogens
W. Craig, D. Andes
Madison, Wisconsin, USA
Objectives: The 24-h AUC/MIC is the PK/PD parameter that best
correlates with in vivo activity of NVP-PDF-713, a new peptide
deformylase inhibitor. We used the murine thigh-infection model
Table.
Drug
3 h 6 h 12 h 24 h
)1 )2 )3 )1 )2 )3 )1 )2 )3 )1 )2 )3
NVP 0/0 0/0 0/0 2/3 0/1 0/0 8/9 1/2 1/2 7/10 4/8 2/6
Imipen 11/12 4/5 0/0 11/12 6/10 3/3 12/12 11/12 8/11 12/12 11/12 10/12
Meropen 8/9 2/3 1/1 11/12 7/7 3/3 11/12 7/11 4/9 8/12 7/12 5/12
Ceftriax 4/6 1/2 0/0 8/12 5/7 3/3 9/12 9/12 6/10 11/12 8/12 4/10
Moxi1 5/8 0/1 0/0 8/10 4/6 1/2 9/10 8/10 5/9 10/10 8/10 7/10
Levo1 5/5 0/0 0/0 8/10 4/6 1/1 10/10 8/10 3/6 9/10 9/10 5/10
Gati1 4/6 0/1 0/0 7/10 2/7 1/1 10/10 6/10 3/7 9/10 8/10 4/9
Azithro2 1/1 0/0 0/0 1/1 1/1 1/1 2/2 1/2 1/2 2/2 2/2 2/2
Clarithro2 0/0 0/0 0/0 2/2 1/2 0/0 2/2 2/2 2/2 2/2 2/2 2/2
Vanco 4/4 0/1 0/0 12/12 5/6 2/3 12/12 11/11 9/9 11/12 10/12 9/12
Teico 0/0 0/0 0/0 5/6 1/1 0/0 9/10 6/7 3/4 9/12 8/12 7/10
Linez 0/0 0/0 0/0 2/4 0/1 0/1 6/11 1/4 0/1 8/12 4/11 2/7
Depto 7/10 2/4 2/2 12/12 11/11 4/8 11/12 10/11 7/11 8/12 5/11 3/11
Quin/Dal 10/11 7/9 4/5 12/12 11/11 6/9 11/12 10/11 7/11 7/12 5/12 3/12
1Ten strains cipro MIC <8.0. 2Two macrolide sensitive strains.
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in normal and neutropenic mice to determine (1) the magnitude
of the 24-h AUC/MIC needed for efﬁcacy of NVP-PDF-713 with
various pathogens (including MRSA and penicillin-, macrolide-
and tetracycline-resistant strains of S. pneumoniae) and (2) the
impact of neutrophils on the drug’s in vivo activity.
Methods: Mice had 106.7–7.9 CFU/thigh of ﬁve isolates of Staphy-
lococcus aureus (two MRSA) and six isolates of Streptococcus pneu-
moniae (ﬁve penicillin-resistant, four macrolide-resistant, three
tetracycline-resistant strains) when treated for 24 h with 20–
320 mg/kg of NVP-PDF-713 subcutantously every 6 h. Streptococ-
cus pneumoniae ATCC10813 and Staphylococcus aureus ATCC 29213
were studied simultaneously in normal and neutropenic mice.
Mice were sacriﬁced at the start and end of therapy. Ten per cent
thigh homogenates were prepared and serial dilutions were pla-
ted for CFU determinations. Serum levels were determined by
microbiologic assay after subcutaneous doses of 20, 80 and
320 mg/kg. A sigmoid dose–response model was used to estimate
the dose (mg/kg/24 h) required to achieve a net bacteriostatic
effect over 24 h.
Results: PK studies exhibited linear kinetics with AUC/dose val-
ues 0.09–0.11 and half-lives of 26–30 min. Protein binding was
25%. MICs ranged from 0.5 to 2.0 mg/L. Static doses for the var-
ious organisms ranged from 48 to 124 mg/kg/day. Mean 24-h
AUC(free)/MIC values (SD) were 33.3  8.9 for S. aureus and
34.9  10.0 for S. pneumoniae. The differences were not signiﬁcant.
Methicillin and penicillin resistance did not alter the magnitude
of the AUC/MIC required for efﬁcacy. The presence of neutroph-
ils reduced the 24-AUC(free)/MIC required for efﬁcacy by about
fourfold.
Conclusion: The 24-h AUC/MIC of NVP-PDF-713 required for in
vivo efﬁcacy was relatively similar among various pathogens, was
not altered by drug resistance, and was reduced fourfold by the
presence of neutrophils.
P923 Determination of quality control guidelines for MIC
dilution and disk diffusion methods when testing NVP-PDF713,
a novel peptide deformylase inhibitor
T. Fritsche, T. Anderegg, R. Jones
North Liberty, USA
Background: Quality control (QC) guidelines remain necessary for
accurate determination of antimicrobial susceptibility testing and
should be established early in the development of new antimicro-
bial classes. NVP-PDF713 is a PDF inhibitor rapidly progressing
into Phase II and III human clinical trials, thus QC guidelines
appear necessary for NCCLS methods.
Methods: Multi-laboratory (seven or eight sites) trials were initi-
ated using the NCCLS M23-A2 guideline for QC determinations.
Key technical details were: MIC phase – four Mueller–Hinton
(MH) broth lots, eight participant sites and 10 replicates of four
appropriate QC strains; and disk diffusion phase – three MH agar
lots, seven sites and 10 replicates of three QC strains. Results were
analysed by statistical methods found in M23-A2. Control drugs
included vancomycin, clarithromycin, linezolid and levoﬂoxacin;
99.9–100.0% of control results were within published NCCLS ran-
ges (640 and 1050 results for MIC and zone tests, respectively).
Inoculum concentration controls averaged 3.5  105 (MIC trial
only).
Results: Seven or eight participants provided qualifying results in
the two separate QC studies, and the calculated (proposed) ranges
were (range; % results in range): E. faecalis ATCC 29212 (2–8 mg/
L; 95.6), S. aureus ATCC 29213 (0.5–2 mg/L; 99.4), S. pneumoniae
ATCC 49619 (0.25–1 mg/L; 97.5 and 30–37 mm; 97.6), H. inﬂuenzae
ATCC 49247 (1–4 mg/L; 97.5 and 24–32 mm; 99.8), and S. aureus
ATCC 25923 (25–35 mm; 97.8). All QC ranges were maximised to
contain 
95% of reported results and zone sise variation was ele-
vated due to the bacteriostatic character of this PDF inhibitor, cre-
ating non-discreet zone edges.
Conclusions: QC ranges for NCCLS methods when testing
NVP-PDF713 have been established. Results from these NCCLS
M23-A2-conforming trials can be utilised to control the accuracy
of the susceptibility testing of this PDF inhibitor projected to be
among the ‘ﬁrst’ to reach human clinical studies.
P924 Determination of dry-form commercial reagent
reproducibility and MIC validations for NVP-PDF713, a novel
peptide deformylase inhibitor
G. Moet, R. Jones, P. Rhomberg, T. Fritsche
North Liberty, USA
Background: NVP-PDF713 is a new PDF inhibitor rapidly being
advanced to human clinical trials. Commercial reagent broth
microdilution MIC panels will be required for investigator labor-
atory use, especially those products with extended shelf-lives
(dry-form). This study reports the results of reagent qualifying
tests.
Methods: The experiment was performed by NCCLS M23-A2
guidelines to assess dry-form MIC reproducibility (10 organ-
isms  3 tests/day  3 days ¼ 90 tests) and comparative MIC
accuracy to the reference MIC (REF; M7-A6, 2003) using 
100
strains representing the following organism groups: staphylo-
cocci, enterococci, S. pneumoniae, other streptococci, H. inﬂuenzae,
and selected species refractory to PDF inhibitor action. All trays
were manufactured by Sensititre (TREK Diagnostics, Cleveland,
OH).
Results: Reproducibility results showed 80% of MICs were identi-
cal and 97.8% of MICs were within one log 2 dilution step. Valid-
ation test results comparing dry-form to REF MICs were (%
identical/twofold/fourfold): for staphylococci (71/99/100%), for
enterococci (55/99/100%), for S. pneumoniae (33/91/97%), for
other streptococci (69/100/100%) and for H. inﬂuenzae (36/97/
100%). Consistent variations were detected with SPN (49% of
dry-form panel results being one dilution higher than REF) and
HI (60% of results being one dilution lower than REF). NVP-
PDF713 MICs were off-scale (MIC values, >32 mg/L) for Entero-
bacteriaceae and non-fermentative Gram-negative bacilli (40
strains). Overall, 97% of Sensititre MIC results for were within
one log 2 dilution of REF MIC values.
Conclusions: NVP-PDF713 dry-form diagnostic MIC panels have
been validated for accuracy and reproducibility using 520 recent
clinical isolates from ﬁve major pathogen groups. The spectrum of
activity for this PDF inhibitor compound appears focused toward
Gram-positive cocci and speciﬁc fastidious respiratory tract patho-
gens.
P925 Activity of BAY 73-7388, a novel aminomethylcycline,
and other novel antibiotic classes against resistant bacteria in
vitro
B. Bhatia, T. Bowser, J. Chen, M. Ismail, L. Honeyman,
R. Mechiche, M. Nelson, K. Ohemeng, A. Verma, K. Tanaka,
A. Macone
Boston, USA
Objectives: The emergence of antibiotic resistance among Gram-
positive pathogens has impacted the clinical management of these
infections. Paratek Pharmaceuticals initiated a programme to
apply medicinal chemistry to the core structure of tetracycline
(TET) with the goal of creating novel classes of proprietary antibi-
otics that would (a) be unaffected by the known TET resistance
mechanisms and (b) retain the safety and tolerability proﬁle of the
TET family. Since there is no cross-resistance between the TETs
and other antibiotics, such new agents would be expected to be
active against isolates resistant to all other currently available
classes. The aim of the programme was to synthesise new agents
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active against Gram-positive, common Gram-negative, atypical
and anaerobic bacteria.
Methods: A series of 7-position and 7,9-position derivatives of
sancycline were synthesised and tested for activity in vitro against
MRSA, VRE, Enterococcus faecalis and Streptococcus pneumoniae by
microdilution. The presence of TET-resistance determinants was
assessed by PCR and conﬁrmed by resistance to currently avail-
able TETs.
Results: A number of 7-dimethylamino-9-aminomethylcyclines
(AMC) and 7-aryl or heteroaryl sancyclines with potent activity in
vitro (MIC range less than or equal to 0.06–2.0 mg/L) were identi-
ﬁed. Both novel series were more potent against one or more of
the resistant strains than currently available antibiotics tested
(MIC range 16–64 mg/L). The AMC derivatives were active
against bacteria resistant to TET by both efﬂux and ribosome-pro-
tection mechanisms.
Conclusions: This study identiﬁed the AMCs as a novel class of
antibiotics evolved from TET that exhibit potent activity in vitro
against TET-resistant bacteria, including Gram-positive bacteria
resistant to currently available antibiotics. One agent of this class,
BAY 73-7388 (discovered by Paratek Pharmaceuticals, Inc.,
Boston, MA, and designated PTK 0796) has been chosen for
development.
P926 Potent activity of BAY 73-7388, a novel
aminomethylcycline, against susceptible and resistant
Gram-positive and Gram-negative organisms
A. Macone, J. Donatelli, T. Dumont, S. Weir, S.B. Levy, K. Tanaka
Boston, USA
Objectives: BAY 73-7388 is the ﬁrst of a new class of antibiotics,
the aminomethylcyclines, which evolved from the tetracycline
(TET) family. BAY 73-7388 has potent activity against antibiotic
susceptible and resistant Gram-positive and Gram-negative patho-
gens. The present study compared the activity in vitro of BAY
73-7388 and 10 other agents including vancomycin (VAN), linezo-
lid (LIN), levoﬂoxacin (LVX) and TET against recent clinical iso-
lates including MRSA, VAN-resistant Enterococcus faecium (Efa
VRE), Enterococcus faecalis (Ef), penicillin-resistant Streptococcus
pneumoniae (Spn PENR), Groups A and B beta-haemolytic strepto-
cocci (BHS), Escherichia coli (Ec), and other pathogens. Potential
microbiological interactions between BAY 73-7388 and other anti-
biotics were also assessed.
Methods: Microdilution MIC tests were performed according to
NCCLS guidelines. The activity of BAY 73-7388 in the presence of
other antibacterial agents was assessed using standard chequer-
board MIC methods. TET-resistance determinants were identiﬁed
using multiplex PCR.
Results: Susceptibility in vitro (MIC90 mg/L) for selected agents
is shown in the table below.
Conclusions: BAY 73-7388 has potent activity in vitro against a
range of common pathogens, including those resistant to currently
available antibiotics: most notably MRSA, VRE and penicillin-
resistant S. pneumoniae. Chequerboard studies in vitro demonstrate
BAY 73-7388 does not affect, and is not affected by, the activity of
other antibiotics. (BAY 73-7388 was discovered by Paratek Phar-
maceuticals Inc., Boston, MA, and designated PTK 0796.)
P927 BAY 73-7388, a novel aminomethylcycline, exhibits
potent efﬁcacy in pulmonary murine models of infection
D. McKenney, J.M. Quinn, C.L. Jackson, J.L. Guilmet, J.A. Landry,
K. Tanaka, E.P. Cannon
Boston, USA
Objective: With the emergence of resistance to currently avail-
able antibiotics in the treatment of infectious diseases, the devel-
opment of novel antibiotic classes has become of major
importance. BAY 73-7388 is the ﬁrst aminomethylcycline antibac-
terial agent and is characterised by potent activity in vitro
against sensitive and multi-antibiotic resistant Gram-positive,
Gram-negative and atypical bacteria. We have evaluated BAY
73-7388 in several murine pulmonary infection models with a
range of pathogens in both neutropenic (Neut) and immunocom-
petent (IC) mice.
Methods: BAY 73-7388 and reference antibiotics were evaluated in
acute, systemic lethal infections caused by multi-resistant (res)
and susceptible (sus) Streptococcus pneumoniae (Spn); acute, lethal
pulmonary Spn infection in Neut mice; chronic, Spn lung model
in IC mice; and chronic Haemophilus inﬂuenzae (Hﬂu) infection
model in IC mice. In each infection BAY 73-7388 and other antibi-
otics were administered i.v.
Results: PD50 (survival) and ED50 (bacterial burden) results for
BAY 73-7388 and comparators, vancomycin (VAN), linezolid
(LIN), ciproﬂoxacin (CIP), azithromycin (AZI) and doxycycline
(DOX) against sus and res strains of Spn and Hﬂu (sus), are
detailed in the table below.
Conclusions: Overall, BAY 73-7388 performed as well or better
than the currently available therapeutic agents in all the models
investigated in this study. (BAY 73-7388 was discovered by Pa-
ratek Pharmaceuticals Inc., Boston, MA, and designated PTK
0796.)
P928 BAY 73-7388 is highly efﬁcacious in animal models of
intra-abdominal infections caused by a range of aerobic and
anaerobic organisms, including VRE
R. Endermann, C.H. Ladel, H. Broetz-Oesterhelt, H. Labischinski
Wuppertal, D
Objective: BAY 73-7388, a novel antibiotic compound from the
aminomethylcycline class, has an antibacterial spectrum encom-
passing Gram-positive, Gram-negative and anaerobic bacteria,






73-7388 AZI CIP LIN VAN DOX
Acute, systemic Spn,
IC (sus) (PD50)
0.09 2.21 >50 3.5 1.4 1.8
Acute, systemic Spn,
Neut (res) (PD50)
0.14 18.9 21.3 7.1 0.14 >50
Chronic Spn,IC (ED50) 7.4 5.15 >50 >40 >40 31.6
Chronic Hﬂu,IC (ED50) 4.7 31.6 1.0 NA NA 18.6
Acute, pulmonary Spn,
Neut (PD50)
11.0 7.5 31.6 >40 7.2 >50
Acute, pulmonary Spn,
Neut (res) (PD50)




BAY 73-7388 VAN LIN LVX
MRSA (n ¼ 39) 0.5 1.0 2.0 32.0
Efa VRE (n ¼ 19) 0.5 >64.0 2.0 >64.0
Ef (n ¼ 31) 0.5 2.0 2.0 32.0
Spn PENR (n ¼ 23) 0.06 0.25 1.0 1.0
BHS (n ¼ 48) 0.25 0.5 1.0 0.5
Ec (n ¼ 23) 2.0 NA NA 4.0
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efﬁcacy of BAY 73-7388 in four different mouse infection models
with pathogens causing intra-abdominal infections was compared
with that of vancomycin (VAN), linezolid (LIN), imipenem (IMI)
and metronidazole (MTN).
Methods: For systemic infections (sepsis), enterococci (tetracycline
(TET)-resistant Enterococcus faecalis or Enterococcus faecium VRE)
were administered intraperitoneally, and i.v. treatment was star-
ted 30 min post-infection; survival of the infected mice until day 5
was used as read-out. In the pouch model using Bacteroides fragilis
as infecting pathogen, therapeutic efﬁcacy of BAY 73-7388 com-
pared with MTN was determined as reduction of CFU. The
mouse model of caecal ligation was used as a model for polymi-
crobial peritonitis after surgical intervention and 10 days survival
used as read-out.
Results: In systemic infections with TET-resistant E. faecalis or
E. faecium VRE, efﬁcacy of BAY 73-7388 was superior to VAN
or LIN: 100% survival was observed at 1 mg/kg BAY 73-7388,
10 mg/kg VAN and 3 mg/kg LIN. For the E. faecium septicae-
mia model, 100% survival was found at 15 mg/kg BAY
73-7388, while neither VAN nor LIN treatment resulted in
100% survival, even at 50 mg/kg, the highest dose tested. In
the pouch model with B. fragilis, the CFU reduction caused by
BAY 73-7388 was superior to MTN (CFU reduction >6 log com-
pared with 4 log at 25 mg/kg, respectively). Therapy
(2  10 mg/kg i.v. on day 1) of intra-abdominal infections and
post-operative polymicrobial peritonitis with BAY 73-7388
showed increased survival compared with IMI or LIN (80 vs.
70 vs. 30%, respectively).
Conclusions: Against pathogens causing intra-abdominal infec-
tions (including VRE and TET-resistant strains), BAY 73-7388
demonstrated superior therapeutic efﬁcacy compared with
VAN, LIN, MTN or IMI. (BAY 73-7388 was discovered by
Paratek Pharmaceuticals, Inc., Boston, MA, and designated PTK
0796.)
P929 BAY 73-7388 demonstrates greater activity than
linezolid in a range of murine models of skin and soft tissue
infection
C.H. Ladel, R. Endermann, H. Broetz-Oesterhelt, H. Labischinski
Wuppertal, D
BAY 73-7388 is a novel antibiotic compound being developed for
the treatment of severe bacterial infections. It is the ﬁrst com-
pound selected from the novel class of aminomethylcyclines and
was designed to meet an increasingly signiﬁcant need for addi-
tional therapies for treatment of infections, including those resist-
ant to currently available antibiotics. The efﬁcacy of BAY 73-7388
in different mouse models of skin and soft tissue infection (SSTI)
was compared with that of vancomycin (VAN) and linezolid
(LIN).
Methods: Two mouse models were employed to determine the
efﬁcacy of BAY 73-7388: (1) infected abscess model (induced by
implantation and subsequent infection of Gelfoam (TM)) and (2)
infected thigh muscle model in neutropenic mice. Staphylococcus
aureus strain DSM11823 (MSSA) was used to infect the respective
structures in the skin and soft tissues. Infected abscess bearing
mice were treated i.v. bid for 2 days, while thigh muscle infection
model mice were treated s.c. 30 min post-infection. CFU reduction
of infected tissues and bacterial load in different organs (spread
from the infection site) were used as read-out for therapeutic efﬁc-
acy.
Results: As measured by reduction of bacterial load, therapy of
infected abscesses with BAY 73-7388 (CFU reduction >4 log units
at 10 mg/kg) was superior to VAN and LIN (no reduction in
bacterial load). Furthermore, BAY 73-7388 reduced the overall
bacterial load in spleen, liver, lung and heart. In the reduction of
organ load, BAY 73-7388 was as efﬁcacious as VAN or LIN. In the
mouse thigh muscle infection model, BAY 73-7388 proved to be
as least as effective as VAN (2 log CFU reduction) and superior to
LIN, which demonstrated no efﬁcacy at the same dose (0.5 log
CFU increase).
Conclusions: BAY 73-7388 was clearly more potent than LIN and
VAN in the infected abscess model, and more potent than
LIN and at least as effective as VAN in the thigh wound
model. (BAY 73-7388 was discovered by Paratek Pharmaceuti-
cals, Inc., Boston, MA, and designated PTK 0796.)
P930 Superior efﬁcacy of BAY 73-7388, a novel
aminomethylcycline, compared with linezolid and vancomycin
in murine sepsis caused by susceptible or multiresistant
staphylococci
H. Broetz-Oesterhelt, R. Endermann, C.H. Ladel, H. Labischinski
Wuppertal, D
Objective: BAY 73-7388 is the ﬁrst compound selected from the
novel class of aminomethylcyclines and was designed to meet an
increasingly signiﬁcant need for additional therapies for treatment
of bacterial infections, including those resistant to currently avail-
able antibiotics. The increasing frequency of multi-resistant sta-
phylococci is of particular concern in the clinical setting.
Therefore, the efﬁcacy of BAY 73-7388 was compared with that of
vancomycin (VAN) and linezolid (LIN) in different mouse models
of staphylococcal infection.
Methods: Murine sepsis was used to determine the efﬁcacy of
BAY 73-7388 compared with VAN and LIN. For systemic infec-
tions, Staphylococcus aureus MSSA/quinolone-resistant MRSA
and Staphylococcus epidermidis (MRSE, TET-resistant) were
administered intraperitoneally, and i.v. treatment was started
30 min post-infection. Survival of the infected mice was monit-
ored until day 5. For the investigation in immunocompromised
animals, mice were rendered neutropenic by two injections of
150 and 100 mg/kg cyclophosphamide at days 4 and 1 prior to
infection.
Results: In systemic infections with MSSA, BAY 73-7388 was more
effective than VAN or LIN resulting in 100% survival at 0.3 mg/
kg compared with 10 and 10 mg/kg, respectively. The efﬁcacy of
BAY 73-7388 therapy on systemic quinolone-resistant MRSA and
MRSE infection was also pronounced (100% survival for
quinolone-resistant MRSA at 3 mg/kg compared with >10 and
>10 mg/kg, respectively; 100% survival for MRSE at 1 mg/kg
compared with 10 and >10 mg/kg, respectively). Moreover, in
neutropenic mice, BAY 73-7388 was the only curative agent (100%
survival for BAY 73-7388 at 50 mg/kg). In contrast there was zero
survival in the VAN and the LIN groups at the highest dosage
tested, 50 mg/kg.
Conclusions: Treatment with BAY 73-7388 is highly effective in
systemic staphylococcal infections (susceptible and multi-resistant
strains) in mice, and is superior compared with LIN and
VAN. (BAY 73-7388 was discovered by Paratek Pharmaceuticals,
Inc., Boston, MA, and designated PTK 0796.)
P931 BAY 73-7388, a novel aminomethylcycline, is highly
active in vivo in a murine model of pneumococcal pneumonia
R. Endermann, C.H. Ladel, H. Broetz-Oesterhelt, H. Labischinski
Wuppertal, D
Objectives: BAY 73-7388 is the ﬁrst antibiotic compound from the
novel class, the aminomethylcyclines. BAY 73-7388 is being inves-
tigated for the treatment of severe bacterial infections including
those caused by strains resistant to current classes of antibiotics.
The efﬁcacy of BAY 73-7388 was compared with that of vancomy-
cin (VAN) and linezolid (LIN) in a mouse model of pneumococcal
pneumonia.
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Methods: For lung infections, Streptococcus pneumoniae (strain L3
TV, Serotype 3) was administered intranasally to 5 mice per
group, followed by i.v. antibiotic treatment bid over 2 days. The
bacterial counts in the lungs on day 4 were used as read-out. Sur-
vival was monitored until day 4 post-infection.
Results: (a) CFU: Bacterial CFU in the lung at day 4 were lower
with BAY 73-7388 and VAN in comparison with LIN therapy
(reduction in CFU >6 log units at 1 mg/kg BAY 73-7388 vs. no
reduction in CFU at the same doses of LIN). A 4.5 log unit CFU
reduction was only obtained at a 10 mg/kg dose of LIN. (b) Sur-
vival assays: For BAY 73-7388 and VAN all mice survived at the
three tested doses (1, 3 and 10 mg/kg). In contrast for LIN 0, 2,
and 4 animals survived when tested at the same dose range.
Conclusions: Treatment with BAY 73-7388 is highly effective in an
animal model of pneumococcal pneumonia. (BAY 73-7388 was
discovered by Paratek Pharmaceuticals, Inc., Boston, MA, and
designated PTK 0796.)
P932 Activity of dalbavancin against European clinical
isolates of Staphylococci and Streptococci
R. Flamm, D. Draghi, M. Jones, C. Thornsberry, J. Karlowsky,
D. Sahm
Herndon, USA
Objectives: Dalbavancin (DAL) is a semi-synthetic derivative of
the glycopeptide A40926 that has shown potent in vitro activity
against Staphylococcus aureus (SA) and coagulase-negative staphy-
lococci (CNS). DAL has a long half-life (9–12 days), which offers
promise for a convenient weekly dosing regimen. The current
study surveyed DAL activity against isolates from Europe and
provides a baseline to monitor the activity of DAL against com-
mon Gram-positive pathogens.
Methods: DAL and comparator agents were tested against 152
SA, 153 CNS, 99 S. pyogenes (SPY), 57 S. pneumoniae (SP) and 25 S.
agalactiae (SAG) by the NCCLS broth microdilution method. Clin-
ical isolates collected through 2003 from patients in Europe were
chosen to include phenotypes both susceptible (S) and resistant
(R) to clinically available antibiotics.
Results: The DAL MIC90 was 0.06 mg/L for all SA and
0.12 mg/L for all CNS. DAL had similar activity for both oxacillin
(OX) S (MIC90, 0.06 mg/L) and OX R (MIC90, 0.12 mg/L) SA and
CNS isolates. DAL MICs ranged from 0.25 to 0.5 mg/L against
four SA that had vancomycin (VAN) MICs 4 mg/L and
0.03 mg/L against one SA that was non-susceptible to linezolid.
Potent activity was demonstrated against 97 SA and 65 CNS
multi-drug resistant (MDR) isolates as deﬁned by resistance to 3
antimicrobial classes. The MIC90s (mg/L) for DAL against MDR
SA and CNS were 0.12 and 0.25, respectively and against
non-MDR SA and CNS were 0.06 for both. DAL had potent activ-
ity against streptococci with a MIC90 of 0.015 mg/L for all SPY
including erythromycin (ERY) R isolates, 0.03 mg/L for all SP
including penicillin (PEN) and ERY R isolates, and 0.015 mg/L
for all SAG. The MIC90s for DAL against both non-MDR (n ¼ 39)
and MDR (n ¼ 18) SP were 0.03 mg/L.
Conclusions: DAL showed potent in vitro activity against staphy-
lococci and streptococci including resistant and MDR pheno-
types. DAL, currently in Phase 3 clinical trials for use in
complicated and uncomplicated skin and skin structure infec-
tions, may serve as a potent therapeutic choice against Gram-
positive infections.
P933 In vitro antistaphylococcal and antistreptococcal
activity of dalbavancin, assessed by British & NCCLS methods
S. Mushtaq, M. Warner, D.M. Livermore
London, UK
Objectives: Dalbavancin is a new long-half-life (c. 10 days) glyco-
peptide, now in Phase III development. Its pharmacokinetics sup-
port weekly dosing, and may facilitate home i.v. therapy and/or
early hospital discharge. It was tested, in vitro, versus species that
are major agents of Gram-positive infections in neutropenic
patients and of endocarditis.
Methods: MICs were determined by the British Society for Anti-
microbial Chemotherapy (BSAC) and the National Committee for
Clinical Laboratory Standards (NCCLS) agar dilution methods for
92–94 isolates each of S. aureus, coagulase-negative staphylococci
(CNS) and viridans streptococci. The test panels over-represented
strains with resistance to conventional agents, including, for sta-
phylococci, teicoplanin.
Results: By BSAC methodology, the MIC ranges of dalbavancin
for S. aureus, CNS and viridans streptococci were 0.06–1, 0.12–1
and <0.03–0.5 mg/L, respectively, with unimodal distributions
and with mode values of 0.25, 0.25 and 0.12 mg/L, respectively.
Corresponding MIC ranges by NCCLS methodology were 0.016–
2, 0.06–1 and <0.03–0.5 mg/L, respectively, with modes of 0.25,
0.25 and 0.12 mg/L. In general, the MICs of dalbavancin by the
BSAC and NCCLS methods were identical, or else those by the
BSAC method were twofold lower than by the NCCLS method;
in either case the MICs for each study species mostly were 2- to
16-fold below those of vancomycin. Against teicoplanin-non-sus-
ceptible S. aureus strains (MIC 8–16 mg/L) dalbavancin was still
highly active although its MICs were slightly raised (0.5–2 mg/L,
varying with the particular strain and method). For CNS isolates,
dalbavancin MICs were tightly clustered and – as with vancomy-
cin – there was no consistent increase even for strains with
teicoplanin MICs of 16–64 mg/L. MICs of dalbavancin (and other
glycopeptides) were independent of those of non-glycopeptide
agents, including beta-lactams, gentamicin, rifampicin and
linezolid.
Conclusion: Dalbavancin has good activity versus the streptococ-
cal and staphylococcal species that are common agents of neu-
tropenic fevers and endocarditis. Full activity was retained
against teicoplanin-resistant CNS. MIC determination by the
BSAC and NCCLS agar dilution methods gave similar results,
though slightly lower MICs have been recorded elsewhere by
broth microdilution.
P934 Efﬁcacy and safety of once-weekly dalbavancin vs.
vancomycin in catheter-related bloodstream infections
E. Seltzer, M. Wible, B.P. Goldstein, M.B. Dorr, T.J. Henkel,
R. Darouiche, J. Vazquez, I. Raad
King of Prussia, Houston, Detroit, USA
Background: DAL is a novel semisynthetic glycopeptide in phase
3 clinical development, more active in vitro and in animal models
than vancomycin or teicoplanin. The PK and in vitro and in vivo
activity of DAL against Gram-positive bacteria, including most
drug resistant strains, predict that weekly dosing will be effective.
Objectives: To compare the safety and efﬁcacy of DAL vs. VAN
in patients (pts) with CRBSI.
Methods: Pts were required to have a central venous catheter at
the onset of signs and symptoms of CRBSI. Causative pathogens
required at least one positive peripheral blood culture for
S. aureus and at least two for other Gram-positive bacteria; coagu-
lase negative staphylococci (CoNS) were veriﬁed as identical path-
ogens by pulsed ﬁeld gel electrophoresis. Pts were randomised to
DAL 1 g IV on day 1, 500 mg IV on day 8 vs. VAN 1 g IV BID
for 7–14 days. A single dose of DAL or 7 days of VAN was
allowed in cases of CoNS CRBSI with catheter removal. Adverse
events (AEs) and lab safety were assessed. The primary endpoint
was overall [clinical and microbiological (micro)] response at fol-
low up (FU), 21 days after end of therapy, in the micro-ITT popu-
lation. The micro-ITT population included patients who had a
baseline causative pathogen and took at least one dose of study
drug.
Results: 67 pts were enrolled to receive DAL (33) or VAN (34).
The most common pathogen was CoNS (46%), followed by
S. aureus [39% (59% MRSA)] and Enterococcus sp. (14%). Out-
comes in the primary population (micro ITT) were: DAL was
well tolerated and the proportion of pts with AEs was similar
across study arms. The majority of AEs were reported as mild to
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moderate. There were no related serious AEs in the DAL treat-
ment group. Few deaths were reported in either arm DAL (n ¼ 1)
and VAN (n ¼ 2). There were no trends in any lab abnormalities.
Conclusion: Weekly dosing of DAL was highly effective in CRBSI
and superior to VAN. Overall, DAL was well tolerated. Further
studies evaluating DAL in BSIs are warranted.
P935 Once-weekly dalbavancin in catheter-related
bloodstream infections: microbiological ﬁndings
B.P. Goldstein, R.N. Jones, D.J. Biedenbach, E. Seltzer, M.B. Dorr,
D. Krause, T.J. Henkel
King of Prussia, North Liberty, USA
Objectives: Dalbavancin (DAL), a novel semisynthetic glycopep-
tide in Phase 3 clinical development, is more active than vanco-
mycin (VAN) or teicoplanin against Gram-positive bacteria,
including antibiotic-resistant strains, in vitro and in animal mod-
els. The PK and activity of DAL predict that weekly dosing will
be effective. The main objective of this Phase 2 randomised, con-
trolled study was to compare the efﬁcacy of DAL vs. VAN in
patients (pt) with catheter-related bloodstream infections (CRBSI).
Methods: Pt had at least 1 central venous catheter and a positive
peripheral blood culture for S. aureus or at least two cultures for
other Gram-positive bacteria. Isolates were sent to a reference
laboratory (RL) for deﬁnitive identiﬁcation and MIC determina-
tions. Duplicate isolates of coagulase negative staphylococci
(CoNS) were veriﬁed as identical by pulsed ﬁeld gel electrophor-
esis (PFGE). Treatment arms were: DAL 1 g IV on day 1 and
500 mg on day 8; VAN IV for 7–14 days.
Results: Among 67 pt enrolled (DAL 33, VAN 34) the most com-
mon baseline pathogens (BLP) were PFGE-conﬁrmed CoNS
(46%), S. aureus (39%) and Enterococcus sp. (14%). Of 54 BLP sent
to the RL, 63% of S. aureus and 85% of CoNS were methicillin-
resistant (MR) (Table). Per pathogen microbiological success rates
in the microbiological ITT population at follow up were 92%
(DAL) and 79% (VAN). DAL and VAN MICs are in the Table.
Conclusion: DAL had a higher response rate than VAN. As expec-
ted for CRBSI, CoNS were the predominant BLP and the majority
of staphylococci were MR. DAL MICs were tightly clustered and
lower than those of VAN, as previously observed in the in vitro
surveys and in another clinical trial.
P936 Evaluations of dalbavancin activity and spectrum
tested against European isolates
R. Jones, T. Fritsche, H. Sader
North Liberty, USA
Background: Ongoing development of novel resistances (R) and
the increased frequency of currently characterised R requires the
search for alternative antimicrobials. DAL (formerly BI397)) is an
amide glycopeptide derivative of A40926 in late stage clinical
development with an extended elimination half-life enabling once
weekly dosing. A large collection of clinical strains were tested to
establish DAL spectrum and potency against European isolates.
Methods: DAL and over 20 comparators were tested against 2881
recent (year 2002) clinical isolates from Europe using NCCLS
(M7-A6) susceptibility (S) testing methods. The characteristics of
this collection were: oxacillin (OXA)-R S. aureus ¼ 31.1% and
CoNS ¼ 79.0%; VRE ¼ 2.6–8.8% and penicillin (PEN)-non-sus-
ceptible pneumococci ¼ 27.6%. Some fastidious Gram-negative
species, H. inﬂuenzae (HI; 725), M. catarrhalis (MCAT; 238) were
also tested.
Results: Species distribution and MIC data for highly represented
Gram-positive species. OXA-, PEN- or macrolide-R had no effect
on DAL potency among staphylococci or streptococci. DAL results
for VRE were most similar to the teicoplanin-S rates overall (act-
ive against VanB strains). Twenty-four tested strains (Bacillus spp.,
Corynebacterium spp., L. monocytogenes, Micrococcus spp., S. bovis)
not cited in the Table had a combined DAL MIC90 of 0.12 mg/L;
highest MIC at 0.25 mg/L. DAL MICs were lower than those of
available glycopeptides by 4- to >16-fold. DAL also had some
activity against fastidious Gram-negative species, but MICs were
higher (HI MIC90 at 32 mg/L and MCAT MIC90 4 mg/L).
Conclusions: This DAL activity survey indicates that this new gly-
copeptide has signiﬁcant Gram-positive activity (96.9–100.0%
inhibited at 	1 mg/L), superior to available agents in the class,
and the potency was similar for European isolates when com-
pared with prior experience in other geographic areas.
P937 In vitro activity of the glycylcycline tigecycline tested
against a worldwide collection of 10 127 contemporary
Staphylococci, Streptococci and Enterococci
T. Fritsche, H. Sader, J. Kirby, R. Jones
North Liberty, USA
Background: Tigecycline (TIG) is a novel glycylcycline with broad
spectrum activity. Increasing reports of resistance (R) among com-
monly occurring Gram-positive cocci (GPC) that produce respirat-
ory tract and skin and soft tissue infections has created a need for
development of new antimicrobial agents. In this study the activ-
ity and potency of TIG, tetracycline (TC) and other comparator
agents was evaluated using contemporary isolates of commonly





50% 90% Range % 1 mg/L
S. aureus (599) 0.06 0.06 0.015–0.25 100.0
Coag-neg staphylococci(247) 0.03 0.06 0.015–0.25 100.0
Enterococci(195) 0.03 0.06 0.015–>32 96.9
S. pneumoniae(726) 0.015 0.03 0.015–0.25 100.0
b-Streptococci(67) 0.015 0.03 0.015–0.12 100.0
Viridans group
streptococci(65)
0.015 0.03 0.015–0.06 100.0








Clinical 87 (20/23) 50(14/28)
Micro 96(22/23) 79 (22/28)





DAL arm VAN arm DAL VAN
CoNS 14 (11)* 13 (12) 0.03–0.25 0.25-1
S. aureus 8 (4) 11 (8) 0.03–0.12 0.5-2
E. faecalis 4 4 0.06 0.5–2
*In parenthesis for staphylococci, no. MRSA.
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Methods: The activity of TIG and nine comparators was chal-
lenged with a collection of GPC including oxacillin (OXA)-sus-
ceptible (S; 3196 strains) and -R (1881 strains) S. aureus (SA);
OXA-S (321 strains) and -R (1111 strains) coagulase-negative sta-
phylococci (CoNS); penicillin (PEN)-S (1126 strains) and non-sus-
ceptible (NS; 459 strains) S. pneumoniae (SPN); penicillin-S (161
strains) and -NS (51 strains) viridans-group streptococci (VGS);
beta-haemolytic streptococci (BHS; 405 strains); and vancomycin-S
(1294 strains) and -R (122 strains) enterococci (ENT). Broth micro-
dilution susceptibility tests were performed and analysed using
NCCLs reference methods and interpretive criteria.
Results: Whereas OXA-R subsets of both SA and CoNS displayed
cross-resistance to TC, macrolides, clindamycin and quinolones,
no differences were seen with TIG (MIC50/90 being 0.25 and
0.5 mg/L, respectively). Among streptococci, all SPN and VGS
(regardless of PEN-S), and BHS demonstrated TIG MIC50/90s of
	0.12 mg/L (one exception being PEN-intermediate VGS with the
MIC90 at 0.25 mg/L). TIG was also uniformly active against
enterococcal isolates, with MIC50/90s of vancomycin-S and -R
subsets being 0.25 and 0.5 mg/L, and 0.12 and 0.25 mg/L,
respectively. When using the NCCLS TC S breakpoint of
	4 mg/L, all 10 127 staphylococci, streptococci and enterococci
tested would be classiﬁed as S to TIG.
Conclusions: TIG displays a remarkable spectrum of activity and
potency against S and R subsets of GPC with the highest MIC90
being 0.5 mg/L. In addition to for use in treating community-
acquired respiratory tract infections, TIG may also be a candidate
for treatment of complicated skin and soft tissue infections and,
possibly, urinary tract infections caused by GPC.
P938 Endemic, highly resistant Acinetobacter in the
intensive care unit – is tigecycline the answer?
P. Wilson
London, UK
Objective: To ﬁnd satisfactory antibiotic treatment against an
organism, Acinetobacter baumanii, that became endemic on the
intensive care unit of a busy District General Hospital. This organ-
ism is resistant to many antibiotics and in one case was ultimately
resistant to all currently marketed antibiotics.
Methods: (1) Surveillance of patients in the intensive care unit for
the presence of Acinetobacter baumanii. (2) Clinical assessment of
patients with the organism to establish those needing antibiotic
therapy. (3) Patients requiring treatment were given an antibiotic
combination using colistin (usually combined with oral minocy-
cline) or tigecycline monotherapy, a ﬁrst-in-class glycylcycline
agent. (4) Treatment and outcome were monitored. The study was
observational. Allocation to treatment categories was not random-
ised or blinded. The tigecycline was used on a compassionate basis.
Results: The intensive care unit was free of Acinetobacter until the
beginning of 2001. By the end of 2001, 5–10 new isolates of Acine-
tobacter baumanii were isolated per quarter. Initially these patho-
gens were sensitive to imipenem, meropenem, tobramycin,
amikacin, colistin, and minocycline. This sensitivity began to wane
and, by the end of 2002, one patient had died with Acinetobacter
baumanii in his bloodstream that was resistant to everything avail-
able. After this death, we tested further isolates of Acinetobacter
against tigecycline, a new broad spectrum agent currently in
Phase 3 development, and found it to be active against the ende-
mic strain. Two patients with ventilator-associated pneumonia
caused by this organism were treated with tigecycline and made a
full recovery. There were no adverse effects related to tigecycline
treatment. Conversely, ﬁve patients with ventilator-associated
pneumonias caused by the same organism were treated with col-
istin and failed to respond. Acinetobacter ﬁnds the respiratory sys-
tem a favourable environment, and this, combined with the fact
that the vast majority of the patients were ventilated resulted in
ventilator-associated pneumonia being the commonest infection.
Conclusion: Tigecycline is likely to be a useful agent in clinical
practice on intensive care units when dealing with this difﬁcult
organism. Further evaluation is warranted. It may well be the
antibiotic of choice.
P939 Antimicrobial activity of tigecycline (GAR-936) tested
against enterobacteriaceae, and selected non-fermentative
Gram-negative bacilli, a worldwide sample
R. Jones, T. Fritsche, H. Sader, M. Beach
North Liberty, USA
Background: As resistances (R) among Gram-negative bacilli
(GNBs) expand, few antimicrobial agents have been developed to
address this clinical problem. Tigecycline (TIG), a novel glycylcy-
cline, has an expanded spectrum of activity and potency, tigecy-
cline covers many routine Gram-negative resistant strains and
additionally possesses activity versus some uncommonly isolated
non-fermentative GNBs. This study compares TIG with contem-
porary broad-spectrum agents using recent clinical isolates from
Europe and other continents.
Methods: All strains (2420) were centrally processed by reference,
broth microdilution methods against more than 20 antimicrobials.
All concurrent QC results were within NCCLS published ranges,
with identiﬁcations performed by traditional methods and/or the
Vitek System. Over 2400 isolates were tested from the Enterobac-
teriaceae (ENT) and non-fermentative GNBs categories. Suscepti-
bility (S) for TIG was deﬁned as 	4 mg/L, that breakpoint used
for all tetracyclines by the NCCLS.
Results: The ENT were divided into three groups for analysis:
ESBL-producing isolates (154 strains), Proteae group (131 strains;
includes P. mirabilis and indole-positive species) and all enteric
bacilli. TIG was very active against all ESBL-producing isolates
(MIC90, 0.25–2 mg/L; highest among TC-R subsets), and all ENT
(MIC50/90, 0.25/1 mg/L). Proteae had a MIC90 at 4 mg/L and
all but one of TIG-R or intermediate strains (MICs, 8 and
16 mg/L) were M. morganii or P. mirabilis. P. aeruginosa was mar-
ginally inhibited by TIG (MIC90, 32 mg/L). In contrast, Acinetob-
acter spp. (MIC90, 2 mg/L; 96.1% S) and S. maltophilia (MIC90,
2 mg/L; 100.0% S) were readily inhibited by TIG. Among all ENT
studied, 31.0% were TC-R, but only one strain (P. mirabilis) was
TIG-R (MIC at 16 mg/L).
Conclusions: Remarkable potency and breadth of spectrum was
observed for TIG against ENT (99.4% at 	4 mg/L vs. 66.8% for
TC), S. maltophilia and Acinetobacter spp. Limited activity was
noted versus P. aeruginosa (16.0% at 	4 mg/L) and some Proteae
(MIC90, 4 mg/L). TIG should be of value for the treatment of
infections caused by several commonly R GNB groups.
P940 Activity of tigecycline tested against clinical isolates
of Haemophilus inﬂuenzae, Moraxella catarrhalis and Neisseria
menigitidis, a worldwide perspective
H. Sader, T. Fritsche, J. Kirby, R. Jones
North Liberty, USA
Background: Tigecycline (TIG, formerly GAR-936), is a novel gly-
cylcycline which is currently in phase 3 clinical trials. The in vitro
activity of the TIG was evaluated in comparison with tetracycline
(TET) and other antimicrobial agents against recent (2000–2002)
clinical isolates collected worldwide from patients with respirat-
ory infections and meningitis.
Methods: A total of 1727 isolates were tested against TIG and
more than 20 comparator agents by broth microdilution according
to the NCCLS reference methods and interpretative criteria. The
collection included, H. inﬂuenzae (HI; 1215 strains, 20% beta-
lactamase-producing), M. catarrhalis (MCAT; 495 strains, 96%
beta-lactamase-producing), and N. meningitidis (NM; 17 strains).
Results: TIG demonstrated excellent activity against these organ-
isms with all isolates being inhibited at 	4 mg/L (TET suscepti-
bility breakpoint). TIG was highly active against HI (MIC90,
1 mg/L) and MCAT (MIC90, 0.25 mg/L), and its potency against
these pathogens was not affected by beta-lactamase production.
TIG was fourfold more potent than TET against HI and TET-
resistant isolates showed low (	1 mg/L) TIG MICs. NM isolates
were highly susceptible to TIG (MIC90, 	0.12 mg/L) and to the
vast majority of antimicrobial agents evaluated.
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Conclusions: These results indicate that tigecycline has potent in
vitro activity against clinically important Gram-negative bacteria
that cause community-acquired respiratory infections and menin-
gitis, including TET-R isolates. Further evaluations of TIG activity,
as well as, clinical studies are necessary to assess the role of this
compound in the treatment of both community- and hospital-
acquired infections.
Molecular bacteriology: antibiotic susceptibility
P941 DNA microarray technology for detection of
beta-lactamase genes in pathogenic bacteria
M.M. D’Andrea, M. Cassone, T. Giani, G. Coratza, G. Pozzi,
G.M. Rossolini
Siena, I
Background and objectives: Beta-lactamase production is the major
mechanism of bacterial resistance to beta-lactam antibiotics in
Gram-negative pathogens, and surveillance of beta-lactamase
determinants is an important issue of microbial drug resistance.
Given the great diversity of beta-lactamases and their overlapping
substrate speciﬁcities, molecular analysis is necessary to identify
the nature of beta-lactamase genes in clinical isolates. In this work
we investigated the potential of the DNA microarray technology
for a rapid and comprehensive detection of beta-lactamase genes
in drug-resistant bacteria.
Methods: A total of 104 oligonucleotide probes were designed for
speciﬁc recognition of beta-lactamase genes of 65 different line-
ages (18 of molecular class A, 19 of class B, 13 of class C and 15
of class D). A DNA chip was designed including a triplicate set of
probes, as well as positive hybridisation controls. The microarray
was printed on epoxy-modiﬁed glass slides using an Affymetrix
GMS 417 robotic spotter. Genomic DNA was labelled with Cy3 or
Cy5 by random priming. Hybridisation signals were then detected
using an Affymetrix 418 laser scanner and images were analysed
by the GenePix Pro (version 5.0) software.
Results: The DNA chip was tested with 23 Gram-negative
strains (including both reference strains and clinical isolates) in
which the repertoire of beta-lactamase genes was partially
known or unknown. All the predicted beta-lactamase genes
(among which there were members of the blaTEM, blaSHV,
blaCTX-M, blaPER, blaVIM, blaIMP, blaCMY-LAT groups of
acquired genes) were correctly detected by microarray hybridi-
sation. In clinical isolates of unknown beta-lactamase content,
the microarray detected genes whose presence was subsequently
conﬁrmed by conventional PCR assays. False-positives were
observed with a subset of probes, which had to be redesigned
to overcome the problem.
Conclusions: Successful detection of several different beta-lacta-
mase genes of clinical importance was achieved by using a DNA
microchip. The DNA microarray technology appears to be a sensi-
tive and speciﬁc tool for rapid detection and characterisation of
beta-lactamase genes in clinical isolates.
Acknowledgement: This work was funded in part by grants from
the University of Siena (P.A.R. 2001), and MURST (COFIN 2003).
P942 Multiplex PCR detection of CTX-M type gene
C.J. Munday, V.M. Ensor, W.E. Liu, P.M. Hawkey
Birmingham, UK
Objective: The CTX-M family of Extended Spectrum beta-lacta-
mase (ESBL) can be divided into four groups of enzymes based
on amino acid homology, CTX-M-1, CTX-M-2, CTX-M-8 and CTX-
M-9. The molecular detection of genes from each of these CTX-M
groups has previously relied on the use of multiple PCR reactions
due to nucleic acid heterogeneity between groups, and previous
publications have been fraught with inaccuracies or incomplete
CTX-M group detection. We aimed to design a multiplex PCR for
the detection and subsequent sequencing of blaCTX-M from all
family groups found in Enterobacteriaceae spp.
Methods: Primers were designed based on a central homologous
region found in all blaCTX-M and the upstream (ﬁve primers)
and downstream (four primers) consensus regions of each respect-
ive CTX-M group giving a universal forward or reverse primer
and further primers correlating to each CTX-M group. PCR reac-
tions were conducted in 25 lL reaction volume containing equal
amounts (25 pM) of each primer, suitable for screening to a range
of known CTX-M producing Enterobacteriaceae spp.
Results: Previously characterised isolates producing blaCTX-M
were included for PCR. This included isolates of K. pneumoniae
producing CTX-M-26 and E. coli producing one of CTX-M-3, CTX-
M-9, CTX-M-14 or CTX-M-15. After multiplex PCR, for the
upstream region (c. 300 bp) and downstream region (c. 650 bp)
products of the indicted sizes were found for all isolates. Further-
more, this method was used to characterise ESBL producing clin-
ical isolates of E. coli and K. pneumoniae to detect the presence of
CTX-M genes, with subsequent sequencing conﬁrming the pres-
ence of CTX-M-15.
Conclusion: We have designed a multiplex PCR for the detection
of CTX-M type genes using a single reaction tube allowing the
screening of ESBL producing isolates for blaCTX-M genes and
their direct DNA sequencing, without the need for multiple PCR
reactions. Recent data from the UK shows that CTX-M ESBLs are
rapidly increasing in importance.
P943 Differentiation of Citrobacter koseri and Citrobacter
amalonaticus isolates using beta-lactamase gene sequences
M. Avison, S. Underwood
Bristol, UK
Objectives: Some members of the genus Citrobacter are potential
pathogens of debilitated hospital patients. They can become resist-
ant to beta-lactamases, including third generation cephalosporins
due to over-expression of a chromosomal beta-lactamase. Eleven
species are currently known, but speciation is often difﬁcult using
biochemical tests. Isolates previously typed as Citrobacter diversus
are now known as Citrobacter koseri. Here we measured sequence
variation at the beta-lactamase structural gene amongst a group of
clinical isolates, originally identiﬁed as C. diversus by API 20E pro-
ﬁling.
Methods: Nine C. diversus isolates were collected from faecal sam-
ples of children being treated in the oncology department of Bris-
tol Children’s hospital in the early 1980s. Beta-lactamase and 16S
rRNA genes were ampliﬁed by PCR and sequenced by standard
methods. Beta-lactamase induction was attempted in liquid-grown
cultures using cefoxitin (10 mg/L for 2 h). Nitroceﬁn hydrolysis
assays were performed using a spectrophotometer.
Results: Analysis of 16S rRNA gene sequences conﬁrm that, of
the nine clinical isolates, Five, which all have an inducible beta-
lactamase gene whose sequence is closely related to C. diversus
NF85 and ULA27, are actually Citrobacter amalonaticus. Given that
C. diversus isolates have all been renamed C. koseri, this error in
nomenclature must be addressed. The reason for the error is that
C. diversus was known to have variability in its ability to utilise
malonate, the only differentiation between C. koseri and
C. diversus. Four of the test isolates do type as C. koseri using 16S
rRNA sequencing. These true C. koseri isolates produce a novel,
acidic, class A beta-lactamase, named CkoA, constitutively. The
sequence of this beta lactamase gene was determined, and is only
40% identical to the C. diversus (now C. amalonaticus cdiA).
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Conclusions: We present a new beta-lactamase sequence, from C.
koseri and shows that C. koseri NF85 and ULA27 should be
retyped as C. amalonaticus. Beta-lactamase-speciﬁc PCR may pro-
vide a valuable tool for typing Citrobacter spp. isolates, and is very
suitable for separating C. amalonaticus and C. koseri, which are
very closely related biochemically. The knowledge that clinical C.
koseri isolates produce a beta-lactamase constitutively at low levels
may be useful clinically.
P944 A single-tube PCR with MGB Eclipse probes for
detection of SHV-type extended-spectrum beta-lactamases
(ESBLs)
A. Ekimov, M. Edelstein, E. Belousov
Smolensk, RUS; Bothell, USA
Objectives: ESBLs of the SHV-type are one of the most common
and clinically signiﬁcant beta-lactamases. The number of SHV var-
iants is continuously growing; however ESBL activity of SHV
enzymes has been associated with mutations at relatively few
amino acid positions (aa-s) as compared with the TEM enzymes.
Here we propose a simple and rapid method that allows detection
of all the known SHV ESBLs in a single real-time PCR reaction.
Methods: The proposed method is based on ampliﬁcation of
blaSHV genes in the presence of short (13–14 nt) ﬂuorogenic
probes capable of hybridisation-triggered ﬂuorescence. These
probes commercially known as MGB Eclipse probes contain a dark
quencher with a conjugated minor groove binder at the 5¢-end and
a ﬂuorescent dye at the 30-end. This structure allows detection and
differentiation of nucleotide polymorphisms at targeted sites by
post-PCR melting curve analysis. Four probes were designed to
perfectly match the wild-type (WT) sequences at mutation sites
corresponding to aa-s 146, 149, 156, 179 and 238. Thus, mutations
conferring ESBL activity were expected to speciﬁcally lower the
melting temperatures (Tm-s) of the probe-template duplexes. Each
probe was labelled with a unique dye permitting analysis of muta-
tions at multiple sites in a single reaction.
Results: The method was validated using laboratory strains pro-
ducing the SHV-1 (WT, non-ESBL control), SHV-2, 3, 4, 5 (G238S),
SHV-18 (G238A), SHV-6 (D179A), SHV-8 (D179N) and strains car-
rying cloned blaSHV fragments to which the naturally occurring
mutations D179G, G156D, T149S and A146V were introduced by
site-directed mutagenesis. Following careful design of the probes
and optimisation of PCR conditions, all the above mutations were
successfully detected and discriminated from the WT sequence
and each other according to speciﬁc Tm-s. The detection was pre-
cise and highly reproducible in repeated experiments. Further-
more, when applied to the analysis of 10 clinical isolates of
Klebsiella pneumoniae expressing ESBL phenotype, the method was
able to detect multiple SHV alleles (WT and G238S or D179A) in
the same isolates. This observation is particularly important con-
sidering the high frequency of co-production of the SHV-1 and
ESBLs in klebsiellae.
Conclusions: A PCR with MGB Eclipse probes has a great poten-
tial for studying the epidemiology of SHV ESBLs and possibly for
analysis of other antimicrobial resistance mechanisms associated
with mutations at deﬁned loci.
P945 Evaluation of gentamicin disk diffusion method for
detecting high-level Gentamicin-resistant Enterococci by
comparison with a polymerase chain reaction technique detecting
the aac(6¢)-Ie-aph(2¢¢)-Ia aminoglycoside modifying gene
B. Saeedi, A. Ha¨llgren, B. Isaksson, J. Jonasson, L.E. Nilsson,
H. Hanberger
Linko¨ping, S
Objectives: To evaluate the efﬁciency of a gentamicin disk diffu-
sion method for detection of high-level gentamicin resistance
(HLGR) in clinical isolates of enterococci by comparison with a
polymerase chain reaction (PCR) technique detecting the aac(6¢)-
Ie-aph(2¢¢)-Ia aminoglycoside modifying gene.
Methods: A total of 356 non-repeat enterococcal blood isolates
(250 E. faecalis and 106 E. faecium) were collected during 1994 to
2001 from hospitals located in south east of Sweden. The bacterial
isolates were identiﬁed by standard microbiological methods and
susceptibility testing was performed with a 30-lg gentamicin disk
on PDM-agar (AB Biodisk) to detect HLGR isolates. All isolates
were tested for the presence of the aac(6¢)Ie-aph(2¢¢)Ia gene using
the polymerase chain reaction (PCR) technique.
Results: There was complete correlation between the gentamicin
disk diffusion test and the PCR results. All 40 HLGR isolates, as
deﬁned by disk diffusion, and the positive control (E. faecalis
ATCC 51299) carried the aac(6¢)Ie-aph(2¢¢)Ia gene as judged from
the PCR results. The resistant gene was not found in the negative
control ATCC 29212 or any of the 316 non-HLGR enterococci.
Conclusion: This study shows that in our setting the sensitivity
and speciﬁcity of the disk diffusion method for the detection of
HLGR enterococci is very high and there is a total agreement with
the results obtained by using a PCR technique for detection of the
aac(6¢)Ie-aph(2¢¢)Ia aminoglycoside modifying gene.
P946 Identiﬁcation of Enterococcus spp. of the human
normal microbiota by pyrosequencing
M. Lindgren, P. Huovinen, C. Edlund, J. Jalava
Turku, FIN; Stockholm, S
Objectives: The main objective was to develop a pyrosequencing
method for identiﬁcation of Enterococcus spp. species with Pyro-
sequencing method. Also, development of antibiotic resistance
with special reference to macrolide resistance will be studied by
susceptibility testing in samples isolated serially from subject
exposed to clindamycin.
Methods: Biochemical identiﬁcation of the enterococcal strains
from faecal samples was done by growth at 45C, catalase and
hydrolyse of 1-pyrridonyl-beta-naphtylamide (PYR). Species iden-
tiﬁcation was done with Pyrosequencing method. PSQ 96MA
pyrosequencing technique enabled identiﬁcation of different
Enterococcus species based on their 16S rRNA V2-regions signa-
ture-sequences. Antibiotic susceptibility testing was done by agar
dilution method on Mu¨ller–Hinton II medium, according to
NCCLS. MIC values were tested against erythromycin, clindamy-
cin, ciproﬂoxacin, ampicillin, gentamicin, vancomycin and tetra-
cycline. Macrolide resistance genes; erm(B), erm(TR) and mef(A)
was studied by Multiplex-PCR.
Results: With Pyrosequencing method, we identiﬁed 46 Enterococ-
cus faecium, 22 E. faecalis, 11 E. avium and 33 E. casseliﬂavus species,
and 54 non-enterococci species. The antibiotic susceptibility test-
ing showed that 26.5% of the Enterococcus strains were resistant to
erythromycin, 14.8% to ciproﬂoxacin and 17.4% to tetracycline.
About 31.6% of the Enterococcae had erm(B)-gene.
Conclusion: Pyrosequencing was rapid and easy method for iden-
tiﬁcation of bacterial strains even to the species level. Antibiotic
resistance varied a lot between different bacterial strains, as
E. faecium and E. casseliﬂavus species being the most resistant ones.
Pyrosequencing results correlated well with species phenotype
and antibiotic resistance.
P947 Detection of resistance genes of vancomycin-resistant
enterococci by sandwich hybridisation method
V. Skandami, A. Tsiringa, A. Xanthaki, M. Toutouza,
C. Kontou-Castellanou
Athens, GR
Objectives: To determine the species distribution of vancomycin
resistant enterococci (VRE) isolated from hospitalised patients and
detect genes encoding resistance to vancomycin and teicoplanin,
by sandwich hybridisation method.
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Methods: The study was performed on 57 strains of enterococci
all from patients with severe underlying diseases. Strains were
isolated from urine (37.9%), blood cultures (18.9%), pus (5.4%),
peritoneal ﬂuid (5.4%), intravenous catheter (21.6%), infection of
the drainage site (10.8%). Identiﬁcation to the species level was
performed by VITEK 2 (Bio-Merieux, France). Antibiotic suscepti-
bility testing was done by Kirby-Bauer and MIC by E-test and
VITEK 2. The sandwich hybridisation method was performed in
all strains using the commercially available EVIGENETM VRE
Detection kit (Statens Serum Institute), for the presence of vanA
and vanB genes.
Results: From the stains tested, 37 were vancomycin and teicopla-
nin resistant (vanA phenotype) and 20 susceptible to these antibi-
otics, as determined by Kirby–Bauer and MICs by VITEK 2 and
E-test methods. Of them, 10 were E. faecalis, 22 E. faecium, three
E. casseliﬂavus and two E. hirae. All the VREs strains, which were
suggesting the presence of vanA phenotype by Kirby–Bauer and
MIC, were identiﬁed to be vanA positive by the sandwich hybridi-
sation method. The 20 susceptible strains were negative for the
detection of the genes vanA and vanB.
Conclusions: Identiﬁcation of VRE to the species level and know-
ledge of the type and the proﬁle of resistance is critical for infec-
tion control purposes in the hospital environment. The sandwich
hybridisation is a rapid (3.5 h) and easy to use commercially
available molecular method to detect the vanA and vanB genes,
while the phenotypic resistance determination requires incubation
for at least 24 h and other molecular methods require speciﬁc
instruments and experienced technicians. The sensitivity and
speciﬁcity of the method is 100%.
P948 Evaluation of the EvigeneTM VRE detection kit for
detecting of enterococci including vancomycin resistance genes
A. Kilic, M. Baysallar, G. Bahar, A. Kucukkaraaslan, L. Doganci
Ankara, TR
Objectives: Evaluating the correlation of the EVIGENETM VRE
Detection kit using PCR, which is the golden standard for gene
detection and correlating the minimum inhibitory concentration
(MIC) for vancomycin and teicoplanin are the aim of this study.
Methods: The vancomycin-resistant enterococci (VRE) Detection
Kit is based on microwell plates where to DNA probes speciﬁc
for the bacterial targets DNA are bound. Test wells include: a pos-
itive (16S rRNA) and a negative control, a vanA microwell and a
vanB microwell. The PCR detects the vanA, vanB, and vanC-2
genes. The MIC determination was performed by E-test according
to the NCCLS guidelines.
Results: We tested a total of 64 diverse vancomycin resistant
enterococci: Enterococcus casseliﬂavus (n ¼ 50) and Enterococcus fae-
cium (n ¼ 14). All strains were vanA positive (OD: all strains
>1.192). All results obtained with the VRE kit were conﬁrmed by
the PCR. The MIC determination correlated with the PCR and kit
results for all vanA positive strains with high MIC for vancomycin.
Conclusion: As a result, the EVIGENE VRE Detection Kit can
clearly distinguish VRE with the vanA and vanB genotypes among
a large collection of enterococci and with the same speciﬁcity as
PCR.
P949 Development of antibiotic resistance in
enterobacteria
S.D. Nyberg, A. Hakanen, M. O¨sterblad, P. Huovinen, C. Edlund,
J. Jalava
Turku, FIN; Stockholm, S
Objectives: The main objective is to get a better knowledge of the
human microﬂora in gastro-intestinal organ by following varia-
tions among intestinal enterobacteria in four healthy subjects
receiving oral clindamycin. The microﬂora in the chosen subjects
will be monitored for a 2-year period. The presence and stability
of speciﬁc resistance genes will be studied in samples collected
serially from selected antibiotic exposed subjects. blaTEM and
blaSHV that code for an extended spectrum beta-lactamase in En-
terobacteriaceae will be studied. The study will be done by using
identiﬁcation, susceptibility testing, PCR and molecular ﬁnger-
printing methods.
Methods: Serially collected faecal samples from four healthy sub-
jects who had received clindamycin perorally for 7 days were cul-
tured and screened for Enterobacteriaceae. Sampling was
performed pretreatment, day 7, 3 weeks, 3, 6, 9, 12 and 18 months
after clindamycin administration. Between 20 and 50 colonies of
suspected Enterobacteriaceae were picked from each sample. Bio-
chemical identiﬁcation of the bacterial isolates was done by oxid-
ase, indole production and activity of beta-glucoronidase. MICs
were determined according to NCCLS by standard agar dilution
method on Mu¨ller–Hinton II medium. The following antimicrobi-
als were tested: ampicillin, cephalothin, cefuroxime, piperacillin/
tazobactam, amoxicillin–clavulanic acid, ceftazidime, cefotaxime,
imipenem, aztreonam, gentamicin, streptomycin, chloramphenicol,
tetracycline, nalidixic acid, trimethoprim, sulfamethoxazole and
ciproﬂoxacin.
Results: A total of 521 isolates were identiﬁed as oxidase negative,
Gram-negative rods and thus belonged to the Enterobacteriaceae.
The isolates were then screened for indole and betaglucoronidase
activity. These results showed that 81% of all strains were E. coli.
Of all strains, 60% were resistant to ampicillin, 46% against sulfa-
methoxazole, 11.9% against cephalothin and 7.7% against nali-
dixic acid. The variation of antibiotic resistance between subjects
is broad.
Conclusion: Enterobacteriaceae are naturally resistant to clindamy-
cin. However, after clindamycin treatment alterations in the sus-
ceptibility to other antimicrobial agents still occur in the
microﬂora. Additional research needs to be done to clarify if these
alterations in antibiotic resistance are caused by variation of
strains/species or exchange of resistant elements.
P950 Prevalence and implication of the cﬁA and cphA
genes in imipenem resistance among Bacteroides spp.
M. Theron, M.N. Janse van Rensburg, C. Roussouw
Bloemfontein, ZA
Objectives: Bacteroides is a major cause of intra-abdominal and
female genital tract infections as well as subcutaneous abscesses.
Beta-lactam agents and carbapenems are currently used in mono-
therapy against anaerobic infections. The study was done to: (1)
investigate the susceptibility of Bacteroides strains isolated from
Bloemfontein Academic Hospitals; (2) compare results with a pre-
vious study; (3) determine the prevalence of carbapenemases/
metallo-beta-lactamases in Bacteroides spp.
Methods: Fifty-one Bacteroides spp. strains were isolated from
patients in the Universitas and Pelonomi Hospitals in Bloemfon-
tein. MICs of 12 antimicrobial agents were determined by the
NCCLS agar dilution method. A bioassay was used to screen for
carbapenemase or metallo-beta-lactamase production. PCR ampli-
ﬁcation was performed for the detection of cﬁA and cphA genes.
Plasmids were extracted using a High Pure Plasmid Isolation Kit.
Results: Susceptibility levels were relatively high for imipenem
(95%), meropenem (90%) and metronidazole (88%). Comparing
the results with a previous study (isolates from 1996/1997), showed
a reduction in susceptibility to imipenem (100–95%), meropenem
(100–90%) and metronidazole (100–88%). The bioassay results gave
no indication of the presence of signiﬁcant concentrations of a car-
bapenemase or metallo-beta-lactamase. PCR ampliﬁcation showed
the cﬁA gene (747 bp) in 4/18 strains (imipenem MIC 1 to
>128 lg/mL) and the cphA gene (769 bp) in 3/18 of the isolates
(imipenem MIC 1–4 lg/mL). No plasmids were detected.
Conclusions: Although >90% of the isolates were susceptible to
the carbapenems, it is evident that resistance has increased over
the last decade. Fortunately the production of metallo-beta-lacta-
mases has been found to give rise to MICs that only range from 2
to 4 lg/mL. This study supports these ﬁndings with the exception
of one isolate with a MIC >128 lg/mL. Demonstration of the cﬁA
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and cphA genes by PCR, but not actual enzyme production, may
be attributed to so-called ‘silent’ genes. Susceptible strains are
known to be able to convert to high-level beta-lactam/carbapenem
resistance by increasing the expression of ‘nearly’ silent metallo-
beta-lactamase genes. Metallo-beta-lactamases have been found to
be carried on a small plasmid (13.6 kb) that appears to be self-
transmissible, posing a potential threat of rapid spread of resist-
ance. Therefore early recognition of metallo-beta-lactamase produ-
cing strains is imperative.
P951 Identiﬁcation of Nocardia clinical isolates by PCR
and restriction analysis and susceptibility patterns
M. Marı´n, E. Cercenado, P. Martı´n-Rabada´n, P. Mun˜oz, C. Radice,
E. Bouza
Madrid, E
Objective: To describe the distribution of species in our Nocardia
isolates and to evaluate the usefulness of an easy and rapid
method based on a short battery of susceptibility tests to identify
clinical Nocardia isolates compared with PCR and restriction ana-
lysis of hsp65 routinely used in our laboratory.
Methods: Nocardia sp. isolated from 1995 to 2003 were selected to
study. Molecular identiﬁcation was performed by hsp65 PCR-
RFLP. Identiﬁcation by susceptibility testing was by disk diffusion
with gentamicin (CN), tobramycin (TOB), amikacin (AK) and
erythromycin (E) and by broth microdilution and E-test with amp-
icillin (AMP), ciproﬂoxacin (C), cefotaxime (CTX) and amoxicillin-
clavulanate (AUG).
Results: 34 isolates of Nocardia sp. were studied. Distribution of
species according to results from PCR-RFLP was: N. asteroides I
(4), N. asteroides VI (15), N. farcinica (10), N. nova (3), N. otitidis-cav-
iarum (2). N. asteroides I isolates had two different susceptibility
patterns, two isolates were CN-S, TOB-S, AK-S, E-R and the other
two were CN-R, TOB-S, AK-S, E-R. All N. asteroides I isolates were
AMP > 8 lg/mL and C > 4 lg/mL and CTX < 2 lg/mL. Eighty-
seven per cent of N. asteroides VI were CN-S, TOB-S, AK-S, E-R,
AMP > 8 lg/mL, CTX < 8 lg/mL whereas C was variable. Hun-
dred per cent of isolates of N. farcinica were CN-R, TOB-R, AK-S,
E-R, AMP > 8 lg/mL, C < 4 lg/mL and CTX > 32 lg/mL. N.
nova isolates were CN-S, TOB-S, AK-S, E-S, AMP < 4 lg/mL,
CTX < 2 lg/mL and C < 4 lg/mL. N. otitidis-caviarum isolates
were CN-S, TOB-S, AK-S, E-R, AMP > 8 lg/mL, CTX >
32 lg/mL and C < 4 lg/mL. Medium time to obtain results by
both methods was 48 h.
Conclusions: 94% of isolates belonged to the former N. asteroides
complex. N. farcinica and N. nova were easily distinguished from
other Nocardia species by its susceptibility patterns. The main
group N. asteroides VI was more difﬁcult to distinguish from N. as-
teroides I and N. otitidis-caviarum. A short battery of susceptibility
tests permits rapid differentiation of our most frequent Nocardia
isolates, although genotypic tests are more discriminatory.
Molecular bacteriology: borrelia
P952 Isolation and identiﬁcation of Borrelia strains from
ticks collected in the Czech Republic
H. Drevova´, D. Hulı´nska´, J. Plch, Z. Kurzova
Prague, CZ
Objectives: The Ixodes ricinus tick, common ectoparasite of animals
and humans, is the main vector of Lyme disease in the Czech
republic. Detection of Borrelia under microscope, isolation in BSK-
H medium and PCR identiﬁcation was the aim of this work.
Methods: A tick was crushed in drop of sterile phosphate buffer
saline and admired under microscope in dark-ﬁeld. Samples, in
which spirochetes had been detected, were incubated in liquid
BSK-H medium (Sigma) at 33C and admired weekly for 6 weeks.
Each strais was passaged twice and was frozen in 1.8-mL aliquots
at 70C. Direct ﬂuorescence assay (DFA) with ﬂuorescein
labelled polyclonal antibody to Borrelia burgdorferi was used for
screening. Deoxyribonucleic acid of borrelial strains was isolated
with Invisorb Genomic DNA Kit III (Invitec). Three sets of prim-
ers (for B. burgdorferi sensu lato, B. garinii and B. afzelii) derived
from 16SrRNA gene (Rosa and Schwan) were used for elementary
identiﬁcation of strains. Detailed analysis of strains was made by
Light cycler real-time PCR (RT-PCR). Primers and probe derived
from recA gene were used in this method.
Results: There was a collection of 6283 ticks in urban and subur-
ban localities of the Czech republic from 1998 to 2002 years. Inci-
dence of spirochetes in tick population differed from 1 to 23.5%
in different localities. Spirochetes were cultured from at least one
of six ticks (27 out of 156) that were tested positive by dark-ﬁeld
microscopy. All strains reacted positively by DFA and gave posit-
ive response with primers speciﬁc for B. burgdorferi sensu lato
complex. Nineteen strains belonged to B. garinii, four to B. afzelii
and two to B. burgdorferi sensu stricto genospecies. One strain did
not react with 16SrRNA primers for B. garinii but had melting
temperature of recA gene product identical with B. garinii type
strain. We identiﬁed the genotype of two strains determined as B.
burgdorferi sensu lato neither by PCR, nor by RT-PCR.
Conclusion: Majority of Borrelia strains cultured in our laboratory
was identiﬁed as B. garinii. This might be caused by supposed
higher presence of B. garinii in ticks or possible better adaptation
of this strain to culture medium. The results clearly show the
obvious risk of borreliosis in urban and suburban areas of the
Czech republic.
P953 Identiﬁcation of Lyme disease spirochetes in humans
and animals
D. Hulı´nska´, J. Votpka, H. Drevova´, K. Langrova, M. Bojar,
M. Valesova´
Prague, CZ
Background: To unveil the prevalence of different Borrelia geno-
types and their OspA, OspC variants in the Czech Republic where
Lyme disease is common (3000 cases annually reported). To ana-
lyse sequence types of Borrelia sp. in patients with different symp-
toms, in tick vectors and in animal reservoirs.
Methods: We applied LightCycler real-time PCR assays using SYBR
green I dye and ﬂuorescent probes. Positive PCR products from liq-
Figure. Lightcycler real-time PCR with primers p521–790 shows
temperature value Tri 87.20-87-70C for speciﬁc ehrlichial DNA
from different animals and positive-GE controls in 10-fold dilution.
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uors, blood and tissue were subjected to sequencing with the dide-
oxy chain termination technique using CEQ 2000CX sequencer. Cul-
tivation, immunocytochemistry and Western blots were used for
conﬁrmation.
Results: We cultured four blood, six skin, six CSF isolates, numer-
ous tick and two animal isolates. Real-time PCR targeted recA,
16S and OspA genes showed that involvement of the nervous
system, joints and skin in Czech patients was predominantly
caused by B. garinii, serotypes 3,5,6 (54%), then B. burgdorferi ss
(26%) and B. afzelii (10–16%). The remaining 4–10% comprise co-
infection with Anaplasma phagocytophila or mixed borrelial infec-
tions. Similar results were found in 424 animals. Among game
animals 22% tested positive with B. garinii and B. burgdorferi.
Wild boars and murids hosted Borrelia sp. in 7 and 12% with pre-
valence of B. afzelii. No signiﬁcant differences were noticed
between the infection of adult and nymphal ticks, both reaching
20 and 12% in June and September, respectively. Diferences were
also between regions, in east Bohemia with B. garinii prevailing
and in Moravia with prevalence of B. afzelii and human cases of
Erythema migrans and Acrodermatitis atrophicans. Infection preval-
ence data for patients were in agreement with data for the tick
and animals.
P954 Diversity of Borrelia burgdorferi sensu lato in the
Russian Far East
O. Mediannikov, L. Ivanov, N. Zdanovskaya, R. Vorobyova,
P.-E. Fournier, I. Tarasevich, D. Raoult
Moscow, Khabarovsk, RUS; Marseille, F
Objectives: The aim of our study was to identify the strains of
Borrelia isolated from ticks and Lyme disease patients in the Rus-
sian Far East and to analyse their taxonomic positions based on
ospA gene phylogeny.
Methods: We have analysed 30 strains of Borrelia burgdorferi sensu
lato isolated from Ixodes persulcatus ticks (25) and skin biopsies of
Erythema migrans from Lyme disease patients (5) isolated by
standard methods during last 6 years in the Russian Far East.
After ampliﬁcation with newly designed primers, we obtained
full-length ospA gene sequence of each of the 30 strains.
Results: We identiﬁed four strains as B. afzelii completely identical
to the strain XJ23, isolated in Japan. All of them were isolated from
ticks. The other 26 strains were found to be genetically variable,
but the closest homology found was with B. garinii. After phylo-
genetic analysis of ospA gene we found that these strains form
three distinct and well-deﬁned clades at the phylogenetic tree.
Genogroups 1 and 2 represent only species isolated in the Far Eas-
ter regions of the Russian Federation and in Japan only, whereas
genogroup 3 represents mostly European isolates, including sero-
and genogroups deﬁned in the works of B. Wilsske et al. and G.
Will et al. and four isolates from the Russian Far East. European
serogroups 3 and 7 form the clade localised between genogroups 2
and 3. Human strains were found within genogroups 1 and 2.
Conclusion: B. garinii was found to dominate among other B. burg-
dorferi sensu lato strains isolated from ticks and Lyme disease
patients form the Russian Far East. Phylogenetic analysis showed
that the species identiﬁed as B. garinii have signiﬁcant variability
in the ospA gene and form three major groups. Two groups con-
sisting only of strains isolated in the Far East are signiﬁcantly
remote from all other B. burgdorferi sensu lato species. Bootstrap
values and distances among these groups suggest their solidity,
especially genogroup 1. This, probably, indicates the distinct ori-
gin of deﬁned genogroups 1 and 2 of B. garinii and may suggest
another taxonomic status.
P955 A new recombinant IgG and IgM line immunoblot
improves serodiagnosis of early Lyme borreliosis
G. Goettner, U. Schulte-Spechtel, V. Fingerle, G. Liegl, B. Wilske
Munich, D
Objectives: For diagnosis of Lyme borreliosis (LB) a two-step
approach is recommended by CDC and DGHM (screening ELISA
followed by immunoblot (IB) in case of reactive ELISA). Though
Borrelia IBs are widely used, they are still poorly deﬁned regard-
ing sensitivity, speciﬁcity and standardisation. A recently des-
cribed recombinant Western immunoblot (WIB) complemented
with Borrelia antigens produced in vivo but not in culture
(i.e. VlsE) could improve previous tests (1). Here a recombinant
Borrelia line IB (LIB) was developed where each recombinant anti-
gen is separately detectable, even those antigens with identical
molecular weight.
Methods: The following recombinant IgG and IgM IBs were com-
pared: (a) The WIB described in (1) with p83/p100 (strain PKo, B.
afzelii), p58 (strain PBi, B. garinii OspA-type 4), BmpA (strains
PKa2, B. burgdorferi sensu stricto, PKo, and PBi), VlsE (strain
PKa2), OspC (strains PKa2, PKo, PBi, and B. garinii strain 20047),
and DbpA (strains PKo and PBr, B. garinii OspA-type 3). (b) The
LIB with all antigens of the WIB and in addition VlsE (strains
PKo and PBi), OspC (strain PLe, B. afzelii) and DbpA (strains B31
and PBi). To verify sensitivity and speciﬁcity, 65 sera of patients
with early LB (50 early neuroborreliosis, 15 Erythema migrans) and
110 control sera (60 blood donors, 10 rheumatoid factor positive,
10 syphilis patients and 30 patients with fever of unknown origin)
were studied.
Results: IB interpretation criteria deﬁning a serum as positive
with at least two reactive bands or in case of IgM at least one
strong OspC band were used (2). Sensitivity signiﬁcantly
increased from 63% (WIB) to 80% (LIB) for IgG and from 46%
(WIB) to 69% (LIB) for IgM while speciﬁcity remained unchanged
(99% for IgG tests and 98% for IgM tests). The increase of sensi-
tivity was mainly due to the line blot technique, which allows
detection and identiﬁcation of antibodies differently reactive with
homologues of the same protein.
Conclusion: The LIB is more sensitive than the WIB for both IgG
and IgM antibody detection in acute LB while speciﬁcity remains
unchanged. The LIB is better to standardise and results are easier
to interpret.
References
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P956 The ﬁrst study of identiﬁcation of Borrelia, Ehrlichia
and Babesia in Ixodes ricinus ticks from Lithuania using
molecular methods
D. Ambrasiene, I. Vascilo, A. Jenkins, A.-G. Allum, L. Strand,
B.-E. Kristiansen
Kaunas, Vilnius, LIT; Bo i Telemark, Skien, N
Background: Tick of the Ixodes ricinus group are well known as
major vectors of the causative agents of Lyme borreliosis, granulo-
cytic anaplasmosis, ehrlichiosis and babesiosis in European coun-
tries. The humans infected with these agents can experience a
wide range of clinical manifestations. I. ricinus is a widely distri-
buted tick in Lithuania and may transmit pathogens to mamma-
lian hosts, including human beings. A single tick may contain
several different pathogens so double-infection with borreliosis
and ehrlichiosis may be seen.
Objectives: The aim of this study was to determine whether
I. ricinus ticks collected in different regions of Lithuania were
infected with the causative agents of Lyme borreliosis, anaplasmo-
sis, ehrlichiosis and babesiosis agents and to estimate the preval-
ence of mixed infections in them by PCR. No investigations have
been carried out to assess the prevalence of Borrelia, Anaplasma,
Ehrlichia and Babesia infection in I. ricinus in Lithuania using the
PCR method before.
Methods: Altogether, 243 I. ricinus ticks collected from 10 different
regions of Lithuania, were included in this study. All ticks were
analysed individually. The presence Ehrlichia/Anaplasma group
pathogen was determined by using PCR with Ehrlichia/Anaplas-
ma-speciﬁc primers HR521/EHR747, multiplex PCRs using
species-speciﬁc Borrelia primers GI-R/GI-L (Borrelia burgdorferi
s.s.), GII-R/GII-L (B. garinii), GIII-R/GIII-L (B. afzelii). Real-time
PCR method with the ABI Prism 7000 system was used to detect
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Babesia divergens. Ehrlichia/Anaplasma species were determined
using the reverse line blot hybridisation.
Results: Of the 243 individually processed ticks, 12 (5%) were
positive for Ehrlichia/Anaplasma (HGE – 3, HGE variant – 1, E
Schotii – 2 and 6 were not identiﬁed), 38 (16%) for Borrelia (B.
burgdorferi s.s – one (0.4%), B. garinii – 12 (5%), B. afzelii – 25
(10%) and 5 (2%) were positive for Babesia divergens. One tick
contained both Ehrlichia/Anaplasma and Babesia, two contained
both Babesia and B. afzelii and one Ehrlichia/Anaplasma and
B. garinii.
Conclusions: Our results represent the ﬁrst study in Lithuania in
which Borrelia, Ehrlichia, Anaplasma and Babesia parasites were
directly identiﬁed in I. ricinus ticks by PCR, multiplex PCR,
reverse line blot hybridisation and real-time PCR. It was detected
that B. afzelii was the dominant genospecies in Lithuanian ticks
(10%) and Ehrlichia/Anaplasma and Babesia were found in ticks
too and might cause human diseases.
Molecular bacteriology: characterisation of agents
P957 Improved automated ribotyping using HindIII to
discriminate previously uniform Listeria monocytogenes
serotype 4b strains
I. Heller, K. Grif, M. Dierich, R. Wu¨rzner
Innsbruck, A
Objectives: To develop improved automated subtyping approa-
ches for Listeria monocytogenes, we characterised the discriminatory
power of different restriction enzymes for ribotyping. PvuII and
HindIII were evaluated for their ability to differentiate among iso-
lates representing one of the two major serotype 4b epidemic
clones, having ribotype reference pattern DUP-1038 (which differs
from the other clone DUP-1042 in the EcoRI pattern only). This is
of utmost importance, as the presence of only two major patterns
within the serotype 4b does not allow sufﬁcient epidemiology of
Listeria infections.
Methods and results: The eight selected L. monocytogenes isolates
(serotype 4b) with the ribotype reference pattern DUP-1038 were
responsible for human listeriosis outbreaks in France, Canada,
Switzerland and Turkey from 1978 to 2002, and for sporadic food-
borne cases in Austria (2002), England (1987 and 1989) and the
USA. Ribotyping was performed using the RiboPrinter microbial
characterisation system according to the manufacturer’s instruc-
tions using EcoRI, PvuII and HindIII as restriction enzymes. We
found that the eight isolates belonging to DUP-1038 (i.e. indistin-
guishable by EcoRI) were also indistinguishable by PvuII but
yielded two clearly different patterns when using HindIII.
Conclusions: We conclude that automated ribotyping using Hin-
dIII allows discriminating previously uniform L. monocytogenes 4b
isolates. This discrimination may facilitate the tracing of outbreaks
and may also improve epidemiological surveys.
P958 Detection of BFT, the isoforms of the enterotoxin
gene and cﬁA gene in Bacteroides fragilis isolates of different
origins
G. Terhes, J. Soki, K. Ago, E. Urban, E. Nagy
Szeged, HUN
Objectives: Bacteroides fragilis is an obligate anaerobic, Gram-neg-
ative rod constituting 1% of the normal intestinal ﬂora of humans,
and is the Gram-negative anaerobic rod most frequently isolated
from human clinical samples. Some of the B. fragilis isolates pro-
duce a zinc-dependent metallo-protease, enterotoxin coded by the
bft gene. This protein has enterotoxic activity; it causes ﬂuid accu-
mulation in a lamb ligated ileal loop model. To date, three differ-
ent isoforms, designated bft-1, bft-2 and bft-3, have been
identiﬁed. The literature regards the enterotoxin-producing prop-
erty of B. fragilis as a virulence factor since these strains can be
isolated more often from severe infections such as sepsis, or
abdominal and deep soft-tissue abscesses. It is also thought to be
involved in diarrhoea in 1–5-year-old children.
Aims and methods: The aim of the present study was to examine
the prevalence of enterotoxin production among B. fragilis strains
isolated between 2001 and 2003 from specimens originating in
clinical wards of our university or in other hospitals by HT-29
cytotoxicity testing or PCR detection of the bft gene. The results
obtained with the two methods were compared. The frequencies
of three alleles of bft genes in enterotoxigenic strains from differ-
ent sources were determined by using PCR-restriction fragment
length polymorphism analysis. The B. fragilis strains can be divi-
ded into two major groups by molecular typing methods and
most importantly according to the carriage of the cﬁA gene. We
therefore also examined the occurrence of the cﬁA gene by PCR
and the co-incidence of bft and cﬁA among the above collection
of strains.
Results: The average occurrence of toxigenic B. fragilis strains in
the different groups of clinical samples was 10% and in deep-tis-
sue infections was 15% by both the PCR method and the cytotox-
icity assay. bft genes were found only in the cﬁA-negative
group. The prevalence of the cﬁA gene corresponded to our
earlier ﬁndings and data from the literature and we did not
observe co-incidence of the bft and cﬁA genes in this study.
P959 Prevalence and characterisation of binary toxin (actin
speciﬁc ADP-ribosyltransferase) from Clostridium difﬁcile
D. Decre´, F. Barbut, C. Goncalves, B. Burghoffer, J.C. Petit
Paris, F
Introduction: In addition to the two large clostridial cytotoxins
(LCT – toxins A and B) some strains of Clostridium difﬁcile also
produce an actin-speciﬁc ADP-ribosyltransferase (binary toxin
CDT). CDT may serve as an additional virulence factor.
Methods: We used PCR and Southern blotting methods for detec-
tion of genes encoding the enzymatic (CDTa) and binding (CDTb)
components of binary toxin in 369 strains isolated from patients
with suspected C. difﬁcile-associated diarrhoea or colitis. Binary
toxin production was assessed by Western blotting using antisera
against the iota toxin of C. perfringens (anti-Ia and Ib). Toxin activ-
ity was detected with an ADP-ribosyltransferase assay. PCR
ampliﬁcation was performed to detect the gene encoding for toxin
B. Binary positive strains were subjected to toxinotyping and were
characterised by phenotypic (serogrouping) and genotypic mark-
ers (PCR-ribotyping, arbitrarily primed PCR (AP-PCR) and
pulsed-ﬁeld gel electrophoresis (PFGE)).
Results: Twenty-two strains (prevalence 6%) harboured both
genes cdtA and cdtB; 19 out of the 22 strains reacted with antisera
against the iota toxin of C. perfringens; the binary toxin activity
was positive in only 17 of the 22 strains. All strains also produced
toxins B. However, they had signiﬁcant changes in tcdA and tcdB
genes and belonged to variant toxinotypes III, IV, V, VII, IX and
XIII. With typing methods used we could differentiate 16 proﬁles,
indicating that most of binary toxin positive strains were unre-
lated.
Conclusion: Binary toxin-producing isolates of C. difﬁcile are wide-
spread but prevalence varies from one country to another. More
studies are needed to deﬁne the role of binary toxin in pathogene-
sis.
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P960 Molecular characterisation and prevalence of
Clostridium difﬁcile in Singapore
W.Y. Leong, R. Das Ramadas, T.H. Koh, K.P. Song
Singapore, SGP
Objective: Occurrence of nosocomial Clostridium difﬁcile-associated
diarrhoea and pseudomembranous colitis is related to the produc-
tion of toxins A and B (encoded by tcdA and tcdB, respectively)
from the pathogen. tcdA and tcdB, together with their accessory
genes, tcdC-E are arranged within a well-deﬁned chromosomal
region termed Pathogenicity Locus (PaLoc). Another virulence fac-
tor, ADP-ribosyltransferase binary toxin (encoded by cdt genes)
was reported to be found in approximately 12% of pathogenic
strains of C. difﬁcile. Despite the availability of a number of detec-
tion methods, the identiﬁcation methods commonly used are not
designed to detect all the virulence factors known. We present
here an alternative characterisation of the toxigenic and the rela-
ted genes of C. difﬁcile based on genotyping. The correlation
between PaLoc and cdt genes was also examined.
Methods: All 110 clinical isolates from Singapore General Hospital
(SGH) were screened with PCR and multiplex PCR for the pres-
ence of tcdA-E and cdtA-B in the PaLoc region and cdt operon,
respectively. The production and activity of toxins A and B were
analysed by commercial kit and cytotoxicity testing.
Results: The isolates could be classiﬁed into 16 groups based on
the genotypic analysis of the PaLoc and cdt genes. Approximately
21% of them shared a common proﬁle with the reference strain
VPI 10463, and about 36% were completely devoid of the genes
tested. Variations demonstrated in tcdC-E were complicated and
no speciﬁc proﬁle could be attributed to a particular genotype. An
atypical toxigenic variant was discovered which contains only
tcdB. In contrast to data reported elsewhere, none of the patho-
genic strains was found to contain complete cdt genes. When tes-
ted for TcdA and TcdB production, six strains were identiﬁed to
be toxins A-negative, B-positive.
Conclusion: The great genetic polymorphisms displayed by the C.
difﬁcile isolates here conﬁrm that these strains were highly hetero-
geneous and could originate from endogenous source. There is no
signiﬁcant correlation between presence of the structural genes
(tcdA-B), accessory genes (tcdC-E) and cdt genes. Pathogenic
strains do not necessarily contain all the genes in the PaLoc. In
conclusion, our results using this toxino-genotyping method for
the studies of genetic distribution of toxinogenic genes correlates
well with the phenotype of the bacteria i.e. toxin expression.
P961 CharacterisationofClostridiumdifﬁcile strains isolated
in different time periods and belonging to different ribotypes
P. Spigaglia, V. Carucci, P. Mastrantonio
Rome, I
Objectives: Seventy-four Clostridium difﬁcile clinical isolates, collec-
ted in different time periods, were typed by PCR-ribotyping.
Strains belonging to the two main PCR-ribotypes were character-
ised for virulence determinants and for antibiotics resistance.
Methods: PaLoc genes analysis, detection of binary toxin gene
and antibiotic resistance determinants (ermB, tetM and catD) were
performed by PCR assays. erm(B) sequence type was identiﬁed
by a RFLP-PCR. MICs for erythromycin, clindamycin, tetracycline
and chloramphenicol were determined by E-test.
Results: Two main PCR-ribotypes named A and R, respectively,
were identiﬁed. PCR-ribotype A collected 20 strains whereas 15
strains belonged to PCR-ribotype R. Old strains (from 1985 to
1990) belonged to PCR-ribotype A, whereas recent strains (from
2000 to 2001) belonged to PCR-ribotype R. All strains with
PCR-ribotype A had classical PaLoc genes and did not have the
binary toxin gene. Ninety percent of these strains were multi-
resistant and the sequence type of the ermB genes was similar to
that of C. difﬁcile 630. All strains belonging to PCR-ribotype R had
the binary toxin gene, four of them showed major variations in
the toxin A gene and 87% had a mutated toxin negative regulator.
None of these strains was multi-resistant although one showed all
three antibiotic resistance determinants. Fifty three percent had a
tetM gene, 13% tetM and ermB genes and 7% only an ermB gene
with a sequence similar to that of C. perfringens CP592. Interest-
ingly, as far as resistance is concerned, there was no correspon-
dence between phenotype and genotype in 75% of these strains.
In particular, all strains with a tetM or a catD gene were suscept-
ible to tetracycline and chloramphenicol in vitro, whereas ﬁve
strains, resistant to erythromycin but not to clindamycin, did not
have an ermB gene. All these strains showed, after induction with
erythromycin, some clindamycin resistant colonies.
Conclusions: The results seem to indicate a recent spread of C.
difﬁcile clones that add together a potential increase of virulence
by acquisition of the binary toxin, variations in genes belonging to
the PaLoc and acquisition of different mechanisms of antibiotic
resistance.
P962 Virulence in Enterococci: chromosomal versus
plasmidic location of virulence genes
T.M. Leita˜o Semedo, M.F. Silva Lopes, J.J. Figueiredo Marques,
M.T. Barreto Crespo, R. Tenreiro
Lisbon, P
Enterococci are natural inhabitants of the gastrointestinal ﬂora of
humans and animals and are widely distributed in the environ-
ment. Members of this genus are recognised as important oppor-
tunistic pathogens responsible for serious infections but the
molecular mechanisms of enterococcal virulence are not yet com-
pletely understood. In this study 42 Enterococci from different
sources, including clinical isolates (from human and veterinarian
origin), non-clinical isolates and reference strains from 19 entero-
coccal species, were typiﬁed and their virulence potential charac-
terised. The relationships among these Enterococci were ﬁrst
analysed using SmaI pulsed-ﬁeld gel electrophoresis and M13
PCR-ﬁngerprinting, in order to evaluate the genomic heterogen-
eity of the isolates. Enterococci were also screened for several viru-
lence traits such as cytolysin (cyl genes), adhesins (agg, esp,
EfaAfs and EfaAfm genes) and gelatinase (gelE), revealing distinct
virulence potentials. In Enterococcus faecalis, it was recently des-
cribed that some virulence determinants can be clustered on large
pathogenicity islands and not only in pheromone-responsive plas-
mids. Dot–blot DNA–DNA hybridisation was used to locate viru-
lence determinants in the bacterial genome of the Enterococci
under study. No conclusive results were obtained for esp and
gelE, whereas EfaAfs and EfaAfm were found on the chromosome
as expected. Although cyl genes and agg are plasmidic, in most
isolates, they were detected on the chromosome of ﬁve strains,
suggesting that these Enterococci may harbour a pathogenicity
island. Beyond the widespread nature of virulence traits, chromo-
somal integration of virulence genes seems to occur in different
enterococcal species and isolates from non-clinical sources.




Introduction: Salmonella abortusovis, S. dublin, S. montevideo and
S. typhimurium are more common serotypes in sheep. One way of
transferring of contamination is from visceral organs specially
gallbladder, intestine and liver, which can be transferred from
meat to human. Because of this, this research was essential to con-
sider about it.
Objectives: (1) Isolation of Salmonella serotypes from visceral
organs of sheep and goats. (2) Detection of invA gene in isolated
serotypes by PCR.
Materials and methods: For these goals, samples from 96 livers, 86
gallbladders, 110 mesenteric lymph nodes and 10 faeces (totally
302 samples) were taken, and then cultured in enrichment and
selective media. Doubtful colonies were selected and transferred
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to TSI agar, urea agar, SIM, MR-VP broth and nitrate broth. PCR
reaction was carried out in Master cycle (Eppendorf). For DNA
extraction isolated Salmonella serotypes was cultured in LB broth
for 24 h at 37C. LB broth (200 lL) was boiled for 10 min and cen-
trifuged at 6000g for 3 min. A total of 1.5 lL of the supernatant
was used for ampliﬁcation by PCR with Salmonella-speciﬁc (139
and 141) primers.
Results: Three Salmonella serotypes were isolated from mesenter-
ic lymph nodes (two cases) and gallbladder (one case). Serotyp-
ing test showed that two of them belong to group B and one
of them to group D of Salmonella. When subjected to Salmonella-
speciﬁc primer invA, all isolates, including positive control,
generated a single 284-bp ampliﬁed DNA fragment, on 1.5%
agarose gel.
Conclusion: Salmonella-speciﬁc PCR with primer set invA is rapid,
Sensitive, and reliable for detection of Salmonella in many clinical
samples. The present research supports the ability of this speciﬁc
primer set to conﬁrm the isolates as Salmonella. All isolates, inclu-
ding positive controls (S. typhimurium and S. dublin), screened by
PCR resulted in 284-bp ampliﬁed product. No ampliﬁed products
were obtained from negative controls (water and O2K12 Escherichia
coli serotype).
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P964 Molecular typing of Salmonella enterica serotype
Typhimurium strains from Slovak Republic
H. Drahovska´, E. Mikasova´, E. Kaclı´kova´, R. Karpı´skova´, M. Sa´sik,
J. Turna
Bratislava, SK; Brno, CZ
Objectives: The variability of Salmonella typhimurium strains was
studied by PCR-based methods.
Methods: 28 strains of S. typhimurium were isolated from food or
animal sources in the course of surveillance programmes. Strains
were phagotyped and their antibiotic resistance was determined
by disk diffusion method. Fluorescent AFLP was done using Eco-
RI and MseI enzymes and AFLP products were separated by
capillary electrophoresis.
Results: The presence of integrons was analysed in all 28
strains of S. typhimurium and three different integron proﬁles
(IPs) were detected by ampliﬁcation of variable region of the
integrons. The IP-1 proﬁle, characterised by two PCR products
of 1.0 and 1.2 kb, was present in six strains. All these strains
were multiresistant with resistance ACSSuT or ACSSuTNa. The
IP-2 proﬁle contained single 1.6 kb PCR product and was pre-
sent in six strains resistant to ASuTmp or ASSuTmp. The
dhfrA1 gene was conﬁrmed to be an integral part of IP-2 integ-
ron. A total of 0.2 kb PCR product (IP-3) was ampliﬁed in two
strains sensitive to all antimicrobials. As lysogenic bacteriopah-
ges could frequently transfer their DNA into the bacterial cell
and thus change chromosomal composition, phage-related
sequences were probed in S. typhimurium strains by PCR with
primers complementary to four genes of phage P22 (g8, g13,
eae, eac). Three different types of PCR products were detected
in multiplex reaction: the presence of g8 sequence only, the
simultaneous occurrence of g8 and eac or presence of g8 and
g13. Nine strains did not contain any from the tested phage-
related genes. The relatedness between strains was further mon-
itored by AFLP. We observed high strain-to-strain similarity as
Dice coefﬁcients fell in the range of 94–100%. According to the
presence of several DNA fragments, strains were separated into
eight AFLP clusters.
Conclusions: By comparison of all methods we obtained corres-
ponding results in strain clustering. All methods can be used for
subtyping of S. typhimurium strains.
P965 Detection of ﬁmbrial adhesin genes in ESBL-
producing Klebsiella strains isolated from nosocomial infections
K. Matusiewicz, B. Maczynska, D. Olejniczak,
A. Przondo-Mordarska, R. Franiczek
Wroclaw, PL
Objectives: Klebsiella bacilli present many pathogenic properties,
which determine their ability to survive and rapid spreading in
hospital environment. The adhesive properties of Klebsiella bacilli
associated with the presence of ﬁmbrial and non-ﬁmbrial adhe-
sins play a very important role in pathogenicity of these bac-
teria. Rapid spread of patogenical factors is often connected
with presence of their plasmid-mediated genes. The aim of our
study was to detect plasmid and chromosomally born ﬁmH
and mrkD genes encoding main adhesins: MS and MR, respect-
ively.
Methods: A total of 55 Klebsiella clinical isolates obtained from
patients hospitalised in different hospital wards were studied.
The phenotypic activity of ﬁmbriae was characterised by haemag-
glutination method. The genomic and plasmid DNA were isolated
using manual method as well as Qiagen DNA kits. The presence
of genes encoding main adhesins were detected using
PCR-method with primers detected ﬁmH and mrkD genes
Results: 40% of strains displayed phenotypic activity of both
type 1 and type 3 ﬁmbriae, 25.5% showed only activity of type
1 ﬁmbriae, 30.9% only of 3 type ﬁmbriae and 3.6% strains
showed the lack of hemagglutination activity. The percentage of
detected genes using PCR, was higher then showed results of
phenotypic activity. The presence of mrkD genes was detected
in 100% investigated strains in chromosomal DNA and 85.4%
showed both mrkD and ﬁmH genes. A total of 5.5% strains
demonstrated only ﬁmH genes in chromosomal DNA and 3.6%
strains showed no genes. In plasmid DNA, the presence of main
adhesin genes conﬁrmed in 33% Klebsiella strains (mrkD genes
in 20% strains, both ﬁmH and mrkD in 9% and only ﬁmH in
4% strains).
Conclusions: The presence of ﬁmH and mrkD genes in genomic
and plasmid DNA not always leads to phenotypic expression of
ﬁmbrial adhesins. The activity of type 3 ﬁmbriae is connected
with chromosomal variant of mrkD gene. In case of ﬁmH genes,
the plasmid variant is enough for haemagglutination activity of
type 1 ﬁmbriae. The percentage of detected ﬁmH and mrkD plas-
mid genes depended on hospital units from which these strains
were isolated. This suggests the spread of plasmid-encoded adhe-
sins among Klebsiella strains.
Acknowledgements: This study was supported by the Polish Com-
mittee of Scientiﬁc Studies (KBN Grant No 4 P05A 064 24).
P966 Development and validation of ampliﬁed fragment
length polymorphism (AFLP) for molecular epidemiology and
identiﬁcation of Klebsiella pneumoniae and Klebsiella oxytoca
phylogenetic groups
D. Jonas, B. Spitzmu¨ller, F.D. Daschner, J. Verhoef, S. Brisse
Freiburg, D; Utrecht, NL; Paris, F
Objectives: Bacteria of the genus Klebsiella are opportunistic patho-
gens responsible for an increasing number of multiresistant infec-
tions in hospitals. The two clinically and epidemiologically most
important species, Klebsiella pneumoniae and K. oxytoca, have
recently been shown to be subdivided into three and two respect-
ive phylogenetic groups. The aim of this study was in-depth eval-
uation of the ampliﬁed fragment length polymorphism (AFLP)
genetic characterisation method.
Methods: First, we investigated the variability of AFLP patterns
for Klebsiella strains within and between different outbreaks. Sec-
ond, by use of carefully characterised, phylogenetically represen-
tative strains, we examined whether different Klebsiella species
and phylogenetic groups can be discriminated using AFLP.
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Twenty-four strains originating from seven presumed outbreaks
and 31 non-associated strains were investigated.
Results: The AFLP ﬁngerprints of all epidemiologically associated
strains showed three or fewer fragment differences, whereas unre-
lated strains differed by at least four fragments. Cluster analysis
of the AFLP data revealed a very high concordance with the phy-
logenetic assignation of strains based on gyrA sequence and ribo-
typing data. The species K. pneumoniae, K. oxytoca, K. terrigena and
the possibly synonymous pair K. planticola/K. ornithinolytica each
formed a separate cluster. Similarly, strains of the phylogenetic
groups of K. pneumoniae and K. oxytoca fell into their correspond-
ing cluster, with only two exceptions.
Conclusion: This study provides a preliminary cut-off value for
distinguishing epidemiologically non-related Klebsiella isolates
based on AFLP data, conﬁrms the sharp delineation of the
recently identiﬁed phylogenetic groups and demonstrates that
AFLP is suitable for identiﬁcation of Klebsiella species and phylo-
genetic groups.
P967 Molecular serotyping of Klebsiella by restriction of
the ampliﬁed capsular antigen gene cluster
S. Brisse, S. Issenhuth-Jeanjean, P.A.D. Grimont
Paris, F
Objectives: K-serotyping, i.e. determination of the capsular anti-
gen, has been the preferred typing method for Klebsiella isolates,
as it is highly discriminatory (77-types are known) and as K-types
are known to differ in their pathogenic potential. Unfortunately,
K-serotyping requires a large collection of sera and is restricted to
a few reference centres. Moreover, K-serotyping suffers from
cross-reactions and is not applicable to non-capsulated strains.
The objective of this work was to develop a molecular method
that would enable to determine the K-serotype without using anti-
serum.
Methods: We ampliﬁed by PCR the capsular antigen gene clus-
ter (cps) and the PCR product (10–18 kb long) was digested
with HincII, followed by agarose gel electrophoresis (cps PCR–
RFLP).
Results: The proﬁles (called C-patterns) obtained for 228 strains
representing the 77 known K-serotypes showed four to 13
bands in the size range 0.2–4.361 kb. A total of 128 distinct
C-patterns were obtained. The following important observations
were made: (i) The C-patterns obtained for strains of any
K-serotype were distinct from the C-pattern of all other K-sero-
types, with the only exception of serotypes K22 and K37, which
are known to cross-react. (ii) For 12 K-types, C-pattern variation
was found among strains with the same K-serotype; in most
cases, the strains with variant C-patterns belonged to other
Klebsiella species than the reference strain. Thus, cps PCR–RFLP
has a higher discriminatory power than classical K-serotyping.
(iii) Within K. pneumoniae, we observed C-pattern identity
among strains of a given K-type, for example K1 or K3, that
were collected many years apart and from distinct sources. This
stability of the C-pattern indicates that cps PCR–RFLP is suit-
able for long-term epidemiology of capsular types. (iv) Only
2.8% (compared with 8–23% for classical K-serotyping) of the
strains analysed by cps PCR–RFLP were non-typable, because
PCR ampliﬁcation failed. (v) The value of cps PCR-RFLP for
K-serotype determination was tested on 21 recent K. pneumoniae
clinical isolates. The K-serotype of 18 (86%) of them could be
deduced from the comparison of their C-pattern with the data-
base. (vi) Four of ﬁve non-capsulated strains analysed showed
a recognisable C-pattern.
Conclusions: cps PCR–RFLP allows determination of the K-sero-
type, while being easier to perform and more discriminatory than
classical serotyping, and allowing the characterisation of non-cap-
sulated strains.
P968 Cloning of 16S rRNA genes ampliﬁed from normal
and disturbed vaginal microﬂora points to a strong association
between Atopobium vaginae, Gardnerella vaginalis and bacterial
vaginosis
R. Verhelst, H. Verstraelen, G. Claeys, G. Verschraegen,
J. Delanghe, L. Van Simaey, C. De Ganck, M. Temmerman,
M. Vaneechoutte
Ghent, B
Objective: Genotypic analysis of the microbiological differences
between the bacterial vaginosis (BV) microﬂora and the healthy
vaginal microﬂora.
Methods: A total of 150 vaginal swab samples from healthy
women were categorised on the basis of Gram stain of direct
smear as grade I (only Lactobacillus morphotypes, n ¼ 112), grade
II (intermediate, 26), grade III (bacterial vaginosis, 9) or grade IV
(only Gram-positive cocci, 3). (1) The composition of the vaginal
microbial community of eight of these vaginal swabs (three grade
I, two grade II and three grade III), were studied by culture and
by cloning of the 16S rRNA genes obtained after direct ampliﬁca-
tion. (2) Species-speciﬁc PCR for Atopobium vaginae and Gardnerella
vaginalis was carried out for all 150 vaginal swab samples. (3)
Forty-six cultured isolates were identiﬁed by tDNA-PCR and 854
cloned 16S rRNA gene fragments were sequenced, yielding a total
of 38 species.
Results: Cloning revealed that A. vaginae was abundant in four
out of the ﬁve non-grade I specimens and that Lactobacillus iners
was the only Lactobacillus species that was present in non-grade I
specimens, while it was absent from grade I samples. Respectively
1.8% (grade I), 15.7% (grade II) and 77.7% (grade III) of the
vaginal swab samples were positive for both A. vaginae and
G. vaginalis species-speciﬁc PCR (P < 0001, chi square).
Discussion: Culture independent, molecular analysis revealed a
higher microbial diversity in non-grade I specimens than did cul-
ture. Together, culture, 16S rRNA gene cloning and species-speci-
ﬁc PCR point to the presence of nine presumptively novel
bacterial species and to a strong association between A. vaginae,
G. vaginalis and bacterial vaginosis and to an ambiguous role for
L. iners. It appears as if A. vaginae may be a constituent – in low
numbers – of the human vagina, possibly attaining replicative
dominance in association with decreasing lactobacillary grading.
The presence of A. vaginae in bacterial vaginosis(-like) microﬂora
may shed new light on the aetiology of this condition.
P969 Molecular typing of Vibrio cholerae strains having
different sets of ‘pathogenicity islands’
E.A. Kostromitina, G.A. Yeroshenko, N.I. Smirnova
Saratov, RUS
Vibrio cholerae El Tor biovariant is characterised by the presence of
a number of different mobile chromosomal genetical elements.
Using multilocus PCR tests with various primers in the genomes
of 186 strains isolated in the territories of Russia and Turkmenis-
tan we were able to detect three housekeeping genes (hapA, toxR,
rtxA) and nine virulence genes located in prophages and ‘patho-
genicity’ and ‘persistence’ islands: CTXphi (ctxA, zot, ace), RS1phi
(rstC), VPI (tcpA, aldA, toxT), VPI-2 (nanH), EPI (mshQ). Besides,
we used the methods of ribotyping and PCR typing which
involved the ‘random’ primer, 1281, to elucidate genetical rela-
tionship between the strains of varying epidemic signiﬁcance. The
genome of clinical isolates obtained from patients during several
epidemic outbreaks, was shown to be stable and to contain all the
genes tested. C. vibrios isolated during the interepidemic period
from natural ecosystems, formed a heterogenous population rep-
resented by single virulent clones that had retained the complete
set of the genes under study, by non-toxinogenic strains, that had
lost only individual genes and (or) pathogenicity blocks of genes,
i.e. either CTXphi and RS1phi, or CTXphi, VPI and RS1phi, or by
those carrying deﬁcient prophages CTXphi (ctxA zot+ ace+) and
VPI (ctpA aldA+ toxT+), as well as by clones containing only
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housekeeping chromosomal genes and sometimes a gene from the
‘persistence island’. As soon as virulent clones get into water
environment, they lose their virulence blocks in the following
order: CTXphi and RS1phi, then VPI, gene VPI-2 being the last
one to be lost. In conformity with the results of the above three
genotyping methods, epidemically hazardous strains, represented
a homogenous group, suggesting a single clonal origin. Close
genetical relationship between these strains and non-toxinogenic
vibrios, that partly retained their virulence genes, was also estab-
lished. At the same time, as shown by ribotyping and PCR typing
studies, avirulent ‘water’ vibrios formed an independent group,
because their genotypes manifested quite distinct features, in con-
trast to the ﬁrst two vibrio groups. Thus, the observed genotype
heterogeneity of El Tor cholera vibrios living in water ecosystems
was likely to be a result of the loss of DNA fragments varying in
their length and functions. The genotyping procedures used in
the work made it possible to discover evolutional relationships
among the bacterial strains under study.
P970 Comparative study of enterotoxigenic Bacteroides
fragilis (ETBF) strains isolated in France and in Poland
P. Obuch-Woszczatynski, A. Belkum van, L. Dubreuil,
D. Dzierzanowska, H. Pituch, M. Luczak, F. Meisel-Mikolajczyk
Warsaw, PL; Rotterdam, NL; Lille, F
Bacteroides fragilis Gram-negative anaerobic rods, 132 strains isola-
ted in Poland and 53 in France (from intestinal and extraintestinal
sources) were compared in this study. The identiﬁcation of bacter-
ial strains was done on the basis of Gram staining, growth on
selective BBE (Bacteroides Bile Esculine) medium, and biochemi-
cal characteristics determined by the API 20 A test (bioMe´rieux,
France). For assessment of the presence of enterotoxin (fragilysin)
gene in analysed strains, the PCR method was used. DNA for
PCR was isolated using Genomic DNA PREP PLUS (A&A Bio-
technology, Poland) and ampliﬁcation was performed in a Techne
thermocycler with primers 404 (5¢-GAG CCG AAG ACG GTG
TAT GTG ATT TGT-3¢-TGC TCA GCG CCC AGT ATA TGA CCT
AGT-3¢). The PCR program consisted of the following steps: 94C
for 4 min, 40 cycles of 94C (1 min), 52C (1 min) and 74C
(1 min). Among the Polish 132 strains, 16 contained the fragilysin
gene. Of the 53 French strains 10 contained the fragilysin gene.
For all these strains, pulsed ﬁeld gel electrophoresis (PFGE) was
performed. Bacteria were suspended in SE buffer (75 mM NaCl,
2.5 EDTA pH 8.0), embedded in 0.5% agarose plugs and lysed
overnight at 55C. Plugs were washed ﬁve times in SE at room
temperature afterwards. DNA in the plugs was digested using
Not I (Boehringer Mannheim, Germany). Electrophoresis was per-
formed in a CHEF Mapper (BioRad, Venendaal, The Netherlands).
The voltage was 10 V/cm for 18 h with linear ramping from 5 to
35 s at 60 angles. In conclusion, 19% strains isolated in France
and 15% of those isolated in Poland contained the fragilysin gene.
The PFGE analysis revealed that strains isolated in Poland and in
France show genetically differentiation (these strains are genetic-
ally not homogenous).
P971 Rapid detection of mutations in Candida albicans by
pyrosequencing technique
G. Orr, D. Concas, V. Piras, S. Cosentino, M.B. Pisano, M.E. Fadda
Cagliari, Monserrato, I
Objectives: Different molecular mechanisms of resistance to azole
antifungal agents, that can exist simultaneously, have been des-
cribed in Candida albicans strains. One of these mechanisms
includes alterations in the gene encoding the target enzyme
ERG11. In the present study we used Pyrosequencing method to
conduct an epidemiologic survey in Ketoconazole-susceptible and
-resistant strains of clinical C. albicans strains isolated in our
region, to determine differences in the gene encoding lanosterol-
demethylase (ERG11).
Methods: The strains of C. albicans were obtained by swabbing the
oral mucosa of subjects with oropharyngeal candidiasis. Suscepti-
bility to Ketoconazole was tested using the broth microdilution
method recommended by the NCCLS document M27-A. Concen-
trations of Ketoconazole tested were in the range 0.03–16 mg/mL.
The MIC endpoint was deﬁned as the lowest concentration at
which 80% of growth was inhibited, compared with the drug-free
control. Yeasts were grown in Sabouraud agar and DNA was
extracted by using QIAamp DNA Mini Kit (Quiagen). PCR prim-
ers matched an ERG11 gene region of 178 bp. One of the primers
of PCR fragment was biotinylated, a single strand of PCR prod-
ucts was obtained with streptavidin-coated beads method. Sam-
ples were analysed using a PSQ 96 System with SQA Software
and SQA reagent.
Results: A total of 31.2% of strains exhibited DDS or resistance to
ketoconazole (MIC >0.25 lg/mL). The sequence analysis was
designed to cover a region of the ERG11 gene including codons
464–483. Previous studies showed that in this region, the muta-
tions G464S, G465S, R467K and I471T are associated with azole
resistance in C. albicans. In our study the sensitive strains have
shown no mutations. Among DDS and resistant strains, only the
mutation G464S was found in two strains, while no mutations
were demonstrated in the remaining isolates.
Conclusion: This study is the ﬁrst to use the Pyrosequencing sys-
tem to characterise changes in nucleotide sequence of the ERG11
gene fragment involved in azole resistance of C. albicans strains.
The observation of one point mutation in only two resistant
strains tested suggests a limited role of the region of the ERG11
gene analysed in the azole resistance among C. albicans strains
present in our region. However, the Pyrosequencing system has
shown to be a fast and speciﬁc technique for detection of point
mutations in the region of ERG11 gene of C. albicans strains.
P972 Development of a novel typing method for the
Escherichia coli verocytotoxin 2 variants. Correlations to the
clinical manifestations
S. Persson, F. Scheutz, K.E.P. Olsen
Copenhagen, DK
Background: Verocytotoxin 2 (VT2) of verocytotoxin producing
Escherichia coli (VTEC) is a potent toxin, capable of producing seri-
ous complication, when excreted from the bacteria colonising the
intestinal tracts. The mature toxin is composed of one A-subunit
and ﬁve identical B-subunits, and is encoded by the approxi-
mately 1240 bp vtx2AB operon. Based on the variable nucleic acid
sequence of both subunits, several toxin variants have been identi-
ﬁed.
Objectives: The subtype designation, important sequence motifs
and clinical signiﬁcance of the vtx2 variants, are not consistent
throughout the literature. To shed more light on these features, a
novel typing method was developed for the investigation of sub-
type-speciﬁc correlations to the clinical outcome.
Methods: The subtyping method relies on PCR and sequencing.
By use of vtx2 universal primers, a 630-bp fragment covering the
most variable regions of subunit A and B was ampliﬁed by PCR,
and subsequently sequenced.
Results and conclusion: The present method was used for the ana-
lysis of vtx2-positive strains from our strain collection, counting
274 strains, isolated from patients with known clinical manifesta-
tions (HUS, HC, bloody diarrhoea, diarrhoea, fever, etc.). Com-
pared with traditional subtyping, our preliminary results indicate
that most strains in our strain collection harbour the vtx2 or vtx2c
subtype, in addition to a few strains containing the activatable
carboxy-terminus of subunit A, referred to as vtx2d. Correlations
between these subtypes and the clinical complications will be pre-
sented. Additionally, the novel sequences from our strain collec-
tion will be investigated for other sequence motifs connected to
the clinical outcome. As sequencing has become more accessible
and less expensive, we believe that this method, offers a good
and reliable alternative for diagnostic subtyping of VTEC strains
from these infections.
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P973 Application of molecular biological techniques to the
study of alterations in hamster gut microﬂora and assessment of
treatment with Saccharomyces boulardii
L. Coroler, G. Philippe-Taine, E. Bayart, T. Ce´cile, J.-M. Gillardin,
H. Goı¨ot
Compie`gne, F
Objectives: Studies of the intestinal microbial ecosystem by classi-
cal culture techniques suggest that only 30% of the microﬂora can
be cultured. PCR procedures based on 16S rRNA gene speciﬁc for
bacteria were developed to detect bacterial populations in hamster
faeces.
Methods: A total of 30 populations of bacteria were characterised
by their genomic DNA sequences and targeted by PCR probes:
Actinomyces group, Bacteroides distasonis, Bacteroides fragilis, Biﬁdo-
bacterium group, B. adolescentis, B. angulatum, B. catenulatum,
B. infantis, B. longum, Clostridium group, C. clostridiiforme, C. cocco-
ides, C. difﬁcile, C. leptum, C. perfringens, Fusobacterium prausnitzii,
Lactobacillus group, Peptosteptococcus productus, Propionibacterium
group, Pseudomonas aeruginosa, Ruminococcus obeum, Citrobacter
group, C. freundii, Escherichia group, Enterobacteria group, Enterob-
acter cloacae, Morganella morganii, Proteus mirabilis, Staphylococcus
group, Salmonella group.
Results: Sensitivity was measured by extraction of total genomic
DNA and PCR ampliﬁcation and a signiﬁcant detection level of
103 bacteria/faecal sample was obtained. Qualitative variations of
bacteria population were observed during the ﬁrst 2 weeks of
acclimatisation, suggesting a stabilisation period for hamster
microﬂora in new environmental conditions. After oral antibio-
therapy, with one dose of 30 mg/kg amoxicillin-clavulanic acid,
some groups were eradicated from hamster faeces: Propionibacteri-
um, Staphylococcus and C. leptum, C. clostridiiforme. As reported in
the literature, no antibiotic effect was observed on levels of dom-
inant faecal groups: Biﬁdobacterium, Peptostreptococcus. Antibiotic-
associated perturbations are linked with the disruption of the nor-
mal intestinal ﬂora leading to a colonisation of pathogen bacteria
species. In order to understand the role of Saccharomyces boulardii
(S.b.) in prevention of antibiotic-associated diarrhoea,
4  1010 CFU/kg/day of S.b. were administered to hamsters dur-
ing oral antibiotic treatment. The results showed that populations
that were eradicated by antibiotic administration remained
expressed and stabilised with concomitant S.b. treatment, suggest-
ing an effective protection by S.b. on the intestinal ﬂora.
Conclusions: These PCR results should be used to quantify the
intestinal microﬂora by DNA microarray analysis.
P974 Identiﬁcation of Acinetobacter calcoaceticus –
A. baumannii complex by sequence analysis of the 16S–23S
rDNA spacer region
Y.F. Wei, H.C. Chang, M. Vaneechoutte, A.H. Huang, T.C. Chang
Tainan, TW; Ghent, B
Objectives: The Acinetobacter calcoaceticus–Acinetobacter baumannii
complex (Acb complex) includes A. calcoaceticus (genospecies 1),
A. baumannii (genospecies 2), unnamed genospecies 3 and 13TU.
These species are difﬁcult to differentiate by phenotype. In this
study, the feasibility of using sequences of the 16S–23S rDNA
spacer region (ITS) for identiﬁcation of the Acb complex was eval-
uated.
Methods: The bacteria-speciﬁc universal primers 13 BF (GTGAA
TACGT TCCCG GGCCT) and 6R (GGGTT YCCCC RTTCR
GAAAT) (Y ¼ C or T, and R ¼ A or G) were used to amplify a
DNA fragment that encompassed a small portion of the 16S
rDNA region, the ITS, and a small portion of the 23S rDNA
region. The ITS regions from 108 reference strains (42 species) of
nonfermenters including strains of Acb complex were ampliﬁed
by PCR and sequenced; the sequence data in combination with
those available in GenBank were used to construct an ITS
sequence database for the identiﬁcation of Acb complex. For refer-
ence strains of each species of the Acb complex, the sequence
similarities of the ITS regions were obtained by comparing their
ITS sequences with that of the type strain of the same species.
The database was used to test 82 clinical isolates of Acb complex,
including 63 isolates of A. baumannii and 19 isolates of A. calcoacet-
icus, as identiﬁed by API 20NE.
Results: A. baumannii had the shortest ITS fragment (607–609 bp)
followed by genospecies 13TU (608–615 bp), genospecies 3 (619–
621 bp) and A. calcoaceticus (627–638 bp). The intraspecies ITS
similarity of the Acb complex was very high, ranging from 0.98 to
1.0, whereas the interspecies ITS similarity was relatively low
(range: 0.86–0.91). Among the 63 clinical isolates of A. baumannii,
two isolates were genospecies 3 and 14 isolates were ungroupable,
as revealed by ITS sequence analysis. Therefore, about 25% of
clinical isolates of A. baumannii was misidentiﬁed. Furthermore,
among the 19 clinical isolates of A. calcoaceticus, 16 isolates were
genospecies 3 and three isolates were ungroupable. Therefore, the
designation of A. calcoaceticus to clinical isolates is, under most
conditions, not correct. These results were conﬁrmed by ampliﬁed
rDNA restriction analysis (ARDRA).
Conclusions: ITS sequence analysis provides a simple and useful
alternative for species delineation of the Acb complex.
P975 Utility of the CVD432 probe for identiﬁcation of
enteroaggregative Escherichia coli amongst isolates from
traveller’s diarrhoea
L.R. Macfarlane, J.N. Fletcher, R. Ashton, P.A. Chapman,
A.M. Snelling, I.N. Okeke
Bradford, Shefﬁeld, UK; Pennsylvania, USA
Objectives: Enteroaggregative Escherichia coli (EAEC) are increas-
ingly implicated in acute and persistent diarrhoea around the
world. Phenotypically, EAEC have a deﬁning ‘stacked brick’
pattern of aggregative adherence (AA) to epithelial cell lines
in vitro. Genotypically, they are diverse, and while a range of
EAEC pathogenicity factors are known, their distribution
amongst strains varies. The most widely used DNA probe for
EAEC is CVD432, which has been reported to have limited sen-
sitivity in some studies, but it is presumed to be speciﬁc for
EAEC. The aim of this study was to determine whether the
CVD432 probe is a speciﬁc tool for identifying EAEC strains
imported into the UK.
Methods: A total of 520 E. coli isolates (four per patient) were
obtained from consecutive stool samples of 130 diarrhoeal patients
with a recent history of foreign travel (33 different countries). All
were screened for hybridisation with the CVD432 probe, as well
as EAEC plasmid encoded virulence factors aggR (aggregative
adherence regulator), aap (dispersin) and the chromosomal patho-
genicity-island-encoded mucinase pic. Other pathogenic E. coli
were identiﬁed using standard probes. CVD432 probe positive
strains were then examined for adherence to HEp 2 cells after co-
incubation for 3 h.
Results: The prevalence of EAEC-associated genes amongst the
520 isolates was: CVD432 8.3%; aggR 6.3%; aap 11%; pic
13.3%. Adherence assays on the 43 isolates that were CVD432
positive revealed a mixture of aggregative (24 isolates) and
non-adherent strains (nine isolates) plus 10 isolates that gave an
unusual pattern of loose, highly localised aggregation, present
on <5% of the HEp-2 cells. Of the CVD432 positive strains,
65% were aap, aggR, and pic positive as well, but this group
also contained strains of all three adherence types. None of the
other EAEC-associated probes was unequivocally predictive of
actual AA among CVD432 positive strains. Unexpectedly,
CVD432 positive isolates that hybridised with the enteropatho-
genic E. coli probe eae were isolated from one patient (return-
ing from Turkey).
Conclusions: This study suggests that the CVD432 probe may not
be speciﬁc for true EAEC, even when combined with the other
probes used here. The signiﬁcance of the newly described adher-
ence pattern in relation to diarrhoeal disease remains to be eluci-
dated, as does the ﬁnding of E. coli with both EAEC and EPEC
properties.
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P976 Shiga toxin-producing Escherichia coli O157 in
Slovenia
P. Zabukovnik, A. Andlovic, A. Zore
Ljubljana, SI
Objectives: In the Institute of Microbiology and Immunology
(Department for bacterial diagnostics of diarrhoeal infections),
Medical Faculty in Ljubljana, we wanted to introduce multiplex
PCR test for detection of Shiga toxin-producing Escherichia coli
(STEC). Until recently we used only enzyme immunoassay (EIA)
to detect production of Shiga toxin (STX) in specimens. Institute
of Microbiology and Immunology has extensive collection of E.
coli isolates from human faeces (mostly from hospitals in Ljub-
ljana). We decided to test isolates in our collection from 1993 to
2002, with serogroup O157. We used multiplex PCR assay that
ampliﬁed sequences in four virulence genes (Shiga toxin 1 (stx1),
Shiga toxin 2 (stx2), intimin (eaeA), enterohemolysin (ehxA)).
Methods: All isolates were serotyped with rabbit O antisera. We
used multiplex PCR to detect presence of Shiga toxin 1, Shiga
toxin 2 (and sub variants, but did not discriminate between them),
intimin and enterohemolysin genes. We also tested those strains
for production of STX with EIA.
Results: We tested 20 E. coli isolates with serogroup O157 and
found 10 STEC. stx2 and ehxA genes were present in almost all
STEC O157 isolates. The most common PCR proﬁle (ﬁve of 20) of
O157 isolates had stx2, eaeA and ehxA genes. One isolate had
stx2 gene but did not produce Shiga toxin (or possibly EIA did
not detect produced Shiga toxin). Most of those 10 STEC O157
were isolated in summer months of July and August. Two O157
STEC were isolated in the year 1997 shortly one after another.
They had identical multiplex PCR proﬁle. The same happened in
the year 2002.
Conclusion: We notice increase in the number of STEC O157
isolates per year in years after 1997. This may be because of
use of better diagnostic methods. In last years STEC O157 with
PCR proﬁle stx2, eaeA and ehxA is dominant. In years 1993 to
1998 the dominant PCR proﬁle had stx1, stx2, eaeA and ehxA
genes.
Urinary tract infections
P977 Prevalence and aetiology of chronic bacterial
prostatitis
M. Sukhorukova, B. Gvasalia, I. Tascherev, L. Stratchounski
Smolensk, RUS
Background: Chronic prostatitis is recognised to be caused by
infectious and non-infectious prostatic inﬂammation as well as
non-inﬂammatory diseases, but the separation of various prostati-
tis syndromes is difﬁcult to perform. Bacterial prostatitis is a com-
mon diagnosis and a frequent indication for antimicrobial
therapy. However, conﬁrmation of aetiology of inﬂammation is
exceedingly uncommon.
Objectives: The aim of this study was to determine the prevalence
and aetiology of chronic bacterial prostatitis among the patients
with clinically conﬁrmed diagnosis.
Methods: Between October 2002 and October 2003 the patients
with suspected prostatitis were examined. The clinical diagnosis
was conﬁrmed in patients within 3 months or greater duration of
the following signs and symptoms: perineal discomfort, pain fol-
lowing ejaculation, urinary frequency, urgency, dysuria, low back
pain, suprapubic pain, palpation of a tender prostate on physical
examination. The bacteriological diagnosis was determined in
patients, who had not been taking antibiotics in the previous
month, by Meares and Stamey technique. Prostatitis was catego-
rised according to NIH classiﬁcation.
Results: A total of 129 patients were examined. Chronic bacterial
prostatitis (NIH category II) was found in nine patients (7.0%),
inﬂammatory chronic pelvic pain syndrome (NIH category IIIa)
– in 59 (45.7%), non-inﬂammatory chronic pelvic pain syndrome
(NIH category IIIb) – in 61 (47.3%). The following pathogens were
isolated in NIH Category II: Staphylococcus spp. – in three (33.3%),
anaerobic bacteria (Prevotella spp., Prevotella spp. and Peptostrepto-
coccus spp.) – in three (33.3%), Escherichia coli – in two patients
(22.2%), Acinetobacter lwofﬁi – in one (11.1%).
Conclusions: Chronic bacterial prostatitis is an important but rare
clinical entity. Careful examination using quantitative segmented
bacteriologic cultures leads to proper categorisation into the rec-
ognised forms of the prostatic syndrome. The most common path-
ogens of chronic bacterial prostatitis were Staphylococcus spp.,
anaerobic bacteria (Prevotella spp. and Peptostreptococcus spp.) and
E. coli.
P978 Comparison of prevalence and clinical management
of prostatitis in the Italian and North American experience
F. Marchetti, M. Rizzo, F. Travaglini, A. Trinchieri, C. Nickel
Verona, Florence, Milan, I; Kingston, CAN
Objectives: A prospective multicenter urology outpatient survey,
undertaken to examine prostatitis in Italy, is used to compare
the prevalence, characterisation, diagnosis and treatment of
prostatitis patient with the North American (NA) prostatitis
patient.
Methods and materials: Seventy urologists, representing a cross-
section of urologic centres in Italy, counted and recorded the
overall total male patients reported in the clinic and the overall
total patients diagnosed with prostatitis over a 5-week period.
Results were compared with published practice prevalence and
cohort data (in particular the NIH Chronic Prostatitis Cohort
Study – CPC and Seattle Prostatitis cohorts) examining similar
data in NA.
Results: A total of 1148 patients were identiﬁed with prostatitis
(12.8%). The mean age of the prostatitis patients was 47.1 (range
16–83). The most common urinary diseases were benign prostatic
hyperplasia (17.4%), recurrent urinary tract infections (11.2%)
and urinary calculogenesis (11.1%), while the most common con-
current diseases were diabetes (7.2%) and depression (6.8%).
The most frequently reported and most severe symptoms at time
of evaluation were irritative voiding symptoms, perineal and
suprapubic pain and discomfort. Over three quarters of the
patients were dissatisﬁed with their quality of life. Bacteria were
cultured in 15.6, 17.7 and 14.0% of EPS, VB3 and semen speci-
mens, respectively. Comparison to NA data suggests that the
European prostatitis patient and the European urologists’
approach to the diagnosis and treatment of prostatitis are not
that dissimilar to prevalence and management of prostatitis in
NA.
Conclusion: Prostatitis is a common worldwide outpatient diagno-
sis, comprising a signiﬁcant percentage of male outpatient visits
to urologists in both Europe and NA. The similarities in preval-
ence, characterisation and management of the typical prostatitis
suggests that an international collaborative research effort is indi-
cated in this important urological condition.
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P979 Aetiology and resistance of community urinary tract
infections in Sa˜o Paulo, Brazil: a three-year survey with 27 437
positive cultures
C. Kiffer, C. Oplustil, J. Sampaio, L. Kudo, C. Mendes
Sao Paulo, BR
Objectives: Assess the prevalence of pathogens responsible for
urinary tract infections (UTI) in community patients and their
antimicrobial resistance pattern in Sa˜o Paulo, Brazil.
Methods: From January 2000 to December 2002, 199 334 urine cul-
tures from community patients were collected. Positive cultures
with one single pathogen and a colony count  100 000 CFU/mL
were selected. Based on these criteria, 27 437 (13.8%) positive cul-
tures were analysed in this survey. Chi-square test for trend (Alt-
man, 1999) was performed to evaluate the resistance prevalence
ordering in the years surveyed (P < 0.05 was considered signiﬁ-
cant).
Results: Among the 27 437 positive cultures, 88.8% were from
female and 11.2% from male patients. Among the positive cul-
tures 89.3% presented growth of Enterobacteriaceae followed by
6.7% of Gram-positive cocci. Escherichia coli (72%) presented the
highest prevalence, followed by K. pneumoniae (6.3%) and
P. mirabilis (5.9%). Among Gram-positive isolates, E. faecalis was
the most prevalent (4.6%). Susceptibility tests were performed in
23 240 cultures. E. coli presented a resistance rate to ampicillin of
42.8%, to trimeth/sulfa of 33.6% and to tetracycline of 31.5%. For
the quinolones, ciproﬂoxacin and norﬂoxacin, E. coli presented a
higher resistance rate among the age group of 60 years old as
compared with the age group of 13 and <60 years old (22.8 vs.
6.8% and 22.9 vs. 6.9%, respectively). Ciproﬂoxacin presented a
Chi-square trend ¼ 50 388 (P < 0.05), with ascending resistance in
the years studied.
Conclusions: An important difference in the resistance pattern
was observed among pathogens and age groups. The difference in
age groups suggests the possibility of selective pressure due to
previous antimicrobial use in the community setting. Ciproﬂoxa-
cin could be used for empiric therapy in community UTI. How-
ever, its apparent ascending resistance should raise awareness as
to possible usage restriction in this setting. Surveillance studies
are useful for guiding therapy and helping curbing resistance.
P980 Resistance of Escherichia coli isolates from pregnant
and non-pregnant women with community-acquired urinary
tract infections in Russia: results of multicentre studies
UTIAP-2002 and ARIMB
V. Rafalski, A. Shevelev, L. Stratchounski
Smolensk, RUS
Objective: To compare the resistance of Escherichia coli isolates
from non-pregnant women with uncomplicated community-
acquired urinary tract infections (CA-UTI) and pregnant women
in different cities of the Russian Federation.
Methods: One hundred and forty-four non-pregnant and 117
pregnant women with signs of upper or lower community-
acquired uncomplicated UTIs were enrolled in two multicentre
prospective epidemiological studies (eight medical centres),
UTIAP-2002 and ARIMB, respectively. The strains isolated from
the patients who had signiﬁcant bacteriuria (>105 CFU/mL) were
included in the microbiological analysis. The MICs of antibiotics
(ampicillin – AMP, amoxicillin-clavulanate – AMX-CLV, cefuroxi-
me –CFR, cefotaxime – CFT, gentamicin – GNT, co-trimoxazole –
CTZ, nitrofurantoin – NTF, fosfomycin – FSF) were determined
by the agar dilution, as described in the NCCLS (2003) guidelines.
Quality control was performed using reference strains including
E. coli ATCC 25922, E. coli ATCC 35218.
Results: Resistance rates of E. coli from pregnant and non-preg-
nant women with CA-UTI in Russia are shown in Figure. There
are some statistically signiﬁcant differences in antimicrobial resist-
ance between studied groups. Ampicillin resistance was higher
among UTI isolates of E. coli in non-pregnant women (45.8%)
than in pregnant women (31.6%), P < 0.05 (Chi-square statistic).
Similar distinction in co-trimoxazole resistance was found  27.1
and 14.5%, P < 0.05 (Chi-square statistic).
Conclusions: The resistance rates of E. coli from non-pregnant
women with CA-UTIs in Russia to ampicillin and co-trimoxazole
are signiﬁcantly higher than in pregnant ones. There are no signi-
ﬁcant differences in resistance to other antimicrobials tested.
P981 Community-acquired urinary tract infections. A large
scale prospective study of medical practices in French
emergency departments
D. Elkharrat, F. Benhamou, P. Briquet-Brochard, C. Ginzburg,
C. Leroux for the APPUI Study Group
Background: Urinary tract infections (UTI) are the second most
frequent infections in French emergency departments (ED). How-
ever, their management in terms of antimicrobials (AM) and dis-
position of patients, according to anatomical site and severity of
UTI, is unclear.
Objectives: Estimate prevalence and identify management of
patients with UTI presenting in 78 EDs in France.
Methods: Consecutive patients with presumed UTI were included
during 14 days if they were older than 15 years and had a posit-
ive urine dipstick. Subsequently, urine culture (UC) was pre-
scribed and patients classiﬁed according to nine UTI categories.
Centres were also required to notify all visits motivated by infec-
tious diseases (ID) during the study period.
Results: Of 109 potential participants, 78 included 1054 UTI
patients (13  9/centre [2–58]). Based on a total of 47.2  25.1
non-trauma patients and 6.2  3.9 ID patients /centre/day during
the same period, prevalence of ID is estimated at 13.4% of non-
trauma visits and prevalence of UTI at 15.9% of all ID. The main
UTI categories were acute cystitis (AC ¼ 43.3%), acute pyelone-
phritis (AP ¼ 38.0%), bacterial prostatitis (BP ¼ 9.0%). Mean age
of patients was 46.0  23.8 years and sex ratio F in 71%. How-
ever, both differ signiﬁcantly according to UTI category, from
36.5  19.0 years and 92.5% F in uncomplicated AC to
65.0  25.0 years and 72.4% F in complicated AC to
38.9  19.6 years and 85.0% F in AUP. UC was ordered in 820
cases (77.8%) and data collected in 463. The latter were consid-
ered positive in 95% of cases and Escherichia coli was present in
81.6%. AM drugs were 990/846 patients, in combination in 17%
of cases. Fluoroquinolones (FQ), whether in single therapy or in
combination, accounted for 78.2% of all AM. From the ED,
patients (n ¼ 1037) were discharged (55.7%), maintained in the
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observation unit for <24 h. before discharge (7.0%) or admitted
(38.3%). The two factors that signiﬁcantly correlate to hospital
admission were the severity of UTI (53% of complicated AC, 34%
of AUP, 80% of complicated AP and 57.3% of acute prostatitis)
and patients‘ age (76.2  17.9 years in those admitted with com-
plicated AC vs. 48.8  24.9 years in the non-admitted, 44.5  22.0
vs. 33.3  15.0 years in AUP and 61.8  24.3 vs. 48.5  24.1 years
in complicated AP).
Conclusions: (1) Prevalence of UTI in French ED is very high.
Based on seven million non-trauma visits nationwide in 2002, the
number of expected UTI patients in the ED would amount to
147 000 annually. (2) Speciﬁcally designed guidelines for Euro-
pean ED may be helpful to ED physicians.
P982 Prostatitis syndromes and Stamey–Meares test results.
Recording of 6-year experience in the department of internal
medicine of a Greek tertiary hospital
P. Panagopoulos, I. Katsarolis, G. Koratzanis, K. Kanellakopoulou,
H. Giamarellou
Athens, GR
Objectives: To record the results of four-glass test in a group of
patients who have visited our Infectious Diseases Department due
to Chronic Prostatitis symptomatology.
Methods: Two hundred and eighteen (218) males [mean age
32 years (18–70)] were studied retrospectively. The majority of
patients (85%) received antimicrobial treatment during the past
year. A four-glass test was performed for all patients and Gram
(+), Gram (), chlamydia, mycoplasma and ureoplasma were
investigated accordingly.
Results: In a total of 218 patients, prostatic secretion specimens
were collected in 168 (77%). In the remaining 50 (23%), voided
bladder VB1, VB2 and VB3 specimens were collected and
examined. Chronic Bacterial Prostatitis (CBP) was documented
in 64 patients (29.35%), Chronic Pelvic Pain Syndrome (CPPS)
was diagnosed in 131 (60.1%), whereas 23 (10.55%) had ureth-
ritis. Cultures of specimens revealed the following microorgan-
isms: Enterococcus spp. 24, Escherichia coli, 6, Pseudomonas spp.
4, Enterobacter spp. 5, Klebsiella spp. 4, Morganella spp. 1, Citrob-
acter spp. 1, Mycoplasma spp. 1, Chlamydia spp. 3, Ureoplasma
spp. 5.
Conclusion: The four-glass test is absolutely necessary for the
diagnosis of chronic prostatitis syndrome and should be per-
formed correctly in order to elevate the prostatic secretion speci-
men collection. The percentage of CPPS and CBP and the
frequency of Enterococcus spp. as the responsible factor for CBP in
this study are different considered to the English literature.
P983 Simultaneous urinary and respiratory infection or
respiratory manifestations of urinary infection?
J. Losa, M. Tejero, L. Moreno, M. Velasco, R. Barba, A. Espinosa,
C. Guijarro, A. Delgado-Iribarren, J. Valverde, V. Castilla,
A. Zapatero
Madrid, E
Objectives: We often attend disabled old patients with presumed
diagnosis of simultaneous urinary and respiratory infection
(SUARI). Data concerning this problem are scant. We thus
performed a study to describe it.
Methods: Descriptive analysis of all 162 patients diagnosed as
SUARI within 24 h after hospital admission (June 2000 to June
2002). Demographic factors, underlying conditions, symptoms
and signs, laboratory, radiological and microbiological data,
antimicrobial therapy, outcome and ﬁnal diagnosis were evalu-
ated. Results are expressed by percentages or median as appro-
priate.
Results: Median age was 86 years, 50% were female and 56%
were nursing home residents. Seventy-four per cent were
dependent for activities of daily living, 22% had a permanent
urinary catheter and 58% had cognitive impairment. The most
frequent symptoms were fever (72%), decline in function (54%)
and dyspnoea (50%); only 7% referred dysuria. Stupor (46%),
crackles (40%) and ronchi (34%) were the commonest signs.
Leucocytosis (14065/uL), elevated urea (64 mg/dL), respiratory
failure (59%) and high C-reactive protein (142 mg/L) were the
main laboratory abnormalities. Pyuria was observed in 71%,
chest X-ray showed a pulmonary inﬁltrate in 48%, and 52% of
cases fulﬁlled criteria of severe sepsis. Blood and urine cultures
were positive in 18 and 52% of patients, respectively; gram-
negative bacilli (GNB) were found in 82% of positive cultures,
Escherichia coli being the most common agent. No pneumococci
were isolated either in blood or sputum. Amoxicillin-clavulanate
was the antimicrobial therapy most frequently administered
(51%). Median hospital stay and mortality were 6 days and
27% respectively. Urinary tract infection was the commonest
ﬁnal diagnosis (61%).
Conclusion: Respiratory manifestations predominate in disabled
old patients with GNB severe urinary sepsis initially diagnosed as
SUARI. Respiratory distress may underlie this presentation. Fur-
ther studies are required to support this contention.
P984 Risk factors for bacteriuria due to Pseudomonas or
Enterococcus in patients hospitalised through the emergency
department
D. Raveh, I. Rosenzweig, B. Rudensky, A.M. Yinnon
Jerusalem, IL
Objectives: To determine the incidence of, and risk factors for,
isolation of Pseudomonas aeruginosa or Enterococcus from urine
cultures obtained from patients in the emergency department
(ED).
Methods: One year prospective, non-interventional study of all
urine specimens collected in the ED, out of which one organism
was isolated at a concentration of >100 000 CFU/mL. In this
study were included all patients with P. aeruginosa or Enterococcus
bacteriuria (study patients), and control patients with Escherichia
coli bacteriuria subsequently hospitalised, at a ratio of two con-
trols for each study case. Patients were interviewed with a struc-
tured questionnaire and charts were reviewed for demographic,
clinical and laboratory indicators of Enterococcus or Pseudomonas
bacteriuria as compared with E. coli bacteriuria.
Results: Over the 1-year study period, 744 positive urine samples
were obtained from ED patients: 610 (82%) Enterobacteriaceae
(including 476 isolates of E. coli) and 134 (18%) other organisms,
of which 39 (5%) were P. aeruginosa and 28 Enterococcus (4%).
Comparison with a randomly chosen control cohort of 80 patients
with E. coli bacteriuria revealed several indicators for Pseudomonas
bacteriuria, including male gender (odds ratio 3.3, 95%CI 1.5–7.2,
P < 0.005), presence of a permanent urinary catheter (OR 15.4,
95%CI 2.2–140, P < 0.005), past prostatectomy (OR 13.4, 95% CI
1.5–315, P < 0.01), hospitalisation in the previous 2 months (OR
4.2, 95% CI 1.5–4.9, P < 0.005), and pregnancy (OR 2.8, 95%CI
2.1–3.6, P < 0.05). In addition, both Enterococcus and Pseudomonas,
as compared with E. coli, signiﬁcantly more often indicated
asymptomatic bacteriuria in patients with other diagnoses, as
opposed to clinically manifest bacteriuria, than isolation of E. coli
(OR 4.2, 95%CI 1.2–14.4, P < 0.05).
Conclusions: Pseudomonas (5%) and Enterococcus (4%) are isolated
from a signiﬁcant minority of urine samples obtained from ED
patients with clinically suspected bacterial infection. Isolation of
these organisms, as compared with E. coli, more often indicates
asymptomatic bacteriuria in patients with other infectious disease
diagnoses. In addition, several independent clinical indicators for
Pseudomonas bacteriuria were identiﬁed. These data may assist in
selecting optimal antibiotic treatment for patients admitted with
suspected urinary tract infection.
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P985 Inﬂuence of Escherichia coli virulence factors in the
levels of C reactive protein in febrile urinary tract infections
A. Smithson, J. Ruiz, S. Soto, J.P. Horcajada, J.A. Martinez,
A. Moreno-Martinez, J. Vila, J. Mensa
Barcelona, E
Objectives: Certain virulence factors (VF), particularly pap ﬁmb-
riae, are able to trigger production of cytokines, especially
through activation of Toll-like receptor 4 (TLR-4), and therefore
produce inﬂammation. The aim of this study was to assess the
inﬂuence of certain VF in the degree of inﬂammation in febrile
urinary tract infections (FUTI).
Methods: From 2002 to 2003, 117 adult patients with febrile com-
munity acquired FUTI (81 female with acute pyelonephritis (mean
age 50 (SD ¼ 22)) and 36 acute prostatitis (mean age 60
(SD ¼ 16)) caused by Escherichia coli were prospectively included.
Levels of C reactive proteins (CRP), white blood cell count
(WBCC) and days until apirexia after beginning antibiotic treat-
ment were recorded in all patients and considered as indirect
markers of inﬂammation. Genes encoding haemolysin, type 1 ﬁ-
mbriae, pap G ﬁmbriae, cytotoxic necrotising factor, aerobactin
and autotransporter toxin were detected by a PCR. Additionally
expression of type 1 ﬁmbriae and haemolysin were detected by
agglutination and growth on blood agar.
Results: Strains carrying pap G ﬁmbriae were involved in FUTI
with higher CRP levels than pap G ﬁmbriae negative strains
(14.95 vs. 10.51; P ¼ 0.028). The relation between the rest of VF
and CRP levels did not reach statistical signiﬁcance. No differ-
ences were found regarding the WBCC and the duration of the
fever.
Conclusions: These data indirectly suggest that the degree of
inﬂammation in FUTI caused by E. coli is associated with the
presence of pap G ﬁmbriae, which is coherent with the fact that
pap G ﬁmbriae are coreceptors of TLR4.
Mycology: candida and aspergillosis
P986 Initiation of an active surveillance programme on
yeast-related bloodstream infections in France (ASPYRIF)
E. Dannaoui on behalf of the French Mycoses Study Group
An active surveillance program has been implemented in
France to prospectively analyse yeast-related blood stream infec-
tions. A pilot study was conducted from 1 October 2002
through 30 September 2003 in 23 medical centres in Paris and
suburbs. For each patient, one isolate of each identiﬁed species
was sent to the NRCM together with clinical data ﬁlled on a
standard form. Identiﬁcation was conﬁrmed using phenotyping
tests and a PCR assay was performed on all Candida albicans
isolates to identify C. dubliniensis. Antifungal susceptibility test-
ing to amphotericin B, ﬂucytosine, ﬂuconazole, itraconazole,
voriconazole and caspofungin was performed according to EU-
CAST recommendations. The median age of the 282 patients
was 57 years [0–94 years], with a male predominance (59%).
Underlying factors for yeast-related blood stream infections
were often multiple for a given patient dominated by recent
surgery (69%), central venous catheter (66%), hospitalisation in
intensive care unit (53%), malignancy (42%), immunosuppres-
sive therapy (28%), HIV infection (10%), solid organ (6%) or
bone marrow (3%) transplantation and prosthetic devices (6%).
Overall, the mortality rate was high with 43% of deaths within
30 days after the ﬁrst positive blood culture. Candida spp. was
the most frequent genus (96%) with C. albicans (49%), C. glab-
rata (14%), C. parapsilosis (13%) and C. tropicalis (10%) being
the most frequent species isolated. Other Candida were recov-
ered below 3% (C. krusei, C. kefyr, C. lusitaniae). Non- Candida
spp. were Trichosporon asahii, T. mucoides, Geotrichum capitatum
and Cryptococcus neoformans. Our data show that the percentage
of non- albicans species equal that of C. albicans among the ye-
asts recovered during fungaemia. The proportion of the four
major species differed signiﬁcantly according to the presence of
central venous catheter (P ¼ 0.02). Analysis of the antifungal
susceptibility testing results revealed that most of the isolates
had usual antifungal susceptibility proﬁles. In conclusion,
ASPYRIF is a powerful tool that should allow us to accurately
describe the epidemiology of yeast-related blood stream infec-
tions in France without restriction to any underlying disease or
species.
P987 Nosocomial candidaemia: emerging resistance, newer
antifungals and cost implications
A. Guleri, G.D. Corcoran, S.R. Alcock, A.B.J. Speekenbrink,
G.S. Shankland
Glasgow, UK
Background: Nosocomial candidaemia is associated with signiﬁ-
cant morbidity and mortality in the critically ill. Emergence of
ﬂuconazole resistance raises further problems, but the newer anti-
fungal drugs [voriconazole, caspofungin, ambisome and abelcet]
offer alternative therapeutic options. They also raise the issue of
treatment-associated costs. An 8-year [1996 to November 2003]
clinical audit was conducted across two tertiary care hospitals
[Western Inﬁrmary and Gartnavel General Hospital, Glasgow].
The distribution of Candida species and ﬂuconazole/itraconazole
resistance, with emphasis on high-risk areas was studied. It also
addresses the newer antifungal options, cost implications and
patient risk-stratiﬁcation approach.
Methods: Eight-year data on blood culture yeast isolates with in
vitro [NCCLS] antifungal susceptibility [AFST] proﬁles.
Results: Of 154 yeast isolates Candida albicans [55.8%] was com-
monest, C. parapsilosis [18.8%], C. glabrata [18.2%], C. krusei and C.
lusitaniae [1.9% each]. All isolates were sensitive [ in vitro] to
amphotericin B. Sensitivity to ﬂuconazole and itraconazole,
respectively: 70.1 and 78.5% Candida species overall, C. albicans
[84.8 and 90.7%], C. parapsilosis [82.7 and 86.2%], C. glabrata [21.4
and 35.7%] and C. krusei [0% each].
Conclusion: Candidaemia with C. albicans predominates. The like-
lihood of isolating Candida species other than C. albicans from
blood culture is nearly 50% in newly diagnosed candidaemia.
Pending identiﬁcation and AFST, treatment with amphotericin B
deoxycholate, voriconazole, caspofungin, abelcet or ambisome are
options with costs varying from 	18 to 	4017 per week. Patient
risk-stratiﬁcation, local epidemiology and faster diagnostic options
[FISH, E-tests, automated technology] are also discussed.
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P988 Candidaemia: epidemiological data, complications
and outcome of patients from the VAMC during 7 years of
evaluation
G. Gonzalez-Claudio, M. Colon, E. Arroyo, C. Rivera-Vazquez,
S. Saavedra, C. Ramirez-Ronda
San Juan, PR
Objectives: To evaluate the outcome and complications in patients
with candidaemia treated with antifungals. To identify the most
common Candida species isolated in the VAMC patients with Can-
dida and evaluate the risk factors and epidemiological data of the
patients.
Methods: All patients admitted in the VAMC from August 1995
to August 2002 with blood cultures positive for Candida were
included in this study. Epidemiological data, medical history, risk
factors, co-morbid diseases and laboratory results were evaluated
in record review. Candida species were identiﬁed to determine the
prevalence of Candida species in the VAMC. The patients were
assigned to three different groups according to the therapeutic
regime provided to the patient by the primary physician. Out-
come and complications including nephrotoxicity, electrolytes dis-
turbances and hepatotoxicity were evaluated in each therapeutic
group. Statistical analysis was performed using the SPSS (Statisti-
cal Package or Social Science). A regression model was used for
the analysis of risk factors associated with mortality in patients
with candidaemia.
Results: One hundred and seven patients were randomised in the
study. C. tropicalis was the most commonly isolated Candida spe-
cies 45%, followed by C. albicans 31%. Mortality rate is high 73%,
especially in those patients infected with C. tropicalis and C. glab-
rata 88% (P ¼ 0.01). The mortality rate increased to 81.4% if no
treatment was given (P < 0.0001) and was worse if C. tropicalis
was isolated and not treated 92%. The patients treated had a sim-
ilar mortality rate irrespective of the administered agent, Ampho-
tericin (64%), Abelcet (60%) and Diﬂucan (60%), but was worse
in those patients admitted to an ICU, Amphotericin (86.6%), Abel-
cet (60%) and Diﬂucan 71.4% (P < 0.0001). Response rate in the
patients infected with C. albicans was 38.7 vs. 9% in patients with
C. tropicalis. Nephrotoxicity developed in 54% of patients and no
difference was found in those patients treated with Amphotericin
B vs. Abelcet.
Conclusion: Candidaemia has been increasing in frequency. C.
tropicalis is the most commonly isolated Candida species in our
institution. Candidaemia has a high mortality rate and is worse if
C. tropicalis is isolated and the patient is admitted to an ICU and
no treatment is given. There is no difference in response rate
within the different therapeutic options. Nephrotoxicity is higher
in patients treated with Amphotericin irrespective of the formula-
tions administered.
P989 The risk factors of candidaemia in cancer patients
after surgical operation and patients receiving chemotherapy
M. Koziol-Montewka, A. Miroslaw, K. Buczkowski, A. Chudnicka,
A. Magrys, A. Kolodziejek, B. Gabczynska, E. Staroslawska,
M. Montewka, M. Wojtowicz
Lublin, PL
Background: Invasive candidaemia is a life-threatening complica-
tion occurring especially in hospitalised cancer patients due to
surgical operation and application of aggravating chemotherapy.
Candida colonisation, dysfunction of humoral and cellular immune
system and prolonged periods of hospitalisation are considered to
be the risk factors of invasive candidaemia development. Early
diagnosis and evaluation of the risk factors are still a major chal-
lenge.
Objectives: The aim of our study was to evaluate the relationship
between the rate of Candida colonisation, disorders in immune
responses (associated with adverse changes in concentration of
TNF-alpha, IL-12, and myeloperoxidase) and development of
invasive candidaemia in hospitalised cancer patients.
Methods: Study group included 78 patients with lung cancer
admitted for surgical operation and 31 women with carcinoma
ovariorum after the third course of treatment with taxol and cisp-
latin. Patients were examined for fungal colonisation of mucosal
membranes with culture methods. Presence of Candida antigens
and DNA of the pathogen in the bloodstream was determined
with ELISA and PCR assay, respectively. Cytokine and myeloper-
oxidase concentration in serum of the patients was speciﬁed with
ELISA commercial kits.
Results: The study revealed that 43 (39%) lung cancer patients
were colonised with Candida in nosepharynx before the operation.
Pneumonia and wound infections were observed in 15 patients of
this group, Candida albicans was isolated as the only pathogen
from three patients colonised previously with Candida. In case of
patient group with ovariorum carcinoma, colonisation with Can-
dida of two or three sites was demonstrated in ﬁve (15%) of 31
women. The Candida antigen was present in blood in four of
them; positive PCR result was found in blood sample collected
from one of them. Signiﬁcant relationships between Candida colo-
nisation or infection and myeloperoxidase concentration were
found (5.9–13.1 vs. 170 ng/mL in healthy persons).
Conclusions: High rate of Candida colonisation and drastic
decrease in myeloperoxidase serum concentration in patients with
lung and ovariorum cancer are predisposing risk factors for inva-
sive Candida infection. Detection of Candida antigens and DNA of
the pathogen may improve early diagnosis of the candidosis.
P990 Evaluation of BacT/ALERT 3D system to diagnose
bloodstream infections due to yeasts
M.A. Miguel, M. Cuervo, M. Lecuona, B. Castro, M.J. Ramos,
M.I. Montesinos, A. Sierra
St. Cruz de Tenerife, E
Objective: Evaluation of Bact/ALERT 3D system in recovering
yeasts from blood cultures (BC).
Methods: Over a period of 17 months (1/6/02 to 31/10/03), all
BC received in the Microbiology Service were included in our
study. All the specimens were performed with Bact/ALERT 3D
(bioMerieux) initially during 5 days or 30 days in special cases.
Yeast identiﬁcation was performed with ID-YST VITEK TWO
and/or API 20C AUX (bioMerieux).
Results: Of 15 008 analysed BC, 4150 gave a positive result and
142 (3.42%) of them proved to be yeast strains. In 68 cases
(47.89%) both bottles (aerobic and anaerobic) were positive; in
69 cases (48.59%) only the aerobic bottles was positive and in
ﬁve cases (3.52%) only the anaerobic bottles was positive. Rela-
ted to the detection time in aerobic bottles, 36.62% gave a posit-
ive result in the ﬁrst 12 h of incubation (average 6.8 h)
cumulative percentage of 50% at 24 h. In the second day,
80.28% were positive. In anaerobic bottles 50.68% gave a posit-
ive result in the ﬁrst 12 h of incubation (average 7.8 h) cumula-
tive percentage of 67.11% at 24 h. In the second day 93.14%
were positive. Candida albicans was isolated in 47.37% cases. We
recovered a positive result in the ﬁrst 12 h of incubation from
50% aerobic bottles (average 5.82 h) cumulative percentage of
63% at 24 h. For the anaerobic bottles 48.78% were positive in
the ﬁrst 12 h (average 8 h) cumulative percentage of 68.29% at
24 h. C. parapsilosis was isolated in 26.32% cases, always recov-
ered from aerobic bottles. The average of growth was 3.32 days
in the 83% of cases. Anaerobic bottles gave a negative result in
88%. C. glabrata was isolated in 10.53% cases. The average of
growth was 2.7 days in the 90.9% of cases. Anaerobic bottles
gave a negative result in 63.64%. C. tropicalis was isolated in
10.53% cases. Aerobic bottles were positive in 91.67%, and
92.31% of them had 9.55 h average of growth. Anaerobic bottles
were positive in 46.15% (average 15.6 h).
Conclusion: Bact/ALERT 3D system has demonstrated to be an
effective method in recovering yeasts from BC. In our hospital C.
albicans was the yeast most frequently isolated from BC followed
by C. parapsilosis, C. glabrata and C. tropicalis. Strain recovered fast-
est was C. albicans followed by C. tropicalis.
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P991 Candida spp. in a large Italian paediatric hospital:
species distribution and comparison of the susceptibilities to
ﬂuconazole and voriconazole
G. Manno, A. Scaramuccia, L. Pescetto, C. Peri, M. Mentasti,
R. Bandettini
Genoa, I
Objective: The large use of azoles in paediatric setting raise con-
cern about the development of resistance on yeasts and the emer-
gence of some non-susceptible species. We conducted a
prospective surveillance study to determine distribution of species
and azoles antifungal susceptibilities of Candida spp. from patients
(pts) hospitalised in Gaslini Children’s Hospital Genova, Italy.
Methods: From 1/03/2003 to 31/11/2003 we studied all yeasts
considered pathogens from all body sites, from paediatric pts in
all in-hospital locations. Isolation and yeasts species identiﬁcation
were carried out by conventional methods. On isolates, FLU and
VOR susceptibilities were assessed by the NCCLS M44-P method,
with disks tested in Mueller–Hinton medium with glucose and
methylen blue, 0.5 MacFarland inoculum. All susceptibility test
results were read by BIOMIC Plate Reader System (Giles Scienti-
ﬁc). C. albicans (Ca) ATCC 90028 was included. NCCLS FLU
Breakpoints (mcg/ml) were S < 8, S–DD 16–32, R > 64 with corre-
sponding zone interpretative criteria (mm) S > 19, S–DD 15–18,
R < 14. Breakpoints for VOR have not yet been established.
Results: In the study period we recovered 65 Ca, 21 C. parapsilosis
(Cp), 16 C. tropicalis (Ct), two C. krusei, two C. glabrata (Cg), two
C. lusitaniae (Cl) and one Tricosporon beigelii. Species were isolated:
20% from urinary tract, 25%, upper respiratory tract, 19% miscel-
laneous ﬂuids, 13% lower respiratory tract, 10% blood, 9% CVC,
4% various. Patients with yeasts infections were hospitalised:
49% in PICU/NICU, 14% haematology–oncology, 11% surgery,
6% infectious diseases, 6% nephrology, 5% pneumology, 5%
medicine, 2% orthopedics, 2% dermathology. Distribution of
bloodstream isolates were: four Cp, three Ct, one Ca and one Cl.
Seventy percent of Cp strains were recovered from PICU/NICU
pts. The average zone diameter (mm) – MIC50/MIC90 (mcg/mL)
(agar disk gradients) were: Ca FLU 34 – 0.53/1.8, VOR 36 – 0.04/
0.18; Cp FLU 35 – 0.3/0.87, VOR 39 – 0.01/0.05; Ct FLU 31 – 1.1/
14, VOR 33 – 0.15/4.8. Ca (4/65) were resistant to FLU with VOR
MICs >48 mcg/mL, one Ct was FLU SDD, one Gg was R to FLU
and inhibited with 1.1 mcg/mL of VOR.
Conclusions: Our results show that Ca is still the predominant
species recovered from paediatric pts; Cp and Ct appear to be
recovered with increased frequency in serious infections of critic-
ally ill pts. FLU showed a still good ‘in vitro’ susceptibility on our
strains; VOR appeared more active than FLU against Cp and Ct.
P992 Effect of voriconazole on ergosterol content of
Candida krusei
S. Costa-de-Oliveira, C. Pina-Vaz, E. Pinto, A. Oliveira, C. Tavares,
A. Gonc¸alves Rodrigues
Porto, P
Voriconazole (Vor) is a new azole antifungal agent with a similar
structure to ﬂuconazole (Flu). As with other azoles, its primary
mechanism of action is through disrupting the normal sterol bio-
synthetic pathway, leading to a reduction in ergosterol content
(1). Nevertheless Vor is more potent against most Candida spp.,
and shows a wide spectrum of activity. Thus Candida krusei,
which is intrinsically resistant to ﬂuconazole (by unknown mech-
anism), shows low MIC values to Vor. This lack of cross-resist-
ance and the fact of being fungicidal to some fungi suggest a
distinct mechanism of action.
Objective: To study the effect of Vor on the amount of ergosterol
of C. krusei strains, in comparison with Flu.
Methods: The MIC to Vor was determined according to the
NCCLS protocol M27-A on 24 strains of C. krusei, all resistant to
Flu (MIC  64 lg/mL). Ergosterol was isolated from C. krusei
cells by saponiﬁcation and the non-saponiﬁable lipids were extrac-
ted with heptane. Ergosterol was identiﬁed by its spectrophoto-
metric absorbance proﬁle (240–300 nm) (2). A quantiﬁcation of
ergosterol was determined after incubation with and without both
azoles at MIC and sub-inhibitory concentrations.
Results: In all the strains, MIC to Vor ranged between 0.125 and
0.5 ug/mL. All C. krusei have a signiﬁcant amount of ergosterol,
with no signiﬁcant differences among the strains. After incubation
with MIC concentrations of Vor an 80–100% reduction of the
ergosterol content was observed. A similar effect was obtained
with ﬂuconazole but only with highest concentrations (64 ug/
mL).
Conclusion: The Vor induces a considerable impairment on the
biosynthesis of ergosterol by C. krusei strains. It is much more
potent inhibitor of ergosterol biosynthesis than Flu.
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P993 Trends in species distribution and antifungal
susceptibility in Candida wound infections: an overview of a
6-year period
J. Martı´nez-Alarco´n, T. Pela´ez, J.V. Guinea, O. Cuevas, P. Mun˜oz,
M. Rodrı´guez-Cre´ixems, E. Bouza
Madrid, E
Background: Mycotic infections of hospitalised patients are emer-
ging as a signiﬁcant public health issue. Numerous studies have
shown that candidaemia is associated with a signiﬁcant attribut-
able mortality and prolonged hospital stay, but only a few reports
analyse the incidence of Candida spp. in wounds.
Objective: To analyse the species distribution and antifungal sus-
ceptibility of Candida infection in wounds in our hospital during a
6-year period (1997–2002).
Methods: The in vitro activities of amphotericin B (AB), ﬂuconaz-
ole (FZ), itraconazole (IZ), ketoconazole (KZ) and ﬂucytosine were
determined by the broth microdilution method following NCCLS
criteria. MICs were visually determined after 24 and 48 h incuba-
tion at 35C
Results: From 1997 to 2002 we processed 18 573 wound samples
in our laboratory. Of these, 14 060 (75.7%) were positive, 13 413
(95.4%) showed bacterial growth without Candida and 647 (4.6%)
with Candida. The rate of isolation of Candida in wounds/year
was as follows: 1997 (2.7%), 1998 (3.7%), 1999 (4.8%), 2000
(4.3%), 2001 (6.3%) and 2002 (5.7%). Globally, Candida albicans
was the most frequently isolated species per patient (296; 57.9%),
followed by C. parapsilosis (71; 13.9%), C. glabrata (40; 7.8%) and
C. tropicalis (37; 7.2%). The trends in species distribution were
similar in both the adult and paediatric population. The evolution
in the successive years of wounds with more than one species of
Candida was as follows: 2/59, 8/94, 8/97, 4/92, 16/163 and 16/
142. Overall, the percentages of resistance of Candida spp. isolated
were: AB (4.6%), FZ (10.2%), IZ (17%), KZ (12.5%) and FC
(2.3%).
Conclusion: Our study shows an increasing presence of Candida
spp. among the wound isolates in the microbiology laboratory. A
high proportion is due to species other than C. albicans and it can
be probably attributed to the increase in antibiotic burden in our
hospital.
P994 UK enhanced surveillance of invasive fungal
infections in very low birth weight infants
T. Lamagni, L. Clerihew, W. McGuire
London, Dundee, UK
Objectives: Preliminary analyses from enhanced surveillance of
invasive fungal infections in very low birth weight (VLBW)
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infants were performed to estimate disease burden, short-term
outcome and microbiological characteristics of causative organ-
isms.
Methods: Prospective enhanced surveillance of invasive fungal
infections in VLBW (<1500 g) infants began in February 2003,
with cases deﬁned as meeting of one or more of the following
diagnostic criteria: (1) culture from a sterile site – CSF, blood (per-
ipheral sample), urine (supra-pubic aspirate or in–out catheter
sample), bone/joint, peritoneal or pleural space; (2) pathognomo-
nic ﬁndings on ophthalmological examination; (3) pathognomonic
ﬁndings on renal ultrasound examination; and (4) autopsy diag-
nosis of invasive fungal infection. Cases were identiﬁed through
three separate surveillance schemes: monthly notiﬁcations from
paediatricians to the British Paediatric Surveillance Unit; continu-
ous reports from microbiology laboratories to the Communicable
Disease Surveillance Centre (England) and Scottish Centre for
Infection and Environmental Health (Scotland). Reports from the
three systems were reconciled and analysed. Rates were calcu-
lated using Ofﬁce for National Statistics total live birth estimates.
Results: Between February and July, 38 conﬁrmed cases of inva-
sive fungal infection in VLBW infants were reported, 10.02/1000
births of VLBW. Median age at diagnosis was 11 days (range
1–126) and birth weight 800 (520–1200) g. Thirty-four of the 38
infants were of extremely low birth weight (<1000 g). Candida
albicans was the most common pathogen, found in 55% of cases,
and C. parapsilosis in 23%. Organisms were most commonly isola-
ted from blood (73%), followed by urine (23%), CSF (8%) and cen-
tral line tips (53%). Just over a third of cases (36%) had received
prophylactic antifungal therapy. One case of drug resistance was
identiﬁed during this period (ﬂuconazole resistance in a non-albi-
cans Candida spp.). Of the 32 infants for whom outcome data were
available, 22 were alive at 37 weeks post-conceptional age.
Conclusion: Preliminary ﬁndings from enhanced surveillance sug-
gest an incidence of invasive mycoses in VLBW infants of one in
100. As per adult cases, C. albicans was the most common fungal
pathogen involved, although C. parapsilosis was relatively more
common than in adults. The majority of cases occurred in extre-
mely low birth weight infants, and mortality was found to be
high.
P995 Surveillance cultures of throat and rectum combined
with enteral polyenes control fungal infections in prolonged
paediatric illness
S. Rajan, N. Taylor, P.B. Baines, H.K.F. van Saene
Liverpool, UK
Objectives: To evaluate six endpoints [i] carriage rate; [ii] rate of
carriers with overgrowth; [iii] fungal infection rate; [iv] correlation
between overgrowth and infection; [v] impact of oral polyenes on
carriage and infection; [vi] mortality.
Methods: Surveillance swabs of throat and rectum were taken on
admission and twice weekly afterwards. Diagnostic samples were
obtained on clinical indication. All samples were processed using
standard mycological techniques. Overgrowth was deﬁned as 3+
or 1 000 000 yeast cells/mL of saliva and/or gram of faeces.
Carriage index is the ratio of the sum of all semi-quantitative
growth densities of positive surveillance swabs divided by the
total number of swabs; on a particular sampling day. Oral polye-
nes were started following the identiﬁcation of the carrier state.
Results: A total of 1241 children requiring minimally 4 days of
ventilation were enrolled in this 4-year observational, prospective
study [01/03/99 to 28/02/03]. The median paediatric index of
mortality was 0.06 [IQR 0.02–0.13], and the actual mortality was
9.6%. Enteral polyenes as part of selective digestive decontamina-
tion [SDD] were administered to half of the study population
[53%]. The median length of stay was 8 days [IQR 5–13 days].
Carriage rate was 45%. Eighty percent of carriers had overgrowth
concentrations. Forty-four patients [3.5%] developed a total of 59
infections. The median onset of infection was 7 days [IQR 3–12.5].
Eighty-ﬁve percent of all infections were primary endogenous,
due to yeasts present in the patients admission ﬂora. Infections of
wounds [32%], vagina [19%], blood [15%] and bladder [12%]
were predominant. Thirty-nine patients [90%] had overgrowth at
the time of the infection. Only three patients developed an infec-
tion without overgrowth. Oral polyenes reduced the carriage
index below the threshold of overgrowth after 1 week of treat-
ment. Fifty-six children who were yeast carriers died [4.5%]. The
mortality rate in the carriers with overgrowth was 3.9% [48
patients]. Of the 44 infected children 13 died [30%].
Conclusion: Patients develop primary endogenous fungal infec-
tions in the presence of overgrowth within the ﬁrst week of PICU
admission. Oral polyenes reduce the level of carriage and prevent
subsequent secondary endogenous infections.
P996 Candida dubliniensis in Kuwait
Z. Khan, S. Ahmad, E. Mokaddas, N. Al-Sweih, R. Chandy
Kuwait, KWT
Objective: Candida dubliniensis is a newly described pathogenic
species, ﬁrst isolated from HIV-infected patients with oropharyn-
geal candidiasis. It shares many phenotypic features with C. albi-
cans, including the ability to form germ tubes and
chlamydospores. These similarities have caused signiﬁcant prob-
lems in its differentiation from C. albicans in routine clinical micro-
biology laboratories. This study reports isolation and
identiﬁcation of C. dubliniensis for the ﬁrst time from Kuwait and
presents data on antifungal susceptibility proﬁle.
Methods: Over a period of 21 months, 800 germ-tube positive ye-
asts identiﬁed as C. albicans and recovered from different clinical
specimens were screened for their ability to grow at 45C on Sab-
ouraud dextrose agar. Isolates which failed to grow at 45C were
presumptively identiﬁed as C. dubliniensis. The identity of
C. dubliniensis isolates was further conﬁrmed by formation of
rough colonies and chlamydospores on sunﬂower seed agar, by
Vitek 2 system, and by semi-nested PCR using species-speciﬁc
primers corresponding to unique sequences within the internally
transcribed spacer 2 (ITS2) of C. dubliniensis and by direct sequen-
cing of ITS2. The antifungal susceptibility testing was performed
on RPMI 1640 medium as recommended in NCCLS, M27A docu-
ment.
Results: Of the 800 germ tube positive yeast isolates, 27 (3.3%)
were identiﬁed as C. dubliniensis. They were isolated from sputum
(n ¼ 12), vaginal swabs (n ¼ 5), endotracheal secretion (n ¼ 3),
throat swabs (n ¼ 2), urine (n ¼ 2) and one each from bronchoal-
veolar lavage, catheter tip and peritoneal ﬂuid. None of the iso-
lates originated from HIV-positive patients. All the C. dubliniensis
isolates were susceptible to amphotericin B, ﬂuconazole, itraconaz-
ole and voriconazole. However, 19% of the isolates were resistant
to 5-ﬂucytosine (>32 lg/mL) without any known previous expo-
sure.
Conclusion: Identiﬁcation of C. dubliniensis from 3.3% of the yeast
isolates in our study suggests that this species is not uncommon
in Kuwait. There is a need to carry out a systematic study in
high-risk patient groups to know its epidemiologic signiﬁcance.
Acknowledgement: The work is supported by Kuwait University
Research grant MPI-118.
P997 Candida glabrata fungaemia: an uncommon entity
affecting the elderly
M. Sa´nchez-Somolinos, P. Mun˜oz, L. Alcala´, T. Pela´ez,
M. Rodrı´guez, J. Guinea, E. Bouza
Madrid, E
Background: Fungaemia remains a severe nosocomial complica-
tion and the emergence of non-albicans species is posing new
challenges both to clinicians and to microbiologists.
Objective: To assess the incidence and clinical presentation of
C. glabrata fungaemia, its susceptibility and its clinical outcome.
Methods: From 1987 to 2001, we had 479 episodes of fungaemias
and 37 cases corresponded to C. glabrata (7.7%). Thirty cases were
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compared with C. albicans controls. Susceptibility testing was per-
formed with the modiﬁed microdilution method (M-27A,
NCCLS), with RPMI-2% glucose medium.
Results: The distribution of C. glabrata fungaemias was: 1987–
1993, two cases; 1994–2001, 28 cases. Underlying conditions
included: cancer (23%), AIDS (16%), surgery (50%), TPN (37%)
and IV lines (90%). The most common origins were: unknown
(27%) and IV catheters (23%). Clinical presentation included:
fever (93%), shock (17%) and chorioretinitis (10%). When com-
pared with C. albicans, patients with C. glabrata fungaemia were
older (58 vs. 42), had received more previous antifungals (37
vs. 10%, P ¼ 0.01) and antimicrobial agents (97 vs. 73%,
P ¼ 0.01), had more indwelling bladder catheters (90 vs. 50%,
P < 0.001) and had more septic metastasis (23 vs. 6%,
P ¼ 0.07). IV catheters were more commonly withdrawn in
patients with C. glabrata fungaemia (60 vs. 33%, P ¼ 0.03),
whereas these patients received fewer antifungals (57 vs. 70%,
NS). MIC90 of C. glabrata were ﬂuconazole (FLU) 16 mg/L,
itraconazole 1 mg/L, amphotericin B (AMB) 1 mg/L and voric-
onazole 0.5 mg/L. Surprisingly, FLU was more frequently selec-
ted to treat patients with C. glabrata (57 vs. 24%). Mortality
was similar (50 vs. 53%). Six of the 10 patients treated with
FLU died, as well as four of the seven treated with AMB. Two
patients had persistent fungaemia despite catheter withdrawal
and FLU therapy.
Conclusion: C. glabrata fungaemia is an increasingly frequent and
very severe disease. It is clinically indistinguishable from C. albi-
cans and microbiology departments must assure that proper mes-
sages regarding identity and antimicrobial susceptibility of this
yeast reach clinicians in due time.
P998 Candida spp. in patients with otitis externa
I. Radonjic, A. Dzamic, L. Petkovic, A. Trpkovic, N. Arsovic,
V. Arsic Arsenijevic
Belgrade, CS
Objectives: Otomycosis represents a signiﬁcant percentage of clin-
ical external otitis and is usually caused by Candida, Aspergillus,
Penicillium and Malassezia. Clinical symptoms such as otorrea, ery-
thema and stenosis of the external auditory canal are commonly
present and create appropriate conditions for fungal growth. The
objectives of this study were to determine the prevalence of Can-
dida otomycoses and to evaluate the relationship between albicans
and non-albicans species.
Methods: From April 2002 to November 2003, a total number of
67 patients were found to be suffering from symptoms indicating
otitis externa. The specimens were taken by cotton swab from
bony portion of external ear. All specimens were inoculated on
Sabouraud dextrose agar, incubated at 26 and 37C for 7 days
and examined macroscopically every day. Suspected cultures
were examined microscopically in order to conﬁrm ﬁnding of
Candida spp. The identiﬁcation of isolated Candida strains was car-
ried out by germ tube test and API 20C AUX assimilation test
(BioMerieux, France).
Results: In a base of microbiological ﬁndings 12 (17.9%)
patients considered to be negative, 39 (58.2%) conﬁrm bacterial
or mould results and in 16 (23.8%) patients Candida spp. was
found. Out of 16 patients with diagnosed Candida otomycosis,
in 11 patients only Candida spp. was isolated and in ﬁve
patients otitis externa was caused by Candida associated with
bacterial or mould infection. C. albicans was identiﬁed in three
(3/16) cases, while all other was non-albicans strains as three
cases of C. guilliermondii (3/16), four of C. famata (4/16) and six
of C. parapsilosis (6/16).
Conclusion: In clinical ﬁnding of otitis externa mycological exam-
ination could be very important in setting the accurate diagnosis
and appropriate therapy. These results suggest that C. albicans is
not the predominant causative agent of otitis externa. Isolation
of non-albicans species has particular interest in therapy of otitis
externa because of their reduced susceptibility to antifungal
agents.
P999 Recurrent vulvovaginal candidiasis: prevalence,
antifungal susceptibility patterns and genotyping of different
species
S. Asticcioli, R. Migliavacca, E. Nucleo, M. Spalla, L. Sacco,
L. Pagani
Pavia, I
Objectives: Candida albicans is the main species involved in vulvo-
vaginal infections, even if Candida non-albicans species, with
broad resistance to antifungal agents, are emerging. This ﬁnding
emphasises the pathogenic role of non-albicans species in vulvo-
vaginal candidiasis with important implications for therapeutic
management and the possibility of recurrent infections. Thirteen
women with recurrent vulvovaginal candidiasis (RVVC) were
observed out of 157 women attending the Sexual Transmitted Dis-
eases ambulatory of the S. Matteo hospital of Pavia, during the
period 2000–2003. The study was focused on the species involved
and their in vitro antifungal susceptibility. Molecular typing of the
isolates involved in subsequent episodes of RVVC allowed estab-
lishing if the strains showed the same DNA type.
Methods: Isolates were identiﬁed by standard morphological and
biochemical methods. MICs of amphotericin-B, itraconazole, ﬂuc-
onazole, ketoconazole, 5-ﬂuorocytosine, voriconazole were deter-
mined by Sensititre YeastOne colorimetric antifungal panel plates
according to NCCLS document M27-A. The strains were typed
using pulsed-ﬁeld gel electrophoresis (PFGE) and repetitive extra-
genic palindromic-PCR DNA ﬁngerprints.
Results: C. glabrata was isolated in 53.8%, C. albicans in 30.7%, C.
krusei in 15.5% of cases. The yeasts involved in each recurrence
were characterised by identical biochemical proﬁles and drug
resistance phenotypes. C. albicans strains isolated from one RVVC
resulted in in vitro resistant to azoles. The genotyping by PFGE
revealed that C. albicans and C. glabrata obtained from different
patients were clinically unrelated to each other while an identical
proﬁle, indicating clonal relatedness, was observed with yeasts
recovered from the same patient.
Conclusion: Our data underline the persistence of strains, with the
same antifungal susceptibility proﬁle and clinically related geno-
types in patient with recurrent infections, suggesting a colonisa-
tion with the same strain over different periods of time despite
therapy. These results stress the need for molecular tools for
strain typing in order to clarify the epidemiology of the RVVC
and to control drug-resistant fungal agent spread.
P1000 Invasive aspergillosis: an emerging pathogen with a
huge mortality in non-haemato-oncological patients
W. Meersseman, S.J. Vandecasteele, E. Van Wijngaerden,
J. Maertens, A. Wilmer, W.E. Peetermans
Leuven, B
Objectives: Using criteria designed for invasive aspergillosis (IA) in
neutropenic patients, the present study aimed to determine the
impact of invasive aspergillosis in different groups of non-haemato-
oncological ICU patients.
Methods: This study is a retrospective analysis of all patients that
were hospitalised in the 17-bed medical intensive care unit
(MICU) between 1 January 2000 and 1 January 2003. Any admit-
ted patient fulﬁlling one or more of the following criteria was
included in the study: (a) histopathological evidence of Aspergil-
losis (including autopsy) or (b) microbiological evidence of asper-
gillosis during stay in the MICU (positive culture or positive
circulating galactomannan). IA was classiﬁed as proven, probable
or possible, according to the EORTC/MSG deﬁnitions. Aspergillus
isolation from a non-sterile site in patients without appropriate
clinical setting was considered as ‘colonisation’.
Results: Between 2000 and 2003, 127 of 1850 patients (6.9%) ful-
ﬁlled the inclusion criteria. Thirty-eight patients (29%) had haem-
atological malignancies and were not further analysed. Eighty-
nine (71%) were non-haemato-oncological patients (37 COPD,
nine solid organ transplant recipients, 17 autoimmune diseases,
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six cirrhosis patients and 20 miscellaneous). Following the
EORTC/MSG criteria, these patients were classiﬁed as proven IA
(n ¼ 30), probable IA (n ¼ 37), possible IA (n ¼ 2) and ‘colonisa-
tion’ (n ¼ 20). Mean SAPS II score was 52 with a predicted mor-
tality of 48.6%. Overall mortality was 80% (n ¼ 71). Mortality of
the proven and probable group was 96.7 and 86.5%, respectively.
Among the 18 patients who survived, 10 just had ‘colonisation’
with Aspergillus. Post-mortem examination in the non-haemato-
oncological group was done in 46 out of the 71 patients who died
(70%) and 29/46 autopsies (63%) showed hyphael invasion with
Aspergillus (mainly the lung as target organ). There were ﬁve pro-
ven cases in patients without compromising host factors according
to the EORTC/MSG deﬁnitions (three liver cirrhosis, one pneu-
monia in a 95-year-old man, one Klebsiella sepsis with MOF).
Conclusion: IA is an emerging infectious disease in non-haemato-
oncological ICU patients. There seems to be a broad group of
patients at risk of IA. IA was diagnosed in patients without char-
acteristics described in the EORTC/MSG deﬁnitions. It seems
worthwhile to investigate the validity of the available diagnostic
tools in non-haemato-oncological patients at risk for IA in a pros-
pective manner.
P1001 Epidemiology of invasive aspergillosis in a teaching
hospital, France: a 6-year survey (1998–2003)
A. Cornillet, C. Camus, S. Nimubona, V. Gandemer, P. Tattevin,
C. Belleguic, S. Chevrier, C. Meunier, C. Lebert, M. Aupe´e,
B. Lelong, C. Guiguen, J.-P. Gangneux for the Aspergillosis Study
Group
Objectives and methods: The aim of this survey was to characterise
a ﬁle of patients who developed an invasive aspergillosis (IA) in
our institution, their risk factors and management. We analysed
retrospectively the cases of IA, which occurred between 1998 and
2001, then prospectively all new cases until the end of 2003. The
overall survey covered a 6-year period. Cases were classiﬁed as
suspected, probable or proven IA, using criteria derived from the
EORTC/MSG classiﬁcation.
Results and discussion: Until 11/2003, out of the 80 cases of IA
analysed, nine were histologically proven, 47 were probable IA
and 24 were suspected IA. The sex ratio was 1.5 male:one female
with a mean age of 53 years (ranging from 4 to 89 years). Fifty
percent of cases were diagnosed in the Intensive Care Units, and
36% in Haematology units (28% in adults and 8% in paediatrics).
Neutropenia was the major risk factor in 55% of the patients (dur-
ing haematological malignancies and solid cancers). However, we
also noted an increasing number of IA in patients under cortico-
steroid therapy for COBP, asthma, rheumatoid arthritis, Horton
and microvascular diseases, in comparison to available data in the
literature. Other cases occurred in solid organ transplant recipi-
ents and only one out of the 80 patients was infected by HIV.
Prognosis factors will be discussed. Regarding biological diagno-
sis, good sensitivities of the mycologic examination (microsco-
py + culture) and the galactomannan antigen detection by
enzyme immunoassay (Platelia Aspergillus, Biorad) were noted:
75 and 71%, respectively. The sensitivity reached 80% when both
tests were combined. Pulmonary imagery was less efﬁcient, prob-
ably due to the fact that, in our institution, CT scans are per-
formed later than proposed in the literature. During this survey,
we observed great modiﬁcations in therapeutic approaches. First
line treatment progressively switched from deoxycholate Ampho-
tericin B (AmB) to voriconazole and second line treatments now
include lipid formulations of AmB and caspofungin acetate. AmB
deoxycholate and voriconazole were the two drugs used for
empirical therapy. The overall mortality was >70%.
Conclusion: IA remains a major life-threatening infection among
immunosuppressed patients, although protective measures such
as air ﬁltration signiﬁcantly reduced its incidence in neutropenic
patients. However, this 6-year-survey points out the increasing
number of cases in non-neutropenic patients hospitalised in wards
without air ﬁltration. This emerging population of patients must
be taken into account and imposes to reinforce surveillance for
high-risk groups and to rethink our preventive measures.
P1002 Invasive aspergillosis in patients with COPD
G. Serrate, B. Font, D. Mariscal, M. Sala, E. Anto´n, F. Segura
Sabadell, E
Objective: To determine if news deﬁnitions of the Invasive Fungal
Infections (IFI) (1) with the terms: ‘proven’, ‘probable’ and ‘poss-
ible’ could be applied in patients with COPD and Aspergillus spp.
in respiratory samples to express disease certainty.
Methods: Prospective study, between January 1997 and December
2000, of patients with COPD and Aspergillus spp. in respiratory
samples to determine risk factors and outcome.
Results: We identiﬁed 219 patients with COPD and Aspergillus
spp. in respiratory samples. Median age was 72  9.3 years.
Eighty-three percent were men. Forty-one patients had criteria for
‘probable’ IFI and in seven cases of them that was ‘proven’ (17%).
Moreover, three were treated and cured and eight were treated
too but died. In all these cases, the host factor criterion was pro-
longed (>3 weeks) use of corticosteroids in previous 60 days. Sev-
enty-one cases had criteria for ‘possible’ IFI. Of them, one case
treated had a negative necropsy, 14 died for other causes and the
remainder were well at the pursuit (colonisation). None of 107
cases had criteria to suspect an IFI, however, nine were treated
and all but one died. The remainder were colonisations.
Conclusions: A progressive increase of COPD patients with
Aspergillus spp. has been observed but frequently, this is a coloni-
sation. However, we observed that patients in ‘probable’ category
have a high rate (17%) of ‘proven’ IFI, similar to other known risk
groups. We think that these categories could help in clinical prac-
tice and to identify homogeneous groups for clinical research in
diagnostic methods and therapeutic interventions. (1) Cooper-
ative Group of the European Organisation for Research and Treat-
ment of Cancer and Mycoses Study Group of the National
Institute of Allergy and Infectios.
P1003 Evaluation of serum galactomannan ELISA during
caspofungin therapy: results from the Caspofungin Salvage
Invasive Aspergillosis Study
J. Maertens, A. Glasmacher, D. Selleslag, M. Layton, A. Taylor,
C. Sable, N. Kartsonis
Leuven, B; Bonn, D; Brugge, B; West Point, USA
Objectives: A sandwich ELISA assay, which detects circulating
Aspergillus galactomannan antigen using a rat monoclonal antibody
has recently been licensed (Platelia, BIORAD). Yet, animal mod-
els of IA have shown that treatment (Rx) with an echinocandin
may result in a paradoxical increase in antigenemia despite clin-
ical/radiographic improvement. Concern also remains that using
ELISA as the sole means of IA diagnosis may result in exagger-
ated favourable outcomes. To address these concerns, we
reviewed the ELISA experience from the caspofungin (CAS) sal-
vage invasive aspergillosis (IA) study.
Methods: Patients (pts) with proven/probable IA were eligible for
enrolment. Probable IA was limited to pulmonary sites. Probable
pulmonary IA could be diagnosed serologically provided the pt
had an appropriate chest CT appearance (halo sign, air-crescent
sign) and positive ELISA on more than two consecutive tests. All
pts were refractory (>7 days) or intolerant of prior antifungal Rx.
CAS, with doses ranging from 50–100 mg/day, was administered
as monoRx. Efﬁcacy was assessed at the end of CAS Rx. Favour-
able responses were limited to complete or partial responses.
Results: Of the 127 pts enrolled, 20 (16%) had consecutively posit-
ive serum ELISA at the onset of CAS. Positive ELISA (and appro-
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priate chest CT appearance) was the sole basis of the diagnosis in
13 (65%) pts. In the remaining seven (35%) pts, positive ELISA
accompanied either histopathological or microbiological evidence
of IA. Five (38%) of these 13 pts were later upgraded to deﬁnite
IA. Nineteen of the 20 pts were assessed for efﬁcacy at the end of
CAS Rx. The favourable response rate was 26% (5/19). Pts whose
only evidence of IA at CAS onset was ELISA (and characteristic
chest CT ﬁndings) had a 38% (5/13) success rate. Follow-up
ELISA data was available in 17 pts. Four of ﬁve pts with a favour-
able response to CAS had negative ELISA by the end of Rx. The
one other pt with a favourable response had quantitative ELISA
improvement that was temporally associated with clinical and
radiographic response. Of the 12 pts with unfavourable responses
and follow-up ELISA data, 10 had no ELISA improvement and
two had normalisation of ELISA while on CAS.
Conclusions: In this study, the use of ELISA did not result in an
exaggerated favourable response rate. In general, the ELISA was
associated with clinical/radiographic response. Paradoxical ELISA
increases in pts clinically/radiographically responding to CAS
were not noted.
P1004 Screening for Aspergillus galactomannan
antigenemia in a haematology unit: how useful is it in daily
practice?
A. Sonet, Y. DeGheldre, B. Delaere, C. Doyen, A. Bosly,
Y. Glupczynski
Yvoir, B
Objectives: To assess the role of Aspergillus galactomannan (GM)
antigen detection in a general hematology unit.
Methods: Between 06/02 and 12/03, there were 667 admissions
corresponding to 244 patients (pts) in the hematology unit. Over-
all 151 pts were tested at least twice by the Aspergillus GM ELISA.
A total of 1813 serum samples were analysed (mean no. of tests/
pt: 11.85; range: 2–51; SD: 10.52). The mean period of follow-up
(FU) was 100.7 days (range: 3–487, SD: 91.6). GM antigen detec-
tion was made in the setting of: routine surveillance after chemo-
therapy (105 pts), after haematopoietic stem cells transplantation
(HSCT) (2 allo- and 3 ‘mini’ allo-HSCT; 27 auto-HSCT) or in the
FU of infection (14 pts). Underlying diseases were: lymphoid:
55%; myeloid: 40%; non-malignant: 5%. Clinical efﬁciency of the
test was tested at three different cut-off values 1.5, 1.0 and 0.7.
Results: Results are summarised in the table. The overall inci-
dence of invasive aspergillosis (IA) was 6.4% (43/667 admis-
sions). Following EORTC deﬁnition criteria, the repartition was:
two Deﬁnite IA, 16 Probable IA and 25 Possible IA. The deﬁnition
of ‘probable’ IA was substantiated by positive GM antigen tests
(eight cases); both by microbiological (positive cultures) and posit-
ive GM antigen tests (four cases) or only by microbiological cri-
teria (four cases). GM antigen was detected at all different cut-off
values in 30 cases corresponding to: 1/2 Deﬁnite IA, 12/16 Prob-
able IA. Results were considered as false-positives in 17 patients:
four cases without clinical context; 15 cases with a negative chest
CT-scan; two pts were even treated as possible IA, one because of
a positive chest CT-scan (CMV pneumonia), the other because of
past proven IA. All ‘false-positives’ results were in patients who
received antibiotics at time of antigen testing (Pipera/tazobactam
(seven pts); Amoxi/clavulanate (nine pts); Cefepime (one pt)).
Conclusion: Detection of circulating GM antigen may be helpful
for the diagnosis of IA, particularly in the absence of microbiolo-
gical data, but a substantiated number of false-positive results do
occur among patients undergoing antibiotic therapy with Pipera/
tazobactam or Amoxi/clavulanate. Considering different cut-off
values did not improve the sensitivity or the speciﬁcity of the
assay.
P1005 Diagnosing of invasive Aspergillosis during
antifungal therapy by polymerase chain reaction on blood
samples
C. Lass-Flo¨rl, A. Petzer, M. Dierich
Innsbruck, A
Objectives: We evaluated the value of Aspergillus PCR as a tool
for diagnosing invasive aspergillosis during antifungal therapy
from whole blood samples.
Methods: In a 3-year study, 36 patients receiving antifungal ther-
apy due to chest radiographic ﬁndings highly suggestive for fun-
gal pneumonia were evaluated. The PCR results of whole blood
samples were compared with those obtained from bronchoalveo-
lar lavage ﬂuids and/or tissue specimens.
Results: A total of 205 whole blood samples, 15 ﬁne needle aspira-
tions or tissue biopsy specimens, 21 bronchoalveolar lavage ﬂuids
and tracheal secrets were analysed using PCR. Fifteen patients
had proven, nine probable and 12 possible invasive Aspergillus
infections according to European Organization for Research and
Treatment of Cancer/Mycosis Study Group deﬁnitions. In patients
with proven infections, the sensitivities of PCR of lung and blood
samples were 100 and 40%, respectively. The speciﬁcities were
100%. The negative predictive value of blood monitoring under
antifungal treatment was 44%. In patients with probable infec-
tions, the sensitivities of PCR of lung ﬂuids and blood were 66
and 44%, respectively. The speciﬁcities were 100%. The negative
predictive value of blood monitoring under antifungal therapy
was 58%.
Conclusions: The beneﬁts of PCR diagnosing of whole blood are
limited if sampling takes place once treatment has started. The
performance of Aspergillus PCR should be recommended in addi-
tion to microscopic examination and culture technique for sensi-
tive detection of fungal infection.
P1006 Air surveillance of Aspergillus. Are two different
growth media required?
J. Guinea, T. Pela´ez, J. Blanco, O. Cuevas, J. Martı´nez-Alarco´n,
L. Alcala´, P. Mun˜oz, E. Bouza
Madrid, E
Objective: Air is considered the main vehicle of Aspergillus spores
causing community or nosocomially-acquired invasive aspergil-
losis (IA). Air surveillance is nowadays performed in protected
air environments in many institutions. Sabouraud Dextrose Agar
Irradiated (SD) is used for the control of air in our institution but
Czapeck Agar is also recommended for this purpose. The aim of
our study was to compare the efﬁciency of both media for Asperg-
illus isolation in air samples.
Methods: We collected 332 samples using the Merck Air Sampler
MAS 100 with a volume of air per culture of 200 L. Every sam-
ple was cultured in both media (pair of samples), and agar plates
were incubated at 35C for 5 days. Aspergillus spp. was identiﬁed
by conventional methods. The pairs were checked daily to














Proven 2 1 1 0 1 0 0 0
Probable 16 4 12 2 3 0 3 4
Possible 25 – – – – – – –
False Positive - 17 0 7 9 1 0
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results were reported as the number of isolates of each species
per plate of the pair.
Results: A total of 332 pairs of samples were evaluated. Of these,
42 showed growth of Mucor spp. (40 in SD and two in Czapeck)
and could not be studied for Aspergillus. Of the remaining 290
pairs, 157 pairs (54.1%) were positive for Aspergillus spp. [49
(31.2%) on both plates, 59 (37.6%) only in SD and 49 (31.2%) only
in Czapeck]. A. fumigatus was the most frequently isolated species,
98 pairs (33.8%) were positive [28 (28.6%) on both plates, 39
(39.8%) only in SD and 31 (31.6%) only in Czapeck]. Both media
were equally suitable for Aspergillus spp. isolation. Overall, 581
Aspergillus (289 on Czapeck and 292 on SD) and 326 A. fumigatus
(164 on Czapeck and 162 on SD) were isolated in both media.
Conclusions: Our data supports the recommendation that both
media (Czapeck and SD) should be used for correct air sampling.
The use of the standard media alone (Czapeck) led to nearly 40%
false negatives and the use of only SD to nearly 30%. The use of
both media for environmental control of Aspergillus spp. in air
should be mandatory, as this allows more efﬁcient detection of
conidia and improves the interpretation of Czapeck plates when
mucorals are present. (This study was ﬁnanced by Comunidad de
Madrid grant number 08.2/0026/2001 1).
P1007 In vivo interaction between caspofungin and
ﬂucytosine in a murine model of disseminated aspergillosis
E. Dannaoui, O. Lortholary, F. Dromer
Paris, F
Objective: Antifungal combination of caspofungin with ﬂucytosine
has been shown to be additive to synergistic in vitro against
Aspergillus fumigatus. The aim of the present study was to evaluate
the interaction between these two drugs in vivo in an animal
model of disseminated aspergillosis.
Methods: For in vivo experiments, non-immunocompromised out-
bred mice were infected intravenously with a spore suspension
calibrated at the lethal dose 90%. Treatment was started 24 h after
infection and continued for 7 days. Serum level of ﬂucytosine
were determined by HPLC in preliminary experiments for differ-
ent regimen. Flucytosine was given in drinking water at 500 or
1000 mg/kg/day and caspofungin was given by once-daily intra-
peritoneal injection at 0.25 or 0.5 mg/kg/day either alone or in
combination with ﬂucytosine (four combinations were tested).
Control groups received either NaCl intraperitoneally or water
per os. There were 14 mice in each group. Mortality was recorded
daily until the end of experiment at day 14 post-infection. Survi-
val curves were compared by a log–rank test.
Results: An 82% mortality was obtained for control mice receiv-
ing no active treatment. Survival was 50% for mice treated with
ﬂucytosine alone at 500 mg/kg/day and 36% for the higher dose
of 1000 mg/kg/day. Survival of mice treated with caspofungin
alone at 0.25 and 0.5 mg/kg/day were 50 and 64%, respectively.
Survival rates of mice treated with the combination of caspofun-
gin at 0.25 mg/kg/day with ﬂucytosine at 500 and 1000 mg/
kg/day were 79 and 86%, respectively. Mice treated with caspo-
fungin at 0.5 mg/kg/day combined with ﬂucytosine at 500 and
1000 mg/kg/day had a 92 and 79% survival, respectively.
Conclusions: The combination of caspofungin with ﬂucytosine
showed a positive effect in vivo in this animal model of
Aspergillosis. Antagonism was not observed. Further evaluation of
the potential treatment efﬁcacy of this combination is warranted.
P1008 Activation of the complement system in cerebral
aspergillosis
G. Rambach, I. Mohsenipour, H. Maier, J. Rainer, G. Vago,
M. Dierich, C. Speth
Innsbruck, A; Milan, I
Objectives: The spreading of Aspergillus hyphae into the brain of
immunocompromised patients is a complication of invasive asper-
gillosis that leads to death in nearly 100% of the cases. The most
frequent species for induction of cerebral aspergillosis is
Aspergillus fumigatus. Our aim was to study the interaction of
A. fumigatus with the complement system to determine the reason
for the failure of the cerebral immune system. Furthermore, these
experiments might give ﬁrst approaches for a putative immune
therapy to support current antimycotical treatment.
Methods: Different pools of cerebrospinal ﬂuid (CSF) were tested
for their ability to opsonise fungal hyphae with different comple-
ment factors. Germinated conidia were ﬁxated, incubated in CSF,
and the deposition of complement was shown via indirect immu-
noﬂuorescense (IF) by suitable speciﬁc antibodies. The extent of
surface labelling on Aspergillus was compared with Pseudallescheria
boydii, another neurotropic fungus. Immunohistochemical (IHC)
staining of parafﬁn-embedded tissue sections derived from
patients with cerebral aspergillosis allowed the comparison with
the complement deposition in vivo.
Results: The levels of the complement factors C1q, C4, C3, C5, C6
and C7 in the CSF of normal persons were sufﬁcient for opsonisa-
tion of the fungal hyphae, although the deposition was much
weaker than in human serum. However, the recognition of
Aspergillus surface was not optimal in comparison to P. boydii that
showed a clearly stronger deposition. Concentrations of different
complement proteins and complement activation products were
highly elevated in CSF derived from a patient with cerebral
aspergillosis. This CSF showed a signiﬁcantly stronger comple-
ment deposition on the fungal surface than the non-inﬂammatory
CSF. However, IHC-analyses in tissue sections of patients with
cerebral aspergillosis showed only limited opsonisation on the
fungus.
Conclusion: CSF harbours the ability of complement deposition on
the surface of neurotropic fungi. Frequent pathogens like
Aspergillus fumigatus have adopted their surface to minimise
recognition by the complement cascade. Cerebral complement
production is upregulated as a consequence of fungal infection,
which might contribute to antifungal immune defence but also to
inﬂammation and tissue damage. The amount of deposited factors
on the fungal hyphae in vivo is low, indicating the expression of
complement inhibitory factor(s) by A. fumigatus.
P1009 Genotypic characterisation of Aspergillus spp.
isolates from patients with cystic ﬁbrosis by Random Ampliﬁed
Polymorphic DNA PCR
M. Serrano, A. Perkins, T. Alarco´n, B. Buendı´a, D. Monclu´s,
M. Lo´pez-Brea
Madrid, E
Objective: To evaluate the use of RAPD-PCR for typing of
Aspergillus spp. in Cystic Fibrosis (CF) patients.
Methods: Thirty Aspergillus spp. strains (28 A. fumigatus and two
A. ﬂavus) from 12 CF patients were studied between June 1998
and April 2003. The patients were aged 18–44 years. The isolates
were obtained from sputum samples and were identiﬁed by their
culture characteristics and on the basis of conidiophores and coni-
dia morphologies. RAPD-PCR ﬁngerprinting was performed by
using primer R-108 and AP12h.
Results: Fifteen out of 34 patients (44.11%) had colonisation or
infection by Aspergillus spp. The most frequent isolate was
A. fumigatus (86.66%). By using primer R-108, 17 strains were
typed and three types were identiﬁed (A, B, C) with the subtypes
A1, A2 and A3. Using primer AP12h, 19 strains were typed and
nine different types were obtained (A-I), with some subtypes (A1,
A2, A3), (B1–B4) and (F1, F2). Primer AP12h distinguished some
strains that could not be differentiated by primer R-108. Twenty-
two strains were typed when the results of the two primers used
were combined. The patients with more than one isolate showed
different patterns.
Conclusion: RAPD-PCR is a quick and easy procedure to geno-
type Aspergillus spp. in CF patients. Primer AP12h yielded the
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best RAPD patterns with respect to number, spreading and inten-
sity of the bands, but the highest level of discrimination was
achieved by a combination of data generated by both of them.
Therefore, we emphasise the convenience of using at least two
primers for RAPD typing.
Molecular bacteriology: staphylococcus
P1010 Molecular epidemiology of bacteraemia due to
methicillin-resistant and methicillin-susceptible Staphylococcus
aureus in a tertiary hospital in Madrid
J. Garcia-Martinez, S. De Miguel, F. Sanz, F. Chaves, J. Otero
Madrid, E
Objectives: To gain insight into the molecular epidemiology of
Staphylococcus aureus at a tertiary hospital.
Methods: All S. aureus isolates recovered from blood samples
over a 1-year period were analysed. Demographic, clinical and
microbiological data from these patients were collected. Antimi-
crobial susceptibility tests were performed by the Wider System
and the disk diffusion method; all methicillin-resistant S. aureus
(MRSA) isolates underwent conﬁrmatory PCR analysis for the
mecA gene. Molecular characterisation was performed by
pulsed-ﬁeld gel electrophoresis (PFGE) following DNA extraction
and SmaI digestion. Patterns differing by less than seven DNA
fragments and with a Dice coefﬁcient of correlation >80% were
considered a common bacterial type while subtypes included
isolates with indistinguishable PFGE patterns. Univariate and
multivariate analyses were performed with Epi-Info 2002 and
SPSS 10.0 softwares.
Results: One hundred and sixty-two episodes of S. aureus bacter-
aemia, whether methicillin-resistant or methicillin-susceptible
(MSSA), were nosocomial in origin (77.2%) or were cases associ-
ated with the healthcare system (15.4%). Only a total of 12 cases
of bacteraemia (7.4%), one MRSA and 11 MSSA, were strictly
considered to be community-acquired. Thirty-ﬁve unique
S. aureus PFGE types were identiﬁed among 154 DNA macrore-
striction patterns. Within the isolates of MRSA, four major geno-
types were identiﬁed, with 36 isolates (85.7%) represented by a
single PFGE type. In contrast, the 112 isolates of MSSA com-
prised 31 different PFGE types, of which 16 represented more
than one isolate. Three PFGE types were found to represent 42%
of all MSSA isolates. These common strains were found with
equal frequency among adults and paediatric patients, and were
evenly distributed between nosocomial and community-acquired
cases.
Conclusion: Our results provide indirect evidence of ongoing
transmission of MRSA and MSSA in our hospital. In the case of
MRSA, the spread is predominantly due to a single clone, with
transmission favoured by increased length of stay in hospital and
the administration of beta-lactam antibiotics. In contrast, the
spread of MSSA bacteraemia in this population is associated with
multiple, genetically distinct strains.
P1011 Real-time PCR for Staphylococcus aureus:
identiﬁcation at species level and detection of mecA gene
T. Alarco´n, J.A. Garcı´a -Campos, M.S. Abanades, D. Monclus,
D. Domingo, M. Lopez-Brea
Madrid, E
Objetives: (1) To use a real-time PCR (LightCycler, Roche Diag-
nostics, Spain) to differentiate Staphylococcus aureus from coagulase
negative Staphylococcus (CNS) and (2) to use a real-time PCR to
detect the presence of mecA gene in S. aureus clinical isolates.
Methods: Seventy-three strains obtained from clinical specimens
were identiﬁed by MicroScan (Dade Behring) and coagulase test
(28 S. aureus, 15 S. epidermidis and 30 other coagulase negative sta-
phylococci). In vitro susceptibility was determined by MicroScan
and disc diffusion. A total of 39 S. aureus strains were classiﬁed
according to methicillin susceptibility: 21 resistant and 18 suscept-
ible to methicillin. DNA was obtained by incubation at 100C in
lysis buffer. Real-time PCR was performed in a LightCycler
instrument (Roche Diagnostics, Spain) using two commercially
available kits: (1) LightCycler Staphylococcus kit Mgrade: PCR
was positive in all staphylococci and they were differentiated
according to melting temperature (62.1  2C for S. aureus, and
43.4–59C for CNS) and (2) LightCycler MRSA detection kit: PCR
was positive in mecA positive S. aureus. An internal control
excludes the presence of inhibition. Once the DNA was extracted
the whole process takes 1 h.
Results: Twenty-seven out of 28 S. aureus strains were clearly
identiﬁed by real-time PCR due to the melting temperature (range
from 60.2 to 63.4C). One S. aureus showed melting temperature
of 59.8C. All S. epidermidis strains showed melting temperature
from 50.1 to 53.4C. S. lugdunensis showed melting temperature of
58.6, 54.6 and 53.1C. Other CNS showed melting temperature
from 51 to 57.1C. Twenty-ﬁve out of 39 (64.1%) strains tested
were mecA positive by using this LightCycler MRSA kit and real-
time PCR. Among the 25 mecA positive, 21 were fenotipically
methicillin resistant (84%) whilst four were methicillin susceptible
(16%). All 14 mecA negative strains were susceptible to methicil-
lin by phenotypic methods.
Conclusions: Real-time PCR (LightCycler) seems to be an accurate
method to identify S. aureus and differentiate it from different
CNS and to detect resistance to methicillin in S. aureus. Both reac-
tions could be done simultaneously and the whole process takes
less than 2 h (DNA extraction plus real-time PCR).
P1012 A comparative genomic hybridisation study of
epidemic strains of methicillin-resistant Staphylococcus aureus
in Canada
S. Christianson, M.R. Mulvey
Winnipeg, CAN
Objectives: Surveillance of methicillin resistant Staphylococcus
aureus (MRSA) in Canada began in 1995. From this surveillance,
six epidemic strains of MRSA have been identiﬁed and named
CMRSA1–6. In order to better understand the relatedness of these
strains, as well as their genetic content, we have used microarrays
to compare their genomes to that of the fully characterised
genome of the MRSA strain Col.
Methods: Genomic DNA from representatives of the six epidemic
strains, as well as Col was fragmented and labelled using random
primers with Cy5 or Cy3 labelled dCTP. Col and each of the
epidemic strains (labelled with different dyes) were hybridised to
arrays containing PCR products or 70 bp oligomers representing
2740 of the open reading frames (ORFs) in the Col genome. Data
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were processed with the ArrayPro software package, positive/
negative cut-off values were determined using Genomotyping
Analysis by Charles Kim and then analysed using the GeneMaths
program. Macrorestriction digest patters were generated using
SmaI.
Results: Results indicate that all Canadian epidemic strains have
six common regions of deletion, a portion of the type I SCCmec
region, bacteriophage L54a, and four smaller areas composed of
two to four ORFs. The only gene of known function in these smal-
ler areas was the Staphylococcal enterotoxin B. Apart from these
major deletions, many sporadic, single deletions are seen through-
out the strains. Larger regions of deletion that are not present in
all strains also occur. The only obvious ORF duplication is of
IS431 in CMRSA3, 5 and 6, which is found in multiple copies in
the typeIII SCCmec region in these strains. Macrorestriction digest
data were used to approximate the sizes of the CMRSA genomes.
CMRSA4 shows the smallest genome (1862 kb), and the least
genetic content in common with COL (79%). Though CMRSA1
and 2 appear to have larger genomes (2378 and 2706 kb,
respectively), they show fewer ORFs in common with Col than
other strains (81 and 86%, respectively), suggesting a substantial
portion of the genome may be novel.
Conclusions: This is the ﬁrst study of epidemic MRSA using the
comparative genomic hybridisation approach. While the CMRSA
strains show a high degree of relatedness to Col, there are consid-
erable differences in genetic content. This study also indicates that
there may be genetic content which is unaccounted for in the Col
genome. Other studies are being devised to identify and charac-
terise the novel genetic content.
P1013 Recent trends in molecular epidemiology of
methicillin-resistant Staphylococcus aureus (MRSA) in Finland
A.-M. Santala, O. Lyytika¨inen, M. Karde´n-Lilja, S. Ibrahem,
S. Salmenlinna, A. Virolainen-Julkunen, J. Vuopio-Varkila
Helsinki, FIN
Objectives: In Finland, the annual number of MRSA isolates noti-
ﬁed to the National Infectious Disease Register (NIDR) has con-
stantly increased, especially outside Helsinki metropolitan area.
Molecular typing has revealed numerous outbreak strains of
MRSA, and some of them have been associated with community
acquisition. We analysed strain types identiﬁed by pulsed-ﬁeld
gel electrophoresis (PFGE) of MRSA isolates sent to the National
Reference Laboratory (NRL) during 1997–2003.
Methods: All isolates of MRSA notiﬁed by the Finnish clinical
microbiology laboratories were sent to NRL for further veriﬁca-
tion and characterisation, including PFGE analysis. PFGE proﬁles
differing by fewer than six bands were interpreted as identical or
closely related. One isolate per person were included in the analy-
sis. Strain types were categorised as sporadic (strain type only
found from one person), domestic outbreak or international epi-
demic (strain type found from more than one person) as well as
community-acquired (strain type associated with community
acquisition in our previous study). The proportions of MRSA iso-
lates included in each category were assessed.
Results: A total of 2496 MRSA isolates were studied. The number
of MRSA isolates increased from 138 in 1997 to 804 in 2003. PFGE
identiﬁed more than 200 different strain types. Of the MRSA iso-
lates, 9% were sporadic, 66% domestic outbreak and 25% inter-
national epidemic. One strain type disappeared compared with
years before 1997, and 11 new strain types appeared during 1997–
2003. The proportion of sporadic strains varied between 3 and
18% during the study period. Of the international epidemic
strains, Bel EC-3 increased from <1% in 1997 to 27% in 2003,
mainly outside Helsinki metropolitan area. UK EMRSA-16
decreased from 13% in 1997 to <1% in 2003, and Helsinki I (a
representative of MLST ST-5 strains) from 18 to 6%, respectively.
UK EMRSA-15 varied between 1 and 6%. The three main strains
with community-acquisition ﬂuctuated during the study period
(range, 10–30%).
Conclusions: Intensive national surveillance with molecular typing
revealed that the predominant MRSA strains change over time.
The internationally spread epidemic strains of MRSA have also
been found in Finland. However, most of them show a decreasing
trend or have disappeared. These results encourage us to continue
aggressive interventions with each new MRSA case.
P1014 Existence of PVL-genes and SCCmec IV amongst
Finnish CA-MRSA strains
M. Karde´n-Lilja, J. Vuopio-Varkila, S. Ibrahem, S. Salmenlinna,
O. Lyytika¨inen, A. Virolainen-Julkunen
Helsinki, FIN
Introduction: According to recent studies, community-acquired
(CA)-methicillin-resistant Staphylococcus aureus (MRSA) strains
often contain a type IV SCCmec cassette and Panton-Valentine
leukocidin (PVL) locus. It has also been shown that certain multi-
locus sequence types (ST) seem to be connected to CA-MRSA
strains from different continents.
Materials and methods: We studied 108 Finnish CA-MRSA strains
for their genotype by pulsed-ﬁeld gel electrophoresis (PFGE) and
multilocus sequence typing (MLST), the methicillin resistance
genes by SCCmec PCR and the presence of PVL gene locus by
PCR. MRSA was deﬁned as community acquired if the MRSA
specimen was obtained outside hospital settings or within 2 days
of hospital admission from a person who had not been hospital-
ised within 2 years before the date of MRSA isolation. To conﬁrm
the functionality of the PVL-PCR reaction and the quality of the
DNA, nuc gene was ampliﬁed at the same time.
Results: The majority of CA-MRSA strains studied (91/108, 84%)
possessed SCCmec cassette type IV but only 13 (12%) were PVL
positive. All but two PVL positive strains contained SCCmec type
IV. One strain had SCCmec cassette III subtype, and for one strain
the type was not determined. The PVL positive strains were
mostly (9/13, 69%) of multilocus ST80. The four remaining
PVL-positive strains were of ST1 (two strains) and ST8 and 96.
The sequence types correlated well with the PFGE results: All
strains with ST80 were analysed as PFGE proﬁle HkiVIII and
strains with ST1 as PFGE proﬁle Nurmes. ST96 (SCCmec cassette
-III subtype) and ST8 (SCCmec not determined) strains were con-
sidered as sporadic. The 95 PVL negative CA-MRSA strains
belonged to 15 different shared and four sporadic PFGE proﬁle
types. The MLST analysis of PVL negative strains is currently un-
derway.
Conclusions: Most of the Finnish CA-MRSA strains have SCCmec
cassette type IV but only a minority contain PVL gene locus,
which is in contrast to previous reports. Majority of the PVL gene
positive strains possessed ST80. In spite of the strict deﬁnition for
community-acquisition we used, majority (88%) of Finnish
CA-MRSA were PVL negative and showed heterogeneous PFGE
proﬁles.
P1015 Evaluation of susceptibility methods for detection
of methicillin resistance in Staphylococcus aureus
M. Kantzanou, E. Alepopoulou, M. Panopoulou, E. Kantzanos,
A. Grapsa, I. Dimopoulou, S. Kartali
Alexandroupolis, GR
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is
among the major pathogens. The most common methods cur-
rently used for identifying methicillin (oxacillin) resistance in
many clinical laboratories are susceptibility tests. The performance
of these tests has been erratic because the expression of resistance
is variable and commonly heterogeneous within strains.
Methods: A retrospective laboratory-based study was carried out
with clinical isolates of S. aureus in a tertiary care providing Uni-
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versity hospital in Thrace, Greece. Methicillin (oxacillin) suscepti-
bility of 118 S. aureus isolates, which were recovered from various
clinical specimens (blood cultures, tracheal aspirates, wound
swabs and central venous catheters) were studied by four differ-
ent methods: (1) agar screening test [MH-oxacillin (6 lg/mL) agar
supplemented with 4% NaCl], (2) susceptibility determination by
the Vitek 2 (BioMerieux), (3) MIC was determined by E-test (AB
Biodisk), (4) mec-A gene detection by PCR, using speciﬁc primers.
The strains were evaluated by using the presence of mecA gene
detected by PCR, as deﬁnitive criteria for MRSA and non-MRSA.
The susceptibility tests were carried out as recommended by the
NCCLS.
Results: Among all the isolates, 44 were identiﬁed as mecA-posit-
ive and the remaining 74 as mecA-negative. The percentages of
correct results (% sensitivity/% speciﬁcity) were: oxacillin agar
screen, 98/100; E-test, 93/100; and Vitek-2, 100/89. Ten isolates,
negative for the mec-A gene by PCR, were recognised by at least
one phenotyping method as oxacillin resistant. Only one strain
mecA-positive was incorrectly identiﬁed as oxacillin-negative by
the oxacillin agar screen.
Conclusions: As shown in this and other studies, no phenotypic
method is completely reliable for the detection of oxacillin resist-
ance in S. aureus. The speciﬁcity was generally high, especially
with the agar screening and E-test methods, while the sensitivity
varied between the different methods. In particular, the oxacillin
screen test is the most accurate test and approaches the accuracy
of PCR. Although, the presence of the mecA gene, as detected by
PCR, still remains the ‘gold standard’, agar-screening test should
be considered in association with other susceptibility methods to
maximise the ability to correctly detect oxacillin-susceptibility in
S. aureus.
P1016 Ampliﬁcation of DNA fragments surrounding rare
restriction sites (ADSRRS-ﬁngerprinting) for typing
Staphylococcus aureus isolated from patients with recurrent
furunculosis
W. Baranska-Rybak, R. Nowicki, E. Scieburako, J. Kur,
E. Arlukowicz, A. Samet
Gdansk, PL
Introduction: In the present study we report data on phenotypic
and genotypic characteristics of Staphylococcus aureus strains. The
aim of our research was to identify SA genotypes in the patients
suffering from recurrent furunculosis.
Materials: We obtained 70 isolates from 45 patients with recurrent
furunculosis. Purulent discharge from furuncle, nasal and throat
swabs were taken for culture.
Methods: The identity strain of SA was conﬁrmed by novel
DNA-typing technique. Ampliﬁcation of DNA fragments
surrounding rare restriction sites (ADSRRS-ﬁngerprinting ) is an
effective and rapid method for molecular typing of isolates of
bacteria. This method is based on suppression of PCR (polym-
erase chain reaction) reaction. SA DNA was digested with two
restriction enzymes: BamHI (10 U/mL) (Sigma) and XbaI
(10 U/mL) (Sigma). Cohesive ends of DNA were ligated with
adapters (XbaI short adapter and BamHI long adapter) and ampli-
ﬁed. PCR products were electrophoresed on polyacrylamide gels,
stained by ethidium bromide and photographed under UV.
Results: ADSRRS-ﬁngerprinting of 70 SA isolates revealed 10
unique patterns. In most cases the strains isolated from the same
patient (nose, throat and furuncle) gave identical pattern. The
reverse situation was found in ﬁve patients.
Conclusions: (1) In most cases we conﬁrmed the identity between
nasal/throat and furuncle SA isolates. (2) We found no speciﬁc
genotype, which is responsible for recurrent furunculosis. (3)
ADSRRS-ﬁngerprinting seems to be a very useful method for
epidemiological studies of SA.
P1017 Comparison of well-established methods with new
genotyping methods for typing Staphylococcus aureus
N. Malachowa, A. Sabat, K. Kosowska, J. Krzyszton-Russjan,
J. Empel, J. Miedzobrodzki, P.C. Appelbaum, W. Hryniewicz
Cracow, Warsaw, PL; Hershey, USA
Objectives: Rapid and efﬁcient epidemiologic typing systems may
be useful to investigate dissemination of the lineages of Staphylo-
coccus aureus. We have compared the usefulness of well-estab-
lished methods to those of newly developed rapid typing
methods as epidemiological tools.
Methods: A total of 59 S. aureus isolates were analysed by pulsed-
ﬁeld gel electrophoresis (PFGE), multilocus sequence typing
(MLST), repetitive-element PCR technique (rep-PCR) based on the
presence of DNA sequence that are homologous to MP3 repeat in
Mycoplasma pneumoniae, multiple-locus variable-number tandem
repeat analysis (MLVA), and multiplex PCR-based method with
primer mix of the spa gene, the coa gene, and the hypervariable
region adjacent to mecA gene.
Results: Fifty-nine S. aureus isolates clustered by PFGE in 50 dif-
ferent genotypes. MLVA, which had the highest compatibility
with PFGE of all testing methods in this study, clustered into 38
different genotypes, multiplex PCR-based method clustered into
23, and rep-PCR clustered into 16 different genotypes. Rep-PCR
differentiated S. aureus isolates in a way similar to MLST that
clustered these isolates in 19 groups.
Conclusion: Although PFGE is still the gold standard, owing to its
high discriminatory power amongst molecular typing methods,
genotyping methods based on PCR may be useful in respect of
speed and ease of performance. MLVA, multiplex PCR-based
methodology and rep-PCR are rapid, reproducible, and easy to
perform. However, MLVA and multiplex PCR-based method gen-
erate more unambiguous results than those of rep-PCR.
P1018 Coagulase-negative Staphylococci strain types affect
visual outcome in patients with endophthalmitis
S. Lightman, A. Khan, N. Okhravi, W. Lynn, T. Elliott, P. Lambert,
A. Worthington
London, UK
Objectives: To determine whether the variable visual outcome in
endophthalmitis secondary to coagulase-negative Staphylococci
spp. are due to different strains causing intraocular infection, with
a possible difference in virulence of each strain or resistance to
the antibiotics given.
Methods: Twenty-eight intraocular samples infected with coagu-
lase-negative Staphylococci spp. were analysed using both biotyp-
ing and pulsed-ﬁeld gel electrophoresis for strain identiﬁcation.
The results were correlated with the visual outcome after
6 months post-treatment.
Results: Four different strains of coagulase-negative Staphylococci
spp. were found to cause endophthalmitis; S. epidermidis, S. haemo-
lyticus, S. equorum and S. warneri. Twenty-one out of the 28 iso-
lates were identiﬁed as S. epidermidis and the others were grouped
as non- S. epidermidis for correlation with the clinical data. Com-
paring the S. epidermidis with the non- S. epidermidis infected cases,
it was found that the mean visual gain was signiﬁcantly better for
the non- S. epidermidis infected cases [(mean visual gain of 38.1 vs.
83.3 LogMAR letters, respectively) (P ¼ 0.029)].The visual
outcome was signiﬁcantly worse for patients infected with
S. epidermidis and antibiotic resistance was more common among
these isolates although all were sensitive to at least one of the
three/four antibiotics given. Comparing the non- S. epidermidis
infected cases to the S. epidermidis infected cases that were sensi-
tive to all four antibiotics used, the visual outcome was still signi-
ﬁcantly better in the non- S. epidermidis group [mean visual gain
83.3 vs. 25.75 LogMAR letters, respectively) (P ¼ 0.022)].
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Conclusion: SE carries a signiﬁcantly worse visual outcome than
non-SE strains of CNS and is likely to be due to increased
virulence within the eye rather than antibiotic resistance.
P1019 Evaluation of Roche LightCycler kits for the
detection of methicillin-resistant Staphylococcus aureus in
patient screening broths
K. Levi, K.J. Towner
Nottingham, UK
Objectives: To evaluate two LightCycler kits for the detection of
methicillin-resistant Staphylococcus aureus from patient screening
swabs in comparison with conventional culture methods.
Methods: Sets of patient screening swabs (n ¼ 100) were incuba-
ted in an overnight enrichment broth containing oxacillin to elim-
inate methicillin-sensitive S. aureus. Samples were lysed with
lysozyme/lysostaphin before ampliﬁcation. Broths were also cul-
tured on Oxacillin Resistance Screening Agar. Samples were ini-
tially tested with the LightCycler Staphylococcus kit.
Differentiation of S. aureus from coagulase-negative staphylococci
(CNS) was based on melting curve analysis of the ampliﬁed prod-
uct. Samples positive for S. aureus were also tested for the methi-
cillin resistance gene mecA with the LightCycler MRSA Detection
kit.
Results: The LightCycler Staphylococcus and MRSA Detection
kits identiﬁed 29 MRSA-positive samples from overnight screen-
ing broths; MRSA colonies were isolated from 22 of these sam-
ples. All seven samples positive only by the LightCycler assays
remained positive on repeat testing, and negative controls were
consistently negative. Two of these seven samples were
obtained from patients who had been MRSA-positive in the
previous 6 months. One sample, which was MRSA-positive by
culture and LightCycler-negative for S. aureus DNA, was Light-
Cycler-positive on repeat testing. No S. aureus-positive, mecA-
negative samples were detected, indicating that the selective
broth inhibited the growth of methicillin-sensitive S. aureus.
Two melting peaks, characteristic of S. aureus and CNS, were
identiﬁed in 12 samples; MRSA was isolated from eight of
these.
Conclusions: The LightCycler Staphylococcus and MRSA Detec-
tion kits were highly sensitive and may be particularly useful for
rapidly investigating the possibility of MRSA carriage by health
care workers or patients in a potential outbreak situation.
P1020 Sigma B dependent expression of oxacillin
resistance in Staphylococcus epidermidis: transcriptional analysis
of mecA, and other factors required for resistance expression
J.K.-M. Knobloch, J. Huck, S. Ja¨ger, M.A. Horstkotte, D. Mack
Hamburg, D
Objectives: Staphylococcus epidermidis is a major pathogen in no-
socomial infections, and infectious isolates display a high preval-
ence of oxacillin resistance (oxaR). Tn917 mutagenesis of rsbU,
encoding a positive regulator of the alternative sigma factor sigma
B lead to a reduced oxaR in S. epidermidis 1057. However, the
mechanism of this regulatory pathway is still unknown. The role
of sigma B in the regulation of oxaR in S. epidermidis was investi-
gated in this study.
Methods: Two mutants with inactivation of the entire sigma B
operon (1057rsbUVWsigB) or the regulatory cascade rsbUVW
(1057rsbUVW) were generated by allelic gene replacement in S.
epidermidis 1057, which displays a heterogeneous oxacillin resist-
ance phenotype. RNA was extracted at 9 and 17 h from cultures
in Mueller Hinton + 2% NaCl (MHNaCl) and MHNaCl supple-
mented with 1 lg/mL Oxacillin (MHoxa). Quantitative transcrip-
tional analysis of mecA, femABCDF, fmtA, mrp (fmtB), and mprF
(fmtC) were performed by real-time RT-PCR. At least a 2.5-fold
difference compared with the wild type in the average of three
independent experiments was deﬁned as cut-off for differentially
expressed genes.
Results: Population analysis of the mutants and the wild type
strain revealed that mutant 1057rsbUVWsigB displayed a more
heterogeneous phenotype with a smaller subpopulation expres-
sing methicillin resistance compared with the wild type. Mutant
1057rsbUVW with constitutive expression of sigma B displayed
a strong increase of methicillin resistance and a homogeneous
resistance phenotype compared with the wild type. Transcrip-
tional analysis revealed that the homogeneously resistant
mutant 1057rsbUVW displayed no differences compared with
the wild type under all conditions investigated, except of the
gene fmtA, which was downregulated in MHoxa at 9 h. Inter-
estingly, in the less resistant mutant 1057rsbUVWsigB the genes
mecA, femB, femD, fmtA, and mprF were upregulated in
MHNaCl compared with the wild type at both time points,
whereas in MHoxa only the genes femD, fmtA, and mprF were
upregulated at 9 or 17 h.
Conclusions: None of the investigated genes including mecA is
responsible for the homogeneous expression of oxaR in mutant
1057rsbUVW. Mutant 1057rsbUVWsigB displayed a less resistant
phenotype compared with the wild type strain, despite the upreg-
ulation of several genes required for oxaR. Therefore, an addi-
tional sigma B dependent factor must be required for
homogeneous expression of oxaR in S. epidermidis.
P1021 Detecting the response of Staphylococcus aureus to
antimicrobial agents by measuring changes in mRNA levels
using a ﬂow through microarray
R.M. Anthony, A.R.J. Schuitema, L. Oskam, P.R. Klatser
Amsterdam, NL
Objectives: To develop methods to measure the initial response of
S. aureus after exposure to antimicrobial agents. Such an approach
has the potential to allow both the sensitivity and mechanism of
resistance to be rapidly determined from isolated bacterial strains.
Methods: mRNA was extracted from a selection of S. aureus iso-
lates either with or without 30 min exposure to antimicrobial
agents (including oxacillin and mupirocin). The mRNA extracted
was then used to produce labelled nucleic acid suitable for
hybridisation to a low-density ﬂow through oligonucleotide array
targeting speciﬁc genes. These arrays are suitable for high
throughput screening and provide very rapid hybridisation kinet-
ics.
Results: Distinctive changes in mRNA levels were detected for
each agent tested and for isolates with different phenotypic sus-
ceptibilities. Oxacillin resulted in a signiﬁcant increase in the lev-
els of penicillin binding protein 2 (PBP2) mRNA in both
sensitive and resistant isolates and an increase in the levels of
PBP2prime mRNA in resistant isolates only. In contrast mupiro-
cin resulted in very high levels of ile-tRNA synthetase in both
strains with high- or low-level mupirocin resistance but not in
sensitive strains.
Conclusion: Future developments in RNA extraction and labelling
as well as the increased availability of DNA array technology will
allow this approach to be more widely used. This and similar
methods have the potential to provide information on both the
resistance phenotype of the isolate and the mechanism of resist-
ance, in contrast to ‘classical’ molecular tests for drug resistance
which generally target known genotypes.
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